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Abstract 
Kallmann syndrome (KS) is a human genetic disorder characterised by 
delayed/absent pubertal development, associated with lack of olfaction. KS is 
proposed to result from disrupted migration and targeting of olfactory sensory axons 
and hypothalamic gonadotrophin releasing hormone (GnRH1) neurons during early 
embryogenesis. Mutations in anosmin-1 (KAL1), fibroblast growth factor receptor 1 
(FGFR1) and fibroblast growth factor 8 (FGF8) are responsible for some cases of 
KS. Previously, in ex vivo human GnRH neuroblast culture, anosmin-1 was shown 
to enhance FGFR1 signalling in an FGF-dependent manner. Here, using a zebrafish 
in vivo system, the biological functions of anosmin-1- and FGF-mediated signalling 
during olfactory and GnRH system development have been investigated.  
Characterisation of the zebrafish GnRH system, and the role of olfactory 
axonogenesis in its development, was aided by the generation of a transgenic 
reporter line: pGnRH3:mCherry. Two notable mCherry populations were visualised 
by 36 hours post-fertilisation (hpf): the well-characterised terminal nerve cells, and 
an early, hitherto unreported, hypothalamic cluster of cells.  
Antisense morpholino approaches were used to demonstrate that knocking 
down both Kal1a and Kal1b genes, the two zebrafish KAL1 orthologues, caused 
noticeable deficiency in the number of olfactory sensory neurons accurately 
projecting to the olfactory bulbs, concomitant with disruption in the terminal nerve 
GnRH cells and presence of fewer presumptive hypothalamic GnRH cells by 36hpf. 
Moreover, there was a notable failure in formation of one or both of the two 
forebrain commissures in these morphants. In parallel experiments, knocking down 
one of the two FGF8 orthologues, Fgf8a, or specific temporal pharmacological 
inhibition of FGFR signalling at 14-22hpf, resulted in similar phenotypes by 36hpf. 
Interestingly, co-injection of Kal1a/Kal1b and Fgf8a morpholinos at concentrations 
which would give no phenotype individually was able to replicate the commissural 
mutant phenotype. Combined, these data strongly suggest that Kal1a/Kal1b may act 
via the Fgf8a pathway in vivo.  
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“Nothing is more memorable than a smell. One scent 
can be unexpected, momentary and fleeting, yet conjure up 
a childhood summer beside a lake in the mountains.” 
 
Diane Ackerman  
 
 
 
 
 
 
 
 
 
  
  
6 
 
Table of Contents 
 
Abstract ......................................................................................... 3 
Acknowledgements ....................................................................... 4 
Table of Contents ......................................................................... 6 
Figure list ..................................................................................... 13 
Table list ...................................................................................... 17 
Abbreviations .............................................................................. 18 
Chapter 1: Introduction ............................................................ 20 
1.1  Kallmann Syndrome ........................................................... 20 
1.2  Human reproductive axis ................................................... 21 
The onset of puberty ......................................................................................................... 21 
1.3  Human olfactory & vomeronasal systems ........................ 25 
Odorant detection .............................................................................................................. 25 
Olfactory system development and regeneration .............................................................. 25 
Pheromone detection ......................................................................................................... 28 
1.4  An olfactory origin for GnRH neurons ............................. 29 
GnRH neuronal migration in the mouse forebrain ............................................................ 31 
Evidence from an aborted X-KS embryo .......................................................................... 31 
1.5  The known KS genetic loci ................................................. 34 
KAL1 (anosmin-1) ............................................................................................................. 34 
KAL2 (FGFR1) ................................................................................................................. 35 
FGF8 (KAL6) .................................................................................................................... 43 
NELF ................................................................................................................................. 45 
PKR2 (KAL3) and PK2 (KAL4) ........................................................................................ 46 
CHD7 (KAL5) ................................................................................................................... 47 
Non-KS loci ...................................................................................................................... 48 
1.6  The role of anosmin-1 in KS .............................................. 49 
In vitro and ex vivo analyses ............................................................................................. 49 
  
7 
 
In vivo studies ................................................................................................................... 50 
Invertebrate X-KS model (fruitfly & nematode worm) ................................................. 50 
Vertebrate X-KS model (rodents, chicken, fish) ............................................................ 54 
Chicken anosmin-1 ........................................................................................................ 55 
Zebrafish/medaka anosmin-1 ....................................................................................... 56 
The advantages of a zebrafish model ........................................................................... 56 
1.7  The role of FGF signalling in forebrain development ..... 58 
1.8  Anosmin-1 modulates FGF signalling ............................... 61 
1.9  Aims of thesis ....................................................................... 69 
Chapter 2: Materials & Methods ............................................. 70 
2.1  Buffers and solutions .......................................................... 70 
2.2  Animals ................................................................................. 72 
2.2.1  Adult zebrafish ........................................................................................................ 72 
2.2.2  Harvesting zebrafish & medaka embryos ............................................................... 72 
2.2.3  Chicken embryos .................................................................................................... 72 
2.3  Immunohistochemistry of whole embryos ........................ 73 
2.3.1  The standard protocol ............................................................................................. 73 
2.3.2  Anti-GnRH (LRH13) .............................................................................................. 75 
2.3.3  Anti-anosmin-1a/-1b and anti-pERK ...................................................................... 75 
2.3.4  Anti-acetylated tubulin ............................................................................................ 76 
2.3.5  Cryostat sections ..................................................................................................... 76 
2.3.6  Vibratome sections .................................................................................................. 76 
2.4  In situ hybridisation for whole embryos ........................... 77 
2.4.1  DIG-labelled probe synthesis .................................................................................. 77 
2.4.2  Embryo fixation and dehydration ........................................................................... 77 
2.4.3  Hybridisation with RNA probe ............................................................................... 78 
2.4.4  Incubation with anti-DIG antibody ......................................................................... 78 
2.5  Molecular biology techniques ............................................ 79 
2.5.1  DNA electrophoresis ............................................................................................... 79 
2.5.2  Genomic DNA extraction from zebrafish embryos ................................................ 79 
2.5.3  RNA extraction from zebrafish embryos ................................................................ 79 
  
8 
 
2.5.4  cDNA synthesis ...................................................................................................... 80 
2.5.5  Polymerase chain reaction (PCR) ........................................................................... 80 
2.5.6  DNA digestion by restriction endonucleases .......................................................... 82 
2.5.7  Plasmid ligation, transformation, and purification .................................................. 82 
2.6  Cloning strategies ................................................................ 83 
2.6.1  Constructing pGnRH3:mCherry ............................................................................. 83 
- PCR amplification of the GnRH3 promoter ................................................................. 83 
- Cloning mCherry into I-SceI plasmid ........................................................................... 83 
- Cloning GnRH3 promoter into the I-SceI-mCherry plasmid ........................................ 84 
2.6.2  Sub-cloning pOMP:TauEGFP transgene into I-SceI vector ................................... 84 
2.6.3  Cloning Kiss1, Kiss2, Gpr54a, Gpr54b into pBUT3 and hsp70l:MCS-IRES-EGFP 
plasmid .............................................................................................................................. 84 
2.6.4   Cloning Kal1a and Kal1b into pBUT3 plasmid ..................................................... 86 
2.7  In vitro transcription of Kiss1, Kiss2, Gpr54a, Gpr54b, 
Kal1a, and Kal1b ......................................................................... 86 
2.7.1  „Capped‟ mRNA synthesis ..................................................................................... 86 
2.7.2  mRNA purification & quantification ...................................................................... 86 
2.8  Zebrafish embryo micro-injections ................................... 87 
2.8.1  Plasmid DNA micro-injection ................................................................................ 87 
Generating stable transgenic zebrafish (the I-SceI meganuclease approach) .............. 88 
Transient transgenesis .................................................................................................. 88 
2.8.2  RNA micro-injection ............................................................................................. 88 
2.8.3  Morpholino micro-injection ................................................................................. 89 
2.9  Lypophilic dye lineage tracing (DiI, DiD, and DiO) ........ 89 
2.10  FGFR inhibition strategies ............................................... 92 
2.10.1  Using SU5402 inhibitors ....................................................................................... 92 
2.10.2  Heat–shock using dnFGFR ................................................................................... 92 
2.11  Western blotting (immunoblotting) ................................ 93 
2.12  Microscopy ......................................................................... 93 
Chapter 3: Results (I) ................................................................. 94 
3.1  Introduction ......................................................................... 94 
  
9 
 
3.1.1  The zebrafish GnRH neuronal system .................................................................... 94 
Hypophysiotropic GnRH system .................................................................................... 95 
Terminal nerve GnRH system ........................................................................................ 97 
3.1.2  Zebrafish GnRH system development: controversial origins ................................. 97 
3.1.3  Two „waves‟ of GnRH neuronal migration ............................................................ 98 
3.1.4  The zebrafish olfactory system ............................................................................... 99 
3.1.5  Aims of this chapter .............................................................................................. 101 
3.2  Results................................................................................. 102 
3.2.1  GnRH expression in the zebrafish: from embryogenesis to adulthood ................. 102 
Adult GnRH immuno-expression ................................................................................ 102 
Embryonic GnRH immuno-expression ........................................................................ 102 
GnRH3 & GnRH2 mRNA expression ............................................................................ 106 
3.2.2  GnRH expression in another teleost (medaka fish) and an amniote (the chick) ... 108 
3.2.3  Generation and characterisation of a zebrafish pGnRH3:mCherry reporter line .. 109 
3.2.4  The relationship between olfactory axonogenesis and early GnRH system 
development .................................................................................................................... 119 
3.2.5  An olfactory placodal origin for the hypothalamic GnRH cells? ......................... 127 
3.2.6  Over-expression of Kiss1/-2 and Gpr54a/-b had no affect on embryonic GnRH 
immuno-expression at the hypothalamus ........................................................................ 130 
3.3   Discussion .......................................................................... 134 
3.3.1  GnRH protein/ transcript is absent in the hypothalamus during early 
embryogenesis. ............................................................................................................... 134 
3.3.2  The differences in GnRH neuronal ontogeny of amniotes compared with teleost 
fish .................................................................................................................................. 137 
3.3.3  pGnRH3:mCherry embryos recapitulate normal terminal nerve GnRH expression 
and also label a novel early hypothalamic population .................................................... 139 
3.3.4  Olfactory and terminal nerve GnRH3 axons are apparently closely associated, and 
there is some evidence for olfactory epithelium-derived GnRH3 cells .......................... 146 
3.3.5  Embryonic upregulation of kisspeptin signalling does not induce early 
hypothalamic GnRH protein expression ......................................................................... 149 
3.4 Conclusions ......................................................................... 151 
3.5 Future prospects ................................................................. 157 
Chapter 4: Results (II) ............................................................. 159 
4.1  Introduction ....................................................................... 159 
  
10 
 
4.1.1  Zebrafish have two FGFR1 & FGF8 orthologues ................................................ 159 
4.1.2  Expression of Fgfr1a/Fgfr1b and Fgf8a/Fgf8b during zebrafish brain development
 ........................................................................................................................................ 160 
4.1.3  The role of Fgf signalling during zebrafish forebrain development ..................... 161 
4.1.4 Fgfr1 during mammalian forebrain development .................................................. 163 
4.1.5  Role of Fgf8 during mammalian forebrain development ...................................... 163 
4.1.6  Evolutionary conservation of the FGF8/FGFR1 signalling pathway during 
forebrain development .................................................................................................... 165 
4.2   Results ............................................................................... 168 
4.2.1  In situ hybridisation expression analysis of members of the Fgf signalling pathway 
during olfactory axonogenesis and forebrain commissure formation ............................. 168 
Fgfr1a, Fgfr1b, Fgfr2, Fgfr3, and Fgfr4 ....................................................................... 168 
Fgf8a, Fgf8b, and Fgf3 ................................................................................................ 169 
4.2.2 Expression of Fgf downstream modulators during olfactory & GnRH neuronal 
development .................................................................................................................... 172 
4.2.3 Modulation of FGFR signalling by SU5402 inhibition and dominant negative 
approaches ...................................................................................................................... 175 
Forebrain commissure phenotype .............................................................................. 178 
Olfactory and vomeronasal axonal phenotype ........................................................... 180 
GnRH3 neuronal phenotype ........................................................................................ 185 
4.2.4  Modulation of Fgf8a & Fgf8b: olfactory, GnRH, and forebrain commissure 
phenotype ........................................................................................................................ 185 
Fgf8a (‘ace’) mutants .................................................................................................. 185 
Fgf8a & Fgf8b knockdown by morpholinos ................................................................ 189 
4.3   Discussion .......................................................................... 193 
4.3.1  Fgf8a, Fgf3, and all five Fgf receptors have expression profiles consistent with 
their putative roles during forebrain commissure formation & olfactory axonogenesis . 193 
4.3.4  Identification of active Fgf signalling during olfactory/vomeronasal axonogenesis 
and GnRH neuronal specification ................................................................................... 203 
4.3.5  Early inhibition of FGFR signalling causes abnormal olfactory & vomeronasal 
axonogenesis, as well as defects in GnRH system formation ......................................... 205 
4.3.6  Fgf8a is an important ligand for olfactory & GnRH neuronal development ........ 208 
4.4   Conclusions ....................................................................... 210 
4.5  Future prospects ................................................................ 224 
Chapter 5: Results (III) ........................................................... 227 
  
11 
 
5.1  Introduction ....................................................................... 227 
5.1.1  Zebrafish have two KAL1 orthologues: Kal1a & Kal1b ....................................... 228 
5.1.2  A role for Kal1a in teleost fish GnRH system development ................................. 228 
5.1.3  A role for Kal1a in zebrafish olfactory system development ............................... 230 
5.1.4  Aims of this chapter .............................................................................................. 231 
5.2  Results................................................................................. 232 
5.2.1  Kal1a and Kal1b expression during head development ........................................ 232 
In situ hybridisation expression analysis of Kal1a and Kal1b ...................................... 232 
Immuno-expression of anosmin-1a and anosmin-1b in the olfactory epithelium and 
pituitary ....................................................................................................................... 234 
5.2.2  Knocking down Kal1a and Kal1b using translation-blocking morpholinos ......... 237 
Knockdown is incomplete ............................................................................................ 237 
Subtle olfactory and commissural defects .................................................................. 239 
5.2.3  Kal1a and Kal1b over-expression causes no observable forebrain defects .......... 244 
5.2.4  Knocking down Kal1a and Kal1b using splice-blocking morpholinos which target 
the loss of exon 4 ............................................................................................................ 246 
5.2.5  Exon-6-targetted splicing-blockers: confirming the specificity of the phenotypes 
caused by loss of exon 4 ................................................................................................. 263 
High knock-down efficiency confirmed by RT-PCR ..................................................... 264 
5.2.6  Testing the hypothesis that Kal1a and Kal1b act through the Fgf8a signalling 
pathway in vivo ............................................................................................................... 266 
5.3  Discussion ........................................................................... 271 
5.3.1  Anosmin-1a and anosmin-1b are both expressed in the olfactory epithelium region 
during early embryogenesis ............................................................................................ 271 
5.3.2  Anosmin-1b is highly expressed in the presumptive pituitary during early 
embryogenesis ................................................................................................................ 273 
5.3.3  Translation-blocking morpholinos against Kal1a & Kal1b show incomplete 
knockdown, resulting in only subtle olfactory/ commissural defects ............................. 274 
Incomplete knockdown............................................................................................... 274 
GnRH3 neuronal phenotype apparently normal ........................................................ 276 
Subtle defects in olfactory axonogenesis and forebrain commissure formation ....... 277 
5.3.4  Kal1a/ Kal1b over-expression causes no observable defects in olfactory, GnRH, or 
forebrain commissure phenotype .................................................................................... 277 
5.3.5  Using exon-4 targeted splice-blocking morpholinos against Kal1a & Kal1b 
resulted in very efficient knockdown .............................................................................. 279 
  
12 
 
Disrupted terminal nerve GnRH cells, concomitant with a decrease in hypothalamic 
GnRH cell number by 36hpf ........................................................................................ 280 
Olfactory and vomeronasal projections are missing or mis-projected ....................... 284 
Anterior commissure does not form correctly- phenocopying the Fgf8a morphants . 288 
5.3.6  Olfactory, GnRH, and commissure phenotypes were confirmed by a second pair of 
morpholinos against Kal1a and Kal1b ............................................................................ 290 
5.3.7  Kal1a/Kal1b may be acting via the Fgf8a signalling pathway in vivo during 
embryogenesis ................................................................................................................ 291 
5.4 Conclusions ......................................................................... 294 
5.5 Future prospects ................................................................. 297 
Chapter 6: Final Conclusions.................................................. 300 
References ................................................................................. 307 
Appendix ................................................................................... 322 
Publications, presentations & awards .................................... 326 
Chapter 1: Introduction 
 
 
13 
 
Figure list 
                                                                                                                             Page: 
Figure 1.01   The hypothalamic-pituitary-gonadal  (HPG) axis..........................22-23 
Figure 1.02   Organisation of the human olfactory system..................................26-27 
Figure 1.03   GnRH neuronal migration in the mouse forebrain...............................32 
Figure 1.04   Evidence from an aborted embryo with X-linked KS..........................33 
Figure 1.05   The structure of anosmin-1..................................................................36 
Figure 1.06   FGF ligand structure and phylogeny ...................................................39 
Figure 1.07   Structure of FGFR1 and its KS-associated mutations..........................40 
Figure 1.08   FGF receptor downstream signal transduction ...................................42 
Figure 1.09   Differential splicing of the human FGF8 gene....................................44 
Figure 1.10   Phylogenetic tree of the KAL1 gene...............................................51-52 
Figure 1.11   A role for anosmin-1 in neurite outgrowth via FGFR1 signalling ......62 
Figure 1.12   Anosmin-1 & FGFR1 expression during human olfactory and GnRH 
neuronal development....................................................................................64 
Figure 1.13   Putative model for the dual role of anosmin-1 in inhibiting and 
stimulating FGFR1 signalling.......................................................................65 
Figure 1.14   Anosmin-1 and FGFR1 expression in the olfactory system and rostral 
forebrain during human embryogenesis………………………………67-68 
------ 
Figure 2.01   I-SceI plasmid constructs for transgenesis...........................................85 
Figure 2.02   The two types of morpholino...............................................................91 
------ 
Figure 3.01   Vertebrate GnRH neuronal system......................................................96 
Figure 3.02   Zebrafish olfactory system development...........................................100 
Figure 3.03   GnRH immuno-expression in the adult zebrafish brain.....................103 
Figure 3.04   GnRH immuno-expression during zebrafish embryonic 
development.................................................................................................105 
Figure 3.05   Zebrafish GnRH3 & GnRH2 in situ hybridisation expression 
analysis........................................................................................................107 
Figure 3.06   GnRH immuno-expression in another teleost (medaka fish) and an 
amniote (the chick)......................................................................................110 
Chapter 1: Introduction 
 
 
14 
 
Figure 3.07   Transient expression of medaka pGnRH1:GFP and pGnRH3:GFP  
reporter constructs in the zebrafish..............................................................111 
Figure 3.08   Generation of a zebrafish pGnRH3:mCherry reporter line................112 
Figure 3.09   Temporal characterisation of  the pGnRH3:mCherry stable transgenic 
line........................................................................................................114-115 
Figure 3.10   Confirming regional identity for the presumptive hypothalamic 
population  in G3MC...................................................................................117 
Figure 3.11   mCherry expression in an adult G3MC brain....................................118 
Figure 3.12   Generation of a zebrafish olfactory reporter line...............................120 
Figure 3.13   Co-development of the G3MC terminal nerve and OMPG olfactory 
projections............................................................................................122-123 
Figure 3.14    Terminal nerve GnRH axons project across the anterior 
commissure..................................................................................................125 
Figure 3.15   Co-development of the G3MC terminal nerve and pTRPC2:Venus 
vomeronasal projections..............................................................................126 
Figure 3.16   The terminal nerve G3MC cells do not co-express a migrating neural 
crest marker.................................................................................................128 
Figure 3.17   An olfactory epithelium origin for hypothalamic G3MC cells could not 
be confirmed by external application of lypophilic tracer dye, DiI............129 
Figure 3.18   Expression analysis of Kiss1, Kiss2, Gpr54a and Gpr54b................131 
Figure 3.19   Over-expression of Kiss1, Kiss2, Gpr54a, and Gpr54b  does not lead to 
any noticeable changes in GnRH immuno-labelling...................................133 
Figure 3.20   „Two wave‟ model for hypothalamic GnRH neuronal migration/ 
accumulation during zebrafish embryogenesis............................................143 
------ 
Figure 4.01   The zebrafish forebrain commissures................................................162 
Figure 4.02   Formation of the zebrafish forebrain commissures...........................164 
Figure 4.03   The proposed role of Fgf8 in mouse olfactory neurogenesis............166 
Figure 4.04   Fgf receptor expression during olfactory and commissural 
axonogenesis........................................................................................170-171 
Figure 4.05   Fgf8a, Fgf8b, and Fgf3 ligand expression during olfactory and 
commissural axonogenesis..........................................................................173 
Chapter 1: Introduction 
 
 
15 
 
Figure 4.06   Expression of FGFR downstream signalling markers during olfactory 
and commissural axonogenesis...................................................................174 
Figure 4.07   phosphoERK immuno-labelling in the zebrafish forebrain.............176 
Figure 4.08   Diagram illustrating plan for FGFR inhibition using SU5402.........177 
Figure 4.09   FGFR inhibition using SU5402: forebrain commissure 
phenotype.....................................................................................................179 
Figure 4.10   FGFR inhibition: using the dominant negative FGFR approach.....181 
Figure 4.11   FGFR inhibition using SU5402: olfactory phenotype.......................183 
Figure 4.12   FGFR inhibition using SU5402: vomeronasal phenotype................184 
Figure 4.13   FGFR inhibition using SU5402: GnRH (G3MC) phenotype............186 
Figure 4.14   Do Fgf8a mutants (ace) have GnRH defects?...................................188 
Figure 4.15   Using morpholinos to knock down both Fgf8a and Fgf8b...............191 
Figure 4.16   The role of glial bridges during zebrafish forebrain commissure 
formation.....................................................................................................197 
Figure 4.17   A model for the proposed mechanism of olfactory bulb 
morphogenesis.............................................................................................211 
------ 
Figure 5.01   Zebrafish anosmin-1a & anosmin-1b.................................................229 
Figure 5.02   Kal1a & Kal1b in situ hybridisation expression analysis..................233 
Figure 5.03   Anosmin-1a & anosmin-1b immuno-expression during head 
development.................................................................................................235 
Figure 5.04   Anosmin-1b immuno-expression in the pituitary..............................236 
Figure 5.05   Confirmation of Kal1a & Kal1b knockdown by translation-blocking 
morpholinos.................................................................................................238 
Figure 5.06   Morphant phenotypes for translation-blocking morpholinos targeted 
against Kal1a and Kal1b......................................................................240-241 
Figure 5.07   Glomerular map of a zebrafish olfactory bulb...................................243 
Figure 5.08   Kal1a and Kal1b over-expression causes no observable defects......245 
Figure 5.09   Schematic diagram illustrating the mechanism for splice-blocking 
morpholino gene-targeted knockdown........................................................247 
Figure 5.10   Confirming knockdown of Kal1a and Kal1b by exon-4-targetted 
splice-blocking morpholinos.......................................................................248 
Chapter 1: Introduction 
 
 
16 
 
Figure 5.11   Demonstrating the efficiency of KA4 or KB4 morpholinos in 
individual morphant embryos......................................................................250 
Figure 5.12   GnRH (G3MC) phenotype for KA4+KB4 morphants at 36hpf.......252 
Figure 5.13   G3MC phenotype for KA4+KB4 morphants at 60hpf ......................254 
Figure 5.14   Olfactory (OMPG) phenotype for KA4 and KB4 morphants at 
36hpf............................................................................................................255 
Figure 5.15   Vomeronasal phenotype for KA4 and KB4 morphants at 36hpf.......258 
Figure 5.16   Olfactory and vomeronasal phenotype for KA4 and KB4 morphants at 
60hpf............................................................................................................259 
Figure 5.17   Forebrain commissural phenotype for KA4 and KB4 morphants at 
36hpf and 60hpf ..........................................................................................262 
Figure 5.18   Confirming knockdown of Kal1a and Kal1b by a second set of splice-
blocking morpholinos: targeted loss of exon 6............................................265 
Figure 5.19   KA6 and KB6 replicate the phenotypic aspects of KA4 and KB4 
knockdown...................................................................... ............................267 
Figure 5.20   Testing the hypothesis that Kal1a/Kal1b act through the Fgf8a 
signalling pathway in vivo...........................................................................269 
Figure 5.21   The additive effect of Fgf8a & Kal1a/Kal1b in AC formation........292 
------ 
Figure A1   Anosmin-1a & anosmin-1b immuno-reactivity in the pronephric 
duct..............................................................................................................324 
Figure A2   Anosmin-1a/anosmin-1b immuno-expression in the nasal 
compartment............................................................................................................325 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
 
17 
 
Table list 
 
Table 1.1   Human syndromes with FGFR/FGF mutations.......................................37 
Table 1.2   FGFR knockout mouse phenotype..........................................................59 
------ 
Table 2.1   Primary antibodies...................................................................................74 
Table 2.2   Primer sequences.....................................................................................81 
Table 2.3   Morpholino sequences.............................................................................90 
------ 
Table A1   Optimising the morpholino concentrations...........................................322 
Table A2   Optimising the mRNA concentrations..................................................323 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
 
18 
 
Abbreviations 
 
AC: anterior commissure 
CNS: central nervous system 
coMO: Control MO  
DAB: (3,3′-Diaminobenzidine) 
dnFGFR:  dominant negative FGFR  
ECM: extracellular matrix 
FGFR1:  fibroblast growth factor receptor 1 
FGF8: fibroblast growth factor 8  
FSH: follicle-stimulating hormone 
G3MC: pGnRH3:mCherry  
GFP: green fluorescent protein  
GnRH: gonadotrophin releasing hormone  
HH: hypogonadotrophic hypogonadism 
Hpf: hours post fertilisation  
HPG: hypothalamic-pituitary-gonadal axis 
HS: heparan sulphate 
HSPG: HS proteoglycan 
KS: Kallmann syndrome 
KWT: King‟s wild-type 
LH: luteinising hormone 
MAPK: classic mitogen-activated protein kinase (Erk1/2) 
MHB: mid-hindbrain 
Chapter 1: Introduction 
 
 
19 
 
MO: morpholino 
MYA: million years ago 
OB: olfactory bulb 
OE: olfactory epithelium 
OECs: olfactory ensheathing cells  
OMPG:  pOMP:TauEGFP transgene 
OP: olfactory placode 
OR: odorant receptor 
ORNs: olfactory receptor neurons 
PCR: polymerase chain reaction 
pERK: phosporylated Erk1/Erk2 
PI3K: phosphoinositide 3-kinase 
PLLP: posterior lateral line primordium 
POC: post-optic commissure 
PK: Proteinase K  
PTU: phenylthiourea 
RT: room temperature 
sbMO: splice-blocking MO 
SPR: surface plasmon resonance  
tbMO: translation-blocking MO 
VNN: vomeronasal nerve  
VNO: vomeronasal organ  
VRNs: vomeronasal receptor neurons 
X-KS: X-linked KS 
Chapter 1: Introduction 
 
 
20 
 
 
Chapter 1 
Introduction 
 
Chapter 1: Introduction 
1.1  Kallmann Syndrome  
Kallmann syndrome (KS) is a developmental genetic disorder that affects 
about 1 in 8,000 males and 1 in 40,000 females (Hu et al., 2003). The defining 
clinical features of KS are hypogonadotrophic hypogonadism (HH; failure of 
pubertal development) combined with an absent or deficient sense of smell 
(anosmia/ hyposmia).  
KS is named after Franz Josef Kallmann (Kallmann et al., 1944), who, in 
1944, demonstrated the genetic transmission of HH with anosmia in three different 
families; but it is Aureliano Maestre de San Juan (Maestre de San Juan, 1856) who 
was first to publish a report on KS back in 1856: an autopsy finding of a 
hypogonadal man with small testes and absent olfactory bulbs.  
In KS, anosmia and HH result from olfactory bulb dysgenesis and 
hypothalamic gonadotrophin releasing hormone (GnRH) deficiency, respectively. 
These combined defects are proposed to result from disrupted migration and 
targeting of olfactory sensory axons and hypothalamic GnRH neurons during early 
embryogenesis (MacColl et al., 2002).  
KS patients can be brought through puberty, with gonadotrophin or GnRH 
therapy, and may subsequently gain normal fertility; but, there is no treatment for 
the reversal of anosmia (Cadman et al., 2007). Moreover, the HH may occasionally 
be reversible (Pitteloud et al., 2005; see below). 
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1.2  Human reproductive axis 
In humans, pulsatile release of hypothalamic GnRH is essential for the 
correct functioning of the hypothalamic-pituitary-gonadal (HPG) axis. At the 
hypothalamus, GnRH is secreted into the hypophyseal portal circulation of the 
median eminence, where it activates the GnRH receptor (GnRHR1), expressed by 
the anterior pituitary gonadotrophs, thereby stimulating expression, synthesis and 
secretion of the two pituitary gonadotrophins: luteinising hormone (LH) and 
follicle-stimulating hormone (FSH) into the systemic bloodstream. LH and FSH 
then stimulate steroid production and gametogenesis in both sexes. Refer to Figure 
1.01 for an illustration of the HPG axis and further discussion on its role in the 
acquisition of secondary sexual characteristics at the time of puberty and the 
maintenance of reproductive competence thereafter. 
Production of gonadotrophins and resulting reproductive competence are 
therefore dependent on correct development and coordinate functioning of 
hypothalamic GnRH-secreting cells and pituitary gonadotrophs. HH is a disorder of 
the reproductive axis presenting as complete or partial failure of secondary sexual 
development at the time of puberty. In the clinic, HH is most typically characterised 
by abnormally low levels of the gonadotrophins in the systemic bloodstream, in the 
presence of low or undetetctable circulating sex steroid concentrations (Achermann 
et al., 2001; Silveira et al., 2002). 
 
The onset of puberty 
Postnatally, in the male, GnRH secretion is temporarily activated (for 3-6 
months), but then remains quiescent until the onset of puberty, when the HPG axis 
is reawakened and secondary sexual maturation begins (Cadman et al., 2007). In 
recent years it has been demonstrated that it is the kisspeptin-GPR54 signalling 
pathway that plays a significant role in determining the actual time that GnRH 
secretion is re-activated at the time of pubertal onset. 
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Figure 1.01   The hypothalamic-pituitary-gonadal  (HPG) axis
INSET: Summary of the HPG axis: GnRH, secreted by the hypothalamus acts
on the anterior pituitary, causing it to release LH and FSH into the systemic
bloodstream, which act on the gonads. Direction of hormone release is
indicated by green arrows.
The structure of the hypothalamic-pituitary region is depicted towards the top
right of the figure and the downstream effects on the gonads are depicted
towards the bottom left. The GnRH neurons (in green) secrete GnRH at the
median eminence into the hypophyseal network of capillaries which leads into
the anterior pituitary. Here the GnRH binds to its receptor on the gonadotrophs,
which stimulates these cells to secrete FSH and LH which pass into the efferent
veins and enter the systemic bloodstream. LH and FSH act on the gonads
(orange ovals) to bring about secondary sexual maturation at the time of
puberty and maintain subsequent reproductive competency. Specifically, LH
acts on the testes in men to induce testosterone production, which helps to
bring about the male secondary sexual characteristics at puberty (e.g.
deepening of voice, body/facial hair growth etc) and acts with FSH to bring
about spermatogenesis. In women, LH and FSH act on the ovaries to induce
oestrogen production which helps to bring about the female secondary sexual
characteristics (e.g. widening of hips and breast development) and ovulation.
GnRH= gonadotrophin-releasing hormone; LH= luteinising hormone; FSH=
follicle-stimulating hormone.
Figure 1.01 (overleaf) was assembled using two figures from the PhD thesis of Alexis
Robertson (Robertson, 2000)
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Systemic 
bloodstream
Summary:
Figure 1.01   The hypothalamic-pituitary-gonadal (HPG) axis
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           Kisspeptin, a 54-amino acid peptide derived from the KiSS1 gene product, is 
the natural ligand for GPR54, a previously „orphan‟ G-protein-coupled receptor. 
Shorter C-terminal derivatives of human kisspeptin, designated kisspeptin-14, -13, 
and -10, have similar high-affinity binding to GPR54 (Kotani et al., 2001).  
Intracerebroventricular kisspeptin-10 administration induces dramatic 
release of GnRH in sheep (Messager et al., 2005), and intracerebroventricular 
kisspeptin-10 administered to primates results in an immediate gonadotrophin surge 
(Plant et al., 2006). Gpr54 knockout mice (Seminara et al., 2003) fail to secrete FSH 
and LH in response to exogenous murine kisspeptin-15, despite having anatomically 
normal hypothalamic GnRH neurons, indicating that their hypogonadism results 
from abnormalities of GnRH neuronal secretion, and not defective GnRH neuronal 
migration (Messager et al., 2005).  
Intravenous kisspeptin injection has also been shown to stimulate LH, FSH, 
and testosterone secretion in human male volunteers (Dhillo et al., 2005). However, 
when infused continuously into male juvenile rhesus monkeys, human kisspeptin-10 
appeared to desensitise/downregulate Gpr54-induced GnRH release, as monitored 
indirectly by gonadotrophin release (Seminara et al., 2006). Kisspeptin-induced 
GPR54 signalling, in concert with other signalling pathways (e.g. leptin), is thus 
thought to be a major regulatory control point for GnRH release, and is likely to 
have a determining role in pubertal onset (Dhillo et al., 2005). 
These findings have significant potential therapeutic implications for a range 
of human reproductive conditions: for example, modulating GnRH secretion by 
pharmacological manipulation of the GPR54 system may provide a new avenue for 
altering reproductive competency in adults, in terms of fertility and contraception. 
See Chapter 3 for further discussion. 
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1.3  Human olfactory & vomeronasal systems 
Odorant detection 
The odours in the air which we perceive when we smell are detected by 
olfactory receptor neurons (ORNs), which occupy a small area in the upper part of 
the nasal epithelium, at the back of the nose (see Figure 1.02). Specifically, when 
odorant molecules (such as the scent of a flower) pass through our nose, they bind to 
their specific odorant receptor located on the cilia which project from the ORN into 
the nasal cavity. Once activated, these ORNs relay their signal (via their axons 
which traverse the cribriform plate of the ethmoid bone) to specific glomeruli in the 
olfactory bulbs. Within the glomerulus, the ORN nerve endings excite mitral cells 
within the olfactory bulb which forward the signal to higher regions of the brain, 
such as the olfactory cortex, where the olfactory information is then processed 
(Rinaldi, 2007). 
Every ORN expresses only one odorant receptor (OR). ORNs of the same 
type (expressing the same OR) are randomly distributed in the nasal epithelium, but 
converge on the same set of glomeruli within the olfactory bulb. The mouse has 
approximately 1200 ORs, whilst humans make do with less than 400. Each odorant 
is detected by a specific combination of ORs, and our brain then translates the 
„receptor code‟ for that odorant into a distinct smell, thus accounting for the ability 
of humans to detect a wide variety of exogenous olfactory ligands. Olfactory 
receptors, in fact, account for the greatest number of G-protein-coupled receptor 
genes within the human genome (Rinaldi, 2007). 
Olfactory system development and regeneration 
During the formation of the olfactory system, in early embryogenesis, 
olfactory axons traverse tiny pores in the cribriform plate and extend towards the 
olfactory bulb anlage, where they form synapses with dendrites of mitral cells 
within the glomerular layer. Mitral cell axons then extend to form the lateral 
olfactory tract which relays olfactory information to the piriform cortex (Rinaldi, 
2007). 
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Figure 1.02   Organisation of the human olfactory system
Odorant receptors are localised along the membrane of olfactory receptor
neurons (ORNs), which are located in a small area of the upper part of the
olfactory epithelium at the back of the nose. Each ORN expresses just one
specific type of odorant receptor, as represented by three different colours (red,
blue and green). Odorant molecules in the air bind to their specific receptor,
and, once activated, these ORNs then relay this signal to their specific
glomeruli within the olfactory bulb. ORNs of the same type are randomly
distributed in the olfactory epithelium, but their processes converge at the same
glomerulus within the olfactory bulbs. At each glomerulus, the ORN axons
excite mitral cells within the olfactory bulb which forward the odorant signal to
higher regions of the brain, including the olfactory cortex, where the olfactory
signals are interpreted.
Figure 1.02 (overleaf) reprinted by permission from Macmillan Publishers Ltd: EMBO Rep.
8, 629-633, Copyright 2007. Credit for original figure: Karolinska Institutet and Nobel
Foundation, Stockholm, Sweden.
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Figure 1.02   Organisation of the human olfactory system
Chapter 1: Introduction 
 
 
28 
 
           An interesting, and important, facet of the ORNs is their ability to regenerate 
throughout adult life due to a neurogenetic process which continually provides new 
primary sensory neurons at the olfactory epithelium (Graziadei and Graziadei, 
1979a; Graziadei and Graziadei, 1979b). Since the ORNs have an average lifespan 
of 6-8 weeks, in part due to inhalation of smoke and other air toxicants, it is 
essential that they are replaced regularly. New ORNs, which arise from the base of 
the olfactory epithelium, must project to one of the olfactory bulbs and re-establish 
functional synapses. Olfactory ensheathing cells (OECs) are a type of glial cell 
which helps to support and maintain extension of the ORN axons from within the 
olfactory epithelium to their targets in the olfactory bulbs. Due to their rare ability of 
being able to traverse both the peripheral and central nervous systems, OECs are 
being investigated for their potential usage during spinal cord repair (Ruitenberg et 
al., 2006; Raisman et al., 2010). Moreover, proteins, such as anosmin-1, which are 
thought to have a role in olfactory axonogenesis during development, may provide 
new avenues of research in the field of neural repair. 
 
Pheromone detection 
The vomeronasal organ (VNO) is located at the base of the nasal cavity in 
most mammals, where it has a role in pheromone detection. The vomeronasal 
receptor neurons (VRNs), analogous to the ORNs, project to the accessory olfactory 
bulb.  VRNs express their own array of distinct receptors, including, for example, 
the ion channel TRPC2, a member of the superfamily of transient receptor potential 
channels. TRPC2 is expressed on the microvilli of VRNs, where it plays an 
important role in the signal transduction of most, but not all, VRNs. Interestingly, 
TRPC2 has been completely lost from the human genome. However, TRPC2-
knockout mice have severe behavioural abnormalities, including a strong reduction 
in electrophysiological responses of the VRNs to urine and uncharacteristic 
indiscriminate courtship behaviour of male mice with females (Tirindelli et al., 
2009).  
Destruction of the main olfactory epithelium does not impair male hamster 
mating behaviour; however, specifically severing the VRN projections produced 
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severe sexual behavioural deficits in one-third of treated animals, whereas combined 
deafferentation of both vomeronasal and olfactory systems completely abolishes 
copulation in treated animals. The apparent importance of the vomeronasal system 
in these rodents makes it all the more surprising that humans seem to completely 
lack a clearly distinguishable VNO.  However, it has been proposed that humans can 
instead detect pheromones via their main olfactory epithelium (Tirindelli et al., 
2009). Moreover, there is evidence that the VNO does form during human 
embryogenesis, but then later regresses, as is the case with some other mammals 
including apes and bats (Smith et al., 2001).  
Pheromone receptors in the mammalian VNO are encoded by V1R and V2R 
gene superfamilies. All human V2R sequences so far identified have been shown to 
be pseudogenes; whilst only four of the approximately 200 V1R genes have 
demonstrably intact open reading frames in most human individual. This massive 
V1R pseudogenization observed in the human genome is believed to have begun 
shortly before the separation of the hominoids (i.e. humans and apes) from the Old 
World monkeys, most likely due to the reduced importance of vomeronasal 
pheromone communications. Therefore, it is unlikely that the putative remnant of 
the human vomeronasal system has any major role in modulating human 
reproductive activity, as it is believed to in the rodent species discussed above (Grus 
et al., 2005).  
 
1.4  An olfactory origin for GnRH neurons   
 
The migratory route of GnRH neurons from the nasal compartment to the 
hypothalamus was originally characterised using immunohistochemical 
comparisons at certain developmental stages from various model organisms 
(including the rat, mouse, chick, and, rarely, human embryos), assisted by DiI 
labelling and olfactory ablations. However, these characterisations have sometimes 
been complicated because several species have more than one GnRH gene (humans 
have two: GnRH1 and GnRH2), as well as two or more different GnRH-expressing 
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cell populations in the brain, some of which will probably not contribute directly to 
the regulation of pituitary gonadotrophin secretion (Tobet and Schwarting, 2006).  
Furthermore, immortalised GnRH cell lines, explants, and mouse head 
slices, and more recently, transgenic approaches, have also helped in our 
understanding of GnRH neuronal migration (Tobet and Schwarting, 2006). Mice 
and rats in which living GnRH neurons can be traced by GnRH1 promoter-driven 
green fluorescent protein (GFP) expression have allowed us to observe GnRH cell 
migration in real time (Kim et al., 2002). This transgenic technology has also been 
used more recently in two fish models: zebrafish and medaka (Palevitch et al., 2007; 
Okubo et al., 2006), which have the added advantage of producing transparent 
embryos that develop ex utero, permitting all developmental stages to be visualised 
more easily in living embryos. 
In most vertebrates, olfactory and GnRH neurons both originate from the 
nasal compartment, although the exact area of origin within the nasal compartment 
may vary in different species, including, most notably, the zebrafish (see chapter 3). 
The olfactory axons extend and establish contact with the olfactory bulb anlage on 
the telencephalon, a prerequisite for olfactory bulb morphogenesis (Graziadei and 
Monti Graziadei, 1986; Wray et al., 1989) and the GnRH neurons migrate into the 
hypothalamus (Schwanzel-Fukuda and Pfaff, 1989). These migratory steps are 
strictly regulated by specific spatiotemporal expression of certain axonal guidance 
cues, cell adhesion molecules and extracellular matrix (ECM) proteins, as well as 
specific transcription and growth factors and neurotransmitters that determine 
GnRH neuronal fate (Gonzalez-Martinez et al., 2004a). Specifically, the GnRH 
neurons are believed to migrate along a nasal mesenchymal scaffold of olfactory, 
vomeronasal and terminal nerves, expressing neural cell adhesion molecule 
(NCAM) along their central processes, prior to dispersing in the mediobasal part of 
the anterior hypothalamus, where they undergo terminal differentiation and GnRH 
secretion (Schwanzel-Fukuda et al., 1992). 
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GnRH neuronal migration in the mouse forebrain 
In the mouse, the hypothalamic GnRH cells originate anteriorly at the nasal 
compartment area, in and/or around the vomeronasal organ. During embryogenesis, 
these GnRH neurons appear to associate with the vomeronasal nerve (VNN) whilst 
it traverses the nasal septum- through the cribriform plate of the ethmoid bone 
towards the telencephalon. When it reaches its telencephalic target, the VNN then 
defasciculates, leaving the GnRH neurons to follow only a subset of VNN axons 
that take a more caudal and ventral route into the forebrain. Towards the terminal 
part of this migration, the GnRH cells separate from their guiding VNN axons and 
disperse at their final positions within the hypothalamus (Cariboni et al., 2007; 
Tobet and Schwarting, 2006). See Figure 1.03 for a schematic representation of this 
migratory process. 
This migratory route can be separated into at least three regions: (1) within 
the nasal compartment; (2) traversing the cribriform plate; and (3) within the 
forebrain (Cariboni et al., 2007). Each domain is equally important for the correct 
migration of the GnRH cells, and different guidance cues and signalling molecules 
may be present within each of these three individual domains. Deciphering 
molecular constituents of each domain, and the molecular changes which occur in 
the GnRH cells along their route, in response to these external cues, will be 
fundamental for understanding the complexities of GnRH neuron migration (see 
chapter 6 for further discussion). 
 
Evidence from an aborted X-KS embryo 
In 1989, Schwanzel-Fukuda et al. (Schwanzel-Fukuda et al., 1989) described 
a human foetus with X-linked KS (X-KS) whose GnRH neurons terminated in a 
tangle beneath the forebrain on the dorsal surface of the cribriform plate; suggesting 
that the HH in KS might result from a GnRH neuronal migratory defect. Since the 
initial differentiation and migration of olfactory and GnRH neurons appeared 
normal, it was proposed that the developmental defects seen in XKS patients result 
from abnormalities in subsequent axonal elongation, pathfinding, and/or terminal  
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Figure 1.03   GnRH neuronal migration in the mouse forebrain
Schematic diagram of the migratory route of GnRH neurons (green dots) from
their nasal placodal (NP) origin, close to the vomeronasal organ (VNO). From
here, the GnRH neurons can be visualised traversing along
olfactory/vomeronasal nerves (VNN) into the forebrain, in the proximity of the
olfactory bulbs (OB). Their migration then continues on into the basal
forebrain (BF), towards the hypothalamus, where they will finally reside.
During this migratory journey, the GnRH neurons traverse 3 distinct regions:
(1) the nasal compartment; (2) the nasal-forebrain junction; and (3) the basal
forebrain. The precise levels of specific guidance and signal molecules within
these 3 regions determines the correct targeting of the GnRH neurons along this
migratory route.
Figure 1.03 reprinted from Trends Neurosci. 30, Cariboni et al., ‘From nose to fertility: the
long migratory journey of gonadotropin-releasing hormone neurons’, pp.638-644, Copyright
2007, with permission from Elsevier.
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Figure 1.04   Evidence from an aborted embryo with X-linked KS
These diagrams illustrate the disruption to the olfactory and GnRH neuronal
pathways in an aborted 19-week human foetus with X-linked KS, based on
immunohistochemical analysis carried out by Schwanzel-Fukuda et al., in
1989. A: depicts normal co-development of the olfactory receptor neuronal
(ORN) pathway and GnRH neuronal ( ) migration from the olfactory
epithelium (OE), through the cribriform plate (CP), and on into the developing
forebrain. B: depicts a disrupted olfactory pathway in a 19-week aborted foetus
with a KAL1 mutation. The initial trajectory of the ORNs appears normal.
However, the ORN axons are abruptly arrested, along with the GnRH neurons
beneath the dura at the level of the cribriform plate; and the olfactory bulbs fail
to form.
Figure 1.04 is used with permission from the PhD thesis of Youli Hu (Hu, 2005)
A B
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differentiation. Briefly:  in the absence of olfactory nerve synaptogenesis with the 
olfactory bulb anlage, GnRH neurons are denied a navigational pathway towards the 
forebrain, explaining the deficiency of hypothalamic GnRH-secreting neurons in 
KS, as well as olfactory bulb dysgenesis (see Figure 1.04). However, this 
hypothesis remains to be fully tested and proven in vivo. 
 
 
1.5  The known KS genetic loci 
Application of conventional linkage studies in the investigation of the 
genetic basis of KS (as well as HH disorders in general) has proven difficult because 
of the rarity and infrequency of familial transmission, and because the pedigrees 
tend to be small as the majority of patients, without treatment, remain infertile 
(Cadman et al., 2007). Nonetheless, six KS-associated genes have been identified, 
accounting for approximately 30-40% of all KS cases (Dode and Hardelin, 2010). 
These include: KAL1 (OMIM
1
: 308700), KAL2 (FGFR1, OMIM: 147950), KAL3 
(PKR2, OMIM: 607123), KAL4 (PK2, OMIM: 607002), KAL5 (CHD7, OMIM: 
612370), and KAL6 (FGF8, OMIM: 612702).  
 
KAL1 (anosmin-1) 
KAL1, the gene responsible for X-linked KS, and the first KS-causative gene 
to be identified, in 1991, accounts for ~10% of total KS cases. The phenotype 
associated with KAL1 mutations varies significantly, even amongst monozygotic 
twins sharing the same mutation (Matsuo et al., 2000), emphasising the likely role 
of modifier genes, epigenetic factors and environmental factors in the penetrance of 
KAL1 mutations. Whilst the majority of patients with KAL1 mutations have HH and 
some degree of anosmia, other neurological and non-neurological symptoms may 
co-exist. Specifically, up to 30% of X-linked KS patients have a missing or 
                                                 
1
 OMIM: Online Mendelian Inheritance in Man 
(http://www.ncbi.nlm.nih.gov/omim) 
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malformed kidney (renal aplasia), and up to 75% have upper body mirror 
movements (bimanual synkinesis), suggesting that KAL1 has a significant role in 
these other important developmental processes (Kim et al., 2008). 
KAL1 is located on Xp22.3 and encodes a ~100kDa extracellular-matrix 
glycoprotein, anosmin-1. Anosmin-1 is a multi-domain protein consisting of an N-
terminal cysteine-rich region (Cys box), followed by a whey acidic protein-like 
(WAP) four disulphide core motif, four tandem fibronectin type III (FnIII) domains 
and a C-terminal histidine-rich region (see Figure 1.05A). The Cys box contains ten 
cysteine residues, resembling the cysteine-rich region of the insulin-like growth 
factor receptor (Hu et al., 2005). The eight cysteines of the WAP domain form four 
disulphide bonds, highly conserved throughout the serine protease inhibitors of the 
WAP protein family, which includes elafin, SLPI and PS20 (Hu et al., 2004). Large 
positively charged basic regions on the FnIII domains, particularly the first, were 
shown by surface plasmon resonance to be essential for high-affinity dose-
dependent binding of anosmin-1 to negatively charged heparan sulphate (HS) (Hu et 
al., 2004).  
Using X-ray scattering and analytical ultracentrifugation, along with 
constrained homology modelling, it has been shown that the six domains of 
anosmin-1 are extended with flexible inter-domain linkers (see Figure 1.05B), 
suggesting anosmin-1 may act as a platform for coordinate interaction with HS and 
its other biomacromolecular ligands (Hu et al., 2005). Further analysis of the 
expression and function of anosmin-1, including its interaction with the FGF 
signalling pathway, is discussed below. 
 
KAL2 (FGFR1) 
In 2003, loss-of-function mutations in fibroblast growth factor receptor 1 
(FGFR1; referred to as KAL2) were subsequently shown to account for another 
~10% of total KS cases (Dode et al., 2003). By contrast, gain-of-function mutations 
in FGFR1 had previously been shown to result in another disorder, craniosynostosis 
(see Table 1.1 for a summary of the human disorders that are known to be caused by 
mutations in the FGF receptors). Amongst patients with FGFR1 (loss-of-function)  
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Figure 1.05   The structure of anosmin-1
A: the domain-structure diagram of anosmin-1 comprising an N-terminal
secretory sequence (SS), Cysteine box (Cys), whey acidic protein-like motif
(WAP), and four fibronectin type III domains (FnIII-1 to -4), and a C-terminal
histidine-rich region (H). Lines underneath indicate amino acid positions; „Y‟s
indicate six putative N-glycosylation sites.
B:Illustrates the X-ray scattering solution structure best-fit model for
recombinant anosmin-1 using an unglycosylated α-carbon ribbon trace (RCSB
Protein Data Bank accession number 1zlg.). The domains are coloured as
follows: Cys-box, blue; WAP, green; FnIII-1, yellow; FnIII-2, red; FnIII-3, dark
blue; FnIII-4, orange. The linker peptides in this model are shown in purple.
Figure 1.05(B) reprinted from J. Mol. Biol. 350, Hu et al., ‘Extended and flexible domain
solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering,
analytical ultracentrifugation and constrained modelling’, pp553-570, Copyright 2005, with
permission from Elsevier.
A
B
*Drawn to relative scale
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Table 1.1  Human syndromes with FGFR/FGF mutations 
 
 
Gene 
 
Disease 
 
 
Common or characteristic mutations 
 
FGFR1 
 
Kallmann syndrome* 
 
Pfeiffer syndrome 
 
Osteoglophonic dysplasia 
 
 
Widespread (haploinsufficiency) 
 
P252R 
 
N330I, Y374C, C381R 
 
 
FGFR2 
 
Apert syndrome 
 
Crouzon/Pfeffer/Jackson-
Weiss/Antley-Bixler 
syndromes 
 
Beare Stevenson syndrome 
 
S252W, P253R 
 
D3, TKD**, D1 
 
 
Y375C, S372C 
 
 
FGFR3 
 
Muenke syndrome 
 
Hypochondroplasis 
Achondroplasia 
SADDAN*** 
thanatophoric dysplasia I 
thanatophoric dysplasia II 
 
Crouzon syndrome with 
acanthosis nigricans 
 
New syndrome 
 
P250R 
 
N540K 
G380R  
K650M 
R248C, Y373C 
K650E 
 
A391E 
 
 
R621H 
 
 
* Loss-of-function mutations (all other known disorders are believed  to result from 
gain-of-function FGFR mutations). **TKD= tyrosine kinase domain, *** Severe 
chondroplasia with developmental delay and acanthosis nigricans.  
Adapted from (Wilkie, 2005) 
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mutations, there is a high level of variability in the degree of HH with or without 
anosmia (i.e. they may have KS or isolated (normosmic) HH) (Pitteloud et al., 
2006). Moreover, as with KAL1 mutations, penetrance of KAL2 mutations varies 
considerably, even within the same kindred. Thus, Pitteloud et al. (Pitteloud et al., 
2005) have described 3 subjects from the same family who share an identical 
tyrosine kinase domain FGFR1 mutation, but each with a different phenotype. The 
pedigree comprised a male proband with KS (who later recovered from his HH), 
whose mother had delayed puberty and whose maternal grandfather had isolated 
anosmia. Patients with FGFR1 mutations may also present with cleft palate and 
dental agenesis, but do not normally present with renal agenesis or bimanual 
synkinesis, as these symptoms tend to be specific to those with KAL1 mutations 
(Kim et al., 2008). 
FGFR1 signalling has been known to play a wide-ranging role during 
embryogenesis, including promoting proliferation, differentiation and survival of 
neuronal stem cells and progenitor cells.  In humans, there are four known members 
of the FGFR family of receptor tyrosine kinases (FGFR1, FGFR2, FGFR3, and 
FGFR4), which specifically bind to particular members of the 22 FGF ligands (see 
Figure 1.06), in different cellular contexts. As well as requiring two FGF ligands, 
heparan sulphate (HS) is also essential for FGF receptor dimerisation and activation 
(Mohammadi et al., 2005; Eswarakumar et al., 2005).  
FGFRs consist of an extracellular region of three immunoglobulin (Ig)-like 
domains (D1, D2, and D3), a single transmembrane helix, and a cytoplasmic 
tyrosine kinase domain (see Figure 1.07). The D1-D2 linker region contains a 
stretch of negatively charged amino acids („the acid box‟), and there is a HS-binding 
site (HBS) within the first half of D2 (Mohammadi et al., 2005).  
Alternative splice variants exist for FGFR1-3. The common 'IIIa exon' (exon 
7) that encodes the first half of D3 can be spliced to either exon 8A or 8B, resulting 
in 'FGFR1 IIIb' and 'FGFR1 IIIc' isoforms. When neither 8A nor 8B is used, the 
result is a soluble 'FGFR1 IIIa' variant, reviewed in (Mohammadi et al., 2005). 
A specific mutation (L342S) which affects the IIIc isoform of FGFR1, was 
shown by surface plasmon resonance (SPR) analysis to reduce the binding affinity  
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Figure 1.06   FGF ligand structure and phylogeny
A: ribbon model of the FGF protein structure and folding, with contact sites
for the FGF receptor marked in red and those for heparan sulphate
proteoglycan marked in blue.
B: schematic diagram illustrating the seven mammalian FGF sub-families
(FGF1, FGF4, FGF7, FGF9, FGF8, FGF19, and FGF11) . FGF8 belongs to
the FGF8 subfamily, along with FGF17 and FGF18. Evolutionary affinities of
Ciona intestinalis (Ci) FgfL, the viral FGF radiation, Drosophila
melanogaster (Dme) branchless, pyramus and thisbe, and Caenorhabditis
elegans (Ce) EGL-17 are superimposed onto this diagram by dashed lines.
Figure 1.06 reprinted by permission from Macmillan Publishers Ltd: Nat. Rev. Neurosci. 8,
583-596, Copyright 2007.
A
B
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Figure 1.07   Structure of FGFR1 and its KS-associated mutations
Schematic domain-structure diagram of FGFR1. The protein (top) and the
corresponding exons (bottom) are shown. The extracellular regions of FGFR1
that have a role in autoinhibition or ligand binding are indicated (see main
text for further discussion). SP = Signal peptide; D1, D2, and D3 = the three
immunoglobulin-like domains; AB = acid box; HBS = HS binding site;
IIIb/IIIc refers to two major splice isoforms; TM = transmembrane helix, and
PTK refers to the intracellular protein tyrosine kinase domain. Some
characteristic KS-associated (loss-of-function) mutations are shown: missense
mutations are indicated by arrows; all other mutations are represented by
stars.
Figure 1.07 reprinted by permission from S. Karger AG, Basel: Cadman, S.M. et al: Horm
Res 2007;67:231-242.
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to FGF8 by 20 fold, compared with only a minor reduction in binding affinity for 
FGF1 and FGF2 (Pitteloud et al., 2007). Furthermore, mice homozygous for a 
hypomorphic Fgf8 allele lacked hypothalamic GnRH neurons, while heterozygous 
mice had far fewer hypothalamic GnRH neurons. Together, these data suggested 
that FGF8 could be an important ligand for FGFR1 during GnRH neuronal 
development, and has since been shown to be a KS-causative gene (Falardeau et al., 
2008) (see below). 
As with other receptor tyrosine kinases, FGFR1 plays a significant role in 
cell proliferation and differentiation, so its activity is therefore under tight 
regulation. According to the 'autoinhibition model', in quiescent cells, the acidic box 
may bind to the positively charged HBS, consequently bringing the D1 domain into 
a position that will interfere with HS and FGF ligand binding to the D2-D3 regions, 
resulting in a closed, autoinhibited state. The presence of FGF, which has a higher 
affinity for the D2-D3 ligand binding sites, is hypothesised to open up the closed 
configuration, making the HBS accessible to HS (the obligatory cofactor for 
functional activation of the whole signalling complex). In quiescent cells, 'closed' 
(autoinhibited) FGFR1 is in equilibrium with the 'open' (active) FGFR1 
configuration. Therefore, upon binding of HS and FGF, the equilibrium shifts 
towards the 'open' state and FGFR1 dimerises and becomes fully active. KS patients, 
whose loss-of-function mutations map to D1 or the acid box, may have a more 
autoinhibited FGFR1, thus disturbing the equilibrium and resulting in FGFR1 
signalling insufficiency (Eswarakumar et al., 2005; Schlessinger, 2003). 
Specific FGF ligands, along with precisely modified HS, bind to their target 
FGFR to form an „active‟ FGF/FGFR/HS signalling complex. This results in 
receptor dimerisation, followed by autophosphorylation of the receptor tyrosine 
residues on the intracellular kinase domain and activation of downstream signalling 
pathways (see Figure 1.08). Then, by recruitment of specific signalling and docking 
proteins, activated FGF receptors transmit their signal intracellularly, normally via 
one of three major downstream signalling cascades: classic mitogen-activated 
protein kinase (MAPK) (Erk1/2), phosphoinositide 3-kinase (PI3K) or via 
phospholipase C (PLC) activation; the last two are capable of activating protein 
kinase C (PKC) which in turn stimulates Erk1/2 signalling. As an example, in the  
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Figure 1.08   FGF receptor downstream signal transduction
Schematic diagram illustrating the downstream signalling events that occur
intracellularly after FGF ligand binding and receptor dimerisation. Adaptor
proteins such as the FRS2a/SOS/Grb2 complex are recruited to the tyrosine
kinase domains of the FGF receptor, initiating Ras activation, leading to Raf,
MEK and then ERK1/2 phosphorylation . Activation of Ras by other adapter
complexes leads to PI3K and p38/Jun kinase activation. Other downstream
cascades that are activated may include PLC, calcium signalling and
ubiquitinylation via Cbl proteins. Regulatory proteins such as MKP3
(intracellular) and Sef (membrane-localised) are indicated by blue and pink
boxes, respectively.
Figure 1.08 reprinted by permission from Macmillan Publishers Ltd: Nat. Rev. Neurosci. 8,
583-596, Copyright 2007.
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MAPK cascade, the FGF signal is transduced via RAS downstream of an FRS2-
SOS-Grb2 complex, culminating in the phosphorylation of Erk1/2 (also known as 
p42/44) which enters the nucleus and modulates transcription of specific target 
genes (see Chapter 4). This FGFR signalling is tightly-regulated by a multitude of 
endogenous agonists and antagonists, including anosmin-1 (see below) that may act 
both up- and downstream of the FGF receptor in order to regulate and maintain the 
fine-tuning of FGFR activity (Mason, 2007; Kim et al., 2008).  
Significantly, it was recently reported that mutations in SEF (Similar 
Expression as FGF; see Figure 1.08), a conserved transmembrane protein which 
potently inhibits FGF8 signalling, accounts for some cases of KS. Specifically, out 
of total of 225 KS patients studied, six missense SEF mutations were found, which 
were absent from 200 healthy controls. Two of the mutations were homozygous 
(p.P306S and p.P577Q), whilst the remaing four were heterozygous (p.K162R, 
p.Y379C, pS468L, pA735V). Using an AP1-luciferase reporter assay as readout of 
FGF signalling, it was found that the K162R, S468L, and A735V mutations 
decreased FGF signalling; P306S increased signalling; and, P577Q and Y379C had 
no effect. This data, together with its expression in olfactory and hypothalamic 
regions, suggests that SEF may have an important role in regulating FGF signalling 
during GnRH and olfactory system development (Feng et al., 2010). 
 
FGF8 (KAL6) 
In 2008, six FGF8 missense mutations were identified in HH patients with 
varying levels of olfaction. Such FGF8 mutations account for approximately 5% of 
total KS cases (Falardeau et al., 2008). Figure 1.09 illustrates the alternative splicing 
at the N-terminus that gives rise to the four splice isoforms of FGF8 in humans.  
Four of the mutations that were identified affected all four FGF8 splice 
isoforms (Fgf8a, Fgf8b, FGF8e, and FGF8f), whilst the other two affected only the 
FGF8e and FGF8f isoforms.  Two of the FGF8 mutations identified, P26L and 
R127G (both heterozygous), occurred in patients with hyposmia or anosmia (i.e.  
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Figure 1.09   Differential splicing of the human FGF8 gene
A: Genomic structure of FGF8. Boxes denote exons; lines denote introns.
B: Schematic diagram of the four FGF8 splice variants identified in humans,
which differ by whether or not they include exon 1C and part of exon 1D.
Most of the conserved FGF core is encoded by exons 2 and 3. The numbers
above the exons indicate amino acid numberings for each splice variant. KS
mutations identified by Falardeau et al (2008) are indicated by arrows and
have been numbered according to the FGF8f isoform.
SP = Signal peptide (for secretion).
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typical KS). The R127G mutation is located on exon 2, encoding a common region 
of the „core‟ FGF8 protein. The P26L mutation is located in exon 1C, thus affecting 
both FGF8e and FGF8f isoforms, suggesting an essential requirement for one or 
both of these isoforms in GnRH and olfactory neuronal ontogeny. Consistent with 
the loss-of-function prediction for these FGF8 mutations, P26L-mutated FGF8f 
showed reduced signalling activity in an FGFR1c luciferase assay, compared with 
wild-type FGF8f: the same was true for the four other FGF8 mutations that were 
tested in this assay (Falardeau et al., 2008).  
More recently, two unique heterozygous nonsense mutations in FGF8 
(p.R127X and p.R129X) have been reported, resulting in variable degrees of GnRH 
deficiency and olfactory phenotypes, confirming that it is loss-of-function mutations 
in FGF8 that cause human GnRH deficiency (normosmic HH or KS) (Trarbach et 
al., 2010). 
 
NELF 
Nelf, the Nasal Embryonic LHRH
2
 Factor gene, encodes a guidance 
molecule required for olfactory axonal outgrowth and hypothalamic GnRH neuronal 
migration in mice (Kramer and Wray, 2000) and zebrafish (Palevitch et al., 2009). 
The human orthologue, NELF, therefore, for several years, seemed to be a likely 
candidate as another potential KS-associated locus (Miura et al., 2004). In fact, 
N.Pitteloud and colleagues have now subsequently proposed a „digenic model‟ 
whereby the synergistic action of a NELF mutation in the presence of certain 
FGFR1 mutations results in a more severe KS phenotype, whilst patients with either 
one of these two mutations alone do not present with full KS (Pitteloud et al., 2007).  
 
                                                 
2
 now called GnRH 
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PKR2 (KAL3) and PK2 (KAL4) 
Prokineticin receptors 1 and 2 (PKR1 and PKR2) are G-protein-coupled 
receptors which are activated by the prokineticins, PK1 and PK2. Mice with Pk2 
deficiency have smaller olfactory bulbs with abnormal architecture (Ng et al., 2005). 
Similarly, Pkr2 knockout mice exhibit olfactory bulb hypoplasia, which is 
associated with a disrupted reproductive system including severe atrophy of the 
testis, ovary, uterus, vagina, and mammary glands, along with decreased plasma 
levels of testosterone and FSH, and an absence of hypothalamic GnRH neurons 
(Matsumoto et al., 2006). This suggested that PK2 and PKR2 represented two more 
KS-associated genes. 
In a cohort of 192 KS patients, ten mutations were found in PKR2 and four 
mutations were found in PK2; together these two genes therefore account for around 
5-10% of total KS cases. The PK2 mutations were found in the heterozygous state, 
whereas, the PKR2 mutations were found in the heterozygous, homozygous, or 
compound heterozygous state. Moreover, one of the patients with a heterozygous 
mutation in PKR2 also had a mutation in KAL1, suggesting a possible digenic 
inheritance pattern for that patient;  however, whether or not there is any cross-talk 
between these molecules and their signalling pathways requires further investigation 
(Dode et al., 2006; Monnier et al., 2009). 
Both anosmin-1 and PK2 bind to HSPG, the obligatory cofactor for FGF 
signalling. It can therefore be speculated that anosmin-1 may have a role in 
modulating prokineticin-signalling via PKR2, as well as its previously defined role 
in the FGF signalling through FGFR1 (Gonzalez-Martinez et al., 2004b; Kim et al., 
2008). It is interesting to note that only homozygous mouse mutants for Pk2, Pkr2, 
and Fgfr1 have abnormal olfactory bulbs, whereas heterozygous mutations in their 
human orthologues are sufficient to cause KS in humans. This may be because 
anosmin-1 is required at a critical minimum dosage to exert its modulatory role on 
both the FGFR1 and PKR2 signalling complexes in humans. The hitherto 
unidentified murine Kal1, which thus far hasn‟t been isolated from the X-
chromosome, may have translocated to an autosomal region, as has happened in 
other amniotes, such as the chicken, where it is found on chromosome 1 (Ensembl 
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gene: ENSGALG00000016616). This would mean that ansomin-1 is expressed at 
much higher levels compared with its X-linked human orthologues, resulting in a 
comparatively higher dosage of anosmin-1 in the mouse, thus protecting it from 
developmental abnormalities that result from Fgfr1 and Pkr2 signalling 
insufficiency (Kim et al., 2008). 
 
CHD7 (KAL5) 
CHD7 mutations are responsible for some cases of CHARGE syndrome 
(Vissers et al., 2004), a developmental disorder defined by coloboma, congenital 
heart disease, choanal atresia, mental and growth retardation, genital hypoplasia, 
and ear malformations and/or deafness (Hall, 1979; Pagon et al., 1981). 
Significantly, the defining clinical features of KS, HH with olfactory deficiency, are 
also present in patients with CHARGE syndrome (Chalouhi et al., 2005). In fact, 
some cases of KS had previously been reported with additional phenotypes 
including choanal atresia, mental retardation, and hearing loss (Klein et al., 1987; 
Coatesworth and Woodhead, 2002), thus demonstrating a degree of overlap between 
KS and CHARGE syndrome.  
The protein encoded by CHD7, chromodomain helicase DNA-binding 
protein-7, is a member of a superfamily of proteins that uniquely comprise two N-
terminal chromodomains, an SNF2-like ATPase/helicase domain and a DNA-
binding domain (Woodage et al., 1997). It is expressed in many foetal (and adult) 
tissues, including the developing brain, and is predicted to affect both chromatin 
structure and gene expression during early embryonic development (Vissers et al., 
2004).  Kim et al., (2008) carried out mutation-screening of the 37-protein coding 
exons of CHD7 and found seven heterozygous mutations, two splice and five 
missense, in three sporadic KS and four sporadic normosmic HH patients. They 
estimated that CHD7 mutations occur in approximately 6% of sporadic KS cases. 
Given the overlap of KS with CHARGE syndrome, it seems plausible that both 
normosmic HH and KS are mild allelic variants of CHARGE syndrome resulting 
from certain, less severe, CHD7 mutations (Kim et al., 2008). 
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Non-KS loci 
The division between normosmic (nHH) and anosmic HH (KS) is becoming 
more and more arbitrary as we learn more about the complicated genetics of HH, as 
illustrated by FGFR1 mutations which can cause both nHH and KS. It is therefore 
prudent to be aware of the genes underlying cases of nHH, which have thus far not 
been implicated in KS, but may nevertheless be important modifiers that may affect 
the penetrance of other KS-causing genes. These include the two most obvious 
candidates: the GnRH receptor (GnRHR1) and, more rarely, the gene encoding its 
ligand, GnRH1 (Chan et al., 2009). Other examples include the gonadotrophin -
subunits, and transcription factors that are involved in pituitary gland development 
(e.g. LHX3, PROP1, and HESX1). DAX1 mutations cause HH that is associated with 
adrenal insufficiency (adrenal hypoplasia congenita), and mutations of leptin and its 
receptor, as well as mutations in prohormone convertase 1, cause HH that is linked 
with obesity. Moreover, recently, mutations in TAC3 and TACR3 have also been 
shown to cause some cases of nHH (Topaloglu et al., 2009). HH also results from 
mutations in GPR54 and in the gene encoding its ligand, KiSS1; a signalling 
pathway that is implicated in the initiation and regulation of pubertal onset (see 
above). With the exception of GnRH1, TAC3 and TACR3, which are more recent 
findings, all of these genes have been reviewed in (Cadman et al., 2007). 
Some other gene products which have been shown to have a significant role 
in the migration of GnRH neurons in various model organisms or ex vivo systems, 
but have yet to be identified as KS or nHH-causing loci include: hepatocyte growth 
factor (HGF) and its receptor, c-met; the pleiotropic cytokine, Leukemia inhibitory 
factor (LIF); the transcription factor, EBF2; reelin, an extracellular matrix protein, 
Reelin; chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4; 
the neurotransmitter -aminobutyric acid (GABA) and the neuropeptide 
cholecystokinin (CCK) and CCK-1R receptor; Ephrin A3/A5 and EphA5; 
Neuropilin-2 (Npn-2), acts as a co-receptor for class 3 semaphorins and some 
isoforms of vascular endothelial growth factor (VEGF); and the cell surface 
glycoconjugate lactosamine. These are just some examples of the many factors that 
affect the migration of the GnRH neurons from the nasal compartment to the 
hypothalamus.  
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1.6  The role of anosmin-1 in KS 
In vitro and ex vivo analyses 
During human embryogenesis, anosmin-1 expression is restricted to 
basement membranes and interstitial matrices of discrete embryonic areas, including 
the developing olfactory bulb, retina, and kidney (Lutz et al., 1994; Duke et al., 
1995); regions which correlate well with the distribution of phenotypic 
abnormalities seen in X-KS patients.  
In vitro, it has been demonstrated that human anosmin-1 stimulates 
migratory activity in immortalised rodent GnRH-producing neurons (Cariboni et al., 
2004). Anosmin-1 also modulates neurite outgrowth in a cell-type specific manner 
(Soussi-Yanicostas et al., 1998) and stimulates collateral branch formation from rat 
olfactory bulb output neurons (the mitral and tufted cells) (Soussi-Yanicostas et al., 
2002). However, observations from an aborted KS embryo suggested that olfactory 
defects seen in KS patients are the result of earlier abnormalities in olfactory system 
development; specifically, elongation and pathfinding of sensory axons towards, and 
connection with, the olfactory bulb anlage in the developing forebrain (Schwanzel-
Fukuda et al., 1989). However, observations made from this isolated study may not 
be representative of all KS cases. Nontheless, according to this model, anosmin-1 
expressed in the presumptive olfactory bulb area is hypothesised to attract olfactory 
sensory axons towards the forebrain during the latter stages of their trajectory. In the 
absence of olfactory nerve synaptogenesis with the olfactory bulb anlage, GnRH 
neurons are denied a navigational pathway towards the forebrain, explaining the 
deficiency of hypothalamic GnRH-secreting neurons in KS (Soussi-Yanicostas et 
al., 2002). 
Anosmin-1 has also been shown to significantly enhance the amidolytic 
activity of urokinase-type plasminogen activator (uPA) in vitro. This is 
hypothesized to enhance the uPA-induced activation of the plasmin cascade at the 
cell surface and consequently result in proteolytic degradation of ECM components 
that subsequently release cell-cell and cell-ECM interactions that facilitate cell 
migration. Also, the anosmin-1-HS-uPA interaction was shown to induce cell 
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proliferation in the PC-3 prostate carcinoma cell line, in an FGFR1-independent 
manner (as these cells lack this receptor) (Hu et al., 2004). Furthermore, FGF2 
induces uPA expression in mouse brain capillary endothelial cells, which suggests 
that there could also be a functional relationship between uPA and FGF signalling in 
vivo (Mochizuki et al., 2002). Alternatively, anosmin-1 may be a multifunction 
protein with FGFR1-independent activities (Hu et al., 2004).  
 
In vivo studies 
KAL1 orthologues are present throughout animals as diverse as chicken, 
zebrafish, fruitfly, and nematode worm, providing a wide choice of invertebrate and 
vertebrate model organisms for studying X-KS (i.e. anosmin-1 in vivo function). A 
phylogenetic analysis of the various KAL1 orthologues present across 50 different 
species is illustrated in Figure 1.10. 
Invertebrate X-KS model (fruitfly & nematode worm) 
During development, the ability of anosmin-1 to confer GnRH neurons with 
cell-specific chemotactic responsivity, as well as branch-promoting and guidance 
functions in olfactory neurons, is dependent on heparan sulphate proteoglycan 
(HSPG) interactions. In fact, HSPGs are a critical component of the ECM, playing a 
vital role in neuronal navigation during CNS development (Van et al., 2006). 
HSPGs are cell-surface or secreted proteins containing the 
glycosaminoglycan HS. During HS chain biosynthesis, alternating glucuronic acid 
(GlcA) and N-acetylglucosamine (GlcNAc) subunits are extended from the core 
tetrasaccharide attached to a serine residue on the protein. Some of the GlcNAc 
residues are then modified by N-deacetylation/N-sulphation to form N-sulphated 
glucosamine (GlcNS) regions (NS domains) which are interspersed within the 
unmodified GlcNAc regions (NA domains). The polymer is then further modified 
by epimerisation of GlcA to iduronic acid (IdoA) and by three types of sulphation; 
the 2-O-sulphation of IdoA (or more rarely GlcA) to form IdoA(2S) or GlcA(2S); 
the 6-O-sulphation of GlcNS residues to form GlcNS(6S); and the 3-O-sulphation of  
Chapter 1: Introduction 
 
 
51 
 
Figure 1.10   Phylogenetic tree of the KAL1 gene
An Ensembl gene tree was generated using the Gene Orthology/Paralogy
prediction method pipeline at http://www.ensembl.org. This phylogenetic tree
represents the evolutionary history of the KAL1 gene family from a common
ancestor around 580 million years ago (MYA). The position of the common
primate/rodent ancestor at approximately 107 MYA is indicated on the tree by
a purple arrow. The KAL1 orthologues for several important organisms are
indicated by red arrows along with their common names. These include:
Human KAL1: ENSG00000011201;
Zebrafish Kal1a: ENSDARG00000012896;
Zebrafish Kal1b: ENSDARG00000004932;
Squirrel Kal1: ENSSTOG00000000380;
Guinea Pig Kal1: ENSCPOG00000013143
Chick Kal1: ENSGALG00000016616
Fruitfly Kal1: FBgn0039155
Nematode worm Kal1: WBGene00002181
*Ensembl gene numbers are stated for each organism, except for fruitfly where
the FlyBase gene name is given and the nematode worm where the WormBase
gene name is given.
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Zebrafish Kal1a
Human KAL1
Squirrel Kal1
Guinea pig Kal1
Chick Kal1
Zebrafish Kal1b
Fruitfly Kal1
Worm Kal1
107MYA
580MYA
Figure 1.10   Phylogenetic tree of the KAL1 gene
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GlcNS(6S) to form GlcNS(3S,6S). All modification reactions are incomplete in 
vivo, generating many HS chain variants with distinct, highly variable, domains of 
charge density, thereby altering their molecular binding specificities (Van et al., 
2006). 
In C. elegans, particular HS modifications are required for anosmin-1 
activity in certain cell types. 'AIY interneurons' are a subclass of C. elegans neurons 
which receive synaptic input from olfactory neurons. The C. elegans orthologue of 
anosmin-1 (ceKal1) induces a specific axonal branching phenotype in these cells, 
which was abolished in worms lacking 6-O-sulphotransferase (hst-6) or C5-
epimerase (hse-5), but not in those lacking 2-O-sulphotransferase (hst-2). However, 
hypodermal defects induced by ceKal1 over-expression were suppressed only in 
those worms lacking hse-5, but not by those lacking hst-6 or hst-2. It was therefore 
proposed that anosmin-1 function requires distinct HS modifications in different 
developmental contexts (Bulow et al., 2002; Bulow and Hobert, 2004). 
Significantly, specific HS saccharide alterations were also shown to affect binding 
specificity of ligand-receptor interactions of the fibroblast growth factor receptor 1 
(FGFR1) (Guimond and Turnbull, 1999). 
In the fruitfly, Kal1 is expressed during important morphogenetic processes 
such as germ band retraction, dorsal closure and head involution and has a complex 
and dynamic pattern of expression in the second half of embryogenesis. Also, Kal1 
is notably expressed in cells of the antennal organ, which has olfactory function in 
the fruitfly (Andrenacci et al., 2004), demonstrating that the role of anosmin-1 in 
olfactory system development is highly conserved across the vertebrates and 
invertebrates 
However, neither of these invertebrate models can satisfactorily recapitulate 
human olfactory/GnRH neuronal development (and KS-associated defects therein) 
in the same way as a vertebrate model organisms, which have homologous 
olfactory/GnRH systems. Moreover, when the evolutionary gap is so wide between 
two organisms, the signalling pathways have sometimes diverged significantly. For 
example, the C. elegans has only one FGFR orthologue, EGL-15. However, unlike 
vertebrates, C. elegans FGF receptor signalling can occur independently of the 
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multi-substrate adapter FRS2 during processes such as sex myoblast migration 
guidance and fluid homeostasis (Lo et al., 2010). This notable divergence in FGFR 
signalling mechanism suggests that C. elegans may not be an appropriate model for 
studying FGF signalling mechanisms which occur in vertebrates.  
 
Vertebrate X-KS model (rodents, chicken, fish) 
Whilst anosmin-1 is highly conserved (especially the WAP and first FNIII 
domain) across many species, a mouse/rat homologue has remained elusive, 
frustrating attempts to develop a rodent X-KS model, although one group has shown 
that anti-human anosmin-1 antibodies cross-react with a 100-kDa protein in 
cerebellum and olfactory bulb extracts from both the rat and mouse, indicating that a 
mouse/rat anosmin-1 orthologue may exist (Soussi-Yanicostas et al., 2002).  
However, growing evidence casts doubt on this, and the consensus at the moment is 
that a rodent KAL1 orthologue probably does not exist. Firstly, the availability of the 
virtually complete mouse and rat genome sequences in recent years has proven that 
they do not have a homologous sequence for KAL1, despite conservation of 
homology between human and nematode worm KAL1 sequences across a much 
greater evolutionary distance. Furthermore, the putative KAL1 locus is 
pseudoautosomal in rodents and synteny abruptly terminates just before the 
expected location of the KAL1 gene. In fact, steroid sulphatase (STS), the gene most 
adjacent to KAL1 on the human X chromosome is present in the syntenic region in 
the rodent, but there is no KAL1 orthologue beside it (Kim et al., 2008). 
In fact, KAL1 orthologues do exist in two other rodents (see Figure 1.10): 
the guinea pig (Cavia porcellus; Ensembl gene ID: ENSCPOG00000013143) and 
the squirrel (Spermophilus tridecemlineatus; Ensembl gene ID: 
ENSSTOG00000000380) (Bribian et al., 2008), but these two rodent animals are 
less amenable to developmental studies. This has meant that several groups have 
turned to fish models (zebrafish and medaka, see below) or the nematode worm (C. 
elegans) to model X-KS in vivo. 
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Chicken anosmin-1 
An extensive spatio-temporal expression analysis of anosmin-1 in the 
chicken (Gallus gallus) has been reported in the literature (see below); however, a 
full functional characterisation of anosmin-1 in this species has hitherto been 
unreported. It should however be noted that the chicken KAL1 orthologue is located 
on an autosomal chromosome (chr. 1) (Legouis et al., 1993b), and may therefore be 
expressed at higher levels compared with the human X-chromosome orthologue. 
This may give the chicken an anosmin-1 dosage advantage in certain developmental 
processes, thus potentially causing complications in the comparative analysis of 
anosmin-1 function in this organism. 
During the second half of chicken embryonic life, Kal1 transcript is mainly 
found in the neurons of the central nervous system (CNS), including particularly 
high levels of transcript in the mitral neurons of the olfactory bulbs, in the Purkinje 
cells of the cerebellum, in retinal neurons, and in discrete neuronal populations of 
the brainstem and spinal cord. A low level expression is observed in some 
mesenchymal derivatives, including that of the developing kidney (i.e. the small 
blood vessel walls and glomeruli of the mesonephros). Notably, unlike human 
embryos, Kal1 expression is not detected at any stage in the chick embryonic 
epithelium or the surrounding nasal mesenchyme. From embryonic day 8, the 
expression is therefore almost entirely restricted to definite neuronal populations of 
the CNS, some of which (including the optic tectum and striatum) continue to 
express Kal1 after hatching. However, during early chick development (days 2-8), 
Kal1 is transiently expressed in endodermal and mesodermal derivatives (preceding 
cell differentiation); and is also expressed in post-mitotic neuroectodermal 
derivatives which continue to express the gene after differentiation. Therefore, Kal1 
appears to have a role in morphogenetic events and in late neuronal differentiation 
and/or neuronal trophicity (Legouis et al., 1993a; Legouis et al., 1993b; Legouis et 
al., 1994). 
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Zebrafish/medaka anosmin-1 
Two fish models (zebrafish and medaka) have been used to demonstrate the 
phenotypic consequences of knocking down KAL1 gene function. Zebrafish and 
medaka both have two KAL1 orthologues (Kal1a and Kal1b) (Whitlock et al., 
2005b; Okubo et al., 2006). Knocking down one of these orthologues, Kal1a, in the 
medaka resulted in both the GnRH1 and GnRH3 cells losing their ability to migrate 
into the forebrain, and instead accumulating in the olfactory compartment (Okubo 
and Nagahama, 2008b). Similarly, knockdown of Kal1a gene function in the 
zebrafish was shown to result in specific complete loss of „endocrine‟ GnRH cells 
migrating to the hypothalamus, whilst not affecting the „neuromodulatory‟ GnRH 
cells of the terminal nerve and midbrain. However, knockdown of the other 
orthologue, Kal1b, resulted in only a very slight decrease in hypothalamic GnRH 
cell number (Whitlock et al., 2005b). More recently, it has also been demonstrated 
in zebrafish that Kal1a (but not Kal1b) is also required for fasciculation and 
terminal targeting of olfactory sensory neuronal axons in the olfactory system 
(Yanicostas et al., 2009) (see chapter 5 for further discussion), as well as in the 
correct migration of the posterior lateral line primordium (Yanicostas et al., 2008). 
The advantages of a zebrafish model 
The unavailability of a rodent model for X-KS lead us to choose the 
zebrafish as our vertebrate KS model, for investigating the role of anosmin-1 and its 
putative role in the FGF signalling pathway during olfactory and GnRH system 
development. The zebrafish is a very useful vertebrate model organism for studying 
these early developmental processes, for the following reasons:  
i) Zebrafish are small (4-5cm long) and relatively cheap and easy to 
maintain. 
 
ii) They are prolific layers: each female can lay around 200 eggs, 2 to 3 
times per week. 
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iii) Zebrafish embryos are transparent and develop externally (ex utero), 
thus allowing all developmental stages to be visualised under the 
microscope in real-time.  
 
iv) Zebrafish development is very fast: by 24 hours post fertilisation 
(hpf), the body plan has been established and the major organs are 
visible. 
 
Sequencing of the zebrafish genome, which began in 2001, has demonstrated 
that many of the genes that have so far been annotated have very good homology to 
their human orthologues (http://www.ensembl.org). However, during evolution 
(around 350 million years ago), a whole genome duplication event occurred in the 
ray-fin fish lineage, prior to the teleost radiation, meaning that zebrafish often have 
two orthologues for the corresponding tetraplod (human) gene. Since this 
divergence, the zebrafish genome has been resolving back to a diploid state again; 
however, this process is incomplete, and many orthologue pairs have been retained 
(Kleinjan et al., 2008). For example, zebrafish have two orthologues each of KAL1, 
FGF8, and FGFR1 (Ardouin et al., 2000; Jovelin et al., 2007; Rohner et al., 2009). 
Among the remaining co-orthologues, there has sometimes been a partitioning of 
different ancestral gene subfunctions within different teleost lineages: a process 
known as sub-functionalisation (Kleinjan et al., 2008). This process may have 
occurred for the two KAL1 orthologues, where Kal1a, according to recent reports, 
has retained a role in olfactory and GnRH system development, whereas a role for 
Kal1b is yet to be established (Ardouin et al., 2000) (see chapter 5).  
Analysis and characterisation of the zebrafish GnRH and olfactory systems 
is further discussed in chapter 3. 
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1.7  The role of FGF signalling in forebrain 
development 
A summary of the phenotypes of FGFR knockout mouse models is shown in 
Table 1.2.  Due to defects in cell migration through the primitive streak, Fgfr1 gene 
inactivation causes embryonic lethality at E9.5-E12.5. Whilst, specific loss of the 
Fgfr1c isoform shows an identical phenotype, the Fgfr1b knockout caused no 
obvious phenotype. This data suggests that only Fgfr1c (not Fgfr1b) is required 
during embryonic development (Eswarakumar et al., 2005; Kim et al., 2008). The 
targeted abolition of Fgfr1 in the developing mouse telencephalon resulted in 
olfactory bulb aplasia, confirming that Fgfr1 signalling is essential for olfactory 
bulb morphogenesis (Hebert et al., 2003).  
However, in some cases of KS, FGFR1 mutations may result in an isolated 
GnRH deficiency without affecting formation of the olfactory bulbs (Pitteloud et al., 
2006). This suggests that reduced FGFR1 signalling may affect GnRH neuronal 
migration, differentiation or survival within the hypothalamus, without causing 
olfactory bulb defects.    
In fact, specific expression of a dominant-negative Fgfr1 (dnFgfr) in GnRH 
neurons in mice has been shown to result in a 30% decrease in the number of GnRH 
neurons to reach the forebrain, as well as a significant reduction in GnRH axonal 
projections to the median eminence. These mice exhibited delayed puberty and 
premature ovarian senescence. dnFgfr lacks the intracellular tyrosine kinase domain, 
and upon binding ligand, forms a non-functional heterodimer with wild-type Fgfr1, 
Fgfr2, and Fgfr3, which then blocks downstream Fgfr signalling (Tsai et al., 2005). 
This demonstrates that FGF signalling is important for normal GnRH neuronal 
migration, differentiation and/or survival in the hypothalamus, as well as playing an 
essential role during telencephalon morphogenesis, particularly in the olfactory 
bulb.  
There have been some reports of patients with FGFR1 mutations whose KS 
was reversible, whereby normal pulsatile GnRH secretion was activated after they  
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Table 1.2  FGFR knockout mouse phenotype 
  
 
Gene  
  
Survival 
 
Phenotype 
 
 
Fgfr1 
 
Lethal (E9.5-E12.5) 
 
Defective cell migration through primitive 
streak, posterior axis defects 
 
 
Fgfr1b 
 
Viable 
 
No obvious phenotype 
 
 
Fgfr1c 
 
Lethal (E9.5) 
 
Defective cell migration through primitive 
streak, posterior axis defects 
 
 
Fgfr2 
 
Lethal (E10.5) 
 
Defective placenta and limb bud formation 
 
 
Fgfr2b 
 
Lethal (P0) 
 
Agenesis or lungs, anterior pituitary, thyroid, 
teeth and limbs 
 
 
Fgfr2c 
 
Viable 
 
Delayed ossification, proportionate dwarfism, 
chondrocranium 
 
 
Fgfr3 
 
Viable 
 
Bone overgrowth, inner ear defect 
 
 
Fgfr4 
 
Viable 
 
No obvious phenotype, growth retardation 
and lung defects in FGFR3 null background 
 
 
Adapted from (Eswarakumar et al., 2005) and (Kim et al., 2008)
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were given initial gonadotrophin treatments (Pitteloud et al., 2005). And, as 
mentioned above, female mice expressing a dominant negative FGFR1 specifically 
within their GnRH neurons had delayed puberty, yet had normal fertility when they 
reached adulthood (Tsai et al., 2005).  These observations suggest that FGFR1 plays 
an important role during foetal development of the forebrain GnRH system, as 
indicated by a decreased number of hypothalamic GnRH neurons in these mice, but, 
postnatally, other factors may lead to the recovery of the hypothalamic GnRH 
neuronal population, in an FGFR1-independent manner (Kim et al., 2008). 
FGF8 expression is detected in the mouse invaginating-nasal pit and has 
been shown to be a particularly important ligand for olfactory development in mice. 
In fact, mice with a targeted loss of Fgf8 failed to develop a definitive olfactory 
epithelium, vomeronasal organ, and nasal cavity due to apoptosis of cells within the 
morphogenetic centre and in the developing neuroepithelium, despite initial 
invagination of the nasal pit and normal olfactory epithelium neurogenesis. 
Furthermore, Fgf8 knockout mice have absent olfactory bulb development as well 
as midline defects (Kawauchi et al., 2005). Consistently, Fgf8a mutant „acerebellar‟ 
zebrafish have fewer olfactory sensory neuronal condensations at the olfactory bulbs 
(Shanmugalingam et al., 2000) (see chapter 4). As mentioned earlier, Fgf8 also has 
an essential role in forebrain GnRH neuronal development; hence mice 
hypomorphic for Fgf8 lack GnRH neurons of the hypothalamus (Falardeau et al., 
2008). FGF2 is co-expressed with FGFR1 in the nasal epithelium, and may 
therefore represent a further FGFR1 ligand for signalling during olfactory and 
GnRH system development (Britto et al., 2002), although its presence here clearly 
cannot compensate for absence of FGF8 in this region. 
Both Fgfr1 and Fgfr3 are expressed in developing GnRH neurons and are 
capable of binding to Fgf8 equally well. However, the total number of GnRH 
neurons decreased only in homozygous Fgfr1 hypomorphs, but not homozygous 
Fgfr3 knockout mice. Therefore, it is believed that the effects of FGF8 are mediated 
through FGFR1 alone during forebrain GnRH development, and that its action is 
directed on the target migrating GnRH cells, as they themselves express FGFR1 
(Chung et al., 2008). 
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Zebrafish Fgf3 („Lia‟) mutants lack an adenohypophysis (anterior pituitary) 
due to specific apoptosis of adenohypophyseal cells (Herzog et al., 2004), as well as 
defects in forebrain development, including failure of forebrain commissure 
formation (Walshe and Mason, 2003). It been proposed that, in zebrafish, 
hypothalamic GnRH cells may originate from the anterior pituitary placodal region 
(Whitlock, 2005a; Whitlock et al., 2005b). Therefore, it may be interesting to find 
out whether these Fgf3 mutants also lack hypothalamic GnRH neurons. Moreover, 
Fgf8a morphant embryos also had forebrain commissure defects which were 
worsened by concomitant knock down of Fgf3, suggesting that both ligands are 
required for developmental processes within the forebrain (Walshe and Mason, 
2003) (see chapter 3). 
 
 
1.8  Anosmin-1 modulates FGF signalling 
A functional interaction between anosmin-1 and the FGF signalling pathway 
was identified using two in vitro-based cell systems. The first system to be used 
were FNCB4, which is a primary neuroblast cell culture derived from human foetal 
olfactory neuroepithelium, which expresses olfactory and GnRH markers, and 
responds to autocrine GnRH stimulation. Addition of recombinant anosmin-1 to 
these cells induces neurite outgrowth and cytoskeletal rearrangements through an 
FGFR1-dependent mechanism. Specifically, sustained MAPK (p42/44 and p38) 
phosphorylation and Cdc42/Rac1 activation was achieved in these cells, at levels 
equivalent to or higher than those induced by addition of high concentrations of 
exogenous FGF2 alone (see Figure 1.11). The second in vitro cell system utilised 
BaF3 cells, which express specific isoforms of FGFRs and respond to FGF in a 
heparan sulphate dependent manner. Using this system, it was demonstrated that the 
effects of anosmin-1 action on the FGF signalling pathway may be specific to the 
FGFR1 IIIc isoform. The proliferative response to suboptimal concentrations of 
FGF2 in these cells was significantly increased upon addition of anosmin-1, 
suggesting that anosmin-1 may be an isoform-specific co-ligand enhancer for 
FGFR1 (Gonzalez-Martinez et al., 2004b; Kim et al., 2008). 
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Figure 1.11   A  role for anosmin-1 in neurite outgrowth via FGFR1 
signalling
A schematic diagram illustrating the downstream pathways that were
stimulated by anosmin-1 in ex vivo cell culture. In human embryonic GnRH
olfactory neuroblasts, anosmin-1 induces neurite outgrowth and cytoskeletal
rearrangements through FGFR1-dependent mechanisms involving p42/44
(ERK1/2) and p38 mitogen-activated protein kinases and Cdc42/Rac1
activation. These effects were not seen when anosmin-1 with KS-specific
point mutations were used.
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           During human embryogenesis, anosmin-1 and FGFR1 are expressed in the 
olfactory placode from as early as 4.5 weeks, and later, at 8 weeks, are both present 
at the terminal nerve region, part of the migratory route for GnRH-expressing 
neurons as they navigate towards the hypothalamus. This close proximity of 
anosmin-1 with FGFR1 at these stages, as well as the data which shows their in 
vitro interaction, supports the possibility of their interaction during human olfactory 
and GnRH system development (Gonzalez-Martinez et al., 2004b; Cadman et al., 
2007) (see Figure 1.12; a more detailed summary of the spatio-temporal expression 
of anosmin-1 and FGFR1 during early human embryogenesis is presented in Figure 
1.14 at the end of this section ).  
Activation of FGF signalling is initiated by multi-protein complex formation 
between FGF ligand, FGF receptor, and HS proteoglycan (HSPG) on the cell 
surface. However, other factors, such as anosmin-1, have recently been shown to 
affect the assembly of this complex and in this way modulate the response of the 
cell to the FGF ligand, depending on the specific concentration of anosmin-1 (Hu et 
al., 2009). This has significantly enhanced our understanding of the molecular 
mechanism of anosmin-1 action on FGFR1 signalling. However, until now, there 
has been an absence of an in vivo model to demonstrate that this phenomenon is 
physiologically relevant, during vertebrate embryogenesis (see chapter 5). 
It has been demonstrated recently that anosmin-1 binds directly with FGFR1 
at high affinity, and that this interaction involves the N-terminus of anosmin-1 
(cysteine-rich region, whey acidic protein-like domain and the first fibronectin type 
III domain) and the D2–D3 extracellular domains of FGFR1. Whilst an FGFR1-
bound anosmin-1 can bind to FGF2 alone, it cannot bind to an FGF2-heparin 
complex, thus preventing formation of an „active‟ FGF signalling complex. In 
contrast, heparin-bound anosmin-1 does bind to a preformed FGF2-FGFR1 
complex, resulting in an „active‟ anosmin-1-FGFR1-FGF2-heparin signalling 
complex (see Figure 1.13). However, anosmin-1 binds to FGFR2IIIc with much 
lower affinity and has negligible binding affinity for FGFR3IIIc (Hu et al., 2009).  
Furthermore, it was also shown, using transwell migration assays, that 
anosmin-1 induces opposing effects in the chemotaxis of human neuronal cells i.e. it  
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Figure 1.12   Anosmin-1 & FGFR1 expression during human olfactory 
and GnRH neuronal development
Schematic drawing depicting anosmin-1 (green star), FGFR1 (blue star), and
GnRH (red circle) immunoreactivity in the olfactory system and rostral
forebrain during human embryogenesis after 53–54 days (CS21). Red circles
with blue stars at their centre represent GnRH cells that co-express FGFR1.
F= Forebrain; OB= olfactory bulb; OE= olfactory epithelium; ON= olfactory
nerve; TN= terminal nerve; NTg= terminal nerve ganglion cells, sc= sulcus
circularis, LOT= lateral olfactory tract, gc= granule cells, m= meninges, Lv=
lateral ventricle, ne= neuroepithelium.
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Stimulatory role of anosmin-1
Figure 1.13   Putative model for the dual role of anosmin-1 in inhibiting 
and stimulating FGFR1 signalling
Model A: Anosmin-1 binding to FGFR1 inhibits FGF2/FGFR1/HS complex
formation. FGF2 is able to bind to pre-formed anosmin-1/FGFR1 complex to
form anosmin-1/FGF2/FGFR1 complex, but HS is able to „strip‟ the FGF2
from this complex. FGF2/HS complex cannot bind to anosmin-1/FGFR1, so
active FGF2/FGFR1 signalling complex cannot form.
Model B: anosmin-1 binding to HS facilitates FGF2/FGFR1/HS complex
formation. HS-bound anosmin-1 preferentially binds to pre-formed
FGF2/FGFR1 complex, resulting in active anosmin-1/FGF2/FGFR1/HS
complex formation. Figure modified from Hu et al., 2009.
Inhibitory role of anosmin-1
A
B
Anosmin-1
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was shown to promote GnRH neuroblast migration at lower concentrations, but 
inhibit this migration at higher concentrations. These dual properties of 
chemoattractance and chemorepellance may be used to direct cell migration and 
axon targeting in different cellular contexts, at differing anosmin-1 concentrations. 
The binding capacity of HSPG and the expression levels of anosmin-1 may 
determine these opposing actions of anosmin-1, depending on whether the anosmin-
1 is in an FGFR1-bound or a heparan sulphate-bound state. These observations may 
help to explain why FGFR1 mutations cause KS with a wide spectrum of 
reproductive phenotypes. Furthermore, FGF8, another of the six currently identified 
KS genes may form an FGF8-FGFR1-HS signalling complex, whose formation and 
activation is regulated by anosmin-1 in a similar manner, during GnRH and 
olfactory neurogenesis (Hu et al., 2009). 
Finally, these studies may also help to explain the five-fold higher 
prevalence of KS in males compared to females. As anosmin-1 dose-dependently 
enhances GnRH cell migration and neurite outgrowth via the FGFR1 signalling 
pathway, higher KAL1 gene expression in females, due to partial escape from X 
inactivation, might compensate for haploinsufficiency of FGFR1 in heterozygous 
females (Cadman et al., 2007; Hu et al., 2009). 
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Figure 1.14 Anosmin-1 and FGFR1 expression in the olfactory system and
rostral forebrain during human embryogenesis.
This schematic diagram illustrates anosmin-1 (red dots; •) and FGFR1 (green
dots; •) immuno-reactivity at 4 weeks (A), 5.5 weeks (B), and 6 weeks (C)
gestation; corresponding to Carniege Stage (CS) 13, 17, and 18, respectively.
GnRH cells are depicted as triangles ( ). A’ shows an immunofluorescently
labelled sagittal section from a 4.5-week-old human embryo illustrating
FGFR1 (green labelling) and anosmin-1 (red labelling) distribution at the
olfactory placode (OP), corresponding to the region demarcated by a dotted
box in part A.
A: During human embryogenesis, GnRH-positive neurons are first visualised at
around 4.5weeks gestation in the medial OP. Anosmin-1 and FGFR1 are also
first detected around this stage in the OP (see A’). FGFR1 and GnRH are co-
expressed in some cells at the medial positions of the OP (indicated by green
triangles, ).
B: Between 5 and 5.5 weeks (CS15-16), FGFR1 and anosmin-1 expression is
more widespread, and in addition to the OP, now becomes detectable in the
neuroepithelium of the ventral telencephalic and diencephalic part of the
forebrain.
C: By 6 weeks gestation, FGFR1 and anosmin-1 are no longer readily
detectable in the olfactory epithelium, and, instead become more restricted to
the olfactory bulb region and ventral telencephalic and diencephalic regions; a
region where GnRH neurons are actively migrating towards the preoptic
hypothalamus (as demonstrated by a blue dotted arrow). In fact, by this stage,
several GnRH-positive cells are already present in the ventral forebrain surface,
suggesting that the initial migration of GnRH cells through the forebrain may
be independent of olfactory bulb morphogenesis.
See Figure 1.12 for the GnRH, FGFR1, and anosmin-1 immuno-expression at a
later human embryonic stage, CS21; which is approximately 7.5 weeks
gestation).
OP=olfactory placode; PON=primary olfactory neurons; bv= blood vessel;
NM=nasal mesenchyma; CP=cribriform plate; F=forebrain; ORN=olfactory
receptor neurons; OE= olfactory epithelium; OB=olfactory bulb;
ONT=olfactory nerve tract; TN=terminal nerve; NTg=terminal nerve ganglion
cells; r=rostral.
Figure 1.14 (A), (B), and (C) modified from Front Neuroendocrinol. 25, Gonzalez-Martinez
et al., ‘Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the
investigation of inherited forms of Kallmann's syndrome.’, pp. 108-130, Copyright 2004,
with permission from Elsevier. Figure 1.14 (A’) is from Gonzalez-Martinez et al., 2004b.
Copyright 2004 by the Society for Neuroscience.
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(CS18)
A
B
C    
  
 
 
Figure 1.14   Anosmin-1 and FGFR1 expression in the olfactory system 
and rostral forebrain during human embryogenesis. 
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a 
1.9  Aims of thesis 
- To characterise and re-assess our understanding of GnRH and olfactory 
neuronal development in zebrafish, and, in the process, establish an in vivo model 
for Kallmann syndrome and other (normosmic) disorders that include 
hypogonadotrophic hypogonadism in their aetiologies. [Chapter 3]. 
-To ascertain the developmental origins of the forebrain GnRH neurons and 
investigate whether early up-regulation of the kisspeptin signalling pathway can 
affect their migration and/or accumulation at the hypothalamus [Chapter 3]. 
-To investigate the involvement of FGFR signalling, and, in particular, the 
role of the two zebrafish FGF8 orthologues therein, during the development of the 
olfactory and GnRH neuronal systems [Chapter 4]. 
-To investigate the role of the two zebrafish anosmin-1 orthologues during 
development of the olfactory and GnRH neuronal systems, by means of gene 
knockdown and over-expression [Chapter 5]. 
-To identify whether or not the two anosmin-1 orthologues are involved in 
formation of the forebrain commissures in zebrafish; and, if so, to use this 
developmental process to explore a putative role for anosmin-1 action on the Fgf8 
signalling pathway in vivo [Chapter 5].                                        aaaaaa                                    
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Chapter 2 
Materials & Methods 
Chapter 2: Materials & Methods 
2.1  Buffers and solutions  
 
Note: All reagents were supplied by BDH or Sigma and dissolved in water unless 
otherwise stated.   % means weight/volume, unless specified as v/v (volume/volume). 
 
1% Agarose gel: 1g agarose in 100ml 1X TAE 
BBR: 10% Boehringer Blocking Reagent (Roche) in MAB 
Block buffer for TCA protocol: 10% (v/v) DMSO, 2% (v/v) goat serum, 1% BSA 
in PBSTx 
CHAPS: 10% (v/v) [(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate 
in DEPC-treated PBS. 
DEPC treatment: diethylpyrocyanate, 1ml added to 1L solution, left overnight and 
autoclaved. 
DExB: 10mM Tris pH8.2, 10mM EDTA, 200mM NaCl, 0.5% SDS, 200g/ml 
Proteinase K 
Goat serum: (Invitrogen) heat-inactivated by heating to 60
o
C for 30 minutes, 
aliquoted and stored at -20
o
C 
GS/BBR blocking buffer: 20% (v/v) goat serum, 20% BBR in MABT 
Hybridisation (hyb) solution: 50% (v/v) Formamide (Fluka), 5X SSC, 5 mM 
EDTA, 50 g/ml yeast tRNA (Invitrogen), 0.2% (v/v) Tween-20, 0.5% CHAPS, 
100 g/ml Heparin in DEPC-treated water 
Incubation buffer (IB): 10% goat serum (v/v), 1% (v/v) DMSO in PBSTx 
LB: Luria Bertani medium, 10g Bacto-Tryptone (BD), 5g Bacto-yeast extract (BD), 
10g NaCl in 1L water (then autoclaved) 
MAB: 100mM Maleic acid, 150mM NaCl, adjusted to pH7.5 (autoclaved) 
MABT: 0.1% Tween-20 (v/v) in MAB 
Memfa fix:  10% (v/v) MEMFA-10X salts, 10% (v/v) formaldehyde (37%) 
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Milk block: 5% powdered milk in 1X TBST (for Western blots) 
MEMFA-10X Salts: 1M MOPS, 20mM EGTA, 10mM MgSO4 adjusted to pH 7.8 
with NaOH, filter sterilised and stored at 4
o
C. 
5X MO buffer: 600mM KCl, 100mM Hepes (pH7.5), 1.25% phenol red 
NBT/BCIP: 4-nitroblue-tetrazolium chloride and 5-bromo-4-chloro-3indolyl-
phosphate (Roche) 
NTMT (pH9.5): 5 M NaCl, 2 M Tris pH 9.5, 2 M MgCl2, 10% (v/v) Tween-20 
PBS: 0.16 M NaCl, 3 mM KCl, 8 mM Na2HPO4, 1 mM KH2PO4 (Oxoid), 
autoclaved 
PBSTx: 0.1% (v/v) triton X-100 in PBS. 
PBSTw: 0.1% (v/v) Tween-20 in PBS. 
4% PFA: 4% paraformaldehyde and 7% sucrose in PBS, heated to 70
o
C until 
dissolved, whilst adding NaOH drop-wise to approximately pH10, then adjusted to 
pH 7.5 with HCl, aliquoted and stored -20
o
C 
1000X PK: 10mg/ml Proteinase K, aliquoted and stored at -20
o
C. 
PTU (100X): 0.3% phenylthiourea, pH7.0 
SDS-PAGE running buffer: 10g SDS, 30.3g Tris, 144g Glycine in 1L water 
20X SSC: 3 M NaCl, 0.3 M Sodium citrate, adjusted with citric acid to pH 4.5, 
DEPC treated and autoclaved. 
TLB-WB: 1X TLB-10X, 10mM sodium orthovanadate, one Complete Mini-
Protease inhibitor cocktail tablet (Roche) 
TLB-10X: 1% (v/v) triton X-100, 50mM Tris HCl, 150mM NaCl 
2% TCA: 2% (v/v) trichloracetic acid 
Tricaine: 0.01% tricaine methanesulfonate (MS222), pH7.0 
2YT: 16g Tryptone (BD), 10g Yeast (BD) 5g NaCl in 1 L water 
10X transfer buffer: 30.3g Tris, 144g Glycine in 1L water 
1X transfer buffer: 20% (v/v) methanol in 1X transfer buffer (for Western blots) 
10X TBS: 10X stock, 20mM Tris, 150mM NaCl in water, pH 7.5 
TBST: 1X TBS with 0.1% (v/v) Tween-20 
TAE: 40 mM Tris-Acetate, 1mM EDTA 
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2.2  Animals 
2.2.1  Adult zebrafish  
Adult zebrafish were maintained at a constant light/dark cycle (14 hours with 
lights on, followed by 10 hours of lights off) to ensure a reliable breeding pattern.  
Zebrafish strains used in this study: 
 Wild-type zebrafish: King‟s College Wild-type („KWT‟) 
 Transgenic zebrafish: Nkx2.1a:YFP (Danesin et al., 2009), 
pOMP:tauEGFP (Yoshida et al., 2002), pTRPC2:Venus (Sato et al., 
2005), pSox10:GFP (Wada et al., 2005), Dusp6:d2GFP (Molina et al., 
2007), hsp70l:dnfgfr1-EGFP (Lee et al., 2005). 
 Mutant zebrafish: Ace (Fgf8a mutant) (Shanmugalingam et al., 2000) 
 
2.2.2  Harvesting zebrafish & medaka embryos  
Zebrafish and medaka both lay their eggs ex utero at the beginning of a new 
light cycle each day (i.e. when lights are first switched on in the morning). Their 
embryos were harvested and maintained in 90mm Petri dishes containing aquarium 
water supplemented with methylene blue (to deter microbial contamination), and 
then incubated at 28.5
o
C. To ensure that the embryos remained pigment-free and 
transparent after 24hpf, phenylthiourea (PTU) was also added to the Petri dishes, at 
a final concentration of 0.003%. 
 
2.2.3  Chicken embryos 
Fertilised brown chicken eggs (from Henry Stuart Farms) were incubated at 
38
o
C in a humidified room. Chick embryos were then dissected from these eggs and 
staged according to Hamburger and Hamilton (Hamburger and Hamilton, 1992). 
Note: All chicken embryo dissections were performed by Dr Panna Tandon. 
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2.3  Immunohistochemistry of whole embryos 
 
Note: the following protocol is suitable for immuno-labelling embryos with 
anti-GFP, anti-mCherry, or anti-calretinin. However, certain adjustments to this 
protocol were required when using other antibodies listed in Table 2.1, or when 
sections were being used. These modifications are described in sections 2.3.2 
through to 2.3.6. 
 
2.3.1  The standard protocol 
Embryos were fixed in 4% PFA for 3 hours at room temperature (RT, or 
overnight at 4
o
C), and then washed five times in PBSTx for 5mins each. Embryos 
older than 24hpf were then permeabilised using 1000X Proteinase K (PK), diluted in 
PBSTx at the following stage-dependent concentrations:  
For 24hpf: 15min of 1X PK;  
For 48hpf: 45min of 1X PK;  
For 72hpf: 45min of 2X PK;  
For 96hpf: 45min of 3X PK;  
For 120hpf: 45min of 4X PK.  
PK treatments were carried out on a platform rocker at RT, and embryos 
were then re-fixed in 4% PFA for 20mins. Embryos were then washed in PBSTx 
another five times for 10mins each, and „blocked‟ in IB for at least one hour at RT. 
Embryos were then incubated in IB with primary antibody at 4
o
C overnight (see 
Table 2.1 for appropriate dilutions). 
 
 
Chapter 3: Results (I) 
 
74 
 
 
Table 2.1  Primary antibodies 
 
Antibody Species Company Application Dilution 
 
anti-mCherry 
 
Rabbit 
 
MBL International 
(PM005) 
 
IHC 
 
1:500 
 
anti-GFP 
 
Rabbit 
 
Invitrogen (A6455) 
 
IHC 
 
1:500 
 
anti-calretinin 
 
Rabbit 
 
Swant (7699/3H) 
 
IHC 
 
1:500 
 
anti GnRH (LRH13) 
 
Mouse 
 
Gift from K. Wakabayashi 
(Gunma University, Japan) 
 
IHC 
 
1:200 
 
anti-acetylated tubulin 
 
Mouse 
 
Sigma-Aldrich (T6793) 
 
IHC 
 
1:1000 
 
anti-phospho-p44/42 
MAPK (Erk1/2) 
(Thr202/Tyr204) 
 
Rabbit 
 
Cell Signalling Technology 
(#9101) 
 
IHC 
 
1:500 
 
anti-anosmin1a 
 
Rabbit 
 
Gift of N. Soussi-
Yanicostas (INSERM, 
France) 
 
IHC 
WB 
 
1:500 
1:2000 
 
anti-anosmin-1b 
 
Rabbit 
 
Gift of N. Soussi-
Yanicostas (INSERM, 
France) 
 
IHC 
WB 
 
1:500 
1:2000 
 
anti-GAPDH 
 
Rabbit 
 
Abcam (ab8245) 
 
WB 
 
1:5000 
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If Alexa-488 (green fluorescent) or Alexa-594 (red fluorescent) secondary 
antibodies (Invitrogen) were used, embryos were then mounted and visualised using 
confocal microscopy. 
Alternatively, if HRP-conjugated secondary antibody was used, a DAB 
(3,3′-Diaminobenzidine) colour reaction was then carried out using SigmaFast DAB 
reagent (Sigma-Aldrich), as per the manufacturer‟s instructions.  Embryos were 
incubated in SigmaFast DAB for approximately 10 minutes at RT, so that a „brown 
precipitate‟ could form wherever immuno-complexes were present. When sufficient 
labelling was achieved, the DAB reaction was stopped („quenched‟) by removal of 
the DAB reagent and application of several PBSTx washes. Embryos were then 
brought into 80% (v/v) glycerol/PBS (mountant), via 30% (v/v), then 50% (v/v) 
glycerol/PBS washes, and visualised by standard compound light microscopy. 
 
2.3.2  Anti-GnRH (LRH13) 
LRH13 is a monoclonal antibody which detects GnRH1 or GnRH3 
decapeptide (but not GnRH2) from birds, mammals, and fish (Park and 
Wakabayashi, 1986).  
Because the GnRH decapeptide is very small, two modifications to the 
above protocol were applied. Embryos were fixed for 2 hours at RT in 4% PFA 
supplemented with 7% (v/v) saturated picric acid. Also, instead of PK treatment, 
embryos were permeabilised using ice-cold acetone at -20
o
C for 10mins. 
 
2.3.3  Anti-anosmin-1a/-1b and anti-pERK 
Embryos were fixed in 5ml of memfa fix at 4
o
C overnight. The next day, 
2.5ml of fix was replaced with 2.5ml of ice-cold ethanol, and agitated on a rocker 
(in an ice bucket) for 10 minutes. The 50% (v/v) fix/ 50% (v/v) ethanol was then 
replaced with 100% ice-cold ethanol, and repeated for another 10mins; and then 
repeated again for another 30mins with new ethanol. 2.5ml of ethanol was then 
replaced with 2.5ml ice-cold PBS for another 10mins (still on ice). The ethanol/PBS 
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was then replaced with PBS for another 10mins. The embryos were then removed 
from the ice and allowed to return to RT in new ice-cold PBS, followed by five 
washes in PBSTx. The standard immunohistochemistry protocol (2.3.1) was then 
followed, but without the PK permeabilisation/ post-fix steps. 
 
2.3.4  Anti-acetylated tubulin 
Embryos were fixed in 2% (v/v) TCA fixative for 2hrs at RT, and then 
washed five times in PBSTx for 10 minutes each. They were then blocked for 1-2 
hrs at RT in ‘TCA block buffer’, and then subsequently incubated in anti-
acetylated tubulin antibody (diluted in „TCA block buffer‟) overnight at 4oC. The 
standard protocol (2.3.1) was then followed for post-primary antibody incubation. 
 
2.3.5  Cryostat sections 
Cryostat sections of embryos that were adhered to glass slides were washed 
in PBSTx several times, before being blocked in IB. A hydrophobic layer was then 
marked around the cryostat section, and a „droplet‟ of antibody (diluted in IB) was 
placed on top of the section. This was then kept in a moist box in the fridge 
overnight. The standard protocol (2.3.1) was then followed, but with secondary 
antibody applied in this same manner. 
 
2.3.6  Vibratome sections 
Dissected chick embryo heads or adult zebrafish brains were fixed and then 
embedded in 3% agarose, before being sectioned using a vibratory microtome 
(„Vibratome‟). Immuno-labelling was then carried out as described in 2.3.1 on these 
„free-floating‟ sections in vitro (without the PK treatment step). 
Note: All cryostat and Vibrotome sectioning was carried out by Dr Laxmi Iyengar. 
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2.4  In situ hybridisation for whole embryos 
2.4.1  DIG-labelled probe synthesis 
The following reaction mix was assembled for synthesising antisense probe 
(all reagents from Roche): 11.5l of Nuclease-free H2O; 4.0l of „5X‟ transcription 
buffer; 2.0l of DIG-labelled nucleotide mix; ~1.0l linearised plasmid* (from 
~1mg/ml stock); 0.5l of RNase inhibitor; 1.0l of polymerase. The reaction was 
then incubated at 37
o
C for 2 hours. The DIG-labelled RNA probes were then 
purified using a microspin G-50 column (GE Healthcare). 
* Unless otherwise specified, all plasmids used to synthesise DIG-labelled 
probes were kindly provided by the following research groups (see references for 
experimental details): GnRH2 & GnRH3 (Palevitch et al., 2007); Fgfr1a (Scholpp 
et al., 2004); Fgfr1b (Rohner et al., 2009); Fgfr2 (Tonou-Fujimori et al., 2002); 
Fgfr3 (Sleptsova-Friedrich et al., 2001); Fgfr4 (Thisse et al., 1995); Fgf3 (Walshe 
et al., 2002); Fgf8a (Shanmugalingam et al., 2000); Fgf8b (Reifers et al., 2000); 
Sprouty4 (Furthauer et al., 2001); Dusp6 (Tsang et al., 2004); Kal1a & Kal1b 
(Ardouin et al., 2000).  
Kiss1, Kiss2, Gpr54a, and Gpr54b were all previously cloned into a TOPO 
vector (Invitrogen) using full length coding sequences for each gene (Cadman et al, 
unpublished). Kiss1, Gpr54a, and Gpr54b plasmids were linearised with SacI and a 
T7 polymerase was then used for probe synthesis; whereas for Kiss2, NcoI was used 
for linearisation, and an SP6 polymerase was used for probe synthesis. 
  
2.4.2  Embryo fixation and dehydration 
 Embryos were fixed in 4% PFA for 3 hours at RT, or overnight at 4
o
C. 
Embryos were then washed three times in PBSTw for 10mins each; followed by one 
wash in 1:1 PBSTw/methanol, and then two washes in 100% methanol, and then 
stored at -20
o
C overnight (or up to 2 months). 
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2.4.3  Hybridisation with RNA probe 
The zebrafish embryos were rehydrated through 1:1 methanol/PBSTw, and 
then PBSTw. They were then washed three more times in PBSTw at RT, before 
undergoing PK treatment as described in section 2.2.1 (except the PK was diluted in 
PBSTw)*. Embryos were then washed briefly 3 times in PBSTw, re-fixed in 4% 
PFA for 20mins at RT, and then washed another four times in PBSTw (5mins each 
wash). Embryos were then rinsed twice (5mins each) in 1:1 PBSTw/hybridisation 
(hyb) solution, and then transferred to 100% hyb solution and incubated at 65
o
C for 
at least 30mins. Embryos were then incubated overnight at 65
o
C in hyb solution 
containing 1g/ml RNA probe. 
 
2.4.4  Incubation with anti-DIG antibody 
Probes were removed the next day and embryos were rinsed once with pre-
warmed hyb solution (used probes were kept at -20
o
C, and used 1-2 more times). 
Embryos were then washed twice in 1:1 hyb solution/MABT for at least 30mins and 
then rinsed three more times in MABT for 5mins each at RT. Embryos were then 
pre-incubated in GS/BBR blocking buffer for 2-3 hours at RT, before incubation 
overnight at 4
o
C in anti-DIG-AP antibody (Roche) at a dilution of 1:2000 in the 
same blocking buffer. 
The next day, embryos were rinsed briefly at least 3 times with MABT, and 
then washed three times for 1 hour each in MABT at RT. Embryos were then rinsed 
with NTMT (pH9.5) and then transferred to a multi-well plate. Embryos were then 
incubated at RT with NTMT containing 20l/ml NBT/BCIP stock solution (Roche), 
until the appropriate „purple‟ staining was achieved. Embryos were then transferred 
to 80% (v/v) glycerol/PBS, ready for analysis by standard optical microscopy. 
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2.5  Molecular biology techniques 
2.5.1  DNA electrophoresis 
A 1.5% agarose in TAE gel containing 0.5μg/ml ethidium bromide was used 
to analyse DNA and RNA products diluted in 10X „Orange G‟ loading dye to a final 
1X concentration and run at 150V with 1μg of 1Kb plus DNA Ladder (Invitrogen). 
A UV illuminator with camera was then used to visualise and photograph the gel. 
 
2.5.2  Genomic DNA extraction from zebrafish embryos 
Approximately fifty 96hpf embryos were killed by tricaine-overdose and 
added to a 1.5ml tube. All liquid was removed from the tube and replaced with 
200l of DNA extraction buffer (DExB) and then incubated at 50oC for 3 hours, 
with vortexing every 10-20mins. 500l of ethanol was then added, and the tube 
placed on ice for 30mins. This was then centrifuged on full speed for 10mins, and 
the supernatant was removed. The pellet was then washed with 500l 70% (v/v) 
ethanol and centrifuged again for 2mins. The resulting pellet was then dried and 
resuspended in 20l of nuclease-free water and stored at -20oC. 
 
2.5.3  RNA extraction from zebrafish embryos 
The following protocol describes the extraction of RNA from a single 
embryo, but can the same protocol was used to extract RNA from a „pool‟ of 
embryos, by multiplying all reagent volumes, as appropriate. 
One embryo was added to 100l Trizol (Invitrogen) in a 1.5ml tube and 
lysed by pipetting until the embryo fully dissolved, and was then incubated at RT 
for 5mins. 20l of chloroform was then added and the tube was flicked vigorously 
for 15secs, and then incubated at RT for 2-3mins. The tube was then centrifuged at 
4
o
C at 10,000rpm for 10mins in an Eppendorf desktop centrifuge. The „upper layer‟ 
was then transferred into a fresh tube and precipitated with 50l of isopropanol. 
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This was incubated at RT for 10mins and then centrifuged again, as above. The 
resulting pellet was then washed with 100l of 75% (v/v) ethanol and centrifuged 
again, but this time at 6,000rpm for 5mins (at 4
o
C). The pellet was then air dried for 
several minutes, and then resuspended in 20l of nuclease-free water. 
 
2.5.4  cDNA synthesis  
1l of N6 random primer (from Transcriptor reverse transcriptase kit, Roche) 
was added to 14l of RNA sample, which had been extracted as described in section 
2.5.3. The tube was then placed on a 95
o
C heat-block for 5mins, and then put 
straight back on ice again. The cDNA synthesis reaction was then assembled on ice 
by adding the following components (all from Roche): 2l 10X RT buffer, 2l 
(5mM) dNTPs, 0.5l (5U) RNase inhibitor (Roche), and 0.5l (2.5U) Reverse 
transcriptase. The reaction was then allowed to proceed for 2 hours at 37
o
C, and the 
resulting cDNA was then used in a standard PCR reaction (section 2.5.5). Therefore 
the entire „RT-PCR protocol‟ consists of sections 2.5.3 through to 2.5.5. 
 
2.5.5  Polymerase chain reaction (PCR) 
The following standard PCR reaction was assembled (see Table 2.2 for 
primer sequences): <1μg of DNA* diluted with 10X HotStarTaq buffer (Qiagen) to 
a final concentration of 1X with nuclease-free water and 5M of forward and 
reverse primer, 5mM dNTPs (Roche), and 2.5 units of HotStarTaq Polymerase 
(Qiagen), to a final volume of 25l. * cDNA (from 2.5.4) or genomic DNA (from 
2.5.3). 
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Table 2.2  Primer sequences 
 
Name Nucleotide sequence (5’ 3’) Annealing 
 temp (
o
C) 
for PCR 
Expected  
product size 
(bp) 
 
GnRH3 promoter (For) 
GnRH3 promoter (Rev) 
 
CCACTAGTCTCACATGAATGTGATTG 
CCGGATCCGCTAAAACTAAAACACAG 
 
55 
 
2432* 
 
Whole Kal1a (For) 
Whole Kal1a (Rev) 
 
GCTCTAGAATGCGCGACGGGCTCACC 
GCGTCGACTCAGTGACGTTCAATCAC 
 
55 
 
1966 
 
Whole Kal1b (For) 
Whole Kal1b (Rev) 
 
GGTCTAGAATGCTGCTTTTGAGGAATCTCT 
GGGTCGACTCAGTGGATGGTGCTGTTTAAA 
 
62 
 
1910 
 
Fgf8b Exon1(For) 
Fgf8b Exon5(Rev) 
 
AATACCGCGAGGAAACAATG 
AACTTATGTGTGGCTTGGGC 
 
58 
 
1486 
 
Kal1a Exon1 (For)  
Kal1a Exon7 (Rev) 
 
GGGAGTTGAAAGACGGACCTTG 
TGAGTTTGGGTGGCAGATTGTG 
 
55 
 
750 
 
Kal1b Exon1 (For) 
Kal1b Exon6 (Rev1)  or 
Kal1b Exon7 (Rev2)** 
 
TGTGTGTTTGAGGTGAGCGTTG 
AGAAATGCTTGCTGGGAGTGG 
CTCCCACAGGACCAGAACAC 
 
62 
 
62 
 
754 
 
858 
 
GAPDH (For) 
GAPDH (Rev) 
 
TCAATGGATTTGGCCGTATT 
GAGCTGAGGCCTTCTCAATG 
 
55 
 
306 
 
   *Encompassing nucleotides 365–2797 (Genbank no.: AF490354) of the zebrafish 
GnRH3 promoter (Palevitch et al, 2007). 
**This reverse primer is used for the RT-PCR confirmation of the Exon 6 Kal1b 
splice („KB6‟). 
***Genbank codes: Kal1a: AF163310; Kal1b: AF163311; Fgf8b: NM_182856; 
GAPDH: AY818346 
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Standard PCR cycle parameters 
Using a Thermocycler (Eppendorf), the following standard PCR cycle was 
used: 
[1] 95
o
C for 15mins  
[2] 45 cycles of:  
(i) 95
o
C for 40sec;  
(ii) 52
o
C** for 50secs;  
(iii) 72
o
C for 1min*** 
[3] 72
o
C for 10mins  
 
**See Table 2.2 for specific annealing temperatures 
***1 minute of extension time for every 500bp of DNA template  
 
2.5.6  DNA digestion by restriction endonucleases 
1μg of plasmid DNA was diluted in 10X enzyme buffer (Roche) to a final 
1X concentration with nuclease-free water (Sigma) and 5 units of desired restriction 
endonuclease(s) (Roche). This reaction was then incubated at 37
o
C for 1-2 hours. 
Digestion products were either loaded on to a 1.5% agarose gel and extracted using 
a „Gel Extraction kit‟ (Qiagen), or purified directly using a „PCR purification kit‟ 
(Qiagen). 
 
2.5.7  Plasmid ligation, transformation, and purification 
Linearised vector DNA (100ng) was added to desired „insert DNA‟ at a 
molar ratio of 1:3 or 1:6 to give a final volume of 10l. 10l of 2X quick ligation 
buffer (NEB) was added to this reaction mix, followed by 1μl of T4 DNA „quick‟ 
ligase. This was then incubated for 5 minutes at 25
o
C, and then chilled on ice.  
When transforming sub-cloned fragments, XL10-Gold „ultracompetent‟ cells 
(Stratagene) were used, due to their greater efficiency at taking up ligated DNA. At 
all other times, XL1-Blue „competent‟ cells (Stratagene) were used for general 
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cloning of supercoiled plasmids. In both cases, the standard manufacturer‟s 
protocols were used. 
Miniprep kits (Qiagen) were used according to manufacturer‟s instructions 
in order to extract and purify plasmid DNA from single bacterial clones that were 
grown in either LB or 2YT media, supplemented with appropriate antibiotics. 
 
 
 
2.6  Cloning strategies 
2.6.1  Constructing pGnRH3:mCherry 
- PCR amplification of the GnRH3 promoter 
The previously described ~2.4kb zebrafish GnRH3 promoter region was 
PCR amplified from zebrafish genomic DNA as described in section 2.2.3.2 and 
2.2.3.5, but with the following modifications. Standard PCR was used (see above), 
with an annealing temperature of 55
o
C and an extension time of 6mins. Moreover, 
when the first round of PCR had finished, 1l of the PCR reaction was removed and 
used in place of the genomic DNA in a second round of PCR, thus greatly 
amplifying the otherwise low amount of PCR product. Also, the PCR primers that 
were used introduce SpeI and BamHI sites at the 5‟ and 3‟ ends, respectively (see 
Table 2.2). 
- Cloning mCherry into I-SceI plasmid 
The mCherry coding sequence was cut from the pBA2-memb-mCherry 
plasmid (Shaner et al., 2005) by AgeI/ApaI digestion, and then cloned into the 
XmaI/ApaI site of the I-SceI pBS SK+ (Stratagene) plasmid. 
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- Cloning GnRH3 promoter into the I-SceI-mCherry plasmid 
The GnRH3 promoter PCR product was gel purified (as described above). 
This was then digested with SpeI/BamHI and gel purified again.  This was then 
cloned into the XbaI/BamHI site of the I-SceI-mCherry plasmid (see Figure 2.01A). 
 
2.6.2  Sub-cloning pOMP:TauEGFP transgene into I-SceI 
vector 
The I-SceI plasmid was digested with SpeI, gel-purified, and then treated 
with Antarctic phosphatase (NEB), following manufacturer‟s instructions, to 
prevent re-ligation of the digested vector. The whole pOMP:tauEGFP transgene 
(Yoshida et al., 2002) was then removed from its original vector by SpeI digestion, 
and cloned into the SpeI-digested I-SceI vector (see Figure 2.01B).  
 
2.6.3  Cloning Kiss1, Kiss2, Gpr54a, Gpr54b into pBUT3 
and hsp70l:MCS-IRES-EGFP plasmid 
Full length Kiss1, Kiss2, Gpr54a, and Gpr54b were previously PCR-
amplified and cloned into TOPO vectors (unpublished, S. Cadman et al). For this 
current project, these full length coding sequences were sub-cloned into the pBUT3 
vector, which, by addition of extra 5‟ and 3‟ sequences, improves the stability of the 
in vitro transcribed mRNA. Using standard PCR conditions (see above), with an 
annealing temperature of 58
o
C and an extension time of 4mins, the full length Kiss1, 
Kiss2, Gpr54a, and Gpr54b were amplified from their TOPO plasmids using 
primers designed to introduce XbaI/SalI sites at the end of the coding sequences (see 
Table 2.2). These PCR products were then XbaI/SalI digested, gel-purified, and  
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Figure 2.01   I-SceI plasmid constructs for transgenesis
A illustrates the pGnRH3:mCherry construct and B shows the
pOMP:tauEGFP construct. Both transgenes are flanked by I-SceI recognition
sites (in yellow), which had previously been incorporated into a pBluescript
vector (pBS SK+) scaffold.
A
B
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cloned into the XbaI/SalI site of the pBUT3 or Heat-shock (hsp70l:MCS-IRES-
EGFP) vectors. 
 
2.6.4   Cloning Kal1a and Kal1b into pBUT3 plasmid 
Full length Kal1a and Kal1b sequences were PCR-amplified from zebrafish 
whole embryo cDNA, using primers that introduced XbaI/SalI and cloned into 
pBUT3, as described in section 2.2.4.3. Subsequently, the plasmids were fully 
sequenced to ensure that there were no errors introduced to the Kal1a/Kal1b 
sequences during this process.  
 
 
 
2.7  In vitro transcription of Kiss1, Kiss2, 
Gpr54a, Gpr54b, Kal1a, and Kal1b 
 
2.7.1  ‘Capped’ mRNA synthesis 
The pBut3 plasmids were linearised by digestion with SfiI, gel-purified, and 
then eluted into nuclease-free water. An mMESSAGE mMACHINE T3 kit 
(Ambion) was then used to in vitro transcribe „capped‟ RNA from these linearised 
plasmids by assembling the following reaction: 10l of 2X NTP/CAP, 6l of 
linearised plasmid (~1g), 2l of  10X reaction buffer, and 2l of T3 RNA 
polymerase. This reaction was then allowed to proceed for 2 hours at 37
o
C. 
 
2.7.2  mRNA purification & quantification 
1μl RNAse-free DNAse was then added to the reaction mix and incubated at 
37°C for a further 15mins. 15μl of ammonium acetate „stop‟ solution was then 
added, followed by 115μl of nuclease-free water and mixed thoroughly by pipetting. 
The RNA was then precipitated by adding 115μl of isopropanol, mixed again, and 
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then placed at -20°C for 15 min.  This was then centrifuged at 14,000rpm for 15 min 
using a desktop centrifuge, and the resulting pellet was washed three times with 
70% (v/v) ethanol, and centrifuged at 14,000rpm for 5mins between each of these 
washes. All traces of ethanol were removed and the pellet was then dried for 20mins 
at RT. Finally, the mRNA pellet was re-suspended in 20μl of nuclease-free water 
and quantified using standard UV spectrophotometry. The RNA was also run on a 
1% agarose gel to confirm the stability of the mRNA, and then stored as single-use 
aliquots at -80°C. 
 
 
2.8  Zebrafish embryo micro-injections 
 
Using a microinjection needle and Pico-Spritzer apparatus, zebrafish 
embryos were injected at the 1-cell or 2-cell stage with a droplet of morpholino, 
RNA, and/or DNA at a size of 1/8 of the diameter of the embryo yolk. Prior to 
microinjection, morpholinos and DNA (but not RNA) were diluted to a final 
concentration of 1X using 5X MO buffer, to aid in the visualisation of the droplet 
size and embryonic localisation. 
 
2.8.1  Plasmid DNA micro-injection 
There are two commonly used approaches for generating stably transgenic 
zebrafish. The first approach involves linearising the plasmid DNA construct 
(containing desired transgene) with a specific restriction endonuclease, then simply 
injecting the linearised DNA into the cell of one-cell-stage embryos. The other 
common approach (see section 2.6.1) is to use a vector which has the transgene 
flanked by two I-SceI recognition sites. I-SceI is a meganuclease, which is similar to 
a restriction endonuclease, but has a large 18bp recognition sequence. With this 
approach, the plasmid construct is pre-incubated with the I-SceI meganuclease 
before micro-injection into the one-cell-stage embryos. The I-SceI recognition 
sequence is predicted to be absent from the zebrafish genome, so the exact method 
of genome integration is unknown. However, it is believed that the I-SceI pre-
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incubation makes the flanking ends of the transgene highly recombinogenic, causing 
the transgene to integrate very early (at the one cell stage), thus increasing the 
likelihood of germ-line transmission (Rembold et al., 2006). 
 
Generating stable transgenic zebrafish (the I-SceI meganuclease 
approach) 
i.e. pGnRH3:mCherry; pOMP:tauEGFP  
The following reaction was assembled on ice one hour prior to micro-
injection: 300ng of plasmid DNA was diluted with 10X I-SceI buffer (NEB) to a 
final concentration of 1X with nuclease-free water and 2.5U of I-SceI enzyme 
(NEB) to a final volume of 10l. This was incubated at RT for 1 hour. Then, 2l of 
MO buffer was added and the tube was placed on ice. This was then micro-injected 
into the cell cytoplasm of one-cell stage embryos, using a droplet size of 
approximately 1/10 diameter of the cell. Injected embryos were then incubated at 
28.5
 o
C overnight, and then visualised at ~24-36hpf using a fluorescent microscope. 
All fluorescent embryos were separated and allowed to mature into adult zebrafish 
in the fish facility. When they reached sexual maturity (~3 months), these F0 fish 
were crossed with wild-type fish in order to identify any stable transgenic carriers. 
 
Transient transgenesis 
i.e. pGnRH1(Medaka):EGF; pGnRH3(Medaka):EGF 
When only transient transgenesis was required, the whole circular plasmid 
DNA containing the transgene was microinjected at a concentration of 30ng/l. 
 
 
2.8.2  RNA micro-injection 
In vitro transcribed Kal1a/ Kal1b mRNA (section 2.2.5) was micro-injected 
at concentrations of 0.5-2.0μM (0.05-0.2μg/μl) to determine the optimal 
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concentration. For the over-expression experiments, Kal1a and/or Kal1b mRNA 
was injected as described above, but without any 5X MO buffer. Similarly, for the 
„rescue experiments‟, Kal1a/Kal1b mRNA was diluted to the same pre-determined 
optimal concentration with the Kal1a/Kal1b morpholinos. 
 
 
2.8.3  Morpholino micro-injection 
An antisense oligonucleotide (morpholino) approach was used to 
knockdown Fgf8a, Fgf8b, Kal1a, and Kal1b gene function in the zebrafish (see 
Table 2.3 for specific morpholino sequences). There are two types of morpholinos 
that Gene Tools (Oregon, USA) provide: one which blocks translation of the target 
gene („translation-blockers‟), and the other which blocks its correct splicing („splice-
blockers‟). The mechanism for how both types of morpholino work is demonstrated 
in Figure 2.02. Upon arrival, the lyophilised morpholinos were reconstituted in 
nuclease-free water to a final concentration of 5mM, and then stored at -80
o
C in 5l 
aliquots.  
To determine the optimal concentration, each morpholino was initially 
diluted to a final concentration of 0.5mM, 1.0 mM, 1.5 mM, and 2.0 mM. For the 
gene knockdown experiments, the morpholinos were then micro-injected at these 
pre-determined optimal concentrations (as described above). 
 
 
 
2.9  Lypophilic dye lineage tracing (DiI, DiD, 
and DiO) 
 
Whole embryo DiI labelling of external membranes was carried out using a 
previously described procedure (Dynes and Ngai, 1998). Specifically, 20hpf wild-
type embryos were dechorionated using watchmaker‟s forceps and then placed in a 
multi-well dish, with 1% agarose at the bottom of each well to protect the integrity 
of the embryos. A 250μM stock solution of DiI dissolved in DMSO was then added  
Chapter 3: Results (I) 
 
90 
 
 
 
Table  2.3 Morpholino sequences 
 
 
Name 
 
Sequence 
 
 
Optimal conc. 
(mM) 
 
Fgf8a (Sp.bl*) 
 
 
GAGTCTCATGTTTATAGCCTCAGTA 
 
 
1.0 
 
Fgf8b (Sp.bl) 
 
 
CTTATAAAACTGTGACTTGCCATGA 
 
 
1.5 
 
Kal1a (Tr.bl) 
 
 
GAGCCCGTCGCGCATCTTGAAGAAC 
  
 
1.0-1.5 
 
Kal1b (Tr.bl) 
 
 
GCAGAGATTCCTCAAAAGCAGCATC 
 
1.0-1.5 
 
KA4 
 
 
TTCAGGTCTTACCTCTGTAGAGGTT 
 
 
1.0 
 
KA6 
 
 
GTTGTTATCTGAAGCCCACCTTTAG 
 
 
2.0 
 
KB4 
 
 
GTGTGTTTTACCTTTGAACAGGTTG 
 
1.0 
 
KB6 
 
 
GAAAGAGTTTTGCTGTACCTCGCAC 
 
1.0 
 
coMO** 
 
 
CCTCTTACCTCAGTTACAATTTATA 
 
1.5 
 
*Sp.bl= splice blocking; Tr.bl=translation blocking 
** Standard control morpholino from Gene Tools (Oregon, USA) 
 
 
 
 
 
Chapter 3: Results (I) 
 
91 
 
Figure 2.02   The two types of morpholino
A illustrates the gene knockdown mechanism of the „translation-blockers‟ and
B illustrates the „splice-blockers‟. In A, the morpholino binds to a the „start
site‟ region of the target mRNA in the cytoplasm and prevents the initiation
complex from translating the RNA into protein. In B, the morpholino enters
the nucleus and binds to a specific exon-intron region of the pre-spliced target
mRNA. This results in the loss of an entire exon; resulting in an aberrant
„mis-spliced protein, which may be truncated or lack a certain amino acid
sequence. (Morpholinos are depicted in green).
Dr Jon D. Moulton of ‘Gene Tools’ (http://www.gene-tools.com), who holds the copyright
for these images, kindly allowed me to reproduce them here.
A: translation-blocking morpholino:
B: Splice-blocking morpholino:
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to each well containing embryos, to a final concentration of 2.5μM (dissolved in the 
aquarium water). Embryos were then incubated at 32°C for 45mins, rinsed several 
times in aquarium water, and then permitted to develop as usual at 28.5°C. Embryos 
were then visualised using confocal microscopy (using the „Cy3‟ filter) from around 
24hpf onwards to visualise the olfactory epithelium and other placodally-derived 
cells.  
The same procedure worked well using DiD, another lypophilic dye (using 
the „Cy5‟ filter); however, this procedure failed to work with DiO, as this lypophilic 
dye quickly precipitated out in aquarium water and therefore was not available to be 
absorbed by the cell membranes. 
 
 
2.10  FGFR inhibition strategies 
2.10.1  Using SU5402 inhibitors 
A 10mM stock of SU5402 (Mohammadi et al., 1997; Maroon et al., 2002; 
Walshe and Mason, 2003) dissolved in DMSO was added to dechorionated embryos 
(at 14hpf or 22hpf) in 1%-coated wells to final concentration of 100M. Embryos 
were then allowed to develop for 8-14 hours at 28.5°C before the SU5402 was 
removed and embryos could then develop as usual. See Figure 4.08 for a detailed 
summary of the SU5402 treatments that were carried out. 
 
2.10.2  Heat–shock using dnFGFR 
 HSP70:dnFGFR-EGFP (Lee et al., 2005) heterozygous carriers were bred 
together to obtain a clutch of embryos that were 50% dnFGFR  (EGFP-positive) and 
50% wild-type (EGFP-negative). These embryos were „heat-shocked‟ at 18hpf or 
22hpf by placing their dish into a 37°C incubator for 45minutes. From around 2 
hours later, all dnFGFR embryos could be identified by their green-fluorescence, 
and were separated from the non-fluorescent embryos (the „non-dnFGFR‟ controls). 
 
Chapter 3: Results (I) 
 
93 
 
 
2.11  Western blotting (immunoblotting) 
 
Immunoblotting was performed using standard procedures (Laemmli, 1970). 
Briefly, 10-20 embryos were dechorionated and added to 0.5ml of „ice-cold‟ triton 
lysis buffer (TLB-WB, see section 2.1.1). A needle with a very narrow aperture was 
then used to lyse the embryos completely, and then left on ice for 15 minutes to 
allow the completion of cell lysis. The resulting cell lysate was then centrifuged at 
high speed (13,000rpm) at 4
o
C, using a desktop centrifuge. The resulting 
supernatants were then transferred to new tubes, and the „total protein‟ yield was 
quantified on a spectrophotometer. Proteins were then separated electrophoretically 
using 10% acrylamide gels; transferred to nitrocellulose membranes; and probed 
with anti-anosmin-1a/-1b or anti-GAPDH antibodies (see Table 2.1). 
 
 
 
2.12  Microscopy 
Live embryos anaesthetised using tricaine and visualised in their Petri dish 
and visualised using a Leica MZFLIII dissecting microscope with or without 
fluorescence. 
All embryos stained by in situ hybridisation and some of the immuno-
labelled embryos, and adult/ embryo sections, were mounted in 80% (v/v) glycerol 
in PBS and visualised using a Zeiss Axioskop compound microscope.  
Most of the fluorescently labelled embryos, whether live or fixed, were 
mounted in 1% low melting point agarose in PBS and visualised using an Olympus 
FV500 confocal microscope, with Fluoview (Olympus) software analysis. 3D 
rendering analysis was carried out using bioView3D software (Center for BioImage 
Informatics, UCSB). 
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3.1  Introduction 
 
Comparative endocrinology of GnRH neuronal development has 
contributed greatly to our understanding of the human reproductive axis. 
Using morphological, physiological, molecular, and behavioural approaches, 
GnRH neurons have been studied extensively in many vertebrate model 
organisms, including mammals, birds, and fish.  
The ontogeny of the three GnRH neuronal systems of the adult teleost 
fish is, in fact, very similar to that of the amniotes. In particular, the two 
forebrain GnRH systems in the adult teleost are distributed in a similar way to 
other vertebrates, rostro-caudally along the ventral telencephalon and 
diencephalon, thus making the teleost, particularly the zebrafish, an attractive 
model for studying vertebrate GnRH system development in live, transparent 
embryos, in ‘real-time’. 
 
3.1.1  The zebrafish GnRH neuronal system 
At least 24 distinct forms of GnRH decapeptide have been described across 
different species. In most vertebrates, GnRH decapeptides are processed from the 
Establishing an in vivo system for modelling Kallmann 
syndrome: a characterisation of zebrafish GnRH and 
olfactory neuronal ontogeny 
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gene products of 2 to 3 GnRH genes present in their genomes. One of these 
decapeptides is found at each of three brain regions across mammals and fish: an 
„endocrine‟ type found at the hypothalamus/ preoptic area, and two 
„neuromodulatory‟ types present at the midbrain and terminal nerve/ nasal 
compartment (see Figure 3.01). The function of GnRH at the hypothalamus is 
known to be in the hormonal control of reproduction via its regulation of 
gonadotrophin secretion from the pituitary gland. However, less is known about the 
role of GnRH neurons at the midbrain and terminal nerve, other than their proposed 
„neuromodulatory‟ action on reproductive behaviour (Parhar, 2002). 
The GnRH2 decapeptide is highly conserved across most vertebrate species; 
however, the sequence of GnRH1 and GnRH3 differs throughout these species. The 
prevailing hypothesis for why there is an extra form of GnRH (GnRH3) in teleost 
fish, is that the GnRH1 gene duplicated in a teleost fish ancestor some time after its 
evolutionary split from the lineage that would eventually give rise to mammals. 
Whereas some fish, such as the medaka, have retained GnRH1 and GnRH3 (as well 
as GnRH2); other fish, such as the zebrafish, have lost GnRH1 from their genome 
and only retained GnRH3 and GnRH2 (Kuo et al., 2005). 
 
 
Hypophysiotropic GnRH system 
Although the GnRH1 gene is absent from the zebrafish genome, it has been 
shown that GnRH3 is expressed at the hypothalamus (as well as the terminal nerve) 
in zebrafish and has therefore likely assumed the hypophysiotropic role (regulation 
of pituitary gonadotrophin secretion) that is carried out by GnRH1 in humans, and 
in some other fish, such as the medaka (Palevitch et al., 2007; Abraham et al., 
2009). In proof of this, injection of mammalian kisspeptin-10 (a molecule 
implicated in the „molecular switch‟, which re-awakens GnRH pulsatile secretion at 
the time of puberty) into the flathead minnow (a fish belonging to the cyprinid 
family, which includes the zebrafish) increased GnRH3, but not GnRH2 secretion. 
This provided evidence that GnRH3 is the main hypophysiotropic form of GnRH in 
cyprinid fish that have only two forms of GnRH (i.e. GnRH2 and GnRH3) (Filby et 
al., 2008).  
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B
GnRH1/GnRH3
Figure 3.01   Vertebrate GnRH neuronal system
A: Table illustrating the different forms of GnRH expressed at the three well-
characterised GnRH-expressing brain regions.
B: schematic of a typical adult fish brain. „Purple dots‟ represent the
neuromodulatory GnRH populations of the terminal nerve and midbrain;
„orange dots‟ represent the hypothalamic GnRH population.
Figure 3.01 (B) modified from Trends Endocrinol. Metab 16, Whitlock,K.E, ‘Origin and
development of GnRH neurons.’, pp. 145-151, Copyright 2005, with permission from
Elsevier.
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Terminal nerve GnRH system 
GnRH is present within only some of the neurons of the terminal nerve 
(nervus terminalus), the rostral-most cranial nerve (“nerve 0”). In most vertebrates, 
the terminal nerve consists of a bundle of neurons embedded within olfactory or 
vomeronasal axons at the nasal cavity, except in sharks, where it is a separate nerve 
(Demski and Schwanzel-Fukuda, 1987; Whitlock, 2004). Although the terminal 
nerve GnRH system has been studied mainly in teleosts, the terminal nerve is also 
likely to be the main source of the GnRH-immuno-reactive fibres that are 
distributed throughout the mammalian olfactory system (Kawai et al., 2009). In fact, 
lesions of the terminal nerve cause deficits in male hamster mating behaviour, as 
well as abnormalities in male fish nest building behaviour (Wirsig and Leonard, 
1987).  This highlights the significant role played by the terminal nerve GnRH 
system in modifying how olfactory information is perceived, perhaps by altering the 
sensitivity to certain pheromones at reproductively auspicious times. In humans too, 
GnRH cells remain present in the olfactory epithelium throughout adulthood; 
however, their putative neuromodulatory role in this region remains speculative 
(Gonzalez-Martinez et al., 2004a). 
 
3.1.2  Zebrafish GnRH system development: controversial 
origins 
It has been extensively shown in amniotes that hypothalamic GnRH neurons 
originate in the olfactory placode, wherefrom they migrate across the nasal-
forebrain junction, through the basal forebrain and into the hypothalamus during 
early development. This well-characterised „migratory stream‟ is understood so well 
because the GnRH cells begin expressing GnRH soon after they are born in the 
medial olfactory placode (at E10.5 in the mouse, or stage 19 in the chick) and 
continue to express GnRH throughout their migratory route to the hypothalamus 
(Gonzalez-Martinez et al., 2004a).  
In most amniotes studied, including the chick and mouse, the GnRH cells 
appear to begin their migration soon after the first olfactory axons have extended 
towards the forebrain, and they are then believed to migrate along this olfactory (or 
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vomeronasal) axonal scaffold towards the forebrain. An analogous stage during 
zebrafish development is between 24-48hpf, when the olfactory placodes have 
formed and olfactory axonogenesis has begun. However, the exact involvement of 
olfactory axonogenesis during GnRH system development is not well understood in 
the zebrafish. In fact, it is has even been proposed that the hypothalamic GnRH 
neurons do not originate from the olfactory placode in zebrafish, but have an 
anterior pituitary placode origin instead. Moreover, the terminal nerve and midbrain 
GnRH cells have been proposed to originate from cranial neural crest cells 
(Whitlock, 2005a), but this requires confirmation.  
 
3.1.3  Two ‘waves’ of GnRH neuronal migration 
During human embryogenesis, GnRH cells are first detected in the terminal 
nerve region from 6 weeks gestation (Carniege Stage 17, CS17); although studies 
have shown that they are actually „born‟ at around 5.5 weeks (CS16) at the olfactory 
placode. By this stage, the olfactory axons have already established contact with the 
presumptive olfactory bulb anlage; however, actual olfactory bulb morphogenesis 
does not become truly distinct until around week 7 (CS19) (Gonzalez-Martinez et 
al., 2004a).  
Comparable results were also found in the rhesus monkey, where it was 
shown that there are in fact two „waves‟ of GnRH neuronal migration from the 
olfactory placode to the basal forebrain. At a stage equivalent to CS14, prior to 
olfactory bulb morphogenesis, the „early wave‟ of pioneer GnRH neurons 
establishes the migratory pathway; and this is followed by a „later wave‟ of GnRH 
migration around the time of olfactory bulb morphogenesis (as described above, in 
human embryos) (Cadman et al., 2007). This later wave of migrating GnRH neurons 
may form direct or indirect connections with the early wave GnRH neurons in order 
to reach the septo-preoptic hypothalamus, but this is yet to be fully established 
(Gonzalez-Martinez et al., 2004a). This work highlights the complexities of 
forebrain GnRH neuronal migration across different vertebrates, and emphasises 
that a „migratory stream‟ of GnRH neurons occurring in association with olfactory 
Chapter 3: Results (I) 
 
99 
 
axonogenesis, may not always be the entire explanation for how the forebrain GnRH 
neuronal system is formed during embryogenesis. 
 
3.1.4  The zebrafish olfactory system 
In zebrafish, the olfactory placodes (OP) appear as thickenings of the 
ectoderm at approximately 17-18 hours post-fertilisation (hpf) (Whitlock and 
Westerfield, 2000). These thickenings then invaginate by 32hpf to form the naris 
(the external part of the nasal cavity/ nose). At 22-24hpf the first axons extend from 
the OP into the CNS at the presumptive olfactory bulb region; these are the pioneer 
neurons and they establish the preliminary olfactory pathway (labelled green in 
Figure 3.02A).  The olfactory receptor neurons (ORNs, labelled red) extend their 
axons into the CNS, following the axons of the pioneer neurons (and thus replacing 
them) by approximately 48hpf, so that by 60hpf the outline of the zebrafish 
olfactory system has already been completed. In recent years, olfactory transgenic 
reporter fish have been developed, which has permitted „real-time‟ fluorescent 
visualisation of these pioneer and secondary (ORN) olfactory neurons in living 
embryos (Whitlock and Westerfield, 1998). 
Olfactory interneurons within the olfactory bulbs project their axons across 
the anterior commissure (Figure 3.02B-C), which allows communication between 
both sides of the olfactory system. In humans too, the anterior commissure serves to 
connect the two temporal lobes of the brain, but also contains decussating fibers 
from the olfactory tracts. As with other vertebrates, odorant perception is ultimately 
interpreted by higher regions of the brain, including the olfactory cortex, where the 
olfactory information has been relayed via the olfactory tract, which projects from 
the olfactory bulbs (Whitlock and Westerfield, 1998). 
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Figure 3.02   Zebrafish olfactory system development
A: Schematic diagram of the olfactory projections from one olfactory organ.
Pioneer axons are labelled in green, and olfactory receptor neurons are
labelled in red. B: Schematic diagram of the projections from the olfactory
bulb interneurons which cross the anterior commissure.
C: Schematic diagram of the brain commissures at approx 24hpf; with the
anterior commissure (AC) and post-optic commissure (POC) indicated in the
telencephalon. A and B are Ventral views; C is a lateral view.
OB= olfactory bulb; OE= olfactory epithelium; T= telencephalon; D=
diencephalon; SOT= supraoptic tract.
Figure 3.02 (A) is from Whitlock and Westerfield, 1998. Copyright 1998 by the Society for
Neuroscience. Figure 3.02 (B) adapted with permission from Development (Whitlock and
Westerfield, 2000).
C
A
POC
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3.1.5  Aims of this chapter 
The proposal that terminal nerve and hypothalamic GnRH neurons have 
completely different origins and developmental pathways in the zebrafish, even 
though they appear to occupy positions along the same migratory route into the 
forebrain, remains controversial. To improve our understanding of zebrafish 
forebrain GnRH system development, and in turn establish a „zebrafish model‟ for 
studying the molecular pathogenesis of Kallmann syndrome, the following aims are 
set out for this chapter: 
-To confirm spatial and temporal GnRH protein/ transcript expression during 
zebrafish early embryogenesis; and compare this expression with that from 
another teleost (the medaka) and an amniote (the chick). 
- To generate, and spatio-temporally characterise a stable transgenic GnRH3 
reporter zebrafish line, and use it to further understand GnRH neuronal 
migration to the hypothalamus, in „real-time‟. 
- To use olfactory transgenic reporter lines to characterise the involvement of 
olfactory and vomeronasal axonogenesis during forebrain GnRH neuronal 
migration. 
-To obtain a greater understanding of the origins of the hypothalamic GnRH 
neurons, and ascertain whether or not they have an olfactory placodal origin 
in zebrafish. 
-To investigate whether or not early embryonic upregulation of the 
kisspeptin/Gpr54 signalling pathway influences the development of the 
zebrafish GnRH neuronal system. 
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3.2  Results 
3.2.1  GnRH expression in the zebrafish: from 
embryogenesis to adulthood 
Adult GnRH immuno-expression  
GnRH immuno-labelling on a para-sagittal section of a 3 month post-
fertilisation (adult) zebrafish brain (Figure 3.03-A) demonstrated the expected three 
GnRH neuronal populations in the adult brain: at the telencephalon (terminal nerve/ 
olfactory region), diencephalon (preoptic area/hypothalamus), and the 
mesencephalon. There was also some unexpected immuno-labelling in other parts of 
the brain, including a very large cluster of cells at the centre of the 
rhombencephalon.  
Beginning at the anterior of the adult forebrain („TN‟, Figure 3.03-A), a few 
GnRH cells are detected along the olfactory nerve region (presumably in association 
with olfactory/ terminal nerve axonal fibres), projecting their axons throughout the 
whole of the olfactory bulb. These GnRH axons are then visualised coursing 
through the basal perimeter of the anterior telencephalon. Posteriorly, there is then a 
cluster of GnRH immuno-labelled cells in the preoptic area, as well as a large 
number of axonal processes throughout the posterior forebrain, including at the 
hypothalamic region. The GnRH immuno-labelled cells of the mesencephalon 
appear to mainly occupy the ventricular boundary regions of the tectum. 
Embryonic GnRH immuno-expression  
GnRH immuno-expression is first detected in zebrafish embryos from 
around 30-36hpf as a group of 3-6 cells medial to the olfactory pits; defined 
previously as the „terminal nerve GnRH cells‟. By 36hpf, these cells have extended 
axons towards the presumptive olfactory bulbs, and across both forebrain 
commissures: the anterior commissure (towards top, Figure 3.04A) and post-optic  
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TN
Preoptic area
OB
Tel
Hyp
B  Typical fish brain    
POA
A    Adult brain section
GnRH1/GnRH3
Figure 3.03   GnRH immuno-expression in the adult zebrafish brain
A: Anti-GnRH immuno-labelling in a parasagittal section of an adult (3
months post-fertilisation) female zebrafish brain. Anterior is to the left.
B: schematic of a typical adult fish brain. „Purple dots‟ represent the
neuromodulatory GnRH populations of the terminal nerve and midbrain;
„orange dots‟ represent the hypothalamic GnRH population.
Scale bar is 500m.
TN= terminal nerve; OB= olfactory bulb; tel= telencephalon; POA= preoptic
area; hyp= hypothalamus; mesencephalon; rhombencephalon. Figure 3.03 (B)
modified from Trends Endocrinol. Metab 16, Whitlock,K.E, ‘Origin and development of
GnRH neurons.’, pp. 145-151, Copyright 2005, with permission from Elsevier.
Mes
Rho
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commissure (towards bottom). These two forebrain commissures are illustrated in 
Figure 3.02C, from a lateral view; and, in Figure 3.02B, the olfactory bulb 
interneuronal projections which project across the anterior commissure are also 
demonstrated schematically. 
By 60hpf, the same GnRH expression was visualised, except now there was 
also some GnRH immuno-labelling within retinal cells in the eyes (Figure 3.04B). 
Conspicuously, there were no GnRH-positive cells detected in the hypothalamus 
(marked by an asterisk) by 60hpf. Moreover, it was not possible to visualise the 
„migrating‟ stream of hypothalamic GnRH cells which had previously been 
described at around 56hpf (Whitlock et al., 2005), using the same anti-GnRH 
antibody. To ensure that these „migrating‟ GnRH cells were not over-looked, 
embryos were fixed between 36-60hpf at 4hr intervals and immuno-labelled exactly 
how Whitlock and colleagues had described; this included using a HRP-conjugated 
secondary antibody with peroxidase anti-peroxidase („PAP‟) amplification and 
subsequent DAB colour reaction. However, it was still not possible to detect these 
„migrating‟ hypothalamic GnRH cells or indeed any hypothalamic GnRH cells at 
all, as seen in the representative image at 60hpf (Figure 3.04B‟). In fact, PAP 
amplification with DAB gave even less GnRH immuno-labelling than using a 
fluorescently-labelled secondary antibody, which, as mentioned above, also labelled 
the forebrain commissure projections. 
By 6dpf, there is still GnRH immuno-labelling at the terminal nerve, as well 
as GnRH-positive neuronal tracts extending across both forebrain commissures and 
the optic nerve (Figure 3.04C). Furthermore, there are also some GnRH-positive 
cells behind the eyes (indicated by an asterisk in Figure 3.04C), which may be 
trigeminal ganglion cell bodies. However, even by 6dpf it was still not possible to 
detect any GnRH-positive cell bodies in the hypothalamic region. To investigate 
whether „incomplete antibody penetration‟ could be the reason for this, GnRH 
immuno-labelling was carried out on 10m-thick sagittal cryostat sections of 60hpf 
(data not shown) and 6dpf (Figure 3.04D) embryos, in order to increase the 
exposure of the hypothalamic GnRH antigen to the anti-GnRH antibody. However, 
after checking all sagittal sections, only GnRH-positive terminal nerve cells could 
be detected at these stages.  
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Figure 3.04   GnRH immuno-expression during zebrafish embryonic 
development
Anti-GnRH immuno-labelling in zebrafish embryos at 36hpf (A), 60hpf (B)
and 6dpf (C, C‟, D). A, B, and D are confocal images; B‟, C, and C‟ were
treated with DAB and visualised using light microscopy. A-C are ventral
views; C‟ is a lateral view, and D is a parasagittal cryostat section. The
asterisk in A, B and D indicates the centre of the hypothalamic region.
Scale bars are 100m.
TN= terminal nerve; hyp= hypothalamus; e=eye
*
C C’ D
6dpf 6dpf 6dpf (cryostat section)
TN TN
TN
TN
hyp
36hpf 60hpf
A B
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           Throughout this project phenylthiourea (PTU) was added to the zebrafish 
embryos to keep them pigment-free beyond 24hpf, thereby keeping the embryos 
transparent and making microscopy/ photography easier. There have been some 
reports that PTU disrupts thyroid hormone production at the thyroid in developing 
zebrafish (Elsalini and Rohr, 2003). To ensure that PTU was not interfering with 
GnRH production at the hypothalamus as well, some embryos were allowed to 
develop in PTU-free water, and immuno-labelled for GnRH at 36hpf, 60hpf, and 
6dpf.  However, the resulting GnRH immuno-labelling was the same as that shown 
for the PTU-treated embryos shown in Figure 3.04. 
GnRH3 & GnRH2 mRNA expression 
Zebrafish have just two GnRH genes: GnRH3 and GnRH2. In situ 
hybridisation analysis using GnRH2 and GnRH3 antisense probes was carried out 
on zebrafish embryos from 1-15dpf. GnRH3 transcript was first detected at around 
30hpf in the terminal nerve region (Figure 3.05A) and this expression persisted 
through to 60hpf (Figure 3.05B) and 6dpf (Figure 3.05C). Post-in situ GnRH 
immuno-labelling demonstrated that GnRH3 transcript is localised to the same cells 
in the terminal nerve that were GnRH immuno-labelled (Figure 3.05B‟). Most 
GnRH3 transcript remains localised to the terminal nerve region by 6dpf (Figure 
3.05C), except in one anomalous case (n=1/24) where there was some GnRH3 in 
situ labelling in the diencephalic region by this stage (Figure 3.05D). By 15dpf, 
GnRH3 transcript remains localised to the terminal nerve/olfactory region, but 
labelling is faint and is obscured by pigment cells in Figure 3.05E. There is also 
some faint GnRH3 in situ labelling in the diencephalic-midbrain region at 15dpf 
(Figure 3.05E‟). 
GnRH2 transcript was first detected in the midbrain region at 30hpf (Figure 
3.05F), and remained localised to this region at 60hpf, 6dpf, and 15dpf (Figure 
3.05G-J). However, post-in situ GnRH immuno-labelling at 60hpf failed to co-label 
any midbrain cells expressing GnRH2 transcript. Notably, there was some GnRH2 
in situ labelling at the anterior commissure region in the forebrain at 60hpf and 
15dpf, which closely abuts the GnRH immuno-labelled terminal nerve GnRH3 cells. 
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Figure 3.05   Zebrafish GnRH3 & GnRH2 in situ hybridisation expression 
analysis
Expression of GnRH3 (A-E) and GnRH2 (F-J) at 30hpf (A, F), 60hpf (B, H),
5dpf (C, D, I) and 15dpf (E, J). A-E are ventral views; F and H are lateral
views; G, I, and J are dorsal views. B‟ and G‟ show the overlay of anti-GnRH
expression (shown inset: B‟‟ and G‟‟) with GnRH3 (B) and GnRH2 (G)
transcript, respectively. The dotted box in E indicates the hypothalamic region
which is shown in more detail in E‟, demonstrating very weak labelling.
TN= terminal nerve; hyp= hypothalamus; mb= midbrain
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3.2.2  GnRH expression in another teleost (medaka fish) 
and an amniote (the chick) 
Embryogenesis proceeds more slowly in the medaka, and by 2dpf there is no 
GnRH immuno-labelling in the forebrain; however, there was some immuno-
reactivity in the midbrain (Figure 3.06A), but this is no longer apparent from 3dpf 
onwards. At 3dpf terminal nerve GnRH immuno-labelling is first detected (Figure 
3.06B), and remains present at 5dpf (Figure 3.06C) and through to 7dpf (Figure 
3.06D). By 7dpf there is also GnRH immuno-reactivity in 2-4 cells in the 
hypothalamic region, as indicated by arrows in Figure 3.06D‟‟. 
Zebrafish and medaka both have GnRH2 and GnRH3 genes; however, 
medaka also have a third GnRH gene (GnRH1), which is homologous to the human 
GnRH1 gene; the form expressed by human hypothalamic GnRH neurons. Medaka 
GnRH1 and GnRH3 GFP-reporter plasmids provided to us (Okubo et al., 2006) 
were injected in to one-cell stage zebrafish embryos. These injected zebrafish 
embryos were then allowed to develop to 48hpf, and then subsequently fixed and 
subjected to GnRH immuno-labelling (Figure 3.07). Some embryos were also 
allowed to grow until 4dpf, but were found to lack any GFP expression by this 
stage, so were not analysed further. Zebrafish injected with either the GnRH1 or 
GnRH3 medaka reporter constructs showed GFP fluorescence in the terminal nerve 
cells, as confirmed by GnRH co-immuno-labelling of these cells. The 
pGnRH1(medaka):GFP-injected zebrafish embryos also had some telencephalic 
GFP fluorescent cells (Figure 3.07A), whilst those injected with 
pGnRH3(medaka):GFP showed some optic nerve GFP-fluorescence (Figure 3.07B). 
Furthermore, both constructs showed some GFP fluorescence in external epithelial 
cells, and, occasionally, in muscle-like cells along the trunk (data not shown). 
However, these latter occurrences of GFP fluorescence, whilst reproduceable, were 
not corroborated by anti-GnRH immuno-labelling, and could therefore just be 
experimental artefacts. 
GnRH immuno-labelling was also carried out on chick embryos at 
embryonic days 4 and 5 (E4 and E5), to permit a comparison of amniote and fish 
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GnRH system ontogenies, whilst also testing the reliability of the anti-GnRH 
antibody (LRH13). Weak GnRH immuno-labelling was first visualised in the 
olfactory epithelium of E4 chick embryos, Hamburger-Hamilton (HH) stage 20 
(data not shown). However, the GnRH immuno-labelling becomes much more 
prominent in the olfactory epithelium of E5 (HH St.26) embryos, as shown in a 
parasagittal section in Figure 3.06E. A „stream‟ of GnRH immuno-reactive cells can 
be seen along the entire process of the olfactory nerve as it extends towards the 
telencephalon (Figure 3.06E‟); although the telencephalon is not present in this 
section, it is located at the same level as the eye in subsequent sections (not shown). 
 
3.2.3  Generation and characterisation of a zebrafish 
pGnRH3:mCherry reporter line 
A 2.4kb genomic fragment of zebrafish GnRH3 promoter sequence (as 
determined previously (Palevitch et al., 2007)) was amplified and cloned upstream 
of mCherry coding sequence, flanked by two I-SceI recognition sites in a modified 
pBUT3 plasmid (Figure 3.08A). Approximately 100 wild-type embryos were 
injected with this pGnRH3:mCherry („G3MC‟) construct at the one-cell stage, using 
the I-SceI meganuclease approach (Rembold et al., 2006). These injected „F0‟ 
embryos were screened by fluorescence microscopy at 48hpf (Figure 3.08B), and 52 
were transferred to the fish nursery and grown to adulthood (i.e. beyond 3 months 
post-fertilisation). Of the 33 embryos that survived to adulthood, 4 stable transgenic 
G3MC carriers were isolated and named G3MC1 (strongest red fluorescence) 
through to G3MC4 (weakest fluorescence). All four carriers were outcrossed to 
wild-type fish, and their „F1‟ progeny were grown to adulthood and used to generate 
the „F2‟G3MC embryos that were used for the experiments in this thesis. 
The mCherry fluorescence pattern for all four carriers were carefully 
compared with each other, and were found to be identical (both spatially and 
temporally), despite the difference in fluorescence intensity between the four 
groups. Therefore, only G3MC-1 (now just called „G3MC‟) was used for all 
subsequent analysis and experiments because it showed the strongest G3MC  
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Figure 3.06   GnRH immuno-expression in another teleost (medaka fish) 
and an amniote (the chick)
Anti-GnRH immuno-labelling in medaka embryos at 2dpf (A), 3dpf (B), 5dpf
(C) and 7dpf (D); and an E5 (Hamburger-Hamilton stage 26) chick embryo
sagittal section (E). A-D and D‟‟ are ventral views; in D‟ the anterior axis is
projecting from the page. The inset in A shows midbrain labeling. D‟‟: Yellow
arrows indicate two hypothalamic immuno-stained cells. E-E‟‟: the dotted
boxes indicate the area which is amplified in the subsequent picture. Scale
bars are 100m (A-D) and 250m (E)
TN= terminal nerve; OE= olfactory epithelium, E5= embryonic day 5
TN TN
hypothalamus
eye
OE
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Figure 3.07   Transient expression of medaka pGnRH1:GFP and 
pGnRH3:GFP  reporter constructs in the zebrafish
A‟‟ and B‟‟: zebrafish transiently expressing pGnRH1:GFP and
pGnRH3:GFP constructs, respectively (shown in green). A‟ and B‟ shows the
corresponding anti-GnRH expression (in red) in these embryos; and the
overlay of this is shown in A and B, respectively. All views are ventral and
are at 48hpf. An asterisk indicates the hypothalamic region.
Scale bars are 100m.
TN= terminal nerve; ON= optic nerve
ON
TN TN
TN TN
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(‘G3MC’)
48hpf
Figure 3.08   Generation of a zebrafish pGnRH3:mCherry reporter line
A: Schematic of the zebrafish „pGnRH3:mcherry‟ plasmid (abbreviated as
„G3MC‟). B: An example of a G3MC-injected embryo at 48hpf: an asterisk
indicates the hypothalamic region. C is a ventral view at 48hpf of a G3MC
stable transgenic (in red). C‟ shows anti-GnRH immuno-staining of the same
embryo (in green): and C‟‟ shows the overlay. Scale bar 100m.
TN= terminal nerve; hyp= hypothalamus
TN TN
hyp
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fluorescence. This also helped to ensure that all G3MC phenotypes were consistent, 
and therefore comparable (that is assuming that there were no male/ female 
differences in GnRH3 expression during embryogenesis). 
To begin with, a time-course of mCherry fluorescence between 0hpf and 
120hpf was carried out in order to characterise the G3MC stable transgenic line 
(Figure 3.09). At least six embryos were visualised for each time-point, and the 
representative image for each is shown. mCherry fluorescence was first detected at 
20hpf in 2-4 cells at the dorsal part of the anterior neural tube (Figure 3.09A). By 
24hpf, there is now mCherry expression in 1-2 cells at the terminal nerve on one or 
both sides, directly medial to the olfactory pits (Figure 3.09B). By 26hpf, there are 
2-4 mCherry-positive terminal nerve cells on each side and they begin to project 
ventrally and/or dorsally to targets within the forebrain (Figure 3.09C). From around 
28hpf, some of these ventral projections extend across the forming anterior 
commissure in the telencephalon, whilst others project more caudally towards the 
diencephalon, across the developing post-optic commissure (Figure 3.09D). By 
32hpf, some mCherry-positive axons have now extended across the midline, 
traversing both forebrain commissures and the supra-optic tract (Figure 3.09F). 
From a lateral view at 30hpf, another group of mCherry cells behind the eyes 
become apparent: the trigeminal ganglion cells. These cells project to several targets 
in the midbrain, hindbrain and spinal cord/trunk (Figure 3.09E).   
From 32hpf (Figure 3.09E), mCherry cells begin to accumulate in the 
diencephalon, and by 36hpf (Figure 3.09G, G‟) they number between 20-50 cells, 
with an average of approximately 40 cells per embryo (cell counts were estimated to 
within an accuracy of 5 cells, across 20 different 36hpf embryos).  
By 60hpf, the presumptive hypothalamic mCherry cell number and position 
is similar to that specified for the 36hpf time-point; however, the fluorescence 
intensity is somewhat reduced, so some of the previously weak-fluorescent cells 
may no longer be detectable by 60hpf (Figure 3.09H). In contrast, the terminal nerve 
mCherry cells and associated forebrain tracts remain intensely fluorescent at 60hpf, 
as do the retinal mCherry cells and their associated optic nerve projections which 
had first became apparent at around 36hpf (Figure 3.09G, H). By 120hpf, the  
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Figure 3.09   Temporal characterisation of  the pGnRH3:mCherry stable 
transgenic line
The F2 generation from the G3MC carrier (out of a total of four carriers) with
the brightest fluorescence is shown here, and was used for all experiments
henceforward.
Except I, J and J‟ (which are light microscopy images), A-I‟ all show confocal
images of representative live-mounted G3MC embryos at 20hpf (A), 24hpf
(B), 26hpf (C; showing terminal nerve detail), 28hpf (D), 30hpf (E), 32hpf (F),
36hpf (G; with hypothalamic cells shown in more detail in G‟), 60hpf (H),
120hpf (I‟). J and J‟ show a fixed 60hpf embryo that was immuno-stained with
anti-mCherry, as shown by brown DAB precipitate.
A-D, F-H, and J are ventral views; E and J‟ are lateral views; I and I‟ are dorsal
views. The dotted box in J and J‟ indicates the hypothalamic mCherry-positive
cells at 60hpf from ventral and lateral views, respectively.
Scale bars are 100m.
OE= olfactory epithelium; TN= terminal nerve; AC= anterior commissure;
POC= post-optic commissure; Tg= trigeminal ganglion; hyp= hypothalamus;
OC= optic chiasm
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Figure 3.09   Temporal characterisation of  the pGnRH3:mCherry stable 
transgenic line
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terminal nerve and trigeminal ganglion mCherry cells have remained intensely 
fluorescent (Figure 3.09I), and there are extensive mCherry-positive axonal tracts 
across several commissures throughout the whole brain, but it is less easy to 
decipher which of these has emanated from the two aforementioned mCherry cell 
clusters, or perhaps new mCherry neuronal populations (Figure 3.09I‟). By 120hpf, 
it was no longer possible to distinguish a hypothalamic cluster of mCherry cells, 
presumably because they had, by then, stopped expressing mCherry. 
mCherry immuno-labelling (with DAB colour reaction) was carried out to 
confirm the localisation of the diencephalic mCherry cluster by 60hpf (Figure 3.09J, 
J‟). From these ventral and lateral views of the same embryo, it is immediately 
apparent that this cluster is indeed located within the hypothalamic region of the 
brain. To take this one step further, a hypothalamic-region reporter line, 
pNkx2.1a:YFP, was crossed with G3MC and the resulting embryos were visualised 
at 32hpf and 60hpf (Figure 3.09J, J‟). At 32hpf, the initial diencephalic mCherry 
cells are located within a cluster of Nkx2.1a (YFP-expressing) hypothalamic cells 
(Figure 3.10A) and remain so by 60hpf (Figure 3.10B), despite the increment in 
G3MC cell number in this region. Conspicuously, none of the hypothalamic G3MC 
cells actually co-express Nkx2.1a (YFP), as demonstrated in the inset, although they 
are clearly located within the exact same brain region (the hypothalamus).  
Finally, parasagittal sections of an adult zebrafish G3MC (3 months post-
fertilisation) whole brain were analysed for mCherry (GnRH3) expression (Figure 
3.11). To permit straightforward comparisons with the GnRH-immuno-labelled 
brain in Figure 3.03A, a female brain was again used. Consistently, mCherry 
expressing cells located along the olfactory nerve and anterior limit of the olfactory 
bulb, presumably the terminal nerve GnRH cells, were found to project to regions 
throughout the olfactory bulb (not present in section shown), as well as along the 
basal part of the anterior telencephalon, towards the preoptic area (Figure 3.11A‟‟). 
Within the preoptic area, and to a lesser extent within the anterior hypothalamus, 
scattered GnRH cells were also detected, mainly along the basal parts (Figure 
3.11‟). There were some other regions, especially in the mesencephalon, which had 
some mCherry expression, but for the most part it was not cellular. 
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A’’
A’A
32hpf
B B’
B’’
60hpf
G3MC
G3MC
Nkx2.1a:YFP
Nkx2.1a:YFP
Hyp 
Hyp 
TN 
AC 
POC 
Hyp 
TN 
EyeEye
Figure 3.10   Confirming regional identity for the presumptive 
hypothalamic population  in G3MC
G3MC was crossed with a hypothalamic reporter line: Nkx2.1a:YFP (shown in
green). Ventral views of this cross are shown in A and B; at 32hpf and 60hpf,
respectively. The corresponding images of G3MC alone (A‟ and B‟) and
Nkx2.1a:YFP alone (A‟‟ and B‟‟) are also shown. The inset in A shows a single
Z-layer from the corresponding total confocal stack in A; demonstrating a lack
of overlay between individual mCherry-positive cells and Nkx2.1a:YFP cells
within the hypothalamus. Scale bars are 100m.
TN= terminal nerve; AC= anterior commissure; POC= post-optic
commissure; hyp= hypothalamus
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A
B
A’
A’’
Die
Tel
Hyp 
POA
TN
GnRH3
Mes
Figure 3.11   mCherry expression in an adult G3MC brain
A: Parasagittal section of an adult (3 months post-fertilisation) female G3MC
brain. Anterior is to the left. B: Schematic of an adult fish brain (see 3.02(b)
for more details). The blue shaded area in B indicates the region of the brain
which is shown in A. The dotted box in A demarks the telencephalic-
diencephalic area which is shown in more detail in A‟; in turn, the terminal
nerve region demarked in A‟ is then shown in more detail in A‟‟. Scale bar is
250m.
Tel= telencephalon; Mes= mesencephalon; Die= Diencephalon; POA=
preoptic area; hyp= hypothalamus; TN=terminal nerve.
Figure 3.11 (B) modified from Trends Endocrinol. Metab 16, Whitlock,K.E, ‘Origin and
development of GnRH neurons.’, pp. 145-151, Copyright 2005, with permission from
Elsevier.
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           GnRH immuno-labelling was carried out on G3MC embryos at 48hpf to 
confirm the specificity of the mCherry fluorescence, i.e. whether it was reliably 
reporting GnRH3 expression (Figure 3.08C). Unfortunately it was not possible to 
use anti-mCherry to boost the mCherry fluorescence (post-fixation) because this 
antibody was not compatible with the anti-GnRH immuno-labelling protocol (and  
vice versa). However, the remaining mCherry fluorescence in the terminal nerve 
cells was sufficient to allow complete overlay with GnRH-immunoreactivity in 
these cells, and thus verifying their GnRH3 neuronal identity. However, as expected 
(see Figure 3.04B), there was no GnRH immuno-labelling of the mCherry-positive 
hypothalamic cells, meaning that these cells could not be definitively authenticated 
as „real‟ hypothalamic (i.e. hypophysiotropic) GnRH cells, using this strategy. 
 
3.2.4  The relationship between olfactory axonogenesis and 
early GnRH system development 
OMP (olfactory marker protein) is an early marker for a major subset of 
olfactory receptor neurons (ORNs), and the OMP promoter (pOMP) was previously 
shown to be a very reliable reporter for early olfactory axonogenesis (Yoshida et al., 
2002). Here, the pOMP:TauEGFP transgene („OMPG‟), provided by M. Mishina 
(Yoshida et al., 2002), was sub-cloned into a pBUT3 plasmid, so that it became 
flanked by two I-SceI recognition sites (Figure 3.12A), and then micro-injected into 
100 wild-type embryos (Figure 3.12B); once again using the I-SceI meganuclease 
strategy. However, on this occasion, of the 37 F0 adults that were screened, only 
one stable transgenic OMPG fish was identified. Unfortunately, in the subsequent 
OMPG F1/F2 offspring, initiation of GFP expression within the ORNs was a day 
later than previously reported by M. Mishina, i.e. from 48hpf onwards, instead of 
the expected 24hpf onwards.  This was sufficient to label the secondary „mature‟ 
ORNs at 60hpf (Figure 3.12C) and 96hpf (Figure 3.12D), but was inadequate for 
labelling the pioneer ORNs which are present between 24hpf and 36hpf.   
Fortunately, M. Mishina later agreed to provide us with their strain of stable 
transgenic OMPG fish which showed GFP expression in the ORNs from around 
24hpf onwards (when pioneer ORN axonogenesis is initiated), and this OMPG  
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BA
D
(‘OMPG’)
60hpf
OE
OB
4dpf        anti-GFP
F0 (OMPG injected)
F2 (OMPG carrier)
Figure 3.12   Generation of a zebrafish olfactory reporter line
A: Schematic of the zebrafish „pOMP:EGFP‟ plasmid (abbreviated as „OMPG‟).
B: An example of an OMPG-injected embryo at 4dpf, with an inset indicating the
morphology of the embryo. C shows a single olfactory pit from a 60hpf OMPG
stable transgenic (in green). D: Anti-GFP immuno-stained OMPG embryo at 4dpf
(brown DAB precipitate). Whilst OMPG labels a „ciliated-type‟ of olfactory
sensory neuron (OSN), the pTRPC2:Venus transgenic line labels a mutually
exclusive „microvillous-type‟ („vomeronasal-type‟) of OSN. To emphasize that
these two types of OSN are entirely separate, the TRPC2:venus olfactory pit in E
(at 60hpf) is shown in „magenta‟.
Scale bars are 50m. OE= olfactory epithelium; OB= olfactory bulb.
4dpf
E
60hpf
pTRPC2:Venus
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strain was used for all subsequent experiments in this thesis. Furthermore, 
Y.Yoshihara (Sato et al., 2005) kindly agreed to provide another stable transgenic 
line: pTRPC2:Venus, which labels a mutually exclusive „micro-villous type‟ 
(„vomeronasal-type‟) of ORN, in contrast to the „ciliated-type‟ of ORN labelled by 
OMPG. In Figure 3.12E, the TRPC2-positive ORNs are re-coloured in „magenta‟ to 
emphasise that these ORNs are an entirely separate subset, which show no overlap 
with those labelled by OMPG (Figure 3.12C). 
To investigate possible co-development of the G3MC terminal nerve cells 
with olfactory axonogenesis, the OMPG line was crossed with G3MC (Figure 3.13). 
Expression of both GFP (OMP) and mCherry (GnRH3) was first detected from 
around 24hpf, in embryos that had inherited both transgenes (Figure 3.13). By 
24hpf, olfactory axonogenesis has already begun, and a tightly fasciculated bundle 
of olfactory axons can be seen projecting towards the olfactory bulbs (Figure 
3.13A). At this stage, one or two terminal nerve G3MC cells are located medial to 
the olfactory epithelium, below where the olfactory axons are seen to emanate from 
the olfactory pit. However, despite this close proximately, there was no co-
expression of GFP (OMP) and mCherry (GnRH3) detected at this stage.  
In Figure 3.13B (at 28hpf) a small cluster of four terminal nerve G3MC cells 
(and up to four other low-expressing cells, on this occasion) are seen projecting 
towards (dorso-caudally) the ORN fasciculated bundle and also directly away from 
it. Figure 3.13C (at 32hpf) demonstrates this asymmetry that is often found during 
early terminal nerve axonogenesis, but is no longer noticeable by 60hpf onwards. 
There is no bias for this asymmetry; however, in the case of Figure 3.13C, on the 
left side, the terminal nerve projections are seen extending further dorso-caudally 
across the entire length of the olfactory axonal bundle, all the way to the 
presumptive olfactory bulb region of the telencephalon. This is in contrast to the 
right side where the axons do not extend as far dorso-caudally and „loop back‟ 
towards more caudal-ventral parts of the forebrain, as happens on the left side as 
well, to a lesser degree. Moreover, some axons were seen „looping back around‟ the 
olfactory pit itself, thus highlighting the seemingly close interactivity between the 
olfactory and terminal nerve GnRH systems. 
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Figure 3.13   Co-development of the G3MC terminal nerve and OMPG 
olfactory projections
G3MC (in red) was crossed with OMPG (in green) and a representative image
of one olfactory pit (A, B, D) or both pits (C) is shown at 24hpf (A), 28hpf
(B), 32hpf (C), and 36hpf (D). All olfactory pits were visualised by confocal
microscopy from a ventral view. A 3D-rendered image (using
BioView3D software) is shown in A. D‟ shows OMPG alone and D‟ shows
G3MC alone at 36hpf; whilst the overlay of the two is shown in D‟‟. The
dotted box in D highlights a single cell which co-expresses OMPG (GFP; in
the membrane) and G3MC (mCherry) throughout the cell: in the inset this is
shown in more detail as a single Z-layer from the total confocal Z-stack.
Scale bars are 25m.
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G3MCOMPG Overlay36hpf
Figure 3.13   Co-development of the G3MC terminal nerve and OMPG 
olfactory projections
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           Interestingly, by 36hpf, there was co-expression of mCherry (GnRH3) and 
GFP (OMP) in several (4-8) ORN cell bodies in the olfactory epithelium (Figure 
3.13D‟‟). A closer view of one such co-expressing cell is shown in the inset in 
Figure 3.13D‟; illustrating membrane-localised GFP (due to the „Tau‟ tag) with 
whole-cell localised mCherry. This finding may have implications for understanding 
the origin of the hypothalamic G3MC cells which also begin to appear during this 
stage of development, i.e. between 32-36hpf (see discussion). 
Figure 3.14A illustrates a typical anti-acetylated tubulin immuno-stained 
60hpf embryo with all newly formed neuronal tracts labelled with DAB brown 
precipitate, emphasising the outline of the olfactory system and its associated tracts 
at this time-point. Figure 3.14B reveals that there is still some mCherry/GFP co-
expression in the olfactory pits at 60hpf, and that the terminal nerve G3MC cells 
have maintained/increased their projections to the olfactory bulb regions and the 
forebrain commissures; particularly the anterior commissure. Whilst it is known 
(and seen in Fig.12A) that olfactory interneurons within the olfactory bulbs project 
their axons along the anterior commissure; it becomes apparent that significant 
number of these commissural tracts belong to the terminal nerve cells (Figure 
3.14B), thus providing further opportunities for the olfactory and GnRH systems to 
interact. 
The pTRPC2:Venus line, which labels the other major subset of ORNs, was 
also crossed with G3MC, and the resulting double transgenic embryo (at 36hpf) is 
shown in Figure 3.15. Whilst several mCherry-positive cells are again seen in the 
olfactory epithelium, none appear to co-express Venus (TRPC2), suggesting that 
only ciliated (OMP-positive) ORNs are capable of giving rise to these GnRH3 
(mCherry) cells at 36hpf.  In fact, there were some cells which did appear to co-
express mCherry and Venus (inset in Figure 3.15A‟). However, on closer 
inspection, it became apparent that these cells strongly expressed Venus (YFP), so it 
seems likely that this membrane-only red fluorescence was just „bleed-through‟ 
from the YFP fluorescence, and not mCherry (GnRH3).  
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Anti-acetylated tubulin
Figure 3.14   Terminal nerve GnRH axons project across the anterior 
commissure
A: anti-acetylated tubulin immuno-stained embryo (with DAB), labelling all
neuronal tracts. B: Detailed view of G3MC-positive axons projecting across
the anterior commissure (-which is also labelled in A). For B: OMPG (in
green) and G3MC (in red).
Scale bars are 50m (B) and 100m (A)
OE= olfactory epithelium; OB= olfactory bulb; AC= anterior commissure.
AC
60hpf
OE OE
OB OBA
B 60hpf
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pTRPC2:YFP
Figure 3.15   Co-development of the G3MC terminal nerve and 
pTRPC2:Venus vomeronasal* projections
G3MC (in red) was crossed with pTRPC2:Venus (in green) and a
representative image of one olfactory pit (A, A‟, A”) is shown at 36hpf
(confocal ventral view). TRPC2:Venus alone is shown in A, G3MC in A‟, and
the overlay of the two is shown in A‟‟. The dotted box in A‟ indicates likely
bleed-through from Venus (YFP) fluorescence in A. The arrows indicate three
mCherry-positive cells in the olfactory epithelium which do not co-express
TRPC2:Venus in A‟‟. Scale bar is 25m.
*For clarity, TRPC2:Venus olfactory projections will henceforth be called
„vomeronasal‟ projections
A
36hpf pTRPC2:Venus
A’
A’’
G3MC
Overlay
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3.2.5  An olfactory placodal origin for the hypothalamic 
GnRH cells?  
In 2005, evidence was reported showing that the terminal nerve (and 
midbrain) GnRH cells had a cranial neural crest origin, but that the hypothalamic 
GnRH cells had a different (anterior pituitary placodal) origin (Whitlock, 2005b). 
SOX10 has been shown to be a good marker for migrating neural crest cells, and the 
pSox10:EGFP transgenic line faithfully recapitulates this SOX10 expression (Wada 
et al., 2005). However, when the G3MC line was crossed with pSOX10:EGFP, none 
of the terminal nerve or hypothalamic G3MC cells co-expressed GFP (SOX10), 
casting some doubt on whether they do actually have a neural crest origin (Figure 
3.16).  
So, can an olfactory origin for the hypothalamic GnRH (G3MC) cells still be 
excluded? In an attempt to find this out, lypophilic tracer dyes (DiI, DiO, and DiD) 
were used to label the olfactory placode, using a method that had been reported 
previously (Dynes and Ngai, 1998). DiI fluoresces at a „red‟ wavelength, whilst DiO 
is „yellow/green‟, and DiD is in the „far red‟ part of the spectrum. These lypophilic 
dyes were applied externally to embryo water, so that they could be absorbed by all 
external membranes, including, of course, the olfactory placodes/ epithelia. 
However, it became apparent that DiO was unusable because it readily precipitated 
out of the water (so could not be absorbed at membrane surfaces). Fortunately, both 
DiD (data not shown) and DiI successfully labelled the olfactory pits (and all other 
external membranes) from around 24hpf onwards (Figure 3.17A), and this labelling 
was retained until at least 60hpf (Figure 3.17B). However, none of these externally 
labelled ORNs migrated to the hypothalamus; as there was no observable DiI/DiD 
labelling in the hypothalamic region (see asterisk), suggesting that the G3MC 
hypothalamic cells which appear between 32-60hpf may not have an external, 
placodal origin. 
Neither DiI nor DiD could be applied to the G3MC line because they both 
emit fluorescence in the „red‟ region of the emission spectrum, and therefore could 
not be differentiated from mCherry fluorescence at the hypothalamus. In any case,  
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26hpf
Figure 3.16   The terminal nerve G3MC cells do not co-express a 
migrating neural crest marker
The Sox10:GFP line (a migrating neural crest reporter line) was crossed with
G3MC and a representative image at 26hpf is shown above (ventral view).
None of the terminal nerve G3MC cells (in red) co-express GFP (i.e. Sox10;
in green). The hypothalamic G3MC cells at 32-36hpf do not express sox10
(GFP) either (data not shown). Scale bar is 50m.
OE= olfactory epithelium; TN= terminal nerve
26hpfSox10:GFP x G3MC
OE
OE
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24hpf
60hpf
*
OE OE
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DiI
DiI
Figure 3.17   An olfactory epithelium origin for hypothalamic G3MC cells 
could not be confirmed by external application of lypophilic tracer dye, 
DiI
DiI was added externally to dechorionated wild-type embryos at 20hpf, and
uptake of DiI at the olfactory epithelium can be seen by 24hpf in A , as well as
all other external membranes (data not shown). By 60hpf (B) the olfactory
epithelial cells still contain DiI, but the hypothalamic region has not acquired
any DiI-containing cells (as shown by an asterisk). Scale bars are 50m.
OE= olfactory epithelium.
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the result was negative: an olfactory origin for hypothalamic (GnRH/G3MC) cells 
could not be confirmed (or ruled out). 
 
3.2.6  Over-expression of Kiss1/-2 and Gpr54a/-b had no 
affect on embryonic GnRH immuno-expression at the 
hypothalamus 
In recent years, there have been many reports, across many different 
vertebrates, regarding the role of Kisspeptin-GPR54 signalling in the initiation of 
GnRH pulsatile secretion at the time of puberty.  Zebrafish have two kisspeptin 
orthologues (Kiss1 and Kiss2) and two GPR54 orthologues (Gpr54a and Gpr54b) 
(Oakley et al., 2009). In adult brains, Gpr54a and Gpr54b are both highly expressed 
in the hindbrain. Also, Gpr54a has moderate telencephalon expression, whereas 
Gpr54b has moderate diencephalon and midbrain expression. Kiss1 is 
predominantly found in the ventromedial region of the habenula, and Kiss2 in the 
posterior tuberal nucleus and periventricular hypothalamus (Oakley et al., 2009). 
Both Kiss1 and Kiss2, along with GnRH3, show a gradual increase in expression at 
the start of the pubertal phase, indicating that kisspeptin-signalling may have a role 
in the control of puberty in the zebrafish. Significantly, it was also shown that intra-
peritoneal injections of the Kiss2 (but not Kiss1) decapeptide into sexually mature 
female zebrafish up-regulated pituitary gonadotrophin gene expression (Lh and 
Fsh) (Kitahashi et al., 2009). This data, together with its periventricular 
hypothalamus expression, suggests that, in teleosts, Kisspeptin-2 may have adopted 
the role of neuroendocrine control of reproduction carried out by Kisspeptin-1 in 
mammals.  
To characterise spatio-temporal expression of Kiss1, Kiss2, Gpr54a, and 
Gpr54b during zebrafish embryogenesis, in situ hybridisation was carried out on 
embryos at three different stages (24hpf, 36hpf and 60hpf). However, in situ 
expression was found only at 60hpf (Figure 3.18); although the actual initiation of 
expression begins between 36-60hpf, and possibly even earlier, as shown by RT-
PCR (data not shown). The expression pattern obtained for all four members of the 
kisspeptin/Gpr54 signalling pathway were the same; which, interestingly, is the  
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A
Kiss1/anti-GnRH
B
C D
Kiss2/anti-GnRH
Gpr54a/anti-GnRH Gpr54b/anti-GnRH
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*
Figure 3.18   Expression analysis of Kiss1, Kiss2, Gpr54a and Gpr54b
A-D: In situ hybridisation analysis of Kiss1, Kiss2 , Gpr54a,, and Gpr54b (in
purple) with anti-GnRH immuno-labelling (in green) at 48hpf (all ventral
views). An asterisk marks the hypothalamic region in A-D.
TN=terminal nerve
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same as the GnRH2 in situ staining pattern at the same stage (Figure 3.03G) i.e. in 
both forebrain commissures and their associated tracts, including those that extend 
towards the terminal nerve GnRH cells (as shown by GnRH immuno-labelling; 
„green‟ labelling in Figure 3.18A-D). 
 
To ascertain whether or not embryonic up-regulation of kisspeptin-Gpr54 
signalling altered forebrain GnRH neuronal ontogeny, full length (5‟ and 3‟ capped) 
RNA for Kiss1, Kiss2, Gpr54a, and Gpr54b were injected individually (data not 
shown), or as the four alternate Kiss/Gpr54 pairs (data not shown) or all together 
(Figure 3.19) into 1-cell stage embryos. However, upregulating the 
kisspeptin/Gpr54 signalling pathway in this manner had no effect on GnRH 
immuno-labelling at 36hpf (data not shown) or 60hpf (Figure 3.19B, C). The 
untreated control embryo (Figure 3.19B) showed the same terminal nerve/ 
commissural GnRH immuno-labelling as the Kiss1/Gpr54 RNA-injected embryo 
(Figure 3.19C), and no quiescent hypothalamic (see asterisk) GnRH-immuno-
labelled cells were revealed („unmasked‟) using this approach. Moreover, the 
G3MC expression pattern was equally unaffected by the kisspeptin/Gpr54 over-
expression (data not shown). 
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B C
Control K1+K2+Ga+Gb RNA
A K1 K2 Ga Gb
L      R L      R L      R L     R 
L= linearised plasmid  
R = RNA
Figure 3.19   Over-expression of Kiss1, Kiss2, Gpr54a, and Gpr54b  does 
not lead to any noticeable changes in GnRH immuno-labelling
A: An agarose gel showing that RNA for Kiss1/-2 and Gpr54a/-b are all
successfully transcribed in vitro. B and C show confocal images of anti-GnRH
immuno-stained embryos (in green) at 60hpf: B was untreated, whilst C was
injected with Kiss1, Kiss2, Gpr54a and Gpr54b RNA at the one-cell stage. An
asterisk marks the hypothalamic region in B and C.
Scale bars are 100m.
TN=terminal nerve
TN TN
*
TN TN
*
0.5kb
1kb
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3.3   Discussion 
 
Using standard immuno-histochemical techniques, amniotic forebrain GnRH 
system development has previously been well characterised, in several different 
model organisms. These studies showed that the entire migratory route of the GnRH 
neurons can be reliably traced from their medial olfactory placodal origin, across the 
terminal nerve, and then finally at their septo-preoptic hypothalamic destination. 
However, an analogous migratory stream was not detected during early zebrafish 
embryogenesis; and may not occur in this manner until at much later developmental 
stages- in what may be a „second wave‟ of GnRH neuronal migration. 
 
3.3.1  GnRH protein/ transcript is absent in the 
hypothalamus during early embryogenesis. 
LRH13 is a monoclonal anti-GnRH antibody that recognises forms of GnRH 
that contain serine at position 4 and tyrosine at position 5 (of the decapeptide) (Park 
and Wakabayashi, 1986).  In agreement with previously described adult zebrafish 
brain expression patterns (Figure 3.03B), LRH13 reliably detected both of the 
neuromodulatory (terminal nerve and midbrain) populations; and also, importantly, 
the hypophysiotropic (preoptic area/ hypothalamus) population. As LRH13 is 
predicted to bind to GnRH3 more avidly than to GnRH2, the midbrain GnRH 
immuno-labelling was unexpected. The reason may be that GnRH3 is also present in 
the midbrain (and some other regions) or it could be that the levels of GnRH2 
present in the midbrain are very high, thus amplifying the possibly weaker anti-
GnRH labelling in this region. It should also be noted that although the brain 
sections were treated with hydrogen peroxide, residual endogenous peroxidase 
activity may account for some of the unexpected „background‟ brain immuno-
labelling, although this was not seen in the negative controls, so is unlikely. 
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As well as showing that GnRH is actively being synthesised in these adult 
brain regions (as would be expected for a sexually competent zebrafish of 3 months 
old), it also demonstrated the reliability of the anti-GnRH antibody (LRH13), as 
well as the actual immuno-labelling protocol itself. However, unexpectedly, the 
LRH13 immuno-expression patterns for zebrafish embryos and larvae were less 
consistent with previously reported expressions patterns (Whitlock et al., 2005b). 
Another lab has reported the presence of LRH13-labelled GnRH cells 
migrating towards the preoptic area and hypothalamus in embryos at around 56hpf 
(Whitlock et al., 2005b). However, it was not possible for us to replicate this 
expression pattern using the same protocol. Indeed, despite the fact that LRH13 
consistently labelled the terminal nerve GnRH cells between 30hpf and 6dpf, there 
were no GnRH-immuno-reactive cells detected in (or migrating to) the 
hypothalamic region during these developmental stages. Moreover, using a 
fluorescently labelled secondary antibody, hitherto unreported labelling of both 
forebrain commissures could also be demonstrated by us; axonal tracts which 
presumably emanate from the terminal nerve GnRH cells. Whilst this would suggest 
our protocol is both accurate and sensitive, the possibility still remains that the 
reported hypothalamic LRH13-labelled GnRH cells are present and do indeed 
express GnRH at these stages, but at very low levels and/or for a very short period 
of time. This type of expression pattern could have been missed by our analysis. So, 
in an attempt to try and rule out this possibility, embryos at 4-hour intervals between 
36-60hpf were immuno-labelled for GnRH- but, again, no hypothalamic cells were 
detected.  
To make sure that this was not simply a case of poor antibody penetration, 
sections of 60hpf and 6dpf embryos were immuno-labelled for GnRH. Again, whilst 
the terminal nerve GnRH cells were readily detected at both stages, no hypothalamic 
GnRH cells were found. However, here it is possible that the high „background‟ 
fluorescence in these sections may have masked very low levels of hypothalamic 
GnRH expression. Finally, the removal of PTU from embryo medium had no affect 
on hypothalamic GnRH cell immuno-labelling. However, this does not mean that 
PTU has no influence on hypophysiotropic GnRH synthesis, as it does with thyroid 
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hormone synthesis; further analysis at later stages (when hypothalamic GnRH cells 
are present) would be required. 
In situ hybridisation data subsequently demonstrated that most of the GnRH 
immuno-labelling could be accounted for by GnRH3 transcript alone. From 30hpf 
through to 15dpf, GnRH2 transcript localised mainly to the midbrain region, in 
accordance with previously reported data (Palevitch et al., 2007), none of which 
overlaid with the GnRH immuno-labelling. Interestingly though, there was some 
GnRH2 transcript localised to the forebrain commissural regions (where no GnRH3 
transcript was found), which, as mentioned above, also showed immuno-labelling 
by LRH13.  
Up until 5dpf, GnRH3 transcript remains largely restricted to the terminal 
nerve cells, matching almost exactly the GnRH immuno-labelling at these stages 
(apart from the forebrain commissure expression). In an isolated case at 5dpf, there 
was some GnRH3 transcript detected in the diencephalic region, but the infrequency 
of such labelling makes it questionable that this represents bona fide hypothalamic 
(hypophysiotropic) GnRH cell staining. Later, at 15dpf, there was some GnRH3 
transcript found in the diencephalic-midbrain region; however, its veracity is again 
questionable because of the weakness and diffuseness of the staining.  
Palevitch et al (Palevitch et al., 2007) similarly showed that GnRH3 
transcript is restricted to the terminal nerve region until 5dpf, and then between 20-
25dpf a „continuum‟ of GnRH3 neurons is visualised extending from the olfactory 
area, through the terminal nerve ganglion, along the lateral aspects of the 
telencephalon, and then on into the preoptic area and hypothalamus by 30dpf. 
Considering the fast early development of the zebrafish (major organs and brain 
regions are formed by 1dpf, and embryos are free-swimming by 2dpf), this 
represents a very long delay in hypothalamic GnRH cell migration, compared with 
other vertebrates (amniotes) which have a spatially similar migratory route into the 
hypothalamus. Therefore, it could be speculated that instead of revealing the 
migrating cells in „real time‟, in fact the migratory pathway is „unmasked‟ 
approximately 28 days after the cells actually migrated to the hypothalamus by this 
in situ hybridisation analysis. So, the „migratory pathway‟ becomes „revealed‟ as the 
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cells that have remained along its route begin to transcribe GnRH3 closer to the time 
of zebrafish „puberty‟ at 35-45dpf, and not at the time that they were migrating.  
Assuming that the terminal nerve cells represent an entirely separate 
population from the cells which give rise to the hypothalamic GnRH cells, how can 
the hypothalamic (hypophysiotropic) cells be distinguished (visually) from the 
„neuromodulatory‟ terminal nerve cells? And, if they are actually distinguishable 
(i.e. different types of cell), and therefore separate, why do the hypothalamic cells 
only appear after 20-30dpf; and, when and where were they specified? Conversely, 
if the hypothalamic and terminal nerve GnRH cells are not distinguishable (i.e. they 
are the same type of cell); do they have a common origin e.g. at the olfactory 
placode? The remainder of this chapter aims to tackle these questions and tries to 
unravel some of the other complexities of the zebrafish GnRH system compared 
with that of the amniotes.  
 
3.3.2  The differences in GnRH neuronal ontogeny of 
amniotes compared with teleost fish 
The medaka is another teleost fish, which is estimated to have diverged from 
zebrafish around 110–160 million years ago (Wittbrodt et al., 2002), showed very 
similar GnRH immuno-labelling. That is, terminal nerve GnRH cells were immuno-
labelled from 3dpf onwards, at an analogous developmental stage to the faster-
developing zebrafish embryo. Notably, there were a few GnRH immuno-labelled 
cells in the hypothalamus by 7dpf in some medaka; however, these were very low in 
number i.e. often only 2-4 cells. Further work would need to be carried out to fully 
characterise these cells, to ensure they are indeed the hypophysiotropic GnRH cells, 
and to find out if their number increases past 7dpf. Work by Okubo et al showed 
that both GnRH1 and GnRH3 genes were expressed by cells in the preoptic area/ 
hypothalamus by this stage (Okubo et al., 2006); however, it would be interesting to 
ascertain which of these two genes was being expressed by the LRH13-labelled 
cells in this study, as further proof of their identity. 
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Using GFP transgenic reporter lines for GnRH1 and GnRH3, Okubo and 
colleagues (Okubo et al., 2006) showed that by 4dpf GnRH1-GFP cells had reached 
the ventral preoptic area, and by 20dpf that these neurons had extended projections 
to the anterior pituitary.  Similarly, GnRH3-GFP cells had also reached the preoptic 
area/anterior mesencephalon by this stage, but did not project to the anterior 
pituitary. Teleost fish, unlike mammals, do not have a hypophyseal portal 
circulation that transports the secreted GnRH to the pituitary. Instead, the GnRH 
neurons need to directly innervate their target pituitary cells (the gonadotrophs). 
This would suggest that, in medaka, only GnRH1 hypothalamic neurons have the 
hypophysiotropic role. However, because zebrafish don‟t have a GnRH1 gene, they 
must surely have to rely on GnRH3-expressing hypothalamic neurons to fulfil this 
role? 
The medaka GnRH1 and GnRH3 GFP-reporter plasmids, provided by 
Okubo et al (Okubo et al., 2006), were injected into zebrafish embryos to find out 
whether the medaka promoter function was conserved, despite the large 
evolutionary distance between the two teleost fish. The presence of GFP in the 
terminal nerve cells, as proven by anti-GnRH immuno-labelling in these cells, 
showed that the regulatory elements in the medaka GnRH promoters could still be 
used by the zebrafish, either because the zebrafish still uses the same regulatory 
elements, or because its terminal nerve cells still harbour the required regulatory 
transcription factors. Both of the medaka reporter constructs gave some GFP 
expression in cells which were not co-labelled by GnRH immuno-labelling, 
including in the telencephalon; but neither constructs gave any hypothalamic or 
preoptic area expression by 48hpf. Moreover, although some embryos were allowed 
to develop until 4dpf, by 3dpf the expression in the terminal nerve region had 
diminished, and by 4dpf, the GFP expression in the terminal nerve was very weak or 
absent, with just some residual GFP expression in the external epithelial cells. This 
was most likely because the plasmid construct had been lost/ degraded by this stage 
in these transient transgenics, but could also be because the required regulatory 
factors were no longer available for continued transcription of GnRH1 and GnRH3 
in those cells.  
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Whilst the medaka constructs did recapitulate terminal nerve GnRH 
expression, and could be expected to continue doing so in a stable transgenic, to 
ensure that all native zebrafish GnRH3 expression is correctly reported, especially 
hypophysiotropic GnRH, it was decided that using the native zebrafish GnRH3 
promoter to generate the stable transgenic line would be preferable. 
3.3.3  pGnRH3:mCherry embryos recapitulate normal 
terminal nerve GnRH expression and also label a novel 
early hypothalamic population 
In 2002, Torgersen et al characterised the 1.6 kb upstream promoter region 
of the zebrafish GnRH3 gene and found that it contained an enhancer at -976, with 
adjacent binding sites for Oct-1, CREB and Sp1, which were required for GnRH3 
expression at the terminal nerve. However, using reporter constructs containing this 
upstream regulatory region, they were unable to demonstrate any hypothalamic 
GnRH3 expression (Torgersen et al., 2002).  
In 2006, Palevitch et al (Palevitch et al., 2007) used a similar strategy, 
except that their GnRH3 reporter construct also contained downstream regions 
comprising exon 1, intron 1, and part of exon 2 of GnRH3.  Using this construct, 
they were able to confirm the terminal nerve labelling previously reported by 
Torgersen et al; and much later, at 10dpf, GFP fluorescence was first seen in the 
presumptive hypothalamus. However, this was a transient transgenic analysis and a 
stable GnRH3 transgenic reporter line had not yet been reported.  
To study the role of olfactory axonogenesis during GnRH neuronal 
development, a pOMP:tauEGFP reporter line had already been acquired from 
another group (Yoshida et al., 2002), that allowed a subset of olfactory sensory 
neurons to express GFP from around 24hpf.  It was therefore deemed advantageous 
to use mCherry (a form of red fluorescent protein) to co-label the GnRH3 neurons, 
so that both GnRH neurons and olfactory neurons could be identified independently 
of each other (in red and green, respectively). Therefore, to make a stable transgenic 
GnRH3 reporter line, the promoter region reported by Palevitch et al (Palevitch et 
al., 2007) was PCR-amplified from whole genomic DNA and then cloned upstream 
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of mCherry coding sequence, thus generating a „pGnRH3:mCherry‟ reporter 
construct („G3MC‟). mCherry was the best choice of red fluorescent protein due to 
its high level of fluorescence intensity, its high photostability, and also its very fast 
maturation time (Shaner et al., 2005). 
The temporal characterisation of G3MC from 0-120hpf (Figure 3.09) 
revealed that mCherry expression could be detected in the terminal nerve cells from 
around 24hpf onwards, but that the first mCherry cells were visualised in the 
anterior neural tube region around 4 hours earlier. This analysis didn‟t reveal 
whether these earlier mCherry cells gave rise to the terminal nerve cells, or some 
other later population. However, previously it has been suggested that the terminal 
nerve cells do arise from cranial neural crest cells, so these cells located in the 
anterior neural tube may indeed be migrating towards the terminal nerve region; 
though time-lapse video imaging would be required to determine whether or not this 
is true. 
By 32hpf, axons from the terminal nerve cells have extended up towards the 
olfactory bulbs and also across both forebrain commissures. This closely resembles 
the GnRH immuno-labelling that is also seen around this time-point (Figure 3.04A); 
which proves that the transgenic expression is faithfully reporting „real‟ GnRH3 
expression. Unexpectedly, from around 32-36hpf onwards, mCherry-positive cells 
began to appear in the presumptive hypothalamic region. This was subsequently 
confirmed by crossing G3MC with pNkx2.1:YFP (a marker of the hypothalamic 
region). However, when GnRH immuno-labelling was carried out on G3MC, these 
hypothalamic cells, of course, were not co-labelled (as there is no LRH13-labelling 
in the hypothalamus at these stages). Therefore, further proof was required to show 
that these hypothalamic mCherry cells were really the hypophysiotropic GnRH 
cells.  
Interestingly, when brain sections from a 3 month old female G3MC 
zebrafish were analysed, the mCherry expression was found to be very similar to the 
LRH13 immuno-labelled brain sections (Fig 3.03A). Specifically, there were many 
mCherry-expressing cells found in the preoptic area and hypothalamus in a similar 
region to where GnRH immuno-labelled cells were found. This would certainly 
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suggest that these mCherry cells are „real‟ hypothalamic (hypophysiotropic) GnRH 
cells. However, this is not proof that these adult brain hypothalamic GnRH cells are 
related to the early hypothalamic mCherry cells detected between 32-60hpf in 
G3MC embryos.  
Only adult female brains were used in this study, to minimise the confusion 
caused by possible gender differences in GnRH3 spatial expression. Further work 
will be required to find out if there are actually any differences in male/female 
GnRH expression levels; and, in particular, how this relates to the sexual dimorphic 
expression of the kisspeptin receptors (Gpr54a and Gpr54b) in sexually competent 
zebrafish (Oakley et al., 2009). 
Whilst the hypothalamic GnRH cells are most clearly visible between 32-
60hpf, they become less apparent by around 120hpf. This is most likely because 
these cells are no longer expressing mCherry i.e. the cells have become quiescent- 
similar to the hypophysiotropic GnRH cells in amniotes, prior to puberty. Instead, at 
120hpf, there are extensive mCherry-positive tracts present throughout the brain, 
only some of which emanate from the terminal nerve cells. It is not yet clear 
whether some of these projections belong to the hypothalamic cells, and, if so, 
whether they project to the anterior pituitary cells. Prior to 120hpf, when the 
hypothalamic GnRH cells are most visible (due to high mCherry expression levels), 
it is not apparent whether these cells are innervating the anterior pituitary at these 
early stages. However, anosmin-1b immuno-labelling in the presumptive pituitary 
(Figure 5.04, see later), certainly suggest that these hypothalamic G3MC cells are in 
very close proximity to the hypothalamic cells. 
Abraham et al (Abraham et al., 2009; Abraham et al., 2008) recently 
reported the characterisation of a stable transgenic pGnRH3:EGFP line, which gave 
considerably-improved clarity on their previous transient expression analysis. 
Because, in generating G3MC, we used the same promoter region that they had 
previously reported, our expression data closely resembles their recent stable 
transgenic line analysis (with a few exceptions). Their description of the GnRH3 
axonal projections between 26-48hpf matches very closely what we see with the 
G3MC line. They first visualise the GnRH3 perikarya around the olfactory placodal 
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region at 24hpf, which, to avoid confusion, has been referred to by us as the 
„terminal nerve GnRH cells‟ at this time-point. From around 3dpf, some of these 
perikarya re-position themselves between the olfactory epithelium and olfactory 
bulbs, and can perhaps now be more properly called „terminal nerve cells‟, forming 
a continuum from the olfactory epithelium to the terminal nerve ganglion, which, by 
6dpf extends into the ventral telencephalon; and this can also be seen in our 
characterisation of G3MC at 5dpf (Figure 3.09I).  
However, in their characterisation of pGnRH3:EGFP, Abraham et al make 
no mention of the early hypothalamic cluster of cells that we see between 32hpf and 
60hpf. 
The „tangential migration‟ route that forebrain GnRH neurons traverse, from 
the olfactory region, is thought to be axophilic: migrating along olfactory and 
terminal nerve tracts, along the terminal nerve ganglion, into the ventral 
telencephalon, and then on into the preoptic area and hypothalamus (Abraham et al., 
2009; Palevitch et al., 2007). In zebrafish, it has even been suggested that GnRH3 
perikarya may associate with their own axonal tracts during this migration.  
Whilst we didn‟t study the „terminal nerve GnRH cells‟ beyond 5dpf (except 
at adulthood), we can assume that they would continue to follow the same migratory 
route that is described by Abraham et al (see Figure 3.20) (Abraham et al., 2008). 
That is, between 7-12dpf, a few GnRH3 perikarya extend caudally into the ventral 
telencephalon, along existing GnRH3 axonal tracts that project to the hypothalamic 
region. By day 12, one or two will have migrated along the terminal nerve ganglion, 
and will have reached the presumptive preoptic area (Figure 3.20D, (Palevitch et al., 
2009)). This process of perikarya „migrating‟ along their own neurites into the 
hypothalamic region could be visualised all the way up to 30dpf (Abraham et al., 
2008). So, whilst this „continuum‟ of forebrain GnRH neurons is very similar to that 
which occurs in amniotes, the process has apparently taken vastly longer in the 
zebrafish.  
So, what about the much earlier, hitherto unreported, cluster of hypothalamic 
GnRH cells seen in the G3MC embryos between 32-60hpf? Whilst these „early‟  
hypothalamic cells accumulate once GnRH neuronal projections have already been  
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Figure 3.20   ‘Two wave’ model for hypothalamic GnRH neuronal 
migration/ accumulation during zebrafish embryogenesis
A: Schematic diagram illustrating pGnRH3:EGFP (Palevitch et al, 2009, in
green) and G3MC fluorescence (this study, in red) at 2dpf. A green-red
gradient is used to indicate terminal nerve cells ( ) and projections ( )
which are detected in both transgenic lines, whereas solid red is used to
demonstrate G3MC-specific expression at the hypothalamus ( ).
B-D show representative images of the „early wave‟ (B), and progress of the
„later wave‟ (C-D). The hypothalamus is indicated by a „dotted box‟ in B; an
asterisk in C; and white arrow heads in D. Yellow arrows show the proposed
direction of GnRH3 neuronal migration to the hypothalamus, from the
terminal nerve region (white arrows).
Figure 3.20 (D) reprinted from Developmental Dynamics (Palevitch et al, 2009), with
permission from John Wiley and Sons.
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established across the forebrain commissures, it is not clear whether the migrating 
GnRH neurons (or their perikarya) use these axons to reach the hypothalamus; in an 
analogous way to how the „later‟ wave of GnRH cells are believed to reach the 
hypothalamus at around 12dpf (i.e. axophilically).  
So, are there two „waves‟ of GnRH neuronal migration to the hypothalamus 
during zebrafish embryogenesis: an „early‟ wave (at around 1.5dpf to 2.5dpf), 
followed by a much „later‟ wave (at around 3dpf to 12dpf+)?  Two waves of GnRH  
cell migration have already been identified during primate embryogenesis: the first 
wave of GnRH cell migration precedes olfactory bulb formation, whereas the other 
wave occurs in association with olfactory bulb formation. During this „second wave‟ 
of migration, GnRH cells migrate along a nasal mesenchymal scaffold of olfactory, 
vomeronasal and terminal nerves. So, we may speculate that the two apparent waves 
of GnRH cell migration that occur in zebrafish, may be comparable to these two 
waves of migration that have been described in human embryos (although, perhaps 
at different equivalent stages of embryogenesis). 
It has been shown recently that bilateral removal of EGFP-positive GnRH3 
cells, from the terminal nerve region, in pGnRH3:EGFP embryos, subsequently 
resulted in complete lack of hypothalamic GnRH3 neurons in the adult (at 12-weeks 
old). However, surprisingly, regeneration rates of these hypothalamic GnRH3 cells 
were much higher in embryos that were ablated early (at 2dpf), compared to those 
that were ablated much later (at 4dpf or 6dpf) (Abraham et al., 2010). This would 
suggest that the „later wave‟ of GnRH cell migration has a much more significant 
contribution to the number of hypophysiotropic GnRH cells in sexually competent 
adults.  However, if they do not make a direct contribution in terms of cell number, 
the „early wave‟ of GnRH cell migration may still nonetheless make a significant, 
perhaps necessary, contribution to the correct-functioning of the adult 
hypophysiotropic GnRH cells, but this will need to be confirmed. Terminal nerve 
ablations at 4dpf and 6dpf abolish the extensive GnRH3-positve axonal tracts in the 
forebrain; some of which may form essential synaptic contacts with the „early wave‟ 
hypothalamic GnRH3 neurons, which may be important for the prolonged survival 
of these cells i.e. by the secretion of specific cell survival factors. So, an alternative 
interpretation of the ablation experiments could be that the terminal nerve GnRH 
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system may have a very important role in the survival and/or correct physiological 
activity of the hypophysiotropic GnRH neurons (especially after 4-6dpf).  
Assuming that the mCherry-positive cells (from G3MC embryos) which 
accumulate at the hypothalamus between 32hf and 60hpf represent „real‟ 
hypophysiotropic GnRH3 cells (the so-called „early wave‟), why are there no GnRH 
immuno-labelled or GnRH3 in-situ-stained cells in this region, during these stages? 
One possible explanation could be that the pre-migratory GnRH cells down-regulate 
GnRH expression before or during their migration to the hypothalamus (and do not 
start expressing GnRH there until much later, probably after 6dpf). If this is case, 
the G3MC promoter may lack a regulatory element that would normally allow 
GnRH expression to be down-regulated at these early stages. Fortuitously for us, 
this has meant that we have been able to visualise these early-appearing 
hypothalamic GnRH cells, where normally they would have been untraceable by 
standard immuno-labelling or in situ hybridisation techniques.  
The intriguing question is why Abraham & colleagues (Abraham et al., 
2008) did not report the appearance of these early hypothalamic GnRH3 cells when 
they characterised their pGnRH3:EGFP line, which uses the same promoter region? 
During this project, four separate G3MC founder stable transgenics were identified, 
and they all had the same spatial expression pattern. Therefore, it can be assumed 
that the early appearance of hypothalamic GnRH3 cells were not the result of 
transgene insertion positional differences. However, whilst the reason for this 
discrepancy remains elusive, further characterisation of this early hypothalamic 
population was sought, to gain a better understanding of its identity. Moreover, in 
subsequent experiments herein, the early development of the „terminal nerve 
GnRH3 cells‟ is also further investigated; as these are proposed to, at a much slower 
rate, give rise to the „later wave‟ of GnRH cells that reach the hypothalamus from 
around 12dpf onwards. 
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3.3.4  Olfactory and terminal nerve GnRH3 axons are 
apparently closely associated, and there is some evidence 
for olfactory epithelium-derived GnRH3 cells 
To understand the role of the olfactory region in the specification and early 
migration of GnRH3 neurons during early development, two olfactory reporter 
lines, labelling both major subsets of olfactory receptor neurons (ORNs), were 
crossed with G3MC. pOMP:tauEGFP, which labels the ciliated-type of ORN, 
broadly demarcates the outline of the olfactory epithelia. Between 24-32hpf, the 
terminal nerve G3MC cells accumulate medially to the olfactory pit, and project 
their axons along a similar navigational route as the ORN axonal bundle- dorso-
caudally towards the presumptive olfactory bulb region at the telencephalon. The 
„intertwining‟ and close proximity of the terminal nerve and olfactory axons is 
similar to the morphology of the neurites in amniotes. However, rather than 
axophilically follow the olfactory/terminal nerve axons (as is seen in the amniotes), 
the „later wave‟ („terminal nerve GnRH neurons‟) are found to follow axophilically 
a more caudal-ventral route into the ventral telencephalon. It is not, however, 
possible yet to say whether the „early wave‟ of GnRH3 neurons follow this same 
route into the hypothalamus, and if, by doing so, they establish the migratory 
pathway for the later wave, as is believed to happen in primates. 
Interestingly, at around 36hpf, within the olfactory epithelium there are some 
mCherry-expressing (G3MC) ciliated ORNs (pOMP:EGFP positive cells). 
However, there does not seem to be any mCherry co-expression within the micro-
villous („vomeronasal‟) ORNs (pTRPC2:Venus positive cells). Therefore, some 
GnRH3 cells, which originate from the olfactory placode, arise from OMP-positive 
ORN progenitor cells, but not vomeronasal-type ORN progenitors. Whilst these 
mCherry (G3MC) cells can be detected within the olfactory epithelium as late as 
5dpf (and possibly even later); the lack of GnRH3 protein (or transcript) in these 
olfactory cells is most likely due to the absence of a repressor element in the G3MC 
promoter, which would ordinarily repress GnRH3 expression in these cells. 
Previous reports have shown that pre-migratory GnRH cells, which originate 
within the olfactory placode, do co-express both olfactory and GnRH markers 
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(Gonzalez-Martinez et al., 2004a), so this result is consistent with other vertebrate 
model organisms. However, whilst, this data supports a possible olfactory origin for 
the hypothalamic GnRH cells in fish, time-lapse imaging of the olfactory-GnRH3 
cells will be required to ascertain whether or not this is true.   
Assuming that the olfactory-derived GnRH3 cells do contribute to the 
hypothalamic GnRH population, it is not clear whether they migrate during the 
„early wave‟ or the „later wave‟. The „early wave‟ GnRH3 cells begin to accumulate 
in the hypothalamus around the same time-point (36hpf) that the OMP/GnRH3 co-
expressing cells first appear at the olfactory epithelium. However, if these olfactory-
GnRH cells do contribute to the „early wave‟, the migration would have to happen 
very fast, as there has been little evidence of these cells actively migrating  from the 
olfactory epithelium to the hypothalamus between 24pf and 36hpf. Alternatively, if 
they contribute to the „later wave‟, the olfactory-GnRH cells must down-regulate 
EGFP expression by the time they reach the terminal nerve, as none of the GnRH3 
cells in the terminal  nerve region were found to co-express EGFP (OMP); although 
low levels of residual GFP in these cells may in future be revealed by anti-GFP 
immuno-labelling, or similar technique.  
To further investigate a putative olfactory origin for the „early wave‟ 
hypothalamic GnRH3 cells, lypophilic tracer dyes were used; and DiI was found to 
be most useful. When DiI was applied externally to live zebrafish embryos at 20hpf, 
by 24hpf the olfactory pits were very strongly labelled (as were all other external 
epithelial cells). However, by 60hpf, whilst the olfactory epithelia remained strongly 
labelled, there was no DiI labelling in the hypothalamic region. This suggested that 
the „early wave‟ of GnRH migration to the hypothalamus did not have an olfactory 
epithelium origin; unless, of course, the „early wave‟ GnRH cells were specified at 
the olfactory placode before 20hpf, and migrated away from the „external epithelial 
thickening‟ before 20hpf as well. In fact, the olfactory placode actually forms at 
around 17hpf, but when DiI was applied to embryos at this time-point the toxicity 
was high, the subsequent olfactory epithelial labelling was poor, and the embryos 
looked morphologically defective by 24hpf (and showed no hypothalamic DiI 
labelling by 60hpf, data not shown). Of course, the „later wave‟ hypothalamic 
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GnRH cells may have an olfactory placode origin; but to determine this will require 
looking at much later embryos (12dpf+), after a DiI-incubation.  
An alternative, more precise, approach to using lypophilic dyes, would be to 
use a „caged fluorophore‟, such as Kaede (Hatta et al., 2006). In this case, a laser is 
used to photo-activate the Kaede specifically at the olfactory placode of zebrafish 
embryos, so that those cells fluoresce „red‟ amongst a background of green-
fluorescing cells. Therefore, if any of these olfactory-derived „red‟ cells migrate to 
the hypothalamus, this can be easily traced. Unfortunately, this approach cannot be 
used on G3MC embryos because the mCherry-positive cells will also fluoresce 
„red‟, meaning that they could not be distinguished from the photo-activated cells. 
Moreover, whilst more precise, using Kaede may not be any more informative than 
the DiI experiment above; which also, incidentally, cannot be used on G3MC 
embryos anyway because it too fluoresces red. Regardless, DiI proved, at least, that 
the „early wave‟ GnRH3 cells are unlikely to originate from the olfactory placode. 
As mentioned earlier, it has been suggested that the terminal nerve GnRH 
cells originate from cranial neural crest cells. However, mCherry-positive terminal 
nerve GnRH3 cells did not co-express a migrating neural crest cell marker 
(pSOX10:EGFP, (Wada et al., 2005)), and nor did the hypothalamic GnRH3 cells at 
36hpf. This data casts some doubt on whether the terminal nerve GnRH cells do in 
fact originate from neural crest cells; and also whether the terminal nerve cells 
actually do have a different origin from the hypothalamic GnRH cells; however, this 
is yet to be confirmed. Moreover, it has also been suggested previously that the 
hypothalamic GnRH cells which appear around 56hpf may arise from the anterior 
pituitary placode (Whitlock, 2005b). Whilst this was not specifically investigated 
here, the DiI experiment which labelled all external placodes, also labelled the 
anterior pituitary placode. But, as already mentioned, no hypothalamic cells were 
DiI-positive by 60hpf, so an anterior pituitary placode origin for the hypothalamic 
cells is also less likely. However, as before, the time of DiI application may have 
been too late, or the time-point for examination (60hpf) may have been too early to 
definitively rule this out; and this would therefore need to be investigated further. 
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3.3.5  Embryonic upregulation of kisspeptin signalling does 
not induce early hypothalamic GnRH protein expression 
The 4 genes that comprise the Kisspeptin/Gpr54 signalling pathway (Kiss1, 
Kiss2, Gpr54a, and Gpr54b) are all expressed predominately in the forebrain 
commissure regions by 48hpf. The in situ staining prior to this time-point was either 
very weak, or non-existent; however, previous RT-PCR data (unpublished) revealed 
that all 4 genes are expressed much earlier, from around 24hpf onwards. Therefore, 
it would seem that whilst the genes are expressed much earlier, the lower sensitivity 
of the in situ hybridisation protocol means that the expression pattern is seen only 
much later, at around 48hpf.  
The kisspeptin/GPR54 signalling pathway was previously shown to increase 
GnRH expression/secretion both in vitro and in vivo, in pre-pubescent and sexually 
mature animals (Oakley et al., 2009). So, if this signalling pathway was activated/ 
upregulated prematurely, during early zebrafish embryogenesis, could it „unmask‟ 
migrating GnRH cells and/or the „early wave‟ hypothalamic G3MC cells?  
In fact, injecting the RNA for Kiss1, Kiss2, Gpr54a, and Gpr54b 
individually, in pairs, or all 4 together, had no measurable effect on embryonic 
GnRH protein expression i.e. the protein expression remained localised to the 
terminal nerve region and forebrain commissures, and no early embryonic 
hypothalamic expression was „revealed‟. However, whilst the stability of the 4 
different RNA molecules was confirmed electrophoretically (Figure 3.19A), the 
unavailability of specific antibodies meant that the longevity of these RNA 
transcripts in vivo could not be proven. Therefore, the possibility remains that the 
RNA is degraded too quickly in vivo, and that this is the reason for the kisspeptin-
Gpr54 pathway upregulation having no effect.  
As the G3MC spatio-temporal expression pattern was also unaffected, it 
would seem that kisspeptin/Gpr54 over-expression does not affect the migration of 
the „early wave‟ GnRH3 cells; however, this study does not reveal whether the 
„later wave‟ of GnRH neuron migration is affected by the kisspeptin/Gpr54 over-
expression; although it is unlikely that the RNA would persist long enough to affect 
this later GnRH neuronal migration.  
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To solve the possible problem of RNA instability in vivo, plasmids have 
been constructed whereby Kiss1, Kiss2, Gpr54a, and Gpr54b expression is 
controlled by a heat-shock promoter, thus permitting temporal control over the 
upregulation of kisspeptin-Gpr54 signalling during early zebrafish development 
(data not shown). In future experiments, this would allow precise control of 
kisspeptin/Gpr54 signalling at certain critical time-points during GnRH neuronal 
migration. Moreover, because these constructs are also designed to simultaneously 
translate GFP, as a separate protein, from the same transcript, the longevity of the 
Kiss1, Kiss2, Gpr54a, and Gpr54b transcripts can be better understood. Similarly, 
the physiological and behavioural consequences of upregulating these genes (by 
heat-shock) in adult zebrafish could also be investigated. 
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3.4 Conclusions 
The rostro-caudal distribution of GnRH neurons along the ventral 
telencephalon and diencephalon in the adult zebrafish brain is very similar to the 
spatial expression pattern that can be seen in the brain of an amniote, such as the 
chick or mouse. However, there are some notable differences in forebrain GnRH 
neuronal system development in the zebrafish, compared with these amniotes, 
which have been characterised in the course of this chapter. 
To begin with, GnRH immuno-labelling of chick embryos illustrated the 
characteristic GnRH neuronal „migratory stream‟ as it extended towards the 
hypothalamus, along the olfactory/ terminal nerve fibres. In contrast, using the same 
GnRH antibody, at a similar developmental stage in zebrafish or medaka, immuno-
labelling was detected only in the terminal nerve GnRH cells and their associated 
projections across the two forebrain commissures. This suggested that, in zebrafish, 
the hypophysiotropic GnRH neurons migrated at a much later stage (i.e. later than 
6dpf); or, that unlike amniotes, they do not express GnRH decapeptide throughout 
their whole migratory route to the hypothalamus (or, that the GnRH decapeptide 
antigen was „masked‟ in some way, preventing immuno-labelling of these migratory 
cells). 
There have been several conflicting reports regarding the arrival of the 
hypophysiotropic GnRH neurons to the preoptic area/ hypothalamus in zebrafish 
and medaka. There have been reports showing GnRH immuno-labelled cells 
migrating to the hypothalamus at around 56hpf, and other reports using in situ 
hybridisation to conversely show that GnRH3 transcript is restricted to the terminal 
nerve cells at this time-point, and that there is no transcript found in the 
hypothalamus until much later, at around 20-30dpf. Moreover, GnRH transgenic 
reporter analyses showed that GnRH cells do not reach the preoptic hypothalamus 
until around 12dpf in zebrafish, or around 4dpf in medaka. Together with results 
from this current study, a ‘two wave’ model for GnRH neuronal migration to the 
hypothalamus has now been proposed by us, in a manner similar to what has 
previously been described in primate forebrain GnRH neuronal development. 
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Using a zebrafish GnRH3 reporter line, similar to the one used in this study, 
it was recently demonstrated that GnRH3 cells in the terminal nerve region extend 
into the ventral telencephalon between 7-12dpf, and reach the preoptic area from 
around 12dpf onwards. The extension of terminal nerve GnRH cells into the 
telencephalon in this way was also found in this current study, using our G3MC line 
(Figure 3.20C); so, it can be envisaged that there is indeed such a late migration of 
GnRH cells to the hypothalamus. However, in the case of G3MC, this considerably 
later wave of migration is superseded by a much earlier wave of migration into the 
hypothalamus at around 36-60hpf. But, unlike the later wave of migration, there was 
no migratory „trail‟ of GnRH cells along the ventral forebrain, which would have 
alluded to the origin and migratory route of these cells. Therefore, until more 
information is known about this „early wave‟, it is perhaps better referred to as an 
„early accumulation‟ at the hypothalamic region. 
During this study, a placodal (olfactory) origin for this „early accumulation‟ 
of hypothalamic GnRH3 cells could not be proven, nor could a cranial neural crest 
origin be determined for any of the GnRH3 cells. A more recent model put forward 
by Whitlock and colleagues (Whitlock et al., 2009) has suggested that hypothalamic 
precursors may be the source for the hypothalamic GnRH neurons, and this may 
explain why no external origin for the „early accumulation‟ GnRH3 cells could be 
determined during our study. Evidence for this model comes from work by 
Markakis and co-workers who showed that rat hypothalamic progenitor cells 
cultured externally gave rise to GnRH-expressing cells (Markakis et al., 2004). 
However, further work will be required to find out whether the early-accumulation 
GnRH cells do actually arise in situ, and indeed whether the „later wave‟ have a 
similar origin, and are therefore quite separate from the terminal nerve GnRH cells 
which extend into the telencephalon from around 7-12dpf (i.e. the „later wave‟ may 
not actually be a „wave‟ of migration either). 
The zebrafish GnRH immuno-labelling and in situ hybridisation data in this 
study was generally in agreement with the previously-published data. That is, 
GnRH-expressing cells remain localised to the terminal nerve region (and to their 
associated axonal tracts) during early embryogenesis (up to 6dpf), and there is little 
or no hypothalamic expression during these stages. Whilst GnRH-immuno-labelled 
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cells have been reported en route to the hypothalamus at 56hpf (Whitlock et al., 
2005b), such migrating GnRH cells were not detected in our study. Without such 
GnRH immuno-labelling data, it has been difficult to ascertain the authenticity of 
the „early accumulation‟ of GnRH cells i.e. whether or not they really are 
hypophysiotropic GnRH neurons. 
However, it does remain possible that the „early accumulation‟ is truly an 
„early wave‟ of migration, which sets out the migratory pathway for the later wave, 
in a similar manner to that which has been proposed in primates, but where the cells 
don‟t express GnRH transcript/ protein, in this case. Alternatively, if the „early 
wave‟ of GnRH cells are in fact „born‟ within the hypothalamus itself, perhaps they 
still nevertheless have some type of „attractive‟ role for the later wave of migration. 
If this is the case, the „early‟ GnRH cells may not have any hypophysiotropic role as 
such; but their role in the migration of the second wave of GnRH neurons may 
nevertheless still be fundamental for the correct formation of the forebrain 
(hypophysiotropic) GnRH system.  
However, the fact still remains that the „early‟ GnRH cells do not express 
GnRH protein or transcript at 36-60hpf. The reason for their being visualised in the 
G3MC fish may be because the GnRH3 promoter lacks a repressor element that 
would normally ensure that GnRH is „switched off‟ in these cells at this 
developmental stage. If this is the case, mCherry fluorescent protein has been acting 
as a „lineage tracer‟ for these early cells; which, if proven, may have revealed a 
hitherto unreported important step during early GnRH neuronal development in the 
zebrafish. Moreover, while speculative at this stage, it may turn out that the „early 
wave‟ is in actual fact the only wave of hypothalamic GnRH neuronal migration (or 
accumulation), and that subsequent „waves‟ of migration are simply the same 
hypothalamic population down- and upregulating GnRH expression over 
developmental time. 
Regardless of whether or not the terminal nerve GnRH cells contribute to the 
hypothalamic (hypophysiotropic) GnRH cells, or simply form an essential part of 
their migratory environment en route to the hypothalamus, the terminal nerve GnRH 
cells are likely to have their own, separate, important „neuromodulatory role‟ in 
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adulthood. For this purpose, the terminal nerve GnRH neuronal projections across 
the forebrain commissures, and in the region of the olfactory projections, could 
provide plenty of opportunity for the GnRH system to interact with the olfactory 
system, perhaps by regulation of reproductive capability in response to certain 
odours, as well as other external cues. 
In amniotes, such as the mouse and chick, GnRH neurons dispersed within 
the hypothalamus extend their axonal processes to the median eminence portal 
capillary loops, so that secreted GnRH can reach its receptor on gonadotrophin-
releasing cells (gonadotrophs) within the anterior pituitary. In teleost fish, the 
hypothalamic GnRH cells directly innervate the gonadotrophs, delivering GnRH 
decapeptide directly to their target receptor. In both medaka and zebrafish, this final, 
but essential, stage in the development of the hypothalamic GnRH system is thought 
to occur much later in development. So, regardless of whether GnRH cells migrate 
to the hypothalamus, or are specified from within the hypothalamus, this final step 
will need to take place in order to ensure the reproductive capability of the animal. 
Therefore, the establishment of these important synaptic connections should be 
investigated further, using the G3MC line, as this may be an essential „check-point‟ 
in the regulation of fish puberty and fertility. 
Despite the Kisspeptin-Gpr54 signalling pathway having an essential role in 
GnRH secretion at the time of puberty, upregulating this signalling pathway during 
early embryogenesis had no noticeable influences on GnRH expression.  But, most 
disappointingly, this experiment was not able to „reveal‟ quiescent (mCherry-
expressing, non-GnRH-expressing) cells that have migrated to the hypothalamus 
during the „early wave‟; meaning that these cells remain undetectable by GnRH 
immuno-labelling, due to their lack of GnRH expression. However, to avoid the 
possibility of a false-negative from this experiment (caused by early mRNA 
degradation), plasmid constructs which allow temporal control of Kisspeptin/Gpr54 
expression will allow us to further investigate the effects of upregulating this 
pathway during early (and late) embryogenesis. Of course, it remains possible that 
kisspeptin-Gpr54 signalling upregulation affects only the „later wave‟ of GnRH 
migration to the hypothalamus, from 12dpf onwards; this would need to be further 
investigated as well.  
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It is not known what triggers kisspeptin signalling at the time of puberty; and 
it may be the case that other signalling pathways (e.g. leptin pathway) may be 
required for the proper action of kisspeptin signalling. So, upregulating kisspeptin 
signalling alone may be ineffective; hence, perhaps this is the reason for there being 
no effect on early hypothalamic GnRH secretion. In fact the concept of what 
triggers amplification of kisspeptin signalling at the time of puberty remains an 
important question in this field of research (Oakley et al., 2009).  
So, in summary, we have generated a zebrafish GnRH3 reporter line which 
recapitulates some of the immuno-labelling and in situ GnRH expression; but also 
reveals a novel early hypothalamic GnRH population that was not detected using 
these analyses (Figure 3.20). The requirement of these „early‟ GnRH cells during 
hypothalamic GnRH neuronal development is yet to be fully characterised. This 
GnRH3 reporter line, as well as several olfactory reporter lines, can confidently be 
used to readily identify the terminal nerve GnRH cells, the forebrain commissures, 
and the olfactory projections, in normal and genetically-manipulated developing 
zebrafish. However, some caution will need to be used when interpreting putative 
terminal nerve GnRH defects, as this may represent defects in the neuromodulatory 
GnRH system and/or the migratory behaviour of the „later wave‟ of GnRH neuronal 
migration to the hypothalamus. Moreover, any defects in the „early wave‟ of GnRH 
migration will need to be carefully analysed in the context of the information that 
we currently have on this novel GnRH population. 
It is yet to be proven whether or not the „two wave model‟ for hypothalamic 
GnRH neuronal migration actually exists in the zebrafish, in the same way that it is 
thought to occur in primates. Whilst it is interesting to identify unified themes, as 
well as common molecular and cellular mechanisms, that control forebrain GnRH 
system development across all vertebrates, it has become evident during the course 
of this chapter that such mechanisms may have diverged across the different orders 
(rodentia, primates, teleosts etc). So, while the zebrafish GnRH neuronal system 
development may be a very useful model for investigating some of the signalling 
pathways involved in the molecular pathogenesis of Kallmann syndrome, the 
phenotypes may not be directly comparable to human GnRH ontogeny. Moreover, 
in some circumstances, where possible, the chick may be a more useful model, 
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especially for some of the more brain region-restricted comparative analyses where 
electroporation techniques may be used. 
It has become apparent from this chapter that the forebrain commissures, 
especially the anterior commissure, play a significant role in the connectivity of the 
olfactory and GnRH systems; and may also play a role as an „interface‟ between 
these two systems, considering terminal nerve GnRH cells and olfactory bulb 
interneurons both project axons across this same commissure.  
Using the zebrafish model that has been characterised in this chapter, the 
olfactory/ GnRH system phenotypes that results from manipulating the fibroblast 
growth factor, FGF, (Chapter 4) and anosmin-1 (chapter 5) signalling pathways, will 
be discussed in the following results chapters. 
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3.5 Future prospects 
A very important future goal will be to further understand the proposed „two 
wave‟ model of GnRH neuronal migration to the hypothalamus that has been put 
forward in this thesis. In particular, the early-accumulation of GnRH3 neurons at 
the hypothalamus will need to be independently-proven using several well-
characterised hypothalamic GnRH neuronal markers, to ensure that these cells are 
not just an unfortunate artefact of the G3MC transgenic line. It was hoped that 
Kiss1, Kiss2, Gpr54a, or Gpr54b could have fulfilled this role, as kisspeptin has 
been shown to be expressed in the GnRH neurons during human embryogenesis. 
Perhaps the future availability of antibodies directed against these proteins may help 
to label the „early-accumulation‟ GnRH neurons at the hypothalamus. Moreover, it 
would be useful to further characterise „the later wave‟ of GnRH neuronal migration 
(i.e. the GnRH-expressing cells which appear after 12dpf) in this same manner.  
Once the early and later wave GnRH neurons have been more fully 
characterised, it will be useful to fully determine their embryonic origins (i.e. where 
they were specified). The presence of GnRH3 cells in the olfactory epithelium, at 
around 36hpf in G3MC embryos, suggest that at least some of the forebrain GnRH3 
neurons may have an olfactory placodal origin. This will need to be investigated 
further, as the controversy regarding the origins of the hypothalamic GnRH neurons 
persists. 
The midbrain GnRH2 cells are believed to fulfil a „neuromodulatory role‟ 
which may or may not be related to the role played by the terminal nerve GnRH 
system. During embryogenesis, these cells consistently occupy a region in the 
midbrain, which persists on into adulthood. However, it became apparent during this 
study that there is also GnRH2 expression along the region of the anterior 
commissure axonal tracts, extending up to the terminal nerve GnRH region. 
Therefore, we could speculate that the midbrain GnRH2 cells may interact with the 
terminal nerve, and in turn, perhaps also the hypothalamic GnRH system. Whilst 
beyond the scope of this thesis, it would be interesting to investigate these putative 
interactions between the neuromodulatory and hypophysiotropic GnRH systems, 
and how this influences reproductive competency. 
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Failure of proper embryonic hypothalamic GnRH neuronal migration is 
thought to underlie the absence of hypothalamic GnRH secretion at the time of 
puberty in Kallmann syndrome (KS) patients. So, proper understanding of the 
molecular and cellular basis of normal embryonic GnRH neuronal migration in 
humans, and our chosen comparative model (the zebrafish), is essential for 
understanding the congenital abnormalities that occur in this disease. However, to 
confirm that these developmental abnormalities persist into adulthood, it will also be 
necessary to study the adult brains from normal and genetically-altered zebrafish. 
One way to do this is to carry out GnRH immuno-labelling on adult brain sections, 
to identify any reduction in hypothalamic GnRH cell number. An alternative way is 
to study GnRH gene expression levels in adult zebrafish. This could be done by 
dissecting out adult brains (or, more specifically, their forebrains) and carry out 
quantitative RT-PCR for GnRH3, or the gonadotrophin genes (FSH and LH) 
whose expression/upregulation should result from normal hypothalamic GnRH 
secretion. Moreover, in normal reproductively-competent adults, FSH and LH 
have been shown to be upregulated upon systemic injection of Kisspeptin 2 
(Kitahashi et al., 2009), so this „normal‟ response could also be investigated. 
Finally, another way to determine adult reproductive competency would be to 
actually look at breeding success in „normal‟ and genetically-manipulated (KS-
model) adult zebrafish. 
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4.1  Introduction 
 
Fgf signalling has a critical role in vertebrate forebrain development. In 
particular, FGFR1 and FGF8, two KS genes involved directly in this signalling 
pathway, are required for proper olfactory bulb morphogenesis and 
hypothalamic GnRH neuronal development in both humans and mice. 
Moreover, these gene products also have a significant role in the formation of 
the forebrain commissures in these two organisms.  
Interestingly, the role of FGF signalling during formation of the 
forebrain commissures has also been conserved in the zebrafish. Consistently, 
loss of one of the two zebrafish FGF8 orthologues was shown to give defects in 
the targeting of olfactory axons to the olfactory bulbs. However, the role of the 
two FGFR1 and FGF8 orthologues during olfactory, vomeronasal and GnRH 
neuronal development in the zebrafish has, until now, not been fully 
investigated.  
 
4.1.1  Zebrafish have two FGFR1 & FGF8 orthologues  
FGFR1 (KAL2) and FGF8 (KAL5) are two of the autosomal genes which 
have been implicated in approximately 15% of KS cases (Dode et al., 2003; 
Investigating the role of FGFR signalling during GnRH 
and olfactory system development and identification of 
a specific role for the Fgf8a ligand 
Chapter 4: Results (II) 
 
160 
 
Falardeau et al., 2008). Zebrafish have two orthologues of FGFR1 (Fgfr1a and 
Fgfr1b) (Scholpp et al., 2004; Rohner et al., 2009) and two orthologues of FGF8 
(Fgf8a and Fgf8b) (Reifers et al., 1998; Reifers et al., 2000). Fgf8b was previously 
misnamed „Fgf17a‟ (or Fgf17) before it was realised, by looking at conserved 
sytenic regions, that it was an FGF8 orthologue instead of an FGF17 orthologue 
(Jovelin et al., 2007). Fgf8a is also known as „ace‟, in reference to the Fgf8a 
„acerebellar‟ mutant (Reifers et al., 1998). The second FGFR1 orthologue (Fgfr1b) 
was only recently identified, so Fgfr1a was previously known more simply as 
„Fgfr1‟(Scholpp et al., 2004). 
 
4.1.2  Expression of Fgfr1a/Fgfr1b and Fgf8a/Fgf8b during 
zebrafish brain development  
The expression patterns of Fgf8a and Fgf8b have both previously been well-
characterised, and were found to be largely over-lapping (Reifers et al., 2000), 
although there were some notable differences, which may have resulted in sub-
functionalisation of certain ancestral gene functions. The characteristic mid-
hindbrain (MHB; „isthmic‟) labelling seen by around 24hpf (20-somite stage) is 
broadly overlapping for both Fgf8a and Fgf8b; however, only Fgf8a is expressed in 
the dorso-anterior forebrain by this stage. Fgf8b is only detected in a medial sub-
population of Fgf8a-expressing cells in the optic stalk, but, unlike Fgf8a, is not seen 
at all in the olfactory placode, and only very weakly in the dorsal diencephalon, by 
around 30hpf.  So, to summarise, whilst the characteristic MHB staining is largely 
shared with both Fgf8a and Fgf8b, only Fgf8a is expressed in the forebrain 
primordium and olfactory placodes (Reifers et al., 2000; Shanmugalingam et al., 
2000l; Jovelin et al., 2007). 
Like Fgf8a, Fgfr1a is expressed in the prospective forebrain from around 
bud stage (~10hpf), and begins to be expressed in the MHB region by around 14hpf 
(10-somite stage). Fgfr1a is also detected at low levels in the hindbrain at this stage. 
Later, by around 24hpf, Fgfr1a transcript is detected in the pharyngeal arches, the 
MHB, several domains of the telencephalon and the diencephalon, as well as the 
optic stalk and olfactory placode. Again, this is a very similar expression pattern to 
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Fgf8a, suggesting that these two orthologues belong to the same synexpression 
group, like their murine orthologues, Fgf8 and Fgfr1 (Scholpp et al., 2004). In 
contrast, Fgfr1b is expressed in much broader domains of the diencephalon, 
midbrain, cerebellum and ventral hindbrain by 24hpf, whereas the telencephalon 
completely lacks Fgfr1b transcript at this stage (Rohner et al., 2009). However, 
because knowledge of the existence of Fgfr1b has been much more recent than 
Fgfr1a, further expression analyses are required to confirm these results. 
 
4.1.3  The role of Fgf signalling during zebrafish forebrain 
development 
The Fgf8a null mutant zebrafish, named „acerebellar‟ due to the conspicuous 
lack of a cerebellum in these mutants, have several prominent forebrain defects as 
well. This includes fewer olfactory axonal condensations at the anterior 
telencephalon; neuronal connections which are a necessary pre-requisite for normal 
glomeruli formation within the future olfactory bulbs. Moreover, whilst the 
olfactory epithelium was present, differentiation of some ORNs appeared to be 
disturbed in these Fgf8a mutant embryos, and particular subsets of ORNs 
(expressing a certain odorant receptor, „Or2.0‟) were reduced or absent. Other 
forebrain defects included a variable failure in the establishment of the two 
forebrain commissures (see Figure 4.01): the anterior commissure (AC) and the 
post-optic commissure (POC) at the rostral tip of the developing forebrain 
(Shanmugalingam et al., 2000). The AC defect is of particular interest because the 
AC comprises, in part, some axonal projections from both olfactory and GnRH 
neurons traversing the midline (Whitlock, 2004), and would be expected to 
contribute to a failure in coordination of the olfactory and GnRH systems.  
During zebrafish development, at around 16hpf, bilateral clusters of neurons 
appear within the forebrain which will form the two forebrain commissures. These 
include a pair of ventrorostral clusters in the diencephalon which project axons 
towards the midline from around 18hpf onwards to form the POC; and a pair of 
dorsorostral clusters in the telencephalon which extend axons soon after to form the  
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Figure 4.01   The zebrafish forebrain commissures
A three dimensional schematic representation of the forebrain tracts and
commissures is depicted for a 48hpf zebrafish embryo, with the anterior dorsal
axis projecting towards the top. Commissural axons (in green) traverse the
midline to form the anterior commissure (AC) in the telencephalon and the
post-optic commissure (POC) in the diencephalon. Retinal ganglion cells
(RGCs; in red) from the eye form the optic nerve and optic chiasm (OC) close
to the where the POC had formed..
OE= olfactory epithelium
Figure 4.01 reproduced with permission from Development (Barresi et al., 2005).
doi:10.1242/dev.01929
OE
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AC. The outline of both forebrain commissures (POC and AC) have formed by 
around 27hpf in the zebrafish (Walshe and Mason, 2003; Barresi et al., 2005). A 
schematic diagram illustrating the formation of these two forebrain commissures is 
illustrated in Figure 4.02. 
 
4.1.4 Fgfr1 during mammalian forebrain development 
The specific loss of Fgfr1 within the telencephalon of mice results in 
olfactory bulb aplasia (Hebert et al., 2003). However, despite this lack of normal 
olfactory bulb morphogenesis, neurons in the anterior part of the Fgfr1-deficient 
telencephalon, although not organised in a typical bulb like structure, still project to 
their normal targets within the olfactory cortex. Also, the anterior and posterior 
branches of the anterior commissure fail to project across the midline once they 
have joined at the anterior olfactory nucleus, even though the initial formation of 
these neurons is apparently normal. This data would suggest that the olfactory bulb 
and anterior commissure neurons are indeed generated normally in the Fgfr1 mutant 
embryos, but that they are unable to project properly to their intended targets 
(Hebert et al., 2003; Lindwall et al., 2007). Interestingly, mice which are null for 
Ext1 (which encodes an enzyme involved in HS polymerisation), specifically within 
the telencephalon, have a phenotype which is very similar to the Fgfr1-deficient 
telencephalon mutants i.e. they also have missing olfactory bulbs and loss of the 
forebrain commissures and midline structures (Inatani et al., 2003). This emphasises 
the critical role played by HS in the FGF signalling pathway during these 
developmental processes. 
 
4.1.5  Role of Fgf8 during mammalian forebrain 
development 
Mice with a specific telencephalic deficiency of Fgf8 survive gestation but die at 
birth, lacking olfactory epithelium, vomeronasal organ, nasal cavity, and forebrain. 
During embryogenesis, Fgf8 is expressed in the rim of the invaginating nasal pit, in 
a small group of cells that, later in gestation, partially overlaps with putative  
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Figure 4.02   Formation of the zebrafish forebrain commissures
A diagram illustrating the progress of anterior commissure (AC) and post-optic
commissure (POC) formation between 15hpf and 36hpf. From around 16hpf,
clusters of neurons appear in the forebrain that will form the AC and POC: the
NTPOC, Nucleus of the tract of the POC; and NTAC, nucleus of the tract of the
AC. The NTOC axons begin to project across the midline to form the POC from
around 18hpf; and the NTAC axons begin to form the AC soon after. By around
27hpf, the AC and POC have formed; and by 36hpf, the optic nerve (ON) has
also formed from retinal ganglion cells (RGCs) in the eyes.
Figure 4.02 adapted with permission from Development (Barresi et al., 2005).
doi:10.1242/dev.01929
15hpf
27hpf
22hpf
36hpf
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olfactory epithelium neural stem cells. In fact, E10.5 mouse embryos in which the 
Fgf8 gene is inactivated in the anterior neural structures do have at least a 
rudimentary olfactory pit. However, olfactory neurons within the Fgf8-expressing 
domain of the olfactory pit subsequently undergo high levels of apoptosis in these 
mutants, resulting in failure of nasal cavity invagination, combined with loss of 
most of the olfactory epithelium neuronal cell types. This demonstrates that Fgf8 
signalling is essential for development of the olfactory epithelium, nasal cavity, and 
vomeronasal organ in the mouse (Kawauchi et al., 2005).  
A model has thus been put forward whereby Fgf8 expression defines an 
„anterior morphogenetic center‟ which is required for the correct morphogenesis of 
the nasal cavity, as well as maintenance of olfactory epithelium and vomeronasal 
neural stem and progenitor cells thereafter. In the mutants, absence of Fgf8 gene 
function results in severe deficits in primary olfactory neurogenesis due to the 
elevated levels of apoptosis in the Fgf8 expression domain of the olfactory pit 
(Kawauchi et al., 2005) (see Figure 4.03). 
 
4.1.6  Evolutionary conservation of the FGF8/FGFR1 
signalling pathway during forebrain development 
As already mentioned in Chapter 1, mice homozygous for a hypomorphic 
Fgf8 allele lack hypothalamic GnRH neurons (Falardeau et al., 2008; Chung et al., 
2008), and similarly, mice which are homozygous for hypomorphic Fgfr1 allele also 
have a reduction in hypothalamic GnRH neurons too (Chung et al., 2008). This data, 
along with the observations above that these mutants also have missing olfactory 
bulbs, demonstrates that the role played by FGF8 and FGFR1 signalling during 
olfactory and GnRH system development has been well-conserved from mice to 
man. In this chapter, it will be investigated whether this role has been well 
conserved in zebrafish too. 
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Figure 4.03   The proposed role of Fgf8 in mouse olfactory neurogenesis
This diagram illustrates the Fgf8 expression domain („anterior morphogenetic
center‟ in orange; emphasised by orange arrows) and the different neuronal cell
types during primary olfactory neurogenesis at E10.5 in wild type and
conditional Fgf8 mutants that lack Fgf8a expression in the olfactory epithelium.
Sox2 expressing cells (definitive neuroepithelium) are yellow; primordial neural
stem cells (co-expressing Sox2 and Fgf8), are green; Mash1-expressing
committed neuronal progenitors are dark blue; INPs (Ngn1-expressing
immediate neuronal precursors) are light blue; and Ncam1-expressing neurons
are pink. Cells that undergo apoptosis when Fgf8 is inactivated in the olfactory
epithelium are shown in red, and apoptotic primordial neural stem cells are
green with a red jagged border.
LNP: lateral nasal placode; MNP: medial nasal placode.
Figure 4.03 adapted with permission from Development (Kawauchi et al., 2005).
doi:10.1242/dev.02143
Fgf8 mutantWild-type
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4.1.7  Aims of this chapter 
It is well understood that Fgf signalling plays an important role in zebrafish 
forebrain commissure formation, and that zebrafish Fgf8a mutants have fewer 
olfactory bulb glomeruli. However, a detailed analysis of how the Fgf receptors and 
Fgf8a/Fgf8b ligands are involved in olfactory and vomeronasal axonogenesis and 
GnRH system development in the zebrafish has hitherto not been reported.  
So, using the olfactory and GnRH transgenic reporter lines that were 
characterised in the previous chapter, the following aims are set out for this chapter: 
-To ascertain the spatio-temporal expression of the Fgf receptors, ligands 
and downstream effectors during zebrafish forebrain commissure formation 
and olfactory system development. 
-To temporally modulate FGFR signalling by means of pharmacological 
inhibitors and dominant negative approaches to determine how this affects 
zebrafish GnRH and olfactory system development. 
 -To use antisense oligonucleotide (morpholino) and mutant approaches to 
investigate whether Fgf8a and/or Fgf8b are involved in the development of 
the zebrafish GnRH and olfactory systems.  
-To investigate whether Fgf8b is involved in zebrafish forebrain commissure 
development, either alone or synergistically with Fgf8a.  
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4.2   Results 
 
The in situ hybridisation spatio-temporal expression pattern for the two 
zebrafish FGFR1 and FGF8 orthologues has been described previously (Scholpp et 
al., 2004; Rohner et al., 2009; Reifers et al., 1998; Reifers et al., 2000). The aim of 
this part was therefore to look at their expression specifically during forebrain 
development, focussing particularly on olfactory and forebrain commissure 
axonogenesis. Therefore, two significant stages were chosen: 17hpf, when the 
olfactory placode first forms (see Chapter 3) and when the two bilateral clusters 
which give rise to the AC and POC are first apparent (see discussion below); and 
23hpf, when ORN and forebrain commissure axonogenesis is becoming active 
(Walshe and Mason, 2003).  
For comparative purposes, the expression pattern for Fgf3 ligand and the 
other Fgf receptors is also considered. Although Fgf3 does not belong to the same 
Fgf subfamily as Fgf8a and Fgf8b, its essential role in zebrafish AC and POC 
formation means that it could also have an important role in forebrain 
developmental processes where Fgf8 has been implicated, including the olfactory 
and GnRH systems (see discussion).  
Finally, expression analysis of two modulators of Fgf signalling, Dusp6 and 
Sprouty4, are also considered, due to their use as read-outs of active Fgf signalling 
within the forebrain during embryogenesis (Molina et al., 2007). 
 
4.2.1  In situ hybridisation expression analysis of members 
of the Fgf signalling pathway during olfactory axonogenesis 
and forebrain commissure formation 
Fgfr1a, Fgfr1b, Fgfr2, Fgfr3, and Fgfr4  
As expected, at 17hpf, Fgfr1a transcript is present at high levels in the 
anterior forebrain (Figure 4.04A); whilst the other orthologue, Fgfr1b, shows 
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indistinct weak labelling throughout the whole head region at this stage (Figure 
4.04C). By 23hpf, Fgfr1a is more ubiquitously expressed in several regions 
throughout the forebrain (Figure 4.04B, B‟); however, it remains difficult to 
decipher spatial expression of Fgfr1b at this stage (data not shown), which only 
begins to become marginally more distinct by around 26hpf in the 
diencephalic/midbrain/hindbrain regions (Figure 4.04D, D‟). Acetylated tubulin 
immuno-labelling was carried out on the 23hpf embryos to visualise the newly 
forming olfactory and commissural axons, in relation to the in situ expression. This 
showed that Fgfr1a is expressed in regions of the telencephalon and diencephalon 
where olfactory and forebrain commissural axonogenesis is occurring (Figure 
4.04B; see inset); however, analysis of sections from these embryos would need to 
be carried out in order to distinguish the exact regions of Fgfr1a expression in 
relation to axon formation (see discussion).  
Fgfr2, Fgfr3, and Fgfr4 are all expressed throughout most, if not all, regions 
of the forebrain at 17hpf (Figure 4.04E, G, I). By 23hpf, Fgfr2 is still expressed 
throughout the forebrain, but shows strongest expression in the ventral 
telencephalon and anterior diencephalon (Figure 4.04F). Fgfr3 and fgfr4 expression 
is strongest in the diencephalon by 23hpf, but are both still expressed in some 
telencephalic regions, including the ventral telencephalon (Figure 4.04H, J). The 
anti-acetylated tubulin immuno-labelling on these embryos showed that all three 
receptors are expressed in regions of olfactory and commissural axon formation; 
especially where the POC forms in the diencephalon (Figure 4.04F‟, H‟, J‟; see 
insets). 
 
Fgf8a, Fgf8b, and Fgf3 
At 17hpf, Fgf8a, but not Fgf8b, is expressed in the anterior forebrain (Figure 
4.05A, C). By 23hpf, Fgf8a and Fgf8b are both expressed in the optic stalk, but only 
Fgf8a is expressed in the telencephalon, dorsal diencephalon (Figure 4.0B‟) and 
olfactory epithelium (red arrow, Figure 4.05B‟‟) at this stage. The Fgf8a forebrain 
staining was strongest towards the midline region. 
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Figure 4.04   Fgf receptor expression during olfactory and commissural 
axonogenesis
In situ hybridisation analysis for Fgfr1a (A, B, B‟), Fgfr1b (C, D, D‟), Fgfr2
(E, F, F‟), Fgfr3 (G, H, H‟), and Fgfr4 (I, J, J‟) at 17hpf (A, C, E, G, I), 23hpf
(B, F, H, J) and 26hpf (D). Magnified pictures are shown for the 23hpf and
26hpf images in B‟, D‟, F‟, H‟ and J‟. The insets in B‟, F‟, H‟, and J‟ show
anti-acetylated tubulin (AT) immuno-labelling (in green) of the commissural
tracts for those corresponding embryos: the asterisk in these images indicates
the centre of the olfactory placode (-which was identified using the AT
labelling). The labelling for Fgfr1b was quite indistinct at 17hpf (C) and there
was no labelling at 23hpf (not shown), so a 26hpf embryo was used in D and
D‟ (with no AT labelling).
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Figure 4.01
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*
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Figure 4.04   Fgf receptor expression during olfactory and 
commissural axonogenesis
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           Fgf3 showed weak forebrain labelling at 17hpf (Figure 4.05E), which became 
stronger by 23hpf, especially in the diencephalon and anterior telencephalon (Figure 
4.05F), as well as some weak expression in the region of the olfactory pits (Figure 
4.05F‟; see asterisk). 
 
4.2.2 Expression of Fgf downstream modulators during 
olfactory & GnRH neuronal development 
Sprouty4 (Spry4), an Fgf signalling antagonist, has an expression pattern 
that is very similar to Fgfr1a and Fgf8a, including the very distinctive isthmic 
(MHB) expression at 17hpf and 23hpf (Figure 4.06A, B). Moreover, there is 
anterior forebrain staining at 17hpf (Figure 4.06A), as well as staining of the optic 
stalk, telencephalon (weakly) and dorsal diencephalon at 23hpf (Figure 4.06B, B‟). 
However, olfactory epithelium expression for Sprouty4 was not detectable at these 
stages (Figure 4.06B‟; see asterisk).  
Dusp6, another Fgf antagonist, is strongly expressed throughout the 
forebrain at 17hpf and 23hpf, particularly in the ventral diencephalon and anterior 
telencephalon (Figure 4.06C, D). Dusp6 is also expressed in the olfactory placodes 
throughout these stages, as well as within the region of the bilateral clusters which 
project across the midline to form the AC and POC (Figure 4.06D‟). 
The Dusp6 reporter line (pDusp6:d2GFP) was crossed with G3MC 
(pGnRH3:mCherry; see Chapter 3), and the resulting double transgenic offspring 
were visualised between 24-30hpf (Figure 4.06E, F). At 24hpf, GFP expression 
indicated Dusp6 expression at the olfactory pits (Figure 4.06E), which remained 
until at least 30hpf (Figure 4.06F); however, due to the dynamic nature of d2GFP 
expression, not all of the same ORNs will still be expressing d2GFP at this time-
point. However, the terminal nerve GnRH3 (G3MC) cells do not co-express d2GFP 
(Dusp6) between 24hfp and 30hpf, and neither do the initial hypothalamic GnRH3 
(G3MC) cells at 30hpf (Figure 4.06F). Moreover, there was some dynamic d2GFP 
(Dusp6) expression in some cells in the anterior telencephalon at 24hpf and 30hpf, 
in a region where the olfactory bulbs will form (Figure 4.06E, F).  
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Fgf8b17hpf 23hpf
Fgf317hpf 23hpf
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*
Figure 4.05   Fgf8a, Fgf8b, and Fgf3 ligand expression during olfactory and 
commissural axonogenesis
In situ hybridisation analysis for Fgf8a (A, B, B‟, B‟‟), Fgf8b (C, D, D‟), and
Fgf3 (E, F, F‟) at 17hpf (A, C, E) and 23hpf (B, D, F). Magnified pictures are
shown for the 23hpf images in B‟, D‟, and F‟. The insets in B‟, D‟, and F‟
show anti-acetylated tubulin (AT) immuno-labelling (in green or red) of the
commissural tracts for those corresponding embryos: the asterisk in these
images indicates the centre of the olfactory placode (which was identified using
the AT labelling). B‟‟ shows B‟ viewed from the ventral view with a red arrow
indicating Fgf8a labelling in the olfactory epithelium.
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Sprouty4
17hpf 23hpf Dusp6
17hpf 23hpf
E F
24hpf 30hpf
C D D’
A B B’
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*
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Figure 4.06   Expression of FGFR downstream signalling markers during 
olfactory and commissural axonogenesis
In situ hybridisation analysis for Sprouty4 (A, B, B‟) and Dusp6 (C, D, D‟), at
17hpf (A, C) and 23hpf (B, D). Magnified pictures are shown for the 23hpf
images in B‟ and D‟ with asterisks marking the centre of the olfactory placode
(-which was identified using the AT labelling). E and F show a ventral view
from a cross of Dusp6:d2GFP (in green) with G3MC (in red) at 24hpf (E) and
30hpf (F). E and F are confocal views from the same embryo.
OE= olfactory epithelium; TN= terminal nerve; AC= anterior commissure;
hyp= hypothalamus.
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           Anti-pERK immuno-labelling was carried out on G3MC embryos at 24hpf, 
30hpf and 48hpf. However, there was no brain pERK immuno-labelling detected at 
either 24 or 30hpf (data not shown); whereas by 48hpf, pERK labelling was clearly 
visible in the presumptive olfactory bulb region of the anterior forebrain, and also in 
a few cells within the olfactory pits (represented as white dotted circles in Figure 
4.07). However, there was no anti-pERK and G3MC (GnRH3) co-expression 
detectable at 48hpf in the terminal nerve (Figure 4.07) and hypothalamic GnRH3 
cells (data not shown). 
 
4.2.3 Modulation of FGFR signalling by SU5402 inhibition 
and dominant negative approaches 
Dechorionated embryos were incubated in aquarium water containing 10M 
SU5402 (a global FGFR signalling inhibitor) at either 22-36hpf or 14-22hpf, as 
summarised in Figure 4.08. Some of those embryos incubated in SU5402 from 
22hpf to 36hpf were fixed immediately at 36hpf, whilst the remaining embryos were 
left to develop in aquarium water (without additives) until 60hpf, and then fixed.  
Similarly, embryos incubated in SU5402 from 14hpf to 22hpf, were subsequently 
incubated without SU5402 until 36hpf and then fixed, or incubated until 60hpf. 
Embryos incubated in SU5402 at 22-36hpf and fixed at 36hpf (n=44/44, 2 
experiments) and 60hpf (n=40/40, 2 experiments
3
) had an apparently normal 
external morphological phenotype. However, those embryos incubated in SU5402 at 
14-22hpf had some morphological defects: specifically, those fixed at 36hpf showed 
some evidence of lower trunk cell necrosis (n=11/43, 2 experiments), whereas those 
left to develop until 60hpf were all dead by this time-point (n=38/38, 2 
experiments), and therefore not fixed or analysed further. 
 
 
                                                 
3
 The number of embryos representing a stated phenotype (n=?/?), are recorded as fraction of a 
pooled total from a specified number of experiments. E.g. ‘n=40/40, 2 experiments’ means that 40 
out of a total of 40 embryos showed a particular phenotype across two separate experiments 
(within a certain experimental group). 
NOTE: Numbers for dead embryos is not mentioned, unless the number is significantly higher in one 
group compared to the others. 
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Figure 4.07   phosphoERK immuno-labelling in the zebrafish forebrain
A ventral view of a 48hpf G3MC embryo which has been immuno-labelled
with anti-phosphorylated-ERK (anti-pERK, in green). The olfactory epithelia
regions are broadly demarcated with white dotted circles. Within these
demarcated regions the terminal nerve G3MC cells are visualised alongside
approx. 8 pERK-positive cells. The olfactory bulbs, at the anterior end of the
forebrain, have distinctly high pERK immuno-labelling. (No forebrain pERK
immuno-labelling was visualised prior to 48hpf; data not shown).
Scale bar is 50m.
OE= olfactory epithelium; OB= olfactory bulbs; AC= anterior commissure.
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0 10 20 30 40 50 60
14-22h
22-36h
22-36h
36-60h
All died
=With SU5402
=Without SU5402
Fix at 36h Fix at 60h
Progress of development (hpf) 
[1]
[2]
Figure 4.08   Diagram illustrating plan for FGFR inhibition using SU5402
This diagram shows the two routes, [1] and [2], for specific temporal FGFR
inhibition using SU5402. The progress of development is illustrated at the
bottom of the diagram as a linear time-scale from 0-60hpf. The dotted lines
indicate progress of development prior to SU5402 incubation; the green „boxed‟
arrows represent times of SU5402 incubation; and blue boxes show times of
post-SU5402 development. The embryos from routes [1] and [2] were fixed at
either 36hpf or 60hpf (see red arrows): however, embryos treated by route [2]
were either dead or dying by 60hpf, and were therefore not analysed further.
Control embryos were incubated in „DMSO only‟ from 14hpf until 36hpf and
showed identical phenotypes to wild-type non-treated embryos (data not shown),
thus permitting one „universal‟ DMSO control for figures 4.06, 4.08, 4.09, and
4.10.
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           As an alternative to FGFR down-regulation by use of exogenous inhibitors, a 
dominant negative approach was also adopted, using the HSP70:dnFGFR-EGFP 
(Lee et al., 2005) transgenic line. Specifically, the bacterial heat shock promoter 
(HSP70) was utilised to control the concurrent expression of dominant negative 
FGFR (dnFGFR) and EGFP, upon activation by means of „heat-shock‟ (i.e. 45mins 
incubation at 37°C). Heat-shock was carried out 2 hours prior to the intended 
activation of dnFGFR i.e. at 18hpf and 22hpf, to down-regulate FGFR signalling 
from ~20hpf and ~24hpf onwards, respectively. After heat-shock, embryos were 
then incubated normally and fixed when they reached 36hpf, by which time 
dnFGFR was presumably still active (i.e. not yet degraded).  
Forebrain commissure phenotype 
As SU5402 was dissolved in DMSO before application to the embryos, the 
same volume of DMSO was also applied to the control embryos, and incubated in 
this way between 14hpf and 36hpf. These DMSO control embryos had no external 
morphological abnormalities, and upon acetylated tubulin immuno-labelling had 
normal (wild-type) forebrain commissure (AC and POC) formation at 36hpf 
(n=48/48, 2 experiments, Figure 4.09A, A‟) and 60hpf (n=41/41, 2 experiments, 
Figure 4.09B). Embryos incubated with SU5402 between 22hpf and 36hpf were 
either apparently normal (n=37/44, 2 experiments, i.e. similar to Figure 4.09A, A‟) 
or with slight AC defects, such as a subtle reduction in the number of axons crossing 
the midline (n=7/44, 2 experiments, Figure 4.09C, C‟). But, by 60hpf, it was no 
longer possible to detect any of these subtle defects, and the AC looked apparently 
normal in all embryos (n=40/40, 2 experiments, Figure 4.09D).  
In contrast, for embryos incubated with SU5402 between 14hpf and 22hpf, 
and then fixed at 36hpf, defective forebrain commissure formation phenotypes were 
much more severe. In some cases, both the AC and POC had formed, but there were 
several axons mis-projecting between the two commissures (n=14/43, 2 
experiments, Figure 4.09E, E‟, G, G‟); whilst in other cases, the AC failed to form 
correctly (n=13/43, 2 experiments, Figure 4.09F), or didn‟t form at all (n=9/43, 2 
experiments, Figure 4.09H). Also, in just one case, the POC hadn‟t formed at all 
(data not shown), or was highly defasciculated (n=3/43, 2 experiments, Figure  
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Figure 4.09   FGFR inhibition using SU5402: forebrain commissure 
phenotype
Anti-acetylated tubulin (AT) immuno-labelled embryos (with DAB) are shown
for the „DMSO control‟ (A, A‟, B), „SU5402 : 22-36h‟ (C, C‟, D), and „SU5402:
14-22h‟ (E, E‟, F, G, G‟, H) embryos, all at 36hpf , except B and D, which are
at 60hpf (the „SU5402: 14-22h‟ 60hpf embryos all died: data not shown).
Lateral views for A, C, E and ventral-lateral for G; the rest are all ventral
views. E-H demonstrate increasing severity of phenotype for this group. Blue
arrows indicate relevant AT immuno-labelling (see key below).
Scale bars are 100m.
POC= post-optic commissure; SOT= supra-optic tract; AC= anterior
commissure; OE= olfactory epithelium
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4.09G, G‟). The remaining six embryos from this group were dead at 36hpf. All 
embryos from this group which were incubated until 60hpf were dead by this stage 
and not analysed further (n=39/39, 2 experiments, data not shown). 
All HSP70:dnFGFR-EGFP embryos heat-shocked at 18hpf were dead 
(n=32/42, 2 experiments) or dying (n=10/42, 2 experiments) by 36hpf and not 
processed further (data not shown). Whilst embryos heat-shocked at 22hpf were 
mostly apparently normal by 36hpf, and were immuno-labelled for acetylated 
tubulin in order to visualise their forebrain commissures, as a comparison with the 
SU5402-treated embryos. Control embryos, which were heat-shocked at 18hpf, but 
did not express the dnFGFR-EGFP transgene (Figure 4.10A), showed normal 
forebrain commissure development at 36hpf (n=36/36, 2 experiments, Figure 4.10B, 
B‟). HSP70:dnFGFR-EGFP embryos that were heat-shocked at 22hpf were 
fluorescing green by 23-24hpf, demonstrating that the dnFGFR/EGFP transgene 
was successfully switched on. These dnFGFR embryos were fixed at 36hpf, and it 
was found that all had normal forebrain commissure phenotypes (n=40/40, 2 
experiments, Figure 4.10D, D‟), although several embryos showed signs of cell 
necrosis along their trunks (data not shown).  
Olfactory and vomeronasal axonal phenotype 
Once applied to embryos, the autofluorescence emitted by SU5402 is 
retained long after the SU5402 has been removed. As a result of this, visualisation 
of EGFP, Venus, and mCherry fluorescence by confocal microscopy from the 
olfactory, vomeronasal, and GnRH3 transgenic reporter lines was considerably 
hindered. Therefore, in order to improve the clarity and sensitivity of this analysis, 
embryos treated with SU5402 (and their controls) were immuno-labelled with anti-
GFP (for pOMP:tauEGFP and pTRPC2:Venus) or anti-mCherry (for 
pGnRH3:mCherry), followed by HRP-conjugated secondary antibodies and DAB 
colour reactions (see Chapter 2). This meant that standard (non-fluorescent) light 
microscopy could then be used to visualise these embryos. 
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D D’
Control
dnFGFR
Figure 4.10   FGFR inhibition: using the dominant negative FGFR 
approach
HSP:dnFGFR-GFP (C, D, D‟) and wild-type control embryos (A, B, B‟) were
heat-shocked at 22hpf and imaged for fluorescence (A and C) or fixed at 36hpf
for anti-acetylated tubulin immuno-labelling, with DAB (B, B‟, D, D‟). GFP
(green) fluorescence in C indicates that dnFGFR expression has been switched
on, compared with the control (A) which shows no GFP fluorescence (and no
dnFGFR). (Embryos heat shocked at 18hpf, or earlier, were dead or dying by
36hpf (data not shown).
Scale bars are 100m.
HSP= heat-shock promoter.
Control
dnFGFR
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           For embryos treated with SU5402 between 22hpf and 36hpf, no defects in 
olfactory axonogenesis were detected by 36hpf (n=45/45, 2 experiments, Figure 
4.11D, E) or 60hpf (n=39/39, 2 experiments, Figure 4.11F). On the contrary, 
olfactory axonal defects were present in those embryos treated with SU5402 
between 14hpf and 22hpf (Figure 4.11G-N). For these embryos, in some cases there 
were axons extending towards the olfactory bulbs, but they appeared to be less 
ordered, and not tightly fasciculated as they approached the forebrain (n=32/49, 2 
experiments, Figure 4.11G-J), whilst in other cases, this olfactory axonal bundle 
appeared to be entirely missing or much reduced in axonal number (n=17/49, 2 
experiments, Figure 4.11K-N). Moreover, the actual olfactory pits often sometimes 
appeared to be disorganised or irregular, less shaped like the wild-type „rosette‟ 
olfactory pit, (n=29/49, 2 experiments, Figure 4.11I, N), compared with the DMSO 
control embryos, which all had the wild-type morphology at 36hpf (n=43/43, 2 
experiments, Figure 4.11A, B) and 60hpf (n=40/40, 2 experiments, Figure 4.11C). 
Whilst there was considerable variability in olfactory pit size amongst the three 
experimental groups, including the controls, it was not possible to detect a 
significant decrement in average OMP-positive olfactory pit size in the SU5402-
treated embryos, compared with the DMSO-treated controls (data not shown).  
The vomeronasal (pTRPC:Venus) neurons within the olfactory pit were not 
immuno-labelled as strongly by anti-GFP, partly because this cell type is much 
fewer in number compared to the OMP-positive („olfactory‟) neurons. This made it 
somewhat difficult to determine whether there were any defects in vomeronasal 
axonogenesis as well. It was, however, evident that the embryos treated with 
SU5402 between 22hpf and 36hpf (n=37/37, 2 experiments, Figure 4.12B) were 
similar in appearance to the DMSO controls (n=39/39, 2 experiments, Figure 4.12A) 
at 36hpf; whilst many of the embryos treated with SU5402 between 14hpf and 
22hpf appeared to have 50% or fewer the number of vomeronasal axons and soma 
(n=31/39, 2 experiments, Figure 4.12C, D) at 36hpf, compared with the controls.  
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Figure 4.11   FGFR inhibition using SU5402: olfactory phenotype
Anti-GFP immuno-labelled OMPG embryos (with DAB) are shown for the
„DMSO control‟(A-C), „SU5402: 22-36h‟ (D-F), and „SU5402: 14-22h‟ (G-N)
embryos, all at 36hpf , except C and F, which are at 60hpf (the „SU5402: 14-22h‟
60hpf embryos all died: data not shown). All views are ventral. A, D, G, and K
show both olfactory pits; all other images depict a single olfactory pit. G-N
demonstrate increasing severity of phenotype for this group.
Scale bars are 50m.
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Figure 4.12   FGFR inhibition using SU5402: vomeronasal phenotype
Anti-GFP immuno-labelled pTRPC2:Venus embryos (with DAB) are shown
for the „DMSO control‟(A), „SU5402 : 22-36h‟ (B), and „SU5402: 14-22h‟ (C
and D) embryos, all at 36hpf. All views are ventral. C and D illustrate the two
types of phenotype that are found in this group. Scale bars are 50m.
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GnRH3 neuronal phenotype 
It was difficult to quantify hypothalamic GnRH cells from DAB-stained 
embryos, so a qualitative approach was used to assess the size of the hypothalamic 
GnRH cell clusters for the SU5402 treated embryos, compared with the controls. 
Embryos treated with SU5402 between 22hpf and 36hpf (n=47/47, 2 
experiments, Figure 4.13E-H) had the same G3MC phenotype at 36hpf as the 
DMSO control embryos (n=45/45, 2 experiments, Figure 4.12B) i.e. normal 
terminal nerve GnRH3 cell clusters which project axons across the anterior 
commissure, as well as a „normal-sized‟ cluster of „early wave‟ GnRH3 cells at the 
hypothalamus (see Chapter 3 for further discussion on the expected size of these 
GnRH populations). In contrast, embryos treated with SU5402 between 14hpf and 
22hpf have normal-sized terminal nerve GnRH3 cell clusters which don‟t project 
axons correctly across the midline via the anterior commissure (n=44/50, 2 
experiments, Figure 4.13I-K). Moreover, the hypothalamic cluster of GnRH3 cells 
is absent (n=19/50, 2 experiments, Figure 4.13L) or reduced in cell number by less 
than 50% compared with the DMSO controls (n=31/50, 2 experiments, data not 
shown) at 36hpf.  
 
4.2.4  Modulation of Fgf8a & Fgf8b: olfactory, GnRH, and 
forebrain commissure phenotype 
Fgf8a (‘ace’) mutants 
It has previously been reported that Fgf8a mutant („ace‟) zebrafish have 
defective forebrain commissure formation by 36hpf (Shanmugalingam et al., 2000). 
This experiment has been repeated here for control purposes (see Figure 5.12A-E). 
Surprisingly, the forebrain commissural defect was found to be very variable in the 
ace embryos, despite them all sharing the same mutant Fgf8a allele, and being 
homozygous for this allele, as confirmed by a missing cerebellum (red arrow, 
Figure 5.12B). Specifically, some ace embryos had an apparently normal AC and  
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Figure 4.13   FGFR inhibition using SU5402: GnRH (G3MC) phenotype
Anti-mCherry immuno-labelled G3MC embryos (with DAB) are shown for
the „DMSO control‟(A-D), „SU5402 : 22-36h‟ (E-H), and „SU5402: 14-22h‟ (I-
L) embryos, all at 36hpf. All views are ventral. A-C, E-G, and I-K illustrate the
terminal nerve G3MC phenotype; and D, H, and L illustrate the hypothalamic
G3MC phenotype. Scale bars are 50m.
TN= terminal nerve‟ hyp= hypothalamus; ON= optic nerve
hyp hyp
hyp
ON
ON
ON
TN TN
TN
TN
TN
TN
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POC, but with a few axons mis-projecting between the two commissures (n=24/104, 
2 experiments, Figure 4.14B-B‟‟), whilst other embryos had the same phenotype, 
but with many more axons mis-projecting across the two commissures (n=34/104, 2 
experiments, Figure 4.14C, D); whilst other ace embryos had an aberrant POC with 
much fewer commissural axons (n=4/104, 2 experiments, Figure 4.14E), or a 
completely absent AC (n=29/104, 2 experiments, Figure 4.14E). In a few cases, both 
commissures were intact with no obvious defects (n=10/104, 2 experiments, data not 
shown). Rarely, both AC and POC were both missing in the same embryo; but these 
embryos had abnormally small heads with some necrosis, so it is likely that a 
developmental delay was the cause of the commissure malformation (n=3/104, 2 
experiments, data not shown). Due to the rarity of this last phenotype, these severely 
malformed embryos were not studied further here. Of the controls, all embryos that 
were scored had normal forebrain commissure formation (n=42/42, 2 experiments, 
Figure 4.14A-A‟‟). 
Anti-GnRH immuno-labelling was also carried out on ace embryos, at 60hpf 
(Figure 4.14F, G). Terminal nerve GnRH cell clusters were labelled for both the ace 
(Figure 5.12G) and control (KWT, Figure 4.14F) embryos, except that whilst AC 
and POC GnRH-positive axonal projections could be detected in the control 
embryos (n=28/28, 2 experiments), these commissural projections were often absent 
or deficient in the ace embryos (n=18/32, 2 experiments, Figure 4.14G). Anti-GnRH 
does not detect hypothalamic GnRH cells at this stage, so it is not possible to 
comment on whether or not the hypothalamic GnRH cells are also affected in the 
ace embryos at 60hpf (using this method). 
Similarly, inhibitors which target specific cascades that occur downstream of 
FGF signalling were also used. Specifically, these were LY294002, which inhibits 
PI3K signalling; and U0126, which inhibits MAPK signalling (via MEK1/2). These 
were used in a similar manner to SU5402 (i.e. external incubation). However, no 
potency was obtained for these inhibitors i.e. there was no lethality even at high 
concentrations and no defective phenotypes were obtained suggesting that these 
inhibitors did not penetrate the zebrafish external epithelium and therefore had no 
effect on embryogenesis (data not shown). 
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Figure 4.14   Do Fgf8a mutants (ace) have GnRH defects?
Anti-acetylated tubulin (AT) immuno-labelled embryos (with DAB) are shown
for the wild-type (KWT) control (A), and Fgf8a mutants (ace; C-E) at 36hpf.
Confocal images of anti-GnRH immuno-staining are shown for the wild-type
(F) and Fgf8a mutant (G) at 60hpf. A , A‟, and B show lateral views; B‟ shows a
ventral-lateral view; A‟‟, B‟‟, and C-E show ventral views. The red arrow in A
points to the cerebellum, which is missing in the Fgf8a mutant (red arrow, B).
B-E demonstrate increasing severity of commissural phenotype for the ace
embryos. Scale bars are 100m.
TN= terminal nerve; AC= anterior commissure
F G
36hpf
KWTA A’ A’’
36hpf
AceB B’ B’’
C D E
60hpf
KWT
60hpf
Ace
TN TN
AC AC?
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Fgf8a & Fgf8b knockdown by morpholinos 
Whilst ace mutants do not have any normal copies of Fgf8a, they do have 
two functioning copies of the other FGF8 orthologue: Fgf8b. So, does losing both 
Fgf8a and Fgf8b gene function increase the severity of the mutant phenotypes 
described for ace; and does the Fgf8b morphant have any of these abnormalities by 
itself (i.e. with a normal Fgf8a background)? 
The Fgf8a morpholino has previously been well characterised, and, like ace, 
gives an acerebellar phenotype which can be used as a positive indication for the 
high-efficiency of Fgf8a knockdown (black arrow, Figure 4.15B). However, the 
Fgf8b morpholino used („8bMO‟) was novel, and used for the first time in this 
study, so its knockdown efficiency needed to be characterised further. The Fgf8b 
morpholino targets the loss of exon 3 from the Fgf8b transcript (Ensembl no.: 
ENSDART00000057885); a predicted loss of 187 nucleotides of sequence (see 
Figure 2.02 & Figure 5.08 for an explanation of the splice-blocking morpholino 
mechanism). So, when the Fgf8b gene is amplified, the wild-type „1486bp‟ PCR 
product will be reduced to a 1299bp PCR product in the morphant embryos (if only 
exon 3 is lost, as predicted). However, upon RT-PCR of the control and Fgf8b 
morphant embryos, only the „1486bp‟ PCR product was obtained, which, when 
sequenced, corresponded to full length Fgf8b PCR product for both control and 
morphant cDNA samples. Although, this might suggest that the morpholino is not 
working, it was noticeable that the intensity of the morphant PCR product was on 
average around 50% less intense than the control PCR product (Figure 4.15C; 
repeated 3 times, for 3 different morphant/control cDNA samples, using equal 
amounts of total cDNA in the PCR reaction; data not shown). Although this would 
need to be proven quantitatively (i.e. by quantitative PCR, „qPCR‟), it does suggest 
that less Fgf8b transcript is present in the Fgf8b morphants. An explanation for this 
could be that there was partial knockdown of Fgf8b (perhaps up to 50% 
knockdown), but that the morphant mRNA was unstable and readily degraded, so 
was therefore undetectable by RT-PCR. However, if this is correct, it still means 
that the Fgf8b morpholino knockdown efficiency is only around 50% at best; 
nowhere near the approximately 100% knockdown efficiency obtained using other 
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splice-blocking morpholinos, including the Fgf8a and Kal1a/-1b morpholinos (see 
chapter 5). 
The Fgf8a morphants had defects in one or both of the forebrain commissure 
(n=46/54, 3 experiments, Figure 4.15E), similar to what was seen for the ace 
embryos, as discussed above. These Fgf8a morphants also had abnormal olfactory 
pits with stunted axonal growth (n=22/58, 3 experiments, Figure 4.15I) or mis-
projections (n=29/58, 3 experiments, data not shown) and a disorganised olfactory 
pit „rosette‟ (n=39/58, 3 experiments, Figure 4.15I). In contrast, in the Fgf8b 
morphants, the forebrain commissures had formed correctly in most embryos 
(n=47/49, 3 experiments, Figure 4.15F), and the olfactory pits were apparently 
normal in most cases (n=49/52, 3 experiments, Figure 4.15J), although the poor 
knockdown efficiency needs to be considered when interpreting this result (see 
discussion). Knocking down both Fgf8a and Fgf8b together gave commissural 
(n=53/55, 3 experiments, Figure 4.15G) and olfactory (n=50/56, 3 experiments, 
Figure 4.15K) defects similar to knocking down Fgf8a alone (see above). The 
control (coMO-injected) embryos had normal forebrain commissure formation 
(n=47/47, 3 experiments, Figure 4.15D) and olfactory axonogenesis (n=51/51, 3 
experiments, Figure 4.15H) in all cases. 
Consistent with the mouse Fgf8 mutant, there was a noticeable reduction in 
olfactory pit size when both FGF8 orthologues were knocked down, which, whilst 
also noticeable in the single Fgf8a morphants (Figure 4.15I), was more severe in the 
Fgf8a+Fgf8b double morphants (Figure 4.15K). In order to quantify the reduction in 
olfactory pit size in these morphants, both olfactory pits from 10 embryos (i.e. 20 
olfactory pits in total) from each morphant group were measured digitally from a 
confocal stack, in the anterior-posterior (A-P) direction (see double-headed arrow in 
Figure 4.15H).  The average A-P length (in brackets, with corresponding standard 
deviation, as calculated using Microsoft Excel) of the four morphant groups are as 
follows: coMO (77.2m +4.90); Fgf8a MO (61.5m +5.96); Fgf8b MO (76.6m 
+6.64); and Fgf8a+Fgf8b MO (56.9m +10.73). 
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Cont 8bMO
Fgf8b: ~50% 
knockdownControl
BA
Fgf8a MO36hpf 36hpf
„Acerebellar‟ 
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C*
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Figure 4.15   Using morpholinos to knock down both Fgf8a and Fgf8b
A and B: light microscopy images (lateral views) of the „acerebellar‟
phenotype of Fgf8a morphants (B; blue arrow), compared to a control
morpholino (CoMO) -injected embryo (A) with cerebellum present (asterisk).
Fgf8b morpholino (8bMO) knockdown was confirmed by RT-PCR (C). The
anti-acetylated tubulin (D-G), OMPG (H-K), and G3MC (L-O) phenotypes are
shown for the control (D, H, L), the Fgf8a morphants (E, I, M), Fgf8b
morphants (F, J, N), and Fgf8a+Fgf8b double morphants (G, K, O). A single
olfactory pit is shown for OMPG phenotypes. For D-O all views are ventral .
For A-O all embryos are at 36hpf.
Scale bars are 50m. TN= terminal nerve; hyp= hypothalamus.
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TN
hyp
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           The Fgf8a morphants had significantly fewer (i.e. <50%
4
) hypothalamic 
GnRH3 („G3MC‟) cells by 36hpf (n=38/47, 3 experiments, Figure 4.15M), 
compared with the controls which had normal hypothalamic GnRH clusters 
(n=52/52, 3 experiments, Figure 4.15L). Moreover, of the 38 Fgf8a morphants 
which had 50% or fewer hypothalamic GnRH3 cells, 7 embryos had apparently 
completely absent hypothalamic GnRH3 cells by 36hpf. This was not the case for 
the Fgf8b morphants, which mostly had similar cell numbers to the controls, 
although these cells often expressed mCherry much more weakly (n=45/49, 3 
experiments, Figure 4.15N). Moreover, compared with the Fgf8a single morphants, 
the knockdown of Fgf8a and Fgf8b together did not make much difference to the 
number of embryos with less than 50% hypothalamic GnRH neurons, (n=46/51, 3 
experiments, Figure 4.15O). However, the hypothalamic GnRH cells in these double 
Fgf8a/-8b morphants, whilst fewer in number, also expressed mCherry (GnRH3) 
much more weakly, so were more difficult to detect fluorescently (Figure 4.15O).  
Moreover, the Fgf8a/-8b morphants had disrupted terminal nerve GnRH3 cells 
(n=38/51, 3 experiments, Figure 4.15O). 
 
                                                 
4
 Hypothalamic cells were not counted individually, but were instead estimated qualitatively. The 
defective hypothalamic  GnRH phenotypes were scored by whether they had less than 50% of the 
average number seen in the control embryos. 
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4.3   Discussion 
4.3.1  Fgf8a, Fgf3, and all five Fgf receptors have 
expression profiles consistent with their putative roles 
during forebrain commissure formation & olfactory 
axonogenesis  
As the telencephalic-specific Fgf8 mutant mouse has a more severe forebrain 
defect than the Fgfr1 mutant, it seems plausible that Fgf8 may be acting via more 
than one Fgf receptor during mouse forebrain development (Hebert et al., 2003; 
Meyers et al., 1998; Chung et al., 2008). Assuming that the same may be true in 
zebrafish, the expression pattern for all five zebrafish Fgf receptors (including both 
Fgfr1 orthologues) was investigated, in respect to forebrain development. In 
summary, the expression analyses carried out at 17hpf and 23hpf, would suggest 
that four of the Fgf receptors (Fgfr1a, Fgfr2, fgfr3, and Fgfr4) could possibly have a 
role in commissure formation and olfactory system development in the forebrain, 
but that Fgfr1b may be involved later (from around 23-26hpf). 
At 17hpf, when the olfactory placode forms and the cell clusters which give 
rise to the AC and POC can be first distinguished, Fgfr1a, is expressed quite 
strongly in the telencephalon (a region where the AC will form). Fgfr1b is expressed 
very weakly, or not at all, in the forebrain, whilst the other Fgf receptors (Fgfr2, 
Fgfr3, and Fgfr4) are all expressed strongly throughout the forebrain at this stage. 
Of the Fgf ligands looked at, Fgf8a, and more weakly, Fgf3 were also expressed in 
the forebrain, but not Fgf8b. This data may suggest that Fgf8a, Fgf3, Fgfr1a, Fgfr2, 
Fgfr3, and Fgfr4 may all have a role in determining the cells which give rise to the 
olfactory placode and forebrain commissure cell clusters at around 17hpf; but that 
Fgf8b and Fgfr1b are less likely to have a role in this process. However, because 
Fgfr1a expression is more restricted to the telencephalon at this stage, the role of 
Fgfr1a may be more restricted to olfactory and AC (not POC) formation. Further 
investigation will be required to confirm whether these putative functional roles 
exist for each of these receptors or ligands at this stage. 
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At 23hpf, when forebrain commissure and olfactory axonogenesis has 
become active, Fgfr1a is expressed in regions of the telencephalon and diencephalon 
where these olfactory and AC/POC tracts are forming. However, Fgfr1b labelling 
remains diffuse at this stage, and only becomes distinct in these regions by around 
26hpf. However, it is uncertain whether this is „real‟ expression and not just 
„background‟ signal due to poor in situ probe quality. Generation of alternative 
Fgfr1b probes will be required to further investigate the Fgfr1b expression pattern in 
relation to olfactory/commissural axonogenesis.  
Fgfr2, Fgfr3, and Fgfr4 are all broadly expressed in the forebrain region, so 
it can be envisaged that any of these receptors may putatively have a role in 
olfactory/commissural axonogenesis; although this would of course need to be 
confirmed. Of the Fgf ligands studied here, only Fgf8a and Fgf3 (but not Fgf8b) 
showed expression in the diencephalon, telencephalon, and olfactory placodes at 
23hpf, suggesting that these two ligands may putatively have a role in 
olfactory/commissural axonogenesis too. The expression of these Fgf receptors and 
ligands around this stage is also consistent with their putative role in terminal nerve 
GnRH neurogenesis and axon formation, as well as „early wave‟ GnRH neuronal 
migration to the hypothalamus. Whilst Fgf8b is less likely to have a role in these 
forebrain developmental processes (at this stage), it remains possible that this ligand 
is expressed very weakly, below the detection limit of this analysis, and does indeed 
have a role in this forebrain development; this possibility is addressed in the 
functional studies that were carried out (see below). 
Within the course of this chapter, it will not been possible to determine 
which of these individual Fgf receptors is involved in these forebrain developmental 
processes because the methods used herein to block the Fgf receptors are global, 
that is they target all Fgf receptors equally (see conclusions/future work).  
Previous investigations in mice suggest that Fgf8 is likely to act mainly 
through Fgfr1 during telencephalic development (Chung et al., 2008). However, 
given that telencephalic-specific Fgf8 mutant mice have malformed forebrains that 
lack olfactory bulbs, whereas the Fgfr1 mutants have a less severe forebrain 
phenotype with defective olfactory bulb formation, it seems highly plausible that 
Chapter 4: Results (II) 
 
195 
 
another Fgf receptor is also used by Fgf8 during these developmental processes. 
Considering that Fgf8 has significant affinity for Fgfr3 (Ornitz et al., 1996; 
Chellaiah et al., 1999), this receptor would seem to be a likely candidate. However, 
mice deficient for Fgfr3 have normal telencephalons (including normal olfactory 
bulbs), and no reduction in hypothalamic GnRH neuronal number (Deng et al., 
1996; Chung et al., 2008); so Fgfr3 is unlikely to be a very significant interactant of 
Fgf8 during mouse telencephalon development. It remains to be seen whether the 
same is true for the zebrafish. 
 
4.3.2  Requirement for early Fgfr signalling during 
zebrafish forebrain commissure formation (the midline glia 
hypothesis) 
Commissural tracts must, during vertebrate development, traverse across 
long distances within the forebrain to form the necessary connections that will allow 
coordination of activity between contralateral regions of the brain. The navigation of 
commissural growth cones therefore requires a well-defined extracellular 
environment with gradients of specific molecular guidance cues and scaffolds of 
glia and pioneering axons to ensure that the forebrain commissural neuronal circuit 
is formed accurately (Lindwall et al., 2007).  
In particular, the glial cells which surround the forebrain commissures have 
been shown to act as a very important source of these guidance cues, helping to 
make sure that the traversing commissural axons do not stray into surrounding 
adjacent structures. In mice, as with other mammals, there are well-characterised 
groups of these glial cells, including the „midline zipper glia‟, which have an 
important dual role in regulating fusion of the brain hemispheres, as well as 
facilitating the passage of commissural axons across the midline. Mammals have 
three distinct commissural tracts that traverse the telencephalic midline: the corpus 
callosum, the hippocampal commissure and the anterior commissure. The „glial 
wedge‟ and „indusium griseum glia‟, ventral and dorsal to the corpus callosum, are 
two groups of glial cells which have an essential role in the guidance of callosal 
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fibres across the midline, by secreting specific guidance cues including the 
chemorepellant, Slit2 (Tole et al., 2006; Lindwall et al., 2007).  
Similarly, in zebrafish, cells expressing glial fibrillary acidic protein (GFAP; 
a glial cell marker) span regions of the forebrain midline where the AC and POC 
will later cross. Commissural axon extension across the midline is determined partly 
by the spatio-temporal expression of Sonic hedgehog (Shh) and the slit proteins, 
Slit1a, Slit2, and Slit3 (see Figure 4.16). Disrupting the slit signalling pathway 
results in disorganised midline glia, concomitant with subsequent severe defects in 
commissure formation (Barresi et al., 2005). As another example, the belladonna 
mutant zebrafish, which lacks the transcription factor Lhx2, have highly 
disorganised midline glia associated with failure of the AC and POC axons to cross 
the midline, but instead associating with misplaced glial cells (Seth et al., 2006). 
This further illustrates the importance of the midline glia in the formation of the 
forebrain commissures. 
Fgf signalling has an essential role in zebrafish and mouse forebrain 
commissure formation. Whilst Fgfr4 is not expressed in the mouse telencephalon, of 
the three FGFRs which are expressed, only Fgfr1 is present in the midline 
precursors at E12.5, a stage before the midline glial structures have appeared. Fgfr1 
expression remains in these midline precursor cells through to E15.5, including in 
the region where the glial wedge forms. Fgf8, a putative ligand for FGFR1 within 
the telencephalon, is also expressed in the midline at this stage, further supporting 
an interaction between these two proteins (Tole et al., 2006). 
Mice which are brain-specifically null for Fgfr1, or those which are glial-
specifically null for Fgfr1, lack the major commissural tracts, including the corpus 
callosum. It was subsequently shown by GFAP staining that the Fgfr1 deficiency 
resulted in loss of the midline glial structures, including the glial wedge, indusium 
griseum glia and the midline zipper glia. Whilst there were no telencephalic midline  
deficiencies in expression of Slit2, Slit3, or Robo1, Bmp4, GAP43, and only a slight 
decrease in Netrin1, displacement of these midline glial structures, and the short-
range guidance cues that they express, was apparently sufficient to cause failure of 
commissure formation in these Fgfr1 null mutants (Smith et al., 2006; 
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Figure 4.16   The role of glial bridges during zebrafish forebrain 
commissure formation
This schematic diagram illustrates the glial cells (in red) which support the
correct pathfinding of anterior commissure (AC) and post-optic commissure
(POC) axons (in black) across the midline. Specific expression of slit2/slit3 (in
blue) and slit1a (in yellow) ensures that commissural axons are correctly guided
across their glial bridges (in red).
Figure 4.16 reproduced with permission from Development (Barresi et al., 2005).
doi:10.1242/dev.01929
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Tole et al., 2006). Similarly, agenesis of the corpus callosum was also seen in a KS 
patient who was homozygous for a certain deleterious missense mutation (Dode et 
al., 2003), illustrating that the role of FGFR1 in forebrain commissure formation has 
been well conserved in different vertebrate species. 
However, unexpectedly, heterozygous Fgfr1 mutants have normal midline 
glial structures despite the corpus callosum and hippocampal commissures failing to 
cross the midline. This would suggest that an FGF-dependent mechanism which is 
separate from the generation of midline glia may also be required for callosal and 
hippocampal commissure formation. In fact, Fgfr1 is also expressed by midline 
cingulate cortical neurons, which could imply that Fgfr1 is also required for the 
differentiation of the callosal pioneering axons which extend across the midline 
(Tole et al., 2006; Lindwall et al., 2007). In summary, Fgf signalling does have an 
important role in forming the midline glial structures, but the entire mechanism by 
which this signalling pathway effects forebrain commissure formation is yet to be 
fully elucidated. 
The role of Fgfr signalling during zebrafish forebrain commissure formation 
has previously been investigated (Shanmugalingam et al., 2000) using the global 
FGFR inhibitor, SU5402 (Mohammadi et al., 1997). It was reported in this paper, 
that those embryos incubated from 90% epiboly (~9-12hpf) showed the most severe 
defects, consisting of absent forebrain commissures combined with smaller eyes and 
brains, compared with the controls. Those embryos treated at 6 somite stage (~12-
15hpf) gave similar commissural defects to the Fgf8a mutant embryos (see section 
4.1.3 above); and those treated at 18 somite stage (~18-21hpf) gave the weakest 
phenotype, with only mild defects in AC and POC formation. So, in summary, the 
severest commissural defects were caused by early FGFR inhibition (~9-12hpf); 
suggesting that FGFs other than Fgf8a (i.e. expressed earlier than Fgf8a) could be 
involved in AC and POC formation (Shanmugalingam et al., 2000). Indeed, it has 
since been shown that the AC and POC also fail to form correctly in the absence of 
another Fgf ligand, Fgf3. But, the most severe AC/POC defects were observed when 
both Fgf8a and Fgf3 gene function were knocked down together (Walshe and 
Mason, 2003). 
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To investigate the effects of Fgf receptor inhibition on 
olfactory/vomeronasal axonogenesis and GnRH neuronal development, embryos 
were treated with SU5402 at two different time-points. The first SU5402 incubation 
(„route [1]‟ on Figure 4.08) was between 14hpf and 22hpf, with the aim of inhibiting 
Fgf signalling during olfactory placode formation (at 17hpf), and any GnRH 
neuronal specification associated with the nasal compartment at this time-point, as 
well as AC/POC bilateral cell cluster formation and early axonogenesis. The second 
SU5402 treatment („route [2]‟ on Figure 4.08) was between 22hpf and 36hpf, with 
the aim of inhibiting Fgf signalling during olfactory/vomeronasal/commissural 
axonogenesis, and GnRH neuronal specification and/or migration.  
Embryos treated with SU5402 (as described above), as well as DMSO 
controls, were analysed for forebrain commissure defects. This analysis acted as a 
„control experiment‟ to ensure that the SU5402 treatments were working, and 
confirm the forebrain commissure defects which were described previously 
(Shanmugalingam et al., 2000). Consistent with previous findings, embryos treated 
with SU5402 at 14hpf showed much more severe AC/POC defects compared with 
those treated at 22hpf, which showed only minor AC defects in a few embryos; 
whilst the DMSO control embryos were all normal, as expected. In previous studies, 
embryos treated with SU5402 between 9hpf and 12hpf, or 12hpf and 15hpf, showed 
comparable phenotypes to the embryos treated with SU5402 between 14hpf and 
22hpf in this study, but without the head/eye defects that were reported for the early-
treated SU5402 (9-12hpf) embryos. This is perhaps a bit surprising, as the later-
treated (18-21hpf) embryos from that study showed the subtlest defects, whereas as 
this group closely matches the 14-22hpf incubation time used in this study. 
However, critically, the later-treated (18-21hpf) embryos from that study had 
already proceeded past the point of specification of AC/POC (and olfactory 
placodal, see below) cells, whereas the „early‟ time-point used in this study (14-
22hpf) covered this critical cell-specification period. Fgf signalling is still required 
past 18hpf for commissure formation, especially AC formation, which is defective 
in some embryos in the later-treated (22-36hpf) embryos in this study; however, Fgf 
signalling has a more essential role in correct AC/POC cell specification up to 
around 16-18hpf.  
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Alternatively, Fgf signalling may have a critical role in determining 
specification and/or positioning of midline-spanning glial cells (the so-called „glial-
bridge‟) at around 15-18hpf. This „glial bridge‟ contains cells which co-express 
Gfap and Slit1a providing a „favourable substrate‟ for forebrain commissure growth 
cones projecting across the midline. Previous experiments in mice suggest that Fgf 
signalling plays a crucial role in determining correct organisation of similar midline 
glial structures required for correct commissure formation in the mouse. This could 
explain why the early-treated SU5402 embryos showed a more severe AC/POC 
defect, as they are the ones with the disorganised midline glial structures. 
Consistently, Fgf signalling is required for commissure formation at post-glial 
structure formation stages in both zebrafish and mice, as late-treated SU5402 (22-
36hpf) embryos still have some AC defects and heterozygous Fgfr1 mutant mice 
have normal midline glial structures, but still have commissure defects (Tole et al., 
2006). Therefore, as already mentioned, the glial cell hypothesis is not the entire 
explanation for the role of Fgf signalling during commissure formation, but it may 
nonetheless play a significant part in the process. 
It was not possible to determine from this study which of the five Fgf 
receptors are involved in forebrain commissure formation, although we can assume 
from previous studies in the mouse that one or both of the Fgfr1 orthologues (Fgfr1a 
and Fgfr1b) are likely to have a key role. Morpholino approaches will be required to 
investigate the role of each individual Fgf receptor in commissure formation. 
Certainly, the spatio-temporal expression pattern of all five receptors would suggest 
that they could putatively have a role, but this is yet to be proven experimentally.  
 
4.3.3  Is Fgf8b signalling required for forebrain 
commissure formation?  
As mentioned in the introduction to this chapter, it has been reported 
previously that both forebrain commissures, the AC and the POC, are disrupted in 
the Fgf8a („ace‟) mutant zebrafish. Specifically, commissural axons were visualised 
„meandering‟ as they approached the midline, and were shown at slightly later 
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stages wandering in between the two forebrain commissures, close to the optic 
stalks, in a region where axons would normally be excluded. By around 36hpf, one, 
or sometimes both, of the forebrain commissures had failed to form. The severity of 
these commissural defects, combined with morphological analyses, suggested that 
midline tissue was disrupted in these Fgf8a mutants. However, many markers of 
telencephalic domains (bf1, dlx2, eph-A4d, arx1, unc4, eome), with the exception of 
nk2.1b (which was reduced)  showed no obvious differences in expression, 
suggesting that overall induction and patterning of the telencephalon is not severely 
affected by loss of Fgf8a signalling in zebrafish (Shanmugalingam et al., 2000). 
In order to assess the variability of the forebrain commissure defects found 
in the Fgf8a mutants, acetylated tubulin immuno-labelling was carried out on some 
ace and non-ace embryos at 36hpf. In this analysis, the most predominant phenotype 
was mis-projected axons between the AC and POC, accounting for about 56% of the 
embryos. The next most common phenotype was a missing AC, accounting for 
another 28% of the embryos. A missing POC was much less frequent, accounting 
for approximately 4% of the embryos. Approximately 3% of the embryos had both 
commissures missing, giving the appearance of „4 dots‟, „2 dots‟ for the AC cell 
clusters and „2 dots‟ for the POC cell clusters, both of which failed to extend axons 
across the midline. However, this last phenotype was accompanied by a 
significantly smaller head, suggesting that the failed commissure formation may 
have been secondary to forebrain malformation in these embryos.  
The higher penetrance of AC failure, compared with POC failure, suggest 
that Fgf8a signalling is more important for AC formation, than POC formation. Or, 
it may indicate that the POC is more resilient to deficient Fgf8a signalling, perhaps 
because there is more redundancy in the signalling pathways which bring about 
POC formation. Alternatively, it may have something to do with the POC forming 
shortly before the AC: if the POC fails to form correctly, perhaps by mis-projecting 
axons towards the AC, this could in turn cause the AC axons to aberrantly project 
towards the mis-projected POC axons, somewhere between where the AC and POC 
should form (as occurs in approximately 56% of cases). If the POC manages to 
form, by overcoming the Fgf8a signalling deficiency, the AC axons will, instead of 
projecting towards mis-projected POC axons, fail to project across the midline at all 
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(and the AC fails to form). This last scenario suggest that the AC axons are either 
attracted to the mis-projected POC axons, or attracted to something that the mis-
projected POC axons were attracted to i.e. disorganised midline cells (e.g. glial cells 
secreting guidance cues, see below). 
To ascertain whether or not the other FGF8 orthologue, Fgf8b, also has a 
role in forebrain commissure formation, morpholino approaches were used to knock 
down Fgf8a and Fgf8b gene function. Like the Fgf8a („ace‟) mutant, Fgf8a 
morphants have a missing cerebellum; a useful confirmation of successful Fgf8a 
gene knockdown. The Fgf8b morpholino did not result in an acerebellar phenotype, 
so an RT-PCR approach was used to confirm knockdown of Fgf8b. However, this 
showed that Fgf8b potentially only gave approximately 50% knockdown, although 
this would need to be proven more quantitatively by qPCR. Time restraints meant 
that an alternative Fgf8b morpholino could not be used in order to try and obtain 
100% knockdown of Fgf8b; but this would be a future goal. 
Unsurprisingly, given that gene knockdown levels were only 50% efficient 
(at best), forebrain commissure formation was normal in the Fgf8b (partial) 
morphants. Moreover, knocking down Fgf8a and Fgf8b together gave AC/POC 
defects which were equivalent to knocking down Fgf8a alone. It is not possible, 
however, to summarise from this that Fgf8b is not required for forebrain 
commissure formation, as these morphants were only hypomorphic for Fgf8b, and 
not true Fgf8b morphants. Until 100% (or close to 100%) knockdown of Fgf8b is 
achieved, it isn‟t possible to confirm its involvement in forebrain commissure 
formation, although the lack of Fgf8b expression in the forebrain during AC/POC 
development may suggest that its involvement is less likely. 
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4.3.4  Identification of active Fgf signalling during 
olfactory/vomeronasal axonogenesis and GnRH neuronal 
specification 
Two downstream antagonists of Fgf signalling, Sprouty4 and Dusp6, were 
investigated in terms of their spatio-temporal expression during early development 
within the nasal compartment (i.e. during olfactory axonogenesis and GnRH 
neuronal specification).  Whilst both Fgf antagonists were expressed in forebrain 
regions at 17hpf and 23hpf, Dusp6 was expressed more broadly throughout the 
forebrain and olfactory placodes, and was investigated further using a recently 
published Dusp6 reporter line, pDusp6:d2GFP (Molina et al., 2007).  
Dusp6 (also known as MKP3 or Pyst1) is an inhibitor of phosphorylated 
Erk1/2 (pERK); but is itself upregulated by increased MAPK signalling, in an 
important negative feedback regulatory loop. Dusp6 expression may therefore act as 
a dynamic read-out of MAPK signalling, and, indirectly, as an indication of putative 
Fgf signalling (Molina et al., 2007). For this reason, the Dusp6 transgenic reporter 
line is a useful tool for investigating not only dynamic Dusp6 expression, but also 
putative forebrain Fgf signalling during olfactory and/or terminal nerve 
axonogenesis.  
Dusp6 expression correlates well with many sites of Fgf signalling during 
mouse embryogenesis, including the olfactory system. This means that Dusp6 
expression is a useful read-out of Fgf signalling during mouse and zebrafish 
development. In fact, Dusp6 is expressed in the rim of the invaginating olfactory pit 
during mouse embryogenesis, the same site as Fgf8 expression. In Fgf8 mutant 
mice, this Dusp6 expression is strongly down-regulated in this region, 
demonstrating that loss of Fgf8 severely reduces Fgf signalling in the olfactory 
region (i.e. Dusp6 down-regulation indicates reduced Fgf signalling) (Dickinson et 
al., 2002). 
When the Dusp6 reporter line was crossed with the GnRH3 reporter, there 
was no GnRH3/Dusp6 co-expression detectable at 24hpf or 30hpf in the terminal 
nerve region. However, their d2GFP (Dusp6) was dynamically expressed within 
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some olfactory epithelial cells and presumptive olfactory bulb cells at these stages. 
If we assume that this Dusp6 expression represents active MAPK signalling in these 
forebrain regions, it can be concluded that active signalling may also be active in the 
olfactory epithelium and presumptive olfactory bulbs at 24hpf and 30hpf; stages at 
which olfactory axonogenesis is active. However, by extension, there does not seem 
to be active Fgf signalling in the terminal nerve or early hypothalamic GnRH3 cells 
at these stages; although it remains possible that the Dusp6 reporter transgene is 
silenced in the GnRH3-expressing cells, and not reporting Dusp6 activity. Also, 
because d2GFP is intentionally unstable, in order to show dynamic Dusp6 
expression, it remains possible that Fgf signalling occurs briefly in GnRH3-
expressing cells and was missed from this analysis. By 48hpf, d2GFP signal had 
reduced significantly in forebrain/olfactory regions (data not shown), suggesting 
that Dusp6 expression was down-regulated in these regions by this stage, or that the 
reporter transgene had been silenced in this region.  
To judge the reliability of the pDusp6:d2GFP line as a reporter of MAPK 
activity, anti-pERK immuno-labelling was also carried out on G3MC embryos. 
Surprisingly, no pERK immuno-labelling was detected in 24hpf or 30hpf embryos, 
suggesting that there was actually no active MAPK signalling in these embryos. 
However, this is unlikely given the importance of this signalling pathway during 
development. It is more plausible that some technical error (i.e. poor antibody 
penetration or epitope presentation) prevented pERK immuno-labelling at these 
early stages. pERK immuno-labelling was detected throughout the presumptive 
olfactory bulbs, and in some cells in the olfactory epithelium at 48hpf, but was 
absent from all GnRH3-expressing cells at this stage. This pERK immuno-reactivity 
is in agreement with the Dusp6 reporter line expression in these regions, although 
these analyses were of course carried out at different developmental stages. It cannot 
therefore be conclusively determined how reliably the dynamic d2EGFP/Dusp6 
expression represents active MAPK signalling in the forebrain.  
Anosmin-1 increases MAPK signalling to levels equivalent to or higher than 
high levels of FGF2 ligand alone in primary olfactory neuroblast culture (Gonzalez-
Martinez et al., 2004b), suggesting that pERK may be an important downstream 
effector of Fgf signalling during olfactory/GnRH neuronal development. Therefore, 
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the implied pERK signal at 24hpf and 30hpf (from the Dusp6 reporter line analysis), 
and actual pERK immuno-labelling at 48hpf, in the olfactory epithelium and 
presumptive olfactory bulbs, demonstrates that pERK, putatively downstream of Fgf 
signalling, potentially has an important role in olfactory system development in the 
zebrafish.   
 
4.3.5  Early inhibition of FGFR signalling causes abnormal 
olfactory & vomeronasal axonogenesis, as well as defects in 
GnRH system formation 
Taking into consideration the natural variability in the olfactory/vomeronasal 
axonal phenotype at 36hpf, embryos treated with SU5402 between 22hf and 36hpf 
had apparently normal olfactory and vomeronasal axonogenesis, which was 
comparable to the DMSO-treated control embryos. In contrast, embryos treated with 
SU5402 between 14hpf and 22hpf, showed a very noticeable defect in 
olfactory/vomeronasal axonogenesis. Specifically, these embryos had fewer or no 
olfactory axons correctly projecting to the olfactory bulbs. The vomeronasal axons 
were similarly affected, except that these axonal defects were associated with fewer 
vomeronasal soma too; whereas the OMP-positive olfactory soma were not 
apparently reduced in number. Despite no apparent significant reduction in olfactory 
pit size amongst the SU5402-treated embryos, the olfactory epithelial cells were 
disorganised in the 14-22hpf embryos; their olfactory pits no longer pertained to a 
well-ordered „rosette‟ structure that is seen in wild-type embryos (Yoshida et al., 
2002). In summary, Fgf signalling has an essential role in olfactory and 
vomeronasal axonogenesis, as well as vomeronasal neuronal cell survival or 
proliferation, between 14hpf and 22hpf. 
It has been shown previously that Fgf signalling has a crucial role in the 
correct morphogenesis of the mouse nasal cavity; hence, Fgf8 mouse mutants have 
elevated levels of apoptosis (not decreased cell proliferation, as may be expected) in 
the Fgf8-expressing site of the olfactory pit (Kawauchi et al., 2005). Therefore, it 
may at first seem surprising that blocking total FGFR activity did not result in any 
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noticeable decrease in olfactory pit size in the zebrafish (excepting the reduction in 
vomeronasal neuronal number which didn‟t significantly affect overall olfactory pit 
size). However, unlike the Fgf8 mouse mutant, FGF signalling was blocked for only 
a finite period of developmental time in the zebrafish (i.e. 14-22hpf or 22-36hpf); as 
blocking all Fgf signalling from 0hpf would not have been viable, resulting in very 
early embryonic lethality. It therefore remains possible that early olfactory placodal 
neurogenesis begins prior to 14hpf in the zebrafish, and so therefore isn‟t 
significantly affected by blocking Fgf signalling past 14hpf. In fact, it‟s probable 
that olfactory epithelial cells will begin to die  by apoptosis after prolonged SU5402 
exposure from 14hpf onwards, but that this effect is not apparent by 36hpf (and  the 
olfactory epithelium may have recovered by 60hpf in the 22-36hpf SU5402-treated 
embryos).  
Furthermore, if olfactory epithelial cell survival is significantly reduced in 
embryos treated with SU5402 between 14hpf and 22hpf, it is possible that the 
reduced/absent olfactory/vomeronasal axonogenesis is the result of the 
olfactory/vomeronasal soma becoming less viable, and beginning to become 
apoptotic (or going through the early stages of apoptosis) and hence not capable of 
extending axons to the olfactory bulbs. In fact, on closer inspection, it is apparent 
that the OMP-positive olfactory pits from these early SU5402 treated embryos do 
have „gaps‟ in OMP expression. This could represent apoptotic cells which are no 
longer viable, and so do not express OMP (GFP), explaining the „disorganised‟ 
olfactory epithelia that were observed. Therefore, whilst the overall olfactory pit 
may be comparable in size to the control pits, in fact, the olfactory epithelial cell 
number is likely to be reduced in the 14-22hpf SU5402 treated embryos. So, in 
summary, it is not only the vomeronasal neurons which are reduced in number, but 
the OMP-positive olfactory neurons too. Further work is required to assess the 
olfactory OMP-positive neuronal cell number in the olfactory pits of SU5402-
treated embryos, compared with controls, and whether or not these cells are 
apoptotic (see Future work, section 4.5). A significant elevation in apoptosis in the 
olfactory epithelium, and other putative sites, may explain why the 14-22hpf 
SU5402 treated embryos fail to survive to 60hpf. 
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Consistently, G3MC embryos treated with SU5402 between 22hpf and 
36hpf had the same GnRH neuronal phenotype as the DMSO controls, taking into 
consideration the normal variation in the wild-type GnRH3 phenotype (see chapter 
3). Whilst embryos treated with SU5402 between 14hpf and 22hpf had absent or 
reduced hypothalamic GnRH3 neuronal clusters at 36hpf, combined with absent 
terminal nerve GnRH3 neuronal projections across the anterior commissure. Due to 
the uncertainty of the origins of the hypothalamic GnRH neurons which appear at 
36hpf, it is not possible to say whether or not the defect seen in these early SU5402-
treated embryos, resulting from loss of Fgf signalling, is due to a GnRH3 neuronal 
migration failure/delay and/or failure in specification of the GnRH cells. Moreover, 
the significance of the failure of GnRH3 projections to cross the AC is unclear: 
although it seems likely that such projections may be important for the 
neuromodulatory activity of the terminal nerve GnRH system (Palevitch et al., 
2007), and its proposed role in regulating reproductive competence.  
Previous analyses (described in section 4.3.4) indicated that there may not be 
any Fgf signalling occurring in the GnRH3-expressing cells at 24hpf, 30hpf, or 
48hpf, suggesting that Fgf signalling may not be required for GnRH3 neuronal 
development in the zebrafish. However, the SU5402 experiment indicated that Fgf 
signalling is required between 14hpf and 22hpf; stages much earlier than the dusp6 
transgenic/ pERK immuno-labelling analyses could detect Fgf signalling. 
Alternatively, it remains possible that the effects of Fgf signalling loss on the GnRH 
neuronal development may occur by a more indirect mechanism, i.e. caused by loss 
of Fgf signalling in cells within the nasal compartment and/or forebrain where the 
GnRH cells are specified and/or migrate from. In summary, the loss of Fgf 
signalling between 14hpf and 22hpf results in a putative loss (by apoptosis) of Fgf8-
expressing cells within the nasal compartment. This results in the failure of olfactory 
and vomeronasal axonogenesis, and blocks normal specification of GnRH cells 
and/or their putative migration to the hypothalamus following 
olfactory/vomeronasal tracts (which are now missing).  
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4.3.6  Fgf8a is an important ligand for olfactory & GnRH 
neuronal development 
It was shown previously that Fgf8a („ace‟) mutants have fewer Or2.0-
positive olfactory projections and fewer olfactory bulb glomeruli (Shanmugalingam 
et al., 2000). To find out if these ace embryos also have defects in GnRH neuronal 
development, GnRH immuno-labelling was carried out on these embryos at 60hpf. 
GnRH immuno-expression was detected in terminal nerve cells in these ace 
embryos, but the expression levels were weaker than the control (wild-type) embryo 
at the same stage. Moreover, the GnRH-positive axons, which project across the AC 
in all wild-type embryos analysed, are missing in approximately half of the ace 
embryos. Whilst this could be because of the weaker GnRH expression levels, this 
failure of GnRH-projections  to cross the AC is more likely to be the result of 
variable failure of AC formation in ace embryos i.e. the terminal nerve GnRH3 
neuronal axons require a pre-existing AC scaffold before they too can project axons 
across the AC. This, of course, will prevent coordination between both sides of the 
terminal nerve GnRH3 system, and may, in turn, affect reproductive competence, as 
already mentioned above for the SU5402-treated embryos with the same phenotype. 
It was previously reported that the Fgf8a („ace‟) mutants have a defect in the 
midline tissue between the two forebrain commissures, the so-called „preoptic area‟ 
(Shanmugalingam et al., 2000); a region believed to encompass part of the 
migratory route of the „later wave‟ (and „early wave‟?) GnRH neurons migrating to 
the presumptive hypothalamus in zebrafish (see chapter 3). Moreover, by 3dpf, 
there was a reported gross distortion in the shape of the brain in the region of the AC 
and POC; although the hypothalamus appeared superficially normal. The anti-
GnRH antibody (LRH13) used in this project does not label the early-arising 
hypothalamic GnRH neurons at 30-60hpf, so an alternative (morpholino) approach 
was required to investigate GnRH neuronal development in Fgf8a mutants. 
The Fgf8a and Fgf8b genes were knocked down individually and together to 
investigate their role during olfactory and GnRH neuronal development. The Fgf8a  
morphants had similar olfactory and GnRH phenotypes to 14-22hpf SU5402-treated 
embryos. Specifically, the OMP-positive olfactory axons were missing or mis-
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projected and the olfactory epithelia were disorganised in the Fgf8a morphants. 
Whilst there was an approximately <50% reduction in hypothalamic GnRH neurons 
at 36hpf in 81% of embryos analysed. In contrast, the majority of Fgf8b morphants 
had normal olfactory axons and pits, as well as normal-sized hypothalamic GnRH 
populations; however, this may reflect the poor Fgf8b knockdown levels, and can 
not therefore be concluded from this data that Fgf8b does not have a role in these 
developmental processes. Embryos that had both Fgf8a and Fgf8b knocked down 
had olfactory and GnRH defects that were similar to those described for Fgf8a 
single knockdown. However, there is a bigger reduction in average olfactory pit size 
(A-P length) for the Fgf8a+Fgf8b double morphants (26.4% reduction in size, 
relative to the control), compared with the Fgf8a single morphants (20.3% 
reduction). The Fgf8b single morphants had a less than 1% reduction in olfactory pit 
size compared to the control olfactory pits. To be more statistically significant, a 
larger group of olfactory pits will need to be measured for these morphant groups. 
However, this initial data suggests that Fgf8b may also be involved in olfactory 
epithelium development, especially when Fgf8a gene function is lost (i.e. it may 
compensate for reduced Fgf8a signalling), but this will need to be investigated 
further. Moreover, it would seem that Fgf8b signalling may not be required when 
Fgf8a  expression is normal. Of course, a more complete knockdown of Fgf8b is 
required to prove for sure that Fgf8b does not itself have a role in olfactory 
neurogenesis when Fgf8a signalling levels are normal, and confirm whether it has a 
significant role when Fgf8a signalling is lost (i.e. a redundant role). 
Despite the reduction in olfactory pit size obtained by Fgf8a knockdown, it 
is perhaps surprising that the reduction was not larger, given the severe olfactory 
epithelium defects that are seen in the Fgf8 mouse mutant. There are several 
possible reasons for this. Firstly, morpholino knockdown is not permanent and not 
100% efficient, so its effects will decrease over developmental time, as the 
morpholino itself degrades. Secondly, there may be other Fgfs which have an 
important role in olfactory development in the zebrafish, including Fgf8b (as 
described) and Fgf3, which has previously been implicated along with Fgf8a in 
forebrain commissure development, and may be required together during forebrain 
development more generally (this needs to be investigated). 
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4.4   Conclusions 
 
4.4.1  Olfactory bulb morphogenesis upon arrival of 
olfactory axons: the role of Fgf signalling 
It has been proposed that olfactory bulb morphogenesis is induced by the 
arrival of ORN axons from the olfactory epithelium (Gong and Shipley, 1995). This 
hypothesis is supported by the fact that ORN axons reach the anterior telencephalon 
before any signs of olfactory bulb formation, but soon after their arrival there is an 
increase in proliferation of the anterior subventricular zone cells, which supply the 
olfactory bulb with new neuroblasts via the rostral migratory stream. Furthermore, a 
model has been suggested, whereby the arrival of ORN axons induces an FGF-
dependent decrease in cell proliferation in that particular region of the anterior 
telencephalon causing initial olfactory bulb evagination (see Figure 4.17). Here is 
the mechanism that has been proposed: soon after first contact between ORN axons 
and the rostral telencephalon, neuroepithelial cells in close proximity to the axon 
terminals stop dividing and instead differentiate into neuroblasts, whereas cells 
located further away from the point of contact continue dividing. The local decrease 
in cell proliferation at the point of ORN axonal contact results in evagination of the 
olfactory bulb relative to the rest of the telencephalon. Without an Fgf-induced 
reduction in proliferation at the anterior telencephalon, no morphologically 
distinguishable bulbs could be formed (Gong and Shipley, 1995; Hebert et al., 
2003). 
Fgfr1 and Fgf8 both have an essential role in olfactory bulb morphogenesis in mice 
and humans (see chapter 1 and section 4.1 from this chapter). Olfactory bulb 
dysgenesis resulting from mutations in these two genes is the proposed cause of 
anosmia/hyposmia in KS patients (MacColl et al., 2002). However, according to our 
current understanding of olfactory bulb morphogenesis (as outlined above), ORN 
axonogenesis from the olfactory epithelium is a necessary pre-requisite for olfactory 
bulb formation (Gong and Shipley, 1995). Therefore, the focus of this chapter has 
been to look at olfactory axonogenesis, instead of olfactory bulb formation, in order  
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Figure 4.17   A model for the proposed mechanism of olfactory bulb 
morphogenesis
There are three proposed steps to olfactory bulb (OB) morphogenesis. In „Step
1‟, axons from the olfactory epithelium (OE) project to and make contact with
the anterior telencephalon (tel.). In „Step 2‟, there is an FGF-dependent
reduction in the number of proliferating cells (orange spots) at the anterior end
of the telencephalon, in the specific site where the olfactory nerve terminals
arrived; concurrent with an increase in olfactory bulb-specific neuronal
differentiation in these cells (not shown). In „Step 3‟, the decrease in cell
proliferation results in initial OB evagination (in purple).
Figure modified from Hébert et al., 2003.
Figure 4.17 adapted with permission from Development (Hébert et al., 2003).
doi:10.1242/dev.00334
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+ FGF
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to understand how Fgf signalling is involved in development of the zebrafish 
olfactory system. 
In the mouse, Fgf8 is expressed in and around primordial neural stem cells in 
the olfactory epithelium which are responsible for initiating primary olfactory 
neurogenesis at the olfactory epithelium. When Fgf8 expression is absent, these 
primordial stem cells undergo apoptosis, resulting in fewer ORNs being generated 
(Kawauchi et al., 2005). Consistent with these findings, zebrafish with loss of Fgf8a 
(one of two FGF8 orthologues) have reduced and/or aberrant olfactory axons, 
coupled with smaller, more disorganised olfactory epithelia (Shanmugalingam et al., 
2000). It would therefore seem that the role of Fgf8 signalling during olfactory 
system development has been conserved in mice and zebrafish; however, further 
analysis is required to confirm that increased apoptosis in the olfactory epithelium 
(see Figure 4.06), is the cause of olfactory epithelium defects in zebrafish. 
Assuming that Fgf8 signalling does have a similar role in zebrafish olfactory 
neurogenesis, it‟s likely that the olfactory axonal mis-projections obtained were 
secondary to the ORN neurons becoming less viable (i.e. becoming apoptotic). 
Blocking all Fgf receptors between 14hpf and 22hpf also caused defective 
olfactory (and vomeronasal) axonogenesis. However, it was not possible from this 
study to distinguish which of the five Fgf receptors were involved. All five Fgf 
receptors are expressed in the anterior forebrain during this developmental period, 
so all could putatively be involved in olfactory axonogenesis, and subsequent 
olfactory bulb morphogenesis, but it remains to be determined which particular Fgf 
receptors are involved. However, given that Fgfr1 loss in the mouse causes olfactory 
bulb agenesis, it can be assumed that one of the two zebrafish Fgfr1 (Fgfr1a and 
fgfr1b) orthologues is a likely candidate (although there may be more than one Fgf 
receptor involved). Of the two Fgfr1 receptors, Fgfr1a showed the strongest 
expression in the anterior forebrain between 17hpf and 23hpf.  
Fgfr1a belongs to the Fgf8a synexpression group and it has been 
demonstrated that Fgfr1a knockdown phenocopies many of the defects observed in 
the Fgf8a mutant zebrafish, including loss of the MHB structure (Scholpp et al., 
2004). This study demonstrated that Fgf8a apparently exerts its function mainly via 
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Fgfr1a, although a functional role for other Fgf ligands and/or Fgf receptors with 
overlapping expression patterns cannot be ruled out. 
Both Fgfr1a and Fgf8a are expressed in the olfactory placode and anterior 
forebrain between 16-26hpf (Scholpp et al., 2004; Shanmugalingam et al., 2000). 
Therefore a mechanism can be speculated whereby Fgf8a signalling via Fgfr1a has 
a role in firstly maintaining olfactory neurogenesis in the olfactory epithelium, and 
secondly, in initiating a reduction in proliferation (or onset of differentiation) at the 
point of contact between the arriving ORN nerve endings and the anterior forebrain, 
prior to normal olfactory bulb morphogenesis. According to this model, it can be 
envisaged that reduced Fgf8a signalling may cause less olfactory neurogenesis at 
the olfactory epithelium (and increased apoptosis), leading to reduced olfactory (and 
vomeronasal) axonogenesis. This has the knock-on effect of fewer olfactory axons 
reaching the anterior telencephalon, and a lower reduction in local cell proliferation, 
causing abnormal (dysgenesis) or failed (agenesis) olfactory bulb formation. Upon 
MRI inspection, not all KS patients have missing olfactory bulbs, but nonetheless 
still have anosmia (or hyposmia) (Gonzalez-Martinez et al., 2004a). The likely 
explanation for this is that these patients have a mutation in FGF8 or FGFR1 (or 
KAL1, see next chapter), which causes varying degrees of FGF8/FGFR1 signalling, 
depending on the specific mutation, resulting in varying degrees of olfactory bulb 
dysgenesis.  
Regardless of the exact mechanism of olfactory bulb morphogenesis, 
accurate pathfinding of the olfactory axons to their targets in the anterior 
telencephalon is of paramount importance for proper connectivity and correct 
functioning in the olfactory system (Gong and Shipley, 1995). Whilst it is unclear 
whether Fgf signalling itself has a direct role in olfactory/vomeronasal 
axonogenesis, there are many other guidance and signalling molecules which help to 
ensure that the olfactory axons project to the correct region of the anterior forebrain.  
The olfactory axonal mis-projection defects caused by Fgf8a knockdown 
suggest that Fgf8a/Fgfr1a signalling may also have a role in olfactory axonogenesis. 
However, as already mentioned, it seems more likely that these mis-projection 
defects are caused by reduced neurogenesis in the nasal compartment. It can be 
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envisaged that fewer olfactory and vomeronasal neurons in the olfactory epithelium 
results in fewer axons capable of projecting to the anterior forebrain. Moreover, 
because olfactory axonogenesis is a concerted process whereby many 
olfactory/vomeronasal axons project to the anterior telencephalon within a relatively 
short time period between 24hpf and 48hpf, it could be speculated that in a situation 
of fewer neighbouring olfactory axons, some olfactory/vomeronasal axons may 
more easily deviate from the normally otherwise well-ordered axonal bundle 
„scaffold‟ and mis-project away from the anterior telencephalon. Furthermore, 
because the pioneer olfactory axons are affected by Fgf8a signalling loss, as the 
olfactory axonal defects are observed by 36hpf, it is likely that all subsequent 
(secondary) olfactory axons are denied their „guided path‟ towards the presumptive 
olfactory bulb region, and will mis-project too. 
Dusp6 transgenic and pERK immuno-labelling analyses indicated that Fgf 
signalling was active mainly in the olfactory placodes at 24hpf and 30hf, consistent 
with its role in olfactory neurogenesis at these stages. However, there is very little 
Fgf signalling in the presumptive olfactory bulb region at these stages, probably 
because the majority of olfactory axons have not yet arrived. By 48hpf, Fgf 
signalling levels have greatly elevated within many cells located at the anterior 
telencephalon, consistent with olfactory morphogenesis onset in this region.  
The exact mechanism whereby Fgf signalling from arriving olfactory axons 
brings about a reduction in proliferation at the telencephalon (the pre-requisite for 
olfactory bulb morphogenesis) is yet to be determined. However, it can be 
speculated that the arriving olfactory neuron growth cones may secrete Fgf8a upon 
their arrival at the target telencephalic neuroepithelial cells. Fgf8a freely diffuses 
through the extracellular space and binds to its receptor (Fgfr1a?) and activates Fgf 
signalling in those cells.  As there is widespread Fgfr1a expression throughout the 
zebrafish embryonic anterior forebrain, a mechanism is required to ensure that the 
Fgf8a remains local to the olfactory nerve endings which secreted it. A „source-sink 
mechanism‟ has been previously described, whereby Fgf8a morphogen gradients are 
established by fast, free diffusion of Fgf8a molecules away from the source, 
combined with a „sink function‟ of receiving cells, regulated by receptor-mediated 
endocytosis (Yu et al., 2009). Extrapolating from this, it can be envisaged that local 
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telencephalic receiving cells may ensure that the greatest concentration of Fgf8a is 
maintained at the source of the olfactory nerve endings, using the same mechanism. 
Also, HS in the extracellular matrix maybe specifically modified in the presumptive 
olfactory bulb region to prevent the free diffusion of Fgf8a to neighbouring cells 
(Ford-Perriss et al., 2002). Either way, the result is that only the target 
neuroepithelial cells will undergo intracellular changes, via the Fgf signalling 
pathway, that culminate in those cells switching from a proliferative state, to a 
differentiative state instead. 
An alternative explanation for why olfactory fibres fail to enter and establish 
contact with the anterior forebrain and initiate olfactory bulb morphogenesis in Fgf8 
deficient embryos is that they have a defect in the olfactory ensheathing cells 
(OECs). OECs are glial cells which originate from the olfactory epithelium and have 
been shown to be permissive for elongation/growth of olfactory axons (Tisay and 
Key, 1999; Chung et al., 2008). OECs express high levels of Fgfr1, and it has been 
proposed that reduced Fgf8 signalling in these cells impairs their specification 
and/or functioning in olfactory axonogenesis (Hsu et al., 2001); thus maybe 
demonstrating why peripherin-immunoreactive olfactory axons are disorganised in 
Fgf8 hypomorphs. Despite defects in olfactory neurogenesis and axonogenesis in 
these mutants, not all olfactory-placodal derived cells are affected equally, and these 
mutants do have olfactory epithelia, as indicated by the presence of Olf-1 (olfactory 
neuron-specific transcription factor) positive neurons (Chung et al., 2008).  
 
 
4.4.2  A problem of GnRH neuronal specification(?): the 
role of Fgf signalling 
Previous studies in mice have shown that deficiencies in Fgf8 or Fgfr1, but 
not Fgfr3, results in a loss or reduction in hypothalamic GnRH neurons. In 
homozygous Fgf8 hypomorphs, the GnRH neurons never emerge from the olfactory 
epithelium, and are missing from all developmental stages looked at; whereas Fgfr1 
hypomorphy severely reduces the number of GnRH neurons. The discrepancy 
between these two phenotypes may be explained by the fact that the Fgfr1 gene 
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knockdown is variable- somewhere between 66 and 80%. Alternatively, it could be 
because Fgf8 is signalling via more than one Fgf receptor, such as Fgfr3- although 
there was no GnRH neuronal loss caused by Fgfr3 gene loss, even though Fgfr1 and 
Fgfr3 are both present in GnRH neurons from E15.5 mouse embryos. Together this 
data suggests that Fgf8 signals predominantly via Fgfr1 during the generation and/or 
maintenance of GnRH neurons (or their progenitors) within the nasal compartment, 
in mice embryos (Chung et al., 2008). 
GnRH neuronal migration to the hypothalamus is a very important process in 
the development of the GnRH system; and it has been well accepted that a failure in 
this migration is the cause of hypogonadotrophic hypogonadism in patients with KS. 
Previous studies have shown that peripherin-immunoreactive olfactory/vomeronasal 
axonal fibres do not enter the forebrain in homozygous Fgf8 hypomorphic mice 
(Meyers et al., 1998), suggesting that the loss of GnRH neurons may be a 
migrational defect, resulting from the loss of the axonal scaffold required for their 
forebrain migration. However, GnRH neurons were absent from very early 
embryonic stages (i.e. E11.5) in the Fgf8 hypomorphs, suggesting that Fgf 
signalling was instead required for GnRH neuronal specification within the nasal 
compartment. In support of this hypothesis, mice which were homozygous for the 
Fgf8 hypomorphic allele had a 50% reduction in GnRH neurons, despite having 
normal morphogenesis of the nasal region and olfactory bulbs, demonstrating that 
some GnRH neurons failed to enter the forebrain even when their migratory scaffold 
was intact. It was therefore hypothesised that defects in early GnRH neurogenesis, 
not migration, caused hypothalamic GnRH neuronal loss in Fgf8 and Fgfr1 deficient 
mouse embryos (Chung et al., 2008). 
To investigate the role of Fgf signalling during GnRH neuronal 
specification, a nasal explant culture which supported emergence of GnRH neurons 
from E10.5 was utilised. When Fgf signalling was blocked in this system, using 
SU5402, it was found that the GnRH neurons failed to emerge i.e. they were no 
longer specified. Furthermore, it was found that addition of FGF2 to dispersed 
GnRH neurons from E15.5 embryos resulted in neurite outgrowth (Gill et al., 2004). 
Together this data illustrates that Fgf signalling has a crucial role in GnRH neuronal 
specification in the nasal compartment, and plays a role in GnRH axon targeting. 
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Although a direct role for Fgf signalling in GnRH migration cannot be ruled out, the 
fact that Fgf signalling may be involved in GnRH neuronal axonogenesis suggest 
that it may have an indirect role in GnRH neuronal migration, as GnRH neurons are 
believed to migrate along their own (and neighbouring) neuronal processes during 
their hypothalamic migration in zebrafish (see chapter 3). 
 As mentioned above, Fgf8 deficiency has been shown to result in elevated 
levels of apoptosis in specific Fgf8-expressing regions of the olfactory placode and 
surrounding nasal compartment, causing a significant reduction in olfactory 
neurogenesis (Kawauchi et al., 2005). Similarly, GnRH progenitor cells which are 
generated within the olfactory placodal region may also be prematurely eliminated 
in the Fgf8 mutants, or, if present, may be prevented from becoming GnRH neurons. 
Unfortunately, the absence of a specific GnRH progenitor cell marker prevents 
further investigation of the role of Fgf signalling in early GnRH neuronal 
specification.  
Consistent with the mouse Fgf8 mutant analysis, Fgf8a morphant zebrafish 
embryos had 50% or fewer hypothalamic GnRH neurons by 36hpf. Similarly, 
blocking Fgf signalling by SU5402 between 14hpf and 22hpf gave similar reduction 
in hypothalamic GnRH neurons. However, unlike the mouse Fgf8 mutants, even in 
the seven Fgf8a morphant embryos which lacked all hypothalamic GnRH neurons, 
GnRH-expressing cells were still present in the terminal nerve region. As already 
discussed in chapter 3, it is unclear whether terminal nerve GnRH cells (or cells 
which migrate alongside the terminal nerve) or other cells within the nasal 
compartment contribute to the hypothalamic GnRH cells, or whether these so-called 
„early wave‟ hypothalamic GnRH cells actually arise within the hypothalamus itself. 
This affects how the GnRH defects caused by Fgf signalling loss are analysed.  
Firstly, if the „early wave‟ hypothalamic GnRH3 neurons (or their 
progenitors) arise in the olfactory placode, or an adjacent region (including the 
anterior pituitary placode), then the proposed increase in apoptosis which occurs in 
the Fgf8-expressing cells of the nasal compartment in zebrafish, upon loss of 
Fgf8/Fgfr1 signalling, will also affect specification and subsequent emergence of 
hypothalamic GnRH3 neurons (or their progenitors) from this region, as is believed 
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to occur in the mouse Fgf8 hypomorph. Moreover, as Fgf signalling has been shown 
to induce GnRH neurite elongation in primary cell culture (Gonzalez-Martinez et 
al., 2004b), this could result in the loss of the GnRH axonal scaffold that GnRH 
neurons are believed to utilise for their migration in to the forebrain. In fact, the 
projections from terminal nerve GnRH cells which normally extend across both 
forebrain commissures are missing or defective in the Fgf8a morphants, thus 
potentially hindering migration of the GnRH neurons into the hypothalamus. The 
loss of GnRH-positive projections across the POC, in the preoptic area of the brain, 
are particularly significant because this is the same region where the „early wave‟ 
GnRH cells migrate to by 36hpf. 
Alternatively, if some or all of the „early wave‟ hypothalamic GnRH cells 
originate within the hypothalamus itself, the loss of hypothalamic GnRH cells by 
blocking Fgf signalling must result from an defect in proper GnRH neuronal 
specification. This may be due to an increase in apoptosis in the hypothalamic 
GnRH cells or their progenitors; similar to the mechanism of Fgf8 action at the 
olfactory placode, which may have been conserved from the common rodent/fish 
ancestor.  
Although the Fgf receptors and Fgf8a are expressed within the 
telencephalon/diencephalon between 17-23hpf, it remains to be determined whether 
they are expressed within the GnRH cells or their progenitors; although the absence 
of a GnRH progenitor marker prevents such analysis being carried out at earlier 
stages, when such investigations would be most informative.  
Another possibility is that the reduction in hypothalamic GnRH cell number 
secondary to the midline structural defects that are observed in Fgf8a mutant 
embryos. Specifically, the disorganisation of the area between the two forebrain 
commissures (the preoptic area) in the Fgf8a („ace‟) mutant has previously been 
described (Shanmugalingam et al., 2000), suggesting that neuronal cell types (such 
as the GnRH neurons) which arise within this region may be disorganised and/or 
lost.  
Using the GnRH3 transgenic reporter line (G3MC), it is has not been 
possible to observe migration of the hypothalamic GnRH neurons from the nasal 
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compartment, if such a migration exists in the zebrafish for these „early wave‟ 
GnRH cells. It is therefore not possible to comment on „migrational defects‟ for 
these cells. However, the „later wave‟ of GnRH neuronal migration that was 
discussed in chapter 3 may be affected by loss of Fgf signalling in a different 
manner; this will be a future direction of this project. However, it is unknown 
whether Fgf8a morpholino will remain active long enough to block Fgf8a signalling 
when the later wave of GnRH migration into the hypothalamus occurs from around 
120hpf onwards. Moreover, as SU5402 approaches can no longer be used at these 
later stages (due to lack of inhibitor penetration), a dominant negative FGFR 
approach may be required instead. 
The disruption of the terminal nerve GnRH3 cells in the Fgf8a/Fgf8b double 
morphants suggest that Fgf8b may also have a role in the development of the 
zebrafish GnRH system, although this role may be restricted to these 
neuromodulatory neurons. Again, a more complete knockdown of Fgf8b is required 
to ascertain its full role in zebrafish GnRH development. 
The analyses hitherto carried out on mouse and zebrafish to elucidate the 
role of Fgf8 and Fgfr1 during olfactory and GnRH neuronal development has 
already enhanced our understanding of the pathogenesis of human KS. In 
Fgf8/Fgfr1 mutants, olfactory and vomeronasal neurons are reduced in number in 
the olfactory epithelium, and their axons are also fewer in number and fail to project 
correctly to their forebrain neuronal targets. This results in failure of olfactory bulb 
(and vomeronasal organ) morphogenesis, due to failure of local proliferation 
reduction (according to the model described above). GnRH cells and/or their 
progenitors which originate in the nasal compartment (or possibly from within the 
hypothalamus in zebrafish) do not emerge because they fail to get correctly 
specified, perhaps because they or their progenitors die through increased apoptosis. 
Moreover, if there is sufficient Fgf8 signalling, some GnRH cells may be specified, 
but they fail to project neurites into the forebrain, a necessary pre-requisite for their 
migration into the hypothalamus, as they migrate along their own axons. Moreover, 
if the Fgf8 signalling is reduced to levels that cause defects in olfactory 
axonogenesis, the GnRH neurons may be denied a navigational pathway into the 
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forebrain; so regardless of whether they have been specified correctly, they will 
remain outside the forebrain in the olfactory compartment region. 
During human embryogenesis, GnRH neurons have been shown to originate 
at the olfactory placode (Schwanzel-Fukuda et al., 1996; Gonzalez-Martinez et al., 
2004a), so they are more likely to follow the mechanism that has been described in 
mice, if it unfolds that zebrafish have sole hypothalamic origin for their 
hypothalamic GnRH neurons. KS patients with FGFR1 and FGF8 mutations present 
with HH with or without anosmia/ hyposmia, and, more rarely, isolated anosmia 
(Pitteloud et al., 2006). This demonstrates that the processes of olfactory and GnRH 
system development can be affected independently by reduced Fgfr1/Fgf8 
signalling. For example, GnRH neuronal specification may be more susceptible to 
reduced Fgfr1/Fgf8 signalling, so patients who have FGF8 or FGFR1 mutations 
which bring signalling below a certain threshold, GnRH neurons are not specified at 
the olfactory placode. However, at the same level of Fgf8/Fgfr1 signalling olfactory 
neurogenesis may proceed, because its threshold hasn‟t been reached; such patients 
will have isolated HH, not KS.  
Furthermore, some patients with FGFR1 mutations have HH that is 
reversible. For example, a male KS patient who discontinued his testosterone 
therapy, recovered from his HH, as evidenced by normal LH secretion, normal 
serum testosterone levels, and spermatogenesis (Pitteloud et al., 2005). Olfactory 
stem cells present in the olfactory epithelium continue dividing postnatally, and may 
potentially be a source of GnRH cells that migrate into the hypothalamus into 
adulthood (Calof and Chikaraishi, 1989). Moreover, it is possible that, as may occur 
during zebrafish embryogenesis (see Chapter 3), a stem cell population within the 
hypothalamus can give rise to new GnRH neurons, in response to specific 
maturation signals, such as sex steroids (Pitteloud et al., 2005). Another possibility 
is that despite the olfactory defects, a sub-optimal number of GnRH neurons were 
able to migrate into the hypothalamus, but were insufficient in number to initiate 
pulsatile GnRH secretion at the time of puberty; but this was overcome by the intake 
of sex steroids which help to initiate pulsatile GnRH release.  
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4.4.3 Other forebrain defects: the forebrain commissures 
Vertebrate commissure formation is a highly organised developmental 
process whereby axons must traverse long distances in order to navigate towards 
their neuronal targets and form functional connections between both hemispheres of 
the brain. Fgf signalling has been shown to play an essential role in the development 
of the forebrain commissures in mice and zebrafish. Loss of Fgf8 or Fgfr1 cause 
severe defects in forebrain commissure formation in zebrafish and mice (Meyers et 
al., 1998; Shanmugalingam et al., 2000; Tole et al., 2006). It is therefore likely that 
Fgf8 is acting via Fgfr1 during this process, and this mechanism probably involves 
the specification of glial structures at the midline which help to ensure the correct 
navigation of the commissural axons. However, another, more direct, role for 
Fgf8/Fgfr1/HS in commissural axon pathfinding has also been postulated, although 
this is yet to be fully tested and proven (Tole et al., 2006). 
Zebrafish deficient in Fgf8a have missing or abnormal AC and POC 
formation (Shanmugalingam et al., 2000); as do embryos that are treated with 
SU5402 to block Fgf signalling between 14hpf and 22hpf. Although not 
immediately apparent, these defects in forebrain commissure formation are relevant 
to our understanding of the pathogenesis of KS. During zebrafish embryogenesis, 
olfactory and terminal nerve GnRH neuronal axons both project across the forebrain 
commissures (AC and POC) and their associated tracts, and it is likely that such 
„axonal scaffolds‟ are important for migration of the hypothalamic GnRH neurons 
(early wave and/or late wave). Moreover, these forebrain commissure projections 
permit coordination of GnRH and/or olfactory neuronal communications between 
both sides of the brain. Finally, defects in forebrain commissure formation may help 
in our understanding of the biological mechanism of bimanual synkinesis (upper 
body mirror movements) which is a symptom experienced by around 75% of KS 
patients with KAL1 mutations (Kim et al., 2008). 
There are two main hypotheses which have been proposed to explain the 
cause of bimanual synkinesis in KS patients. One proposed mechanism involves 
dysfunctional decussation (crossing over at the midline) of corticospinal tracts 
resulting in the majority of these axons instead projecting down the ipsilateral side 
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of the spinal cord, leading to abnormal development of the primary motor system. 
The other mechanism involves a lack of contralateral motor cortex inhibitory 
mechanisms i.e. abnormal formation of the trans-callosal fibres (of the corpus 
callosum) which coordinate both hemispheres of the brain by inhibiting the 
generation of a motor impulse in the opposite hemisphere during voluntary upper 
body movements (Koenigkam-Santos et al., 2008). In an analysis of patients with 
KS and bimanual synkinesis, cases of hypertrophy of the corpus callosum were 
found in both X-linked and autosomal KS patients, whereas a case of hypertrophies 
corticospinal tracts was found in an X-linked patients. This indicates that both 
hypotheses may be true and that there is may be more than one mechanism involved 
in bimanual synkinesis in KS patients (Krams et al., 1999).  
Abnormalities in zebrafish spinal cord development were not investigated in 
this chapter; however the defects in AC and POC formation in the zebrafish Fgf8a 
morphants may be mechanistically similar to the corpus callosum defects that are 
present in the mouse Fgfr1 and Fgf8 mutants, as well as humans with X-linked KS 
and bimanual synkinesis. Moreover, corpus callosum defects have been described in 
at least one KS patient with an FGFR1 mutation (Dode et al., 2003), further 
supporting the second mechanism described above. 
However, incidence of bimanual synkinesis is far higher in X-linked KS 
patients (i.e. those with KAL1 mutations), compared to autosomal KS patients (e.g. 
those with FGFR1 or FGF8 mutations) (Kim et al., 2008). This may be partly down 
to the genetics of these genes: FGFR1 and FGF8 mutations are normally (but not 
always) heterozygous mutations, meaning that these patients will be hypomorphic 
for these genes; whereas males with KAL1 mutations have no other functioning 
copy of KAL1, and are therefore likely to be „true‟ KAL1 knockouts. This effectively 
means that these X-linked KS patients have no KAL1 gene function; whereas those 
with FGFR1 or FGF8 mutations will still have at least 50% FGFR1 or FGF8 
expression. In regions where KAL1 is expressed, and its function required, loss of 
anosmin-1 signalling will have a more severe defect, compared with the same 
regions where FGF8 or FGFR1 are also required, giving a less severe (more 
variable) phenotype. This could be why bimanual synkinesis, and its putative 
associated defects in corpus callosum formation, is more strongly associated with 
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KAL1 mutations, compared with FGFR1 or FGF8 mutations; and why mouse 
conditional Fgfr1 or Fgf8 knockouts, but not human FGF8/FGFR1 heterozygotes 
have more penetrant defects in corpus callosum formation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4: Results (II) 
 
224 
 
4.5  Future prospects 
 
Fgf signalling has a critical role in bridging the two hemispheres of the brain 
by forming midline cell types, including glial structures, which help to promote the 
midline crossing of commissural axons. Loss of Sonic hedgehog (Shh) signalling 
also causes loss of midline cell types, leading to a disorder called holoprosencephaly 
in humans and mice (Hayhurst and McConnell, 2003). It would therefore be 
interesting to ascertain whether there are any interactions between the Shh and Fgf 
signalling pathways in the induction of midline cell types and subsequent formation 
of the forebrain commissures.  
Whilst defects in corpus callosum formation has already been described in 
both autosomal and X-linked KS patients (Krams et al., 1999), it will be informative 
to investigate whether the other brain commissures are affected in humans, included 
the anterior commissure, using standard MRI techniques. Moreover, it will be useful 
to find out how these putative commissure defects relate to any upper body mirror 
movement they may be present in these patients, and how this relates to their 
specific FGF8/FGFR1 mutations (i.e. their FGF8/FGFR1 signalling levels). 
Fgf3, Fgf15, Fgf17 and Fgf18 are all expressed at the anterior end of the 
developing mouse telencephalon, and may also have a role in the developing 
telencephalon (Hebert et al., 2003). In fact, Fgf3 was shown to have an important 
role in formation of the AC and POC in the zebrafish; and when Fgf3 was knocked 
down with Fgf8a, a more severe forebrain commissure phenotype was obtained 
(Walshe and Mason, 2003). Using similar morpholino approaches, the effects of 
knocking down Fgf3 on olfactory/vomeronasal axonogenesis and GnRH system 
development will be investigated.  
Fgf8 mutants have more severe defects in forebrain development, including 
a much more complete loss of hypothalamic GnRH neurons, compared with the 
Fgfr1 mutants (Chung et al., 2008). This indicates that Fgf8 may not be acting solely 
through Fgfr1 during these developmental processes. Fgfr3 is likely candidate 
because it is expressed in GnRH neurons of E15.5 mouse embryos. Although mouse 
Fgfr3 mutants do not have a noticeable reduction in hypothalamic GnRH neurons 
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(Chung et al., 2008), a role for this Fgf receptor cannot completely ruled out. In 
order to determine which of the five individual zebrafish Fgf receptors are involved 
olfactory axonogenesis, commissure formation, and/or GnRH neurogenesis, it will 
be necessary to use specific morpholinos against each one. However, it is unlikely 
that 100% knockdown can be achieved in these embryos without resulting in early 
embryonic lethality; therefore each morpholino will need to be carefully titrated 
down to a knockdown level which is still viable. Moreover, to further investigate the 
role of Fgf signalling in these developmental processes, various available constructs 
can be injected into zebrafish embryos which modulate the Fgf signalling pathway, 
including constitutively active FGFR constructs. Furthermore, in order to fully 
investigate the role of the second FGF8 orthologue (Fgf8b) during zebrafish 
forebrain development, it will be necessary to design new morpholinos against this 
gene, which permit higher (i.e. closer to 100%) knockdown levels. 
Moreover, if any novel Fgf ligands, Fgf receptors, or downstream 
modulators are identified as being involved in olfactory/GnRH neuronal 
developmental, the KS patient DNA database (at the Centre of Neuroendocrinology, 
Royal Free hospital) may be utilised to discover whether there are mutations present 
in the human orthologous genes. 
In order to further investigate the mechanism of forebrain commissure 
failure in the Fgf8a morphant zebrafish, it will be necessary to find out if the 
midline glial structures are disrupted, as they are in the Fgf8 mouse mutant, using 
GFAP immuno-labelling between 16-22hpf to label the glial cells. Moreover, by 
titrating the Fgf8a morpholino, it can be investigated whether there is a threshold of 
Fgf8a signalling where the midline glial structures are normal, but the commissures 
are disrupted, thus confirming that Fgf8a signalling may be required for more than 
just specifying the midline glial structures. Then, by targeting dnFGFR specifically 
to a subset of commissural axons, e.g. by using the GnRH3 promoter to drive 
dnFGFR expression, it can be determined whether Fgf signalling is required for 
AC/POC axonogenesis, when the midline glial structures are normal. For example, 
if the GnRH-positive commissure axons fail to cross the midline correctly, this 
would suggest that Fgf signalling is essential for forebrain commissure 
axonogenesis, assuming that the terminal nerve GnRH cells are specified normally 
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in these mutants. Indeed, such an experiment will also be useful in determining 
whether Fgf signalling is required in GnRH3-expressing cells which migrate to the 
hypothalamus. 
Similarly, it is unknown whether the Fgf8a signalling is required for 
olfactory/vomeronasal axonogenesis, or whether the failure in correct axonal 
formation is due to an increase in apoptosis in the olfactory epithelium. It may be 
expected that using the OMP promoter to control dnFGFR may caused too much 
apoptosis in the olfactory epithelium, and this will not allow us to answer this 
question. Therefore, instead, a promoter, such as that of an odorant receptor gene, 
may be used to control dnFGFR specifically in a small subset of olfactory neurons; 
the TRPC2 promoter may be used in a similar manner to inhibit Fgf signalling 
specifically in the vomeronasal axons. If Fgf signalling is required in those specific 
olfactory neurons that have their Fgf signalling blocked, their axons will be 
expected to mis-project away from the well-organised, tightly fasciculated olfactory 
nerve bundle which normally projects to the presumptive olfactory bulb region by 
around 36hpf. It is assumed that by the time that the odorant receptor has been 
expressed (at around 24hpf), the olfactory neuron‟s fate has already been 
established; so it won‟t be fated to go through apoptosis when Fgf signalling has 
been lost (as happens to early olfactory stem cells with Fgf signalling loss). 
Similarly, if Fgf signalling can be blocked specifically in a subset of zebrafish 
OECs, by using an OEC-specific promoter, it may be determined whether Fgf 
signalling is required for the correct functioning of the OECs, which are required for 
normal olfactory axonogenesis. Finally, to confirm that Fgf8a signalling is required 
for cell survival within the olfactory placode/ nasal compartment region in 
zebrafish, as happens in mouse embryos, cell apoptosis analyses (such as the 
Lysotracker assay, Invitrogen) will be need to be carried out on Fgf8a morphants, to 
identify increased olfactory neuronal cell death. Moreover, identification of a 
marker for early GnRH progenitor cells, which putatively originate in the nasal 
compartment, will permit an analysis of GnRH progenitor cell survival within the 
Fgf8a-expressing domain of the nasal compartment (and how this may hinder their 
subsequent migration to the hypothalamus).  
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Chapter 5: Results (III) 
5.1  Introduction 
 
In the past few years, several reports regarding the role of KAL1 orthologues in 
zebrafish olfactory and GnRH neuronal ontogeny have, for the first time in a 
vertebrate model organism, helped to advance our understanding of the 
molecular pathogenesis of X-linked Kallmann syndrome in vivo. However, 
during this time, there has also been further progress in our fundamental 
understanding of the development of the zebrafish GnRH and olfactory 
systems. Specifically, using transgenic approaches, it is now well understood 
that there are two major groups of olfactory receptor neurons in the zebrafish 
(an ‘olfactory-type’ and a ‘vomeronasal-type’), and perhaps two ‘waves’ of 
GnRH neuronal migration to the hypothalamus. Moreover, the use of splice-
blocking morpholinos has helped achieve improved knockdown efficiencies, 
which can be more accurately assessed using standard molecular biological 
techniques. Also, the search for defects in forebrain commissure formation in 
these morphants, similar to those caused by another of the other KS genes, 
Fgf8a, may provide a new avenue for identifying the interaction of anosmin-1 
in the FGF8 signalling pathway, in vivo. 
Indentifying combinatorial roles for Kal1a & Kal1b 
during GnRH/olfactory system development and 
forebrain commissure formation. 
Chapter 5: Results (III) 
 
228 
 
5.1.1  Zebrafish have two KAL1 orthologues: Kal1a & 
Kal1b 
Zebrafish have two orthologues of the human KAL1 gene: Kal1a and Kal1b, 
which share an overall homology with KAL1 of 75.5% and 66.5%, respectively 
(Figure 5.01B). The proteins encoded by Kal1a  (anosmin-1a
5
) and Kal1b (anosmin-
1b) share the same domain structure as human anosmin-1: that is, an N-terminal 
cysteine-rich region, followed by a whey acidic protein-like (WAP) four disulphide 
core motif, and four fibronectin type III domains, finishing with a C-terminal 
histidine-rich region; except for anosmin-1b, where this last domain is missing 
(Figure 5.01A) (Ardouin et al., 2000). Moreover, the WAP motif in Kal1b has three 
amino acid substitutions which are conserved in the anosmin-1 proteins found in all 
other vertebrates; and, two highly conserved cysteine residues are substituted in the 
N-terminal cysteine-rich domain of Kal1b too (Yanicostas et al., 2009).  
Ardouin and colleagues carried out initial in situ hybridisation analysis and 
found  that Kal1a transcript was detected from around 37hpf onwards in the 
presumptive olfactory bulbs, whereas Kal1b was detected  later, from around 48hpf 
onwards, in the epithelium of the nasal cavity, suggesting that Kal1a and Kal1b may 
have a role in the development of the zebrafish olfactory system (Ardouin et al., 
2000). 
 
5.1.2  A role for Kal1a in teleost fish GnRH system 
development 
The effects of Kal1a and Kal1b gene knockdown on the GnRH system of 
two teleost fish models, the zebrafish (Whitlock et al., 2005b) and the medaka 
(Okubo et al., 2006), have been reported.  
Medaka, like zebrafish, have two KAL1 orthologues. However, unlike 
zebrafish, they have GnRH1- and GnRH3-expressing cells present in the preoptic 
area of the hypothalamus; but, only the GnRH1 cells project axons to the anterior  
                                                 
5
 To avoid confusion, anosmin-1a and anosmin-1b are referred to throughout as Kal1a and Kal1b, 
respectively; and the genes are referred to as Kal1a and Kal1b (i.e. italicised, as per convention). 
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Figure 5.01   Zebrafish anosmin-1a & anosmin-1b
A: Schematic domain-structure diagrams (drawn to relative scale) of (i)
anosmin-1a and (ii) anosmin-1b. They both have the same domain structure as
human anosmin-1, except anosmin-1b lack the histidine-rich C-terminus. B:
Amino acid sequence alignment of human anosmin-1 („KAL-1‟ ) with
zebrafish anosmin-1a („kal1.1‟) and anosmin-1b („kal1.2‟) . Regions of
conservation are highlighted in blue
SS =Secretory signal sequence; Cys box = cysteine-rich region; WAP = whey
acidic protein-like four disulphide core motif; FnIII-1, FnIII-2, FnIII-3, FnIII-4
= fibronectin type III domains; H = histidine-rich region.
Figure 5.01 (B) reprinted from Mech. Dev. 90, Ardouin et al., ‘Characterization of the two
zebrafish orthologues of the KAL-1 gene underlying X chromosome-linked Kallmann
syndrome.’, pp.89-94, Copyright 2000, with permission from Elsevier.
(ii) anosmin-1b
A (i) anosmin-1a:
B
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pituitary, thus making GnRH1 the hypophysiotropic form of GnRH in the medaka. 
However, Okubo and colleagues showed that knocking down Kal1a, but not Kal1b, 
resulted in both GnRH1 and GnRH3 neurons failing to migrate into the 
hypothalamus, and instead accumulating in the olfactory compartment (Okubo et al., 
2006).  
Similarly, Whitlock and co-workers reported that knocking down Kal1a in 
the zebrafish resulted in specific and complete loss of the „endocrine‟ GnRH cells of 
the hypothalamus, but did not affect the „neuromodulatory‟ cells of the midbrain and 
terminal nerve. Moreover, knocking down Kal1b resulted in only a slight decrease 
in the number of migratory hypothalamic GnRH cells by 56hpf (Whitlock et al., 
2005b).   
 
5.1.3  A role for Kal1a in zebrafish olfactory system 
development 
Using anti-anosmin-1a polyclonal antibodies, it was also recently reported 
that anosmin-1a is expressed from as early as 22hpf in the pioneer olfactory receptor 
neurons (ORNs) and that knockdown of Kal1a, but not Kal1b, impaired the proper 
fasciculation of olfactory axons and their terminal targeting at the olfactory bulbs. 
Moreover, there was a severe decrease in the number of GABAergic and 
dopaminergic olfactory bulb neurons caused by the knockdown of anosmin-1a, thus 
demonstrating once again the need for correct innervations by the ORNs for proper 
olfactory bulb neuronal differentiation (Yanicostas et al., 2009). 
 
 
 
Aaaaaaa 
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5.1.4  Aims of this chapter 
Kal1a has been implicated in olfactory and GnRH system development in 
the zebrafish. Using novel technological approaches, the role of both Kal1a and 
Kal1b will be further examined, and then studied in the context of its involvement in 
the Fgf8a signalling pathway, in vivo. These are therefore the aims for this chapter: 
- To characterise the spatio-temporal expression of Kal1a and Kal1b in 
relation to olfactory and GnRH system development in the forebrain. 
-To knockdown Kal1a and Kal1b using translation- and splice-blocking 
morpholinos, confirm their knockdown efficiencies, and identify any GnRH, 
olfactory, and/or vomeronasal mutant phenotypes caused by their 
knockdown. 
-Establish whether the Kal1a and/or Kal1b morphants, like Fgf8a 
morphants, have defects in forebrain commissure formation.  
-To over-express Kal1a and Kal1b by micro-injection of in vitro transcribed 
mRNA, and identify any developmental defects this may cause.  
-If no measurable olfactory, GnRH, or commissural defects are caused by 
over-expression, the Kal1a and/or Kal1b mRNA can then be used to „rescue‟ 
any morphant defects caused by knockdown of Kal1a and/or Kal1b. 
-To identify whether or not Kal1a and/or Kal1b are acting via the Fgf8a 
signalling pathway in vivo. 
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5.2  Results 
5.2.1  Kal1a and Kal1b expression during head development 
 In situ hybridisation expression analysis of Kal1a and Kal1b 
Kal1a transcript was first detected at around 24hpf in the otic vesicle and the 
posterior lateral line primordium (PLLP); where it has been shown to have an 
essential role in positioning lateral line neuromasts along the trunk (Yanicostas et 
al., 2008) (Figure 5.02A). However, head expression could not be detected until 
around 32hpf, broadly within the diencephalic and hindbrain regions (Figure 5.02B). 
This expression pattern broadened to encompass some of the midbrain by 45hpf 
(Figure 5.02C), but became weaker and more diffuse by 60hpf in these regions 
(Figure 5.02D). Notably, Kal1a transcript could not be reliably detected in the 
telencephalon or olfactory placodes throughout these stages (Figure 5.02A-D).  
Kal1b was detected in the tailbud regions from as early as 17hpf (data not 
shown), as previously reported (Ardouin et al., 2000). However, more anteriorly, 
Kal1b transcript is first detected in the PLLP and otic vesicle, and, more weakly, in 
diencephalic and midbrain regions from around 24hpf (Figure 5.02E). Significantly, 
Kal1b was also detected in the olfactory placodes at this stage (Figure 5.02E); 
particularly in a group of cells at the medial edges, which share a similar appearance 
and localisation to the terminal nerve GnRH3 cells (Figure 5.02E‟, E‟‟). From 
around 32hpf, olfactory epithelium staining could no longer be reliably detected, 
and Kal1b brain expression was similar to that reported above for Kal1a at these 
stages, but weaker and more diffuse (Figure 5.02F-G).  
Interestingly, at 60hpf, in the forebrain, both Kal1a and Kal1b transcripts 
appear to be restricted to regions where the forebrain commissure and terminal 
nerve projections have formed (Figure 5.02D‟, H‟). 
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A
B
B’ B’’
C C’
D D’
E
E’ E’’
F
F’ F’’
G G’ H H’
Kal1a
Kal1b
32hpf
24hpf
60hpf
45hpf
24hpf 32hpf
45hpf 60hpf
* *
* *
Figure 5.02   Kal1a & Kal1b in situ hybridisation expression analysis
Expression of Kal1a (A-D‟) and Kal1b (E-H‟) at 24hpf (A, E), 32hpf (B, F)
45hpf (C, G) and 60hpf (D, H). B‟, B‟‟, C‟, D‟ are ventral views; A, B, C,
D, E, F, G, H are lateral views. B‟‟ and F‟‟ show anti-acetylated tubulin (AT)
immuno-labelling for B‟ and F‟, respectively. The asterisks in B‟ and F‟
indicate the location of the olfactory placodes. E‟‟ shows the overlay of AT
labelling on a ventral-lateral view of a Kal1b in situ at24hpf. The arrow in E‟‟
indicates the terminal nerve position.
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 Immuno-expression of anosmin-1a and anosmin-1b in the olfactory epithelium 
and pituitary 
Between 24hpf and 60hpf, anosmin-1a and anosmin-1b are both expressed 
throughout the whole olfactory epithelium and its associated axonal projections to 
the olfactory bulbs, as well as some projections which extend across the anterior 
commissure (Figure 5.03A-H). Anosmin-1b expression also extended to the 
pituitary region from around 36hpf onwards (Figure 5.03D, F, H; and Figure 
5.04A). Anosmin-1a and anosmin-1b were not detected in any other brain region 
during these stages; however, there was some expression of both orthologues in the 
otic vesicle, PLLP, and pronephric duct from around 30hpf onwards (appendix, 
Figure A1).  
Anti-anosmin-1b immuno-labelling was also carried out on 48hpf 
pGnRH3:mCherry (G3MC) embryos, in order to characterise the position of the 
hypothalamic G3MC cells in relation to the anosmin-1b-labelled pituitary (Figure 
5.04B-C). The presumptive pituitary cells were found to closely abut the 
hypothalamic G3MC cells; however, there was no co-expression of mCherry and 
anosmin-1b in any of these cells, except, perhaps at the interface between the 
pituitary and hypothalamic G3MC cells. Using 3D rendering software, it was 
possible to view the pituitary and hypothalamic cells from the dorsal and side view 
too (Figure 5.04C, C‟). This showed that the pituitary is in the same anterior-
posterior plane as the hypothalamic G3MC cells, and that some of the G3MC cells 
(2-3) are actually positioned on the dorsal side of the pituitary. Whilst it is 
impossible to say from this data whether or not the hypothalamic G3MC cells are 
interacting with the pituitary gonadotrophs (or other pituitary cell-types) at this 
stage, such interactions seem plausible, but would need to be investigated further.  
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24hpf 24hpf
36hpf 36hpf
48hpf 48hpf
60hpf 60hpf
anosmin-1a anosmin-1bA B
C D
FE
G H
Figure 5.03   Anosmin-1a & anosmin-1b immuno-expression during  head 
development
Anti-anosmin-1a (A, C, E, G) and anti-anosmin-1b (B, D, F, H) immuno-
labelling in zebrafish embryos at 24hpf (A, B), 36hpf (C, D), 48hpf (E, F),
and 60hpf (G, H). A-H are all confocal images from ventral view.
Scale bars are 50m.
OE= olfactory epithelium; pit= pituitary
pit
pit
OE
OE
OE
OE
OE OE
OE
OE
pit
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HYP
PIT
HYP
PIT
anosmin-1bA B
C C’
48hpf
Figure 5.04   Anosmin-1b immuno-expression in the pituitary
Anti-anosmin-1b immuno-labelling in the pituitary (in green, A-C). A: a
dotted box indicates the presumptive pituitary labelling at 48hpf; in B this
region is shown in more detail relative to hypothalamic G3MC cells (in red).
A and B are both ventral views. 3D rendering analysis was carried out on B
(shown in C and C‟). The hypothalamic cells closely abut the presumptive
pituitary anosmin-1b positive cells- as seen from a dorsal view (C) and a
lateral view (C‟). Scale bars are 50m.
HYP= hypothalamic G3MC cells; PIT= presumptive pituitary
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5.2.2  Knocking down Kal1a and Kal1b using translation-
blocking morpholinos 
To begin with, translation-blocking morpholinos (tbMOs) were used to 
specifically knock down Kal1a (A-MO) and Kal1b (B-MO) gene function. But, due 
to their unfavourable knockdown efficiency and lack of significant morphological 
defects (see below), these were later replaced with splice-blocking morpholinos 
(sbMOs, see section 5.2.4) for the remainder of the Kal1a/Kal1b knockdown studies 
in this chapter. 
 
Knockdown is incomplete 
To verify the knockdown efficiency of the tbMOs (A-MO and B-MO), 
Western immuno-blotting was carried out using embryonic lysates harvested from 
24hpf embryos previously injected with control MO (coMO, at 1.5mM) or A-MO or 
B-MO at 0.5mM, 1.0mM, or 1.5mM (Figure 5.05A).  
Immunoblots probed with anti-anosmin-1a antibody (Figure 5.05A, top left) 
produced two bands for each lane: one at ~95kDa and another at ~85kDa. Two 
bands of similar molecular weight were also detected when anti-anosmin-1b 
antibody (Figure 5.05A, top right) was used, except that the equivalent ~85kDa 
band was much weaker in intensity. Whilst only a ~95kDa band had previously 
been reported for these antibodies, the ~85kDa band may be a differentially 
glycosylated form of anosmin-1a and anosmin-1b. However, for the purposes of this 
analysis, only the higher ~95kDa band will be assessed.  
Previous titration experiments had shown (see appendix) that the highest 
non-lethal concentrations for A-MO and B-MO were 1.5mM. However, at 1.5mM 
some embryos showed severe overall morphological deformities such as heart 
oedema and „curved trunk‟ (especially the B-MO injected embryos); but, these 
defects were much less apparent at either 1.0mM or 0.5mM (see appendix). 
 „Visual comparisons‟ of relative reduction in band intensities of coMO-
injected embryos were compared with the A-MO and B-MO morphants to obtain  
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Translational 
start site
B
Translation-blocking morpholino                                                       
target sequence comparison:
A
Figure 5.05   Confirmation of Kal1a & Kal1b knockdown by translation-
blocking morpholinos
A: Immunoblotting of 24hpf control („C‟) and morphant* (see below)
embryo lysates, probed with anti-anosmin-1a (top left), anti-anosmin-1b (top
right), or anti-GAPDH (bottom).
B: Diagram comparing target sequences for Kal1a (top) or Kal1b (bottom)
translation-blocking morpholinos used in this thesis (see Figure 5.05 for
phenotype) or papers published by the Whitlock (Whitlock et al., 2005b) or
Soussi-Yanicostas (Yanicostas et al., 2009) laboratories.
*Translation-blocking morpholinos against Kal1a (A-MO) and Kal1b (B-
MO) were used at concentrations of 0.5, 1.0 or 1.5mM
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approximate Kal1a/Kal1b gene knockdown levels. Lysates from embryos injected 
with 1.5mM of  A-MO showed no more than 75% decrease in band intensity (Kal1a 
knockdown) compared with the coMO lysate (Figure 5.05A, top left); whilst the 
knockdown efficiencies for 0.5mM and 1.0mM  A-MO were ~50-75%. For B-MO, 
these knockdown efficiencies were ~50% at 1.0mM and 1.5mM, and only ~25% at 
0.5mM (Figure 5.05A, top right). The GAPDH loading controls (~37kDa bands) 
showed that the amount of total embryonic protein lysate loaded in each lane was 
approximately equal across all lanes, thus making these calculated knockdown 
efficiencies more reliable (Figure 5.05A, bottom).  
Whilst densitometry analysis of these band intensities would have been far 
more accurate, this analysis was sufficient to prove that the knockdown was 
incomplete, and that the „average‟ morphant had no more than around 75% knock 
down of Kal1a/Kal1b gene expression (see discussion). 
Subtle olfactory and commissural defects 
There were no noticeable defects caused by knocking down Kal1a and 
Kal1b individually using the translation-blocking morpholinos A-MO and B-MO 
(data not shown); however, there were some subtle phenotypes caused by co-
injecting A-MO and B-MO together (Figure 5.06).  
The G3MC phenotype was virtually unaffected at 36hpf (data not shown) or 
later at 60hpf in the A-MO+B-MO morphants (n=28/31, 2 experiments, Figure 
5.06B). In Figure 5.06B, the G3MC hypothalamic cluster and G3MC-positive optic 
nerve and tract appear fainter (less mCherry fluorescence), but, on closer inspection 
these tracts and cells nevertheless still appear to be grossly present and intact, 
compared with the wild-type G3MC phenotype seen in the coMO-injected controls 
(n=28/28, 2 experiments, Figure 5.06A).  
The olfactory pits had formed correctly by 48hpf in the A-MO+B-MO 
double morphants, and the ORN axons had extended towards the telencephalon in a 
approximately normal tightly-fasciculated bundle (n=47/50, 2 experiments, Figure 
5.06D), similar to the control embryos (n=44/44, 2 experiments, Figure 5.06C).  
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Figure 5.06   Morphant phenotypes for translation-blocking morpholinos 
targeted against Kal1a and Kal1b
No observable defects were observed for knocking down Kal1a or Kal1b
alone ,using translational-blocking morpholinos . Therefore, only the double
knockdown of both Kal1a and Kal1b is shown here.
G3MC (in red; A, B), OMPG (in green; C, D), anti-calretinin immuno-
labelling (in purple; E, F), and anti-acetylated tubulin immuno-labelling (in
blue; G, H) is shown for control* (A, C, E, G) or Kal1a+Kal1b (B, D, F, H)
morphants at 60hpf (A,B), 48hpf (C-F), or 36hpf (G, H). All views are ventral.
The asterisk indicates the loss/reduction of some calretinin-positive axons in
the „central zone‟ region of the olfactory bulb in F.
Scale bars are 50m (C-H) 100m (A, B).
*Henceforth , „control‟ means control morpholino (CoMO)-injected.
TN= terminal nerve; hyp= hypothalamus; OE= olfactory epithelium; OB=
olfactory bulb; AC= anterior commissure; POC= post-optic commissure.
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60hpf 60hpf
48hpf 48hpf
48hpf 48hpf
36hpf 36hpf
Control A+B tbMO
*
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eye eye
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AC
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OE OE
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*
Figure 5.06   Morphant phenotypes for translation-blocking 
morpholinos targeted against Kal1a and Kal1b
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However, whilst the pOMP:EGFP labelled ORNs in the control embryos had begun 
to defasciculate at the presumptive olfactory bulb region and had formed specific 
axonal condensations (glomeruli) by 48hpf (n=44/44, 2 experiments, Figure 5.06C), 
many of the A-MO+B-MO morphants were less-defasciculated in this region and 
had formed a different, less ordered, pattern of glomeruli at the presumptive 
olfactory bulbs by this stage (n=34/50, 2 experiments, Figure 5.06D). Moreover, the 
A-MO+B-MO morphants often also had mis-projected ORNs (n=19/50, 2 
experiments, Figure 5.06D), which, in the case of Figure 5.06D, sometimes 
appeared to be repelled from the presumptive olfactory bulb region and reversed 
their direction of elongation back towards the olfactory pits (see asterisk in Figure 
5.06D).  
To further investigate this olfactory phenotype, anti-calretinin immuno-
labelling was used to label a subset of the ORNs at 48hpf. Consistently, the A-
MO/B-MO morphants were found to have fewer medial calretinin-positive ORN 
projections in the „central zone area‟ of the olfactory bulbs (n=38/48, 2 experiments, 
Figure 5.06F), compared with the controls which labelled all expected calretinin-
positive projections (n=42/42, 2 experiments, Figure 5.06E); whereas those 
projections which form the „lateral glomeruli‟ were much less affected (data not 
shown). See Figure 5.07 for a schematic map of a zebrafish olfactory bulb at 
approximately 48hpf, illustrating the locations of the different glomeruli regions 
referred to above. 
Finally, anti-acetylated tubulin immuno-labelling was also carried out to see 
if the forebrain commissures (AC and POC) were also affected (Figure 5.06G, H), 
as they in Fgf8a morphants. At 36hpf, whilst the AC had formed in most of the A-
MO/B-MO double morphants; in some cases, fewer axons had projected across the 
midline (n=28/56, 3 experiments, Figure 5.06E), compared with the control embryos 
which all had normal commissure formation (n=51/51, 3 experiments, Figure 
5.06E), whereas the POC appeared normal morphants and control embryos. 
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Figure 5.07   Glomerular map of a zebrafish olfactory bulb
A schematic map showing the glomerular pattern in the olfactory bulb of a
3.5dpf zebrafish embryo, based on a study by Dynes and Ngai, using
lipophilic tracer dyes in live embryos. Bilaterally symmetric and distinct
structures in the developing olfactory bulb that were characterised include: the
olfactory plexus, four lateral glomeruli, four medial glomeruli, five glomeruli
in the central zone, a ventral posterior glomerulus, and a dorsal zone.
Glomeruli within the central zone region are indicated by dotted lines, as their
boundaries are less distinct.
Figure 5.07 reprinted from Neuron 20, Dynes and Ngai., ‘Pathfinding of olfactory neuron
axons to stereotyped glomerular targets revealed by dynamic imaging in living zebrafish
embryos.’, pp.1081-1091, Copyright 1998, with permission from Elsevier.
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5.2.3  Kal1a and Kal1b over-expression causes no 
observable forebrain defects 
In vitro transcribed Kal1a and Kal1b capped mRNA (Figure 5.08A) were injected 
individually at a concentration of 0.5μM, 1.0μM, or 2.0μM (data not shown) or co-
injected together at 0.5μM each, at the one-cell stage (Figure 5.08B-E). At 1.0μM 
Kal1a or Kal1b, there were occasionally some trunk-shortening defects, but the 
heads appeared normal. At 2.0μM of Kal1a or Kal1b, the majority of embryos died 
by 24hpf: an effect which was, to a lesser extent, mirrored by using1.0μM Kal1a + 
1.0μM Kal1b. However, embryos injected with 0.5μM Kal1a or Kal1b had normal 
morphologies; and those injected with 0.5μM Kal1a + 0.5μM Kal1b were mostly 
normal, and only occasionally had subtle trunk defects (see appendix for summary 
of lethalities and gross morphological abnormalities in these Kal1a/Kal1b mRNA 
titration experiments). In vitro transcribed GFP mRNA, at a concentration of 
1.0μM, was injected into the control embryos that were subsequently immuno-
labelled with acetylated tubulin (Figure 5.08B), and there did not appear to be any 
morphological abnormalities (controls for the pOMP:EGFP embryos were 
uninjected, as injecting GFP would have interfered with transgenic EGFP 
fluorescence). 
Both forebrain commissures had formed correctly by 36hpf for those 
embryos injected with 0.5μM Kal1a + 0.5μM Kal1b mRNA (n=32/32, 2 
experiments, Figure 5.08C) or GFP mRNA (controls; n=29/29, 2 experiments, 
Figure 5.08C); and by 48hpf, the olfactory pits also appeared normal, with typical 
tightly fasciculated bundles of ORNs projecting to the telencephalon. Moreover, the 
pattern of defasciculation at the presumptive olfactory bulbs fell within the range of 
accepted natural variability for the Kal1a/Kal1b mRNA-injected embryos (n=36/36, 
2 experiments, Figure 5.08D) and GFP controls (n=30/30, 2 experiments, Figure 
5.08E); and consistently, there were no observable defects in the G3MC phenotype 
at 36hpf or 60hpf (data not shown). Fortuitously, this meant that Kal1a and Kal1b 
mRNA (at 0.5μM + 0.5μM) could be used in subsequent experiments to „rescue‟ the 
Kal1a/Kal1b morpholino-induced phenotypes, and thereby proving the specificity of 
those morphant phenotypes (see below). 
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A
48hpf 48hpf
36hpf 36hpf
B B’ C C’
D E
Control A+B RNA
Figure 5.08   Kal1a and Kal1b over-expression causes no observable 
defects
A: An agarose gel showing that RNA for Kal1a and Kal1b was successfully
transcribed in vitro. Anti-acetylated-tubulin immuno-labelling with DAB at
36hpf (B, C) and OMPG confocal analysis at 48hpf (D, E) are shown for the
Control (B, B‟, D) and Kal1a+Kal1b RNA-injected (C, C‟, E) embryos .
Ventral views are shown for B, C, D, and E; lateral views for B‟ and C‟. No
observable defects were observed for embryos injected with Kal1a or Kal1b
RNA alone (data not shown) or together (shown here). Scale bars are 50m
(D, E) 100m (B, C).
L= linearised plasmid; R= RNA
1kb
2kb
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5.2.4  Knocking down Kal1a and Kal1b using splice-
blocking morpholinos which target the loss of exon 4 
Splice-blocking morpholinos (sbMOs), which target the loss of either exon 4 
(see below) or exon 6 (see section 5.2.5) from Kal1a or Kal1b, were used in order to 
try and achieve higher levels of knockdown (i.e. 75-100%) compared with the 
tbMOs (A-MO and B-MO).  Figure 5.09 schematically illustrates the mechanism for 
the morpholinos which target the loss of exon 4 from Kal1a or Kal1b („KA4‟ and 
„KB4‟). The exact same mechanism is also true for the morpholinos which target the 
loss of exon 6 from Kal1a and Kal1b („KA6‟ and „KB6‟), and all other sbMOs, 
including the Fgf8b morpholino used in chapter 4. The resulting mis-spliced Kal1a 
and Kal1b transcripts are predicted to be shorter than their wild-type versions due to 
the expected loss of a whole exon; and this was confirmed when this region of the 
transcripts was amplified by RT-PCR (see below). 
 
High knock-down efficiency confirmed by RT-PCR 
Initially, to confirm that the KA4 and KB4 sbMOs were successfully 
targeting the loss of the whole of exon 4 from Kal1a and Kal1b, RT-PCR was 
carried out on cDNA pooled from 10 embryos (Figure 5.10A). GAPDH control 
PCR reactions were used to confirm that cDNA synthesis was successful in all of 
the pooled cDNA samples, in case the morphant Kal1a/Kal1b PCR products were 
degraded.  
The expected PCR product sizes for wild-type Kal1a and Kal1b of (750bp) 
and (754bp), respectively, were obtained for the control cDNA sample (Figure 
5.10A[1]). These PCR products were excised from the gel and sequenced to confirm 
that they were indeed amplified from Kal1a and Kal1b, respectively (data not 
shown).  
For the KA4 morphant cDNA sample (Figure 5.10A[2]), the Kal1a PCR 
reaction gave a band of reduced size, which was equivalent to the size predicted for 
the loss of the whole of exon 4 (527bp); whereas the Kal1b PCR reaction from the  
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Figure 5.09   Schematic diagram illustrating the mechanism for splice-
blocking morpholino gene-targeted knockdown
Exons 3, 4, and 5 from a Kal1a or Kal1b mRNA transcript are represented as
boxes separated by „V‟ shapes (two introns). The dotted line before exon 3
represents exons 1 and 2; and the dotted line after exon 5 represents exons 6-
14. During normal splicing, both introns will be spliced out and the spliced
transcript will contain all three of the pictured exons (bottom left). However,
if the morpholino (purple box) is present, it will bind to a specific exon-intron
junction - in this case exon 4 (red box). The splicing machinery „skips‟ the
whole intron-exon4-intron sequence, and the resultant (morphant) spliced
transcript will lack exon 4 (bottom right).
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G   A   B   G   A   B   G   A   B   G   A   B   
(1) Control (2) KA4 MO (3) KB4 MO (4) KA4 + KB4 MO 
A
Exon 3>     <Exon 5
Exon 4 missing!
B   KA4 MO
D
Full length anosmin-1a:
Expected MO-induced truncation:
Exon 3>     <Exon 5
Exon 4 missing!
E
Full length anosmin-1b:
Expected MO-induced truncation:
C   KB4 MO
Figure 5.10   Confirming knockdown of Kal1a and Kal1b by exon-4-
targeted splice-blocking morpholinos
A: An agarose gel depicting RT-PCR analysis of Kal1a and Kal1b transcript
from morphant cDNA samples synthesised from the pooled RNA of
twenty36hpf embryos. A GAPDH control PCR reaction („G‟ lanes) and a
PCR reaction encompassing exon4-6 for Kal1a („A‟ lanes) or Kal1b („B‟
lanes) is shown for control (1), KA4* morphant (2), KB4*morphant (3), or
KA4+KB4 morphant cDNA samples. B and C show the raw sequencing data
from the bands in A marked by blue and red asterisks, respectively:
demonstrating that exon 4 is missing from Kal1a (B) and Kal1b (C)
morphants. D and E illustrate the expected WAP-truncated Kal1a (D) and
Kal1b (E) proteins that would result from loss of exon 4.
* Splice-blocking morpholinos targeted against exon 4 of Kal1a (KA4) and
Kal1b (KB4) were used at concentrations of 1.0mM
0.5kb
1kb
0.5kb
1kb
* *
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same cDNA sample gave the wild-type product size, thus demonstrating that Kal1b 
transcripts were unaffected by the KA4 sbMO. The converse was true for the KB4 
cDNA sample, i.e. the predicted 549bp band was obtained for the Kal1b PCR lane 
(Figure 5.10A[3]). Finally, unsurprisingly, when KA4 and KB4 sbMOs were co-
injected, both Kal1a and Kal1b PCR reactions gave the shorter „morphant‟ PCR 
products (Figure 5.10A[4]). 
The KA4 (blue asterisk) and KB4 (red asterisk) morphant PCR products in 
(Figure 5.10A[4]) were gel-extracted, cloned into TOPO, and sent off for DNA 
sequencing; and they were both found to lack the whole of exon 4, as predicted 
(Figure 5.10B,C). The loss of exon 4 from Kal1a and Kal1b transcripts means that 
exon 3 is spliced to exon 5, causing a frame-shift that introduces a stop codon in to 
the early part of exon 5. Post-translation, this means that the resulting anosmin-1a 
and anosmin-1b proteins will be WAP-domain truncated, thus lacking all 
succeeding C-terminal domains, including the remainder of the WAP domain and 
all four FnIII domains, as shown schematically in Figure 5.10D, E. 
To get a better understanding of the knockdown efficiency of KA4 and KB4 
in individual embryos, RT-PCR was carried out on eight single KA4 and KB4 
morphants (Figure 5.11A, B). For KA4, there was virtually complete (~100%) 
knockdown of Kal1a for six embryos (lanes 1, 3-6, and 8), and ~75% knockdown 
(lanes 2 and 7) for the remaining two embryos (Figure 5.11A). For KB4, there was 
~100% knockdown for 7 embryos (lanes 1-5, 7 and 8), and ~75% knockdown (lane 
6) for the remaining one embryo (Figure 5.11B). Whilst this was a very small group 
of embryos, it can be estimated that in approximately three quarters of the KA4 or 
KB4 morphants there is ~100% knockdown, whilst the remainder will have ~75% 
knockdown, and that on average there is more than 90% knockdown of Kal1a/Kal1b 
gene function by these morpholinos (KA4 and KB4). 
 
GnRH system phenotype 
Two developmental stages were chosen for G3MC phenotype analysis in 
KA4/KB4 morphants: 36hpf and 60hpf. 36hpf was chosen because it represents the 
time when the number of („early wave‟) hypothalamic and terminal nerve GnRH3  
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Figure 5.11   Demonstrating the efficiency of KA4 or KB4 morpholinos in 
individual morphant embryos
Agarose gels depicting the RT-CR analysis of knockdown levels for eight
individual KA4 (A) or KB4 (B) morphants at 36hpf. The „control‟ cDNA
is to the left of the DNA ladder (with 0.5 and 1.0kb bands labelled) and
individual morphant cDNA (labelled „1‟ through to „8‟) is to the right of the
ladder. „G‟ indicates GAPDH (control) PCR reactions; „A‟ and „B‟ indicate the
Kal1a and Kal1b PCR reactions, respectively.
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(G3MC) cells has stabilised and is maximal in number, for most embryos of the 
same stage. However, there are two caveats for using 36hpf G3MC embryos. 
Firstly, there are some cells which transiently appear in the region of the anterior 
commissure at 36hpf, often obstructing/interfering with the detection of the 
mCherry-positive projections here; and secondly, there are extra mCherry-positive 
cells that begin to appear in the olfactory epithelia, which can sometimes make it 
confusing to distinguish the terminal nerve G3MC cells in this region. 60hpf was the 
other stage which was chosen because it may allow late-emerging („early wave‟) 
hypothalamic GnRH cells to finally show their presence at the hypothalamus; which 
may be a possible morpholino-induced defect. 
G3MC defects were present in embryos injected with both KA4 and KB4 
together (both at 1mM; Figure 5.12 & Figure 5.13); whereas embryos injected with 
either KA4 (1mM) or KB4 (1mM) alone were apparently normal (data not shown). 
The number of hypothalamic G3MC cells (referred to as the „early wave‟ in chapter 
3), and their position in the forebrain, was really quite variable amongst the 
KA4+KB4 double morphants at 36hpf (Figure 5.12B-E), compared to the control 
(Figure 5.12A). Sometimes the actual number of hypothalamic G3MC cells fell 
within the normal range (as discussed in chapter 3), but their spatial arrangement 
was quite disorganised (n=25/29, 3 experiments, Figure 5.12B). Whilst in other 
morphants, the hypothalamic G3MC cells were much fewer in number i.e. <50% of 
the number found in the control embryos of the same stage (n=29/70, 3 experiments, 
Figure 5.12C), or even completely absent/undetectable at 36hpf (n=16/70, 3 
experiments, Figure 5.12D, E). The majority of the coMO-injected (control) 
embryos had a cluster of hypothalamic G3MC cells that fell within the previously 
stated normal range (n=40/42, 3 experiments, Figure 5.12A). 
There was also an apparent disruption in the organisation of the terminal 
nerve G3MC cells for some of these KA4+KB4 morphants (Figure 5.12B-E), but 
this was difficult to quantify due to the appearance of other G3MC cells in the 
olfactory compartment around this stage. Indeed, the disruption of these terminal 
nerve cells is likely to be due to the disruption of the adjacent olfactory epithelium 
in these morphants (see below). 
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Figure 5.12   GnRH (G3MC) phenotype for KA4+KB4 morphants at 
36hpf
A-F show confocal images (ventral views) of the G3MC phenotype at 36hpf
for the control (A); „KA4+KB4‟ morphants (B-E); and „rescue*‟ embryos. B-
E illustrates variability in the morphant phenotype. There was no apparent
G3MC mutant phenotype when KA4 or KB4 morpholinos were injected alone
(data not shown). Scale bars are 50m
*Henceforth „rescue‟ means KA4+KB4 MOs co-injected with Kal1a+Kal1b
RNA
TN= terminal nerve; hyp= hypothalamus
KA4+KB4 MO KA4+KB4 MO
TN
TN
hyp
TN TN
hyp
TN TN
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TN TN
hyp
TN
TN
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           Most of the G3MC phenotypic abnormalities at 36hpf could be „rescued‟ by 
co-injecting the Kal1a and Kal1b mRNA together with the KA4 and KB4 sbMOs 
(n=17/24, 1 experiment, Figure 5.12F). That is, the majority of the rescued embryos 
had „normal‟-appearing hypothalamic and terminal nerve G3MC clusters (which fell 
within the aforementioned normal range in turns of cell number); and it may 
therefore be concluded that the GnRH3 neuronal defects reported above were 
specific for the knockdown of Kal1a and Kal1b by the KA4 and KB4 sbMOs (see 
discussion). However, some embryos had 50% or fewer hypothalamic GnRH 
neurons (n=7/24,, 1 experiment, data not shown), demonstrating that the rescue was 
not complete. 
KA4+KB4 morphants continued to exhibit a variable G3MC phenotype at 
60hpf, as demonstrated using anti-mCherry immuno-labelled embryos in Figure 
5.13B-D. Control (coMO) embryos had the expected tightly-clustered terminal 
nerve G3MC cells with associated forebrain commissural projections, as well as 
hypothalamic and retinal G3MC cells (n=44/45, 2 experiments, Figure 5.12A). Of 
the KA4+KB4 morphants, most had fewer mCherry-positive projections across the 
anterior commissure compared to the control (n=39/48, 2 experiments, Figure 
5.13B-D) and some had disrupted terminal nerve G3MC cells (n=23/48, 2 
experiments, Figure 5.13D). However, the hypothalamic G3MC cell clusters seemed 
to be largely present and intact by 60hpf, with most embryos having similar 
(n=29/48, 2 experiments, Figure 5.13D) or moderately reduced i.e. 50-75% 
(n=19/48, 2 experiments, Figure 5.13B, C) the number hypothalamic GnRH cells 
compared to the controls. 
 
 
Olfactory and vomeronasal axonal phenotype 
 
Olfactory (pOMP:tauEGFP) phenotype  
At 36hpf, the pOMP:tauEGFP wild-type phenotype comprises a tightly-
fasciculated olfactory bundle which projects towards the anterior telencephalon and 
defasciculates in the presumptive olfactory bulb region. This is the phenotype that 
was seen in the coMO-injected embryos (n=56/56, 3 experiments, Figure 5.14A).  
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Figure 5.13   G3MC phenotype for KA4+KB4 morphants at 60hpf
G3MC embryos immuno-labelled with anti-mCherry (with DAB) at 60hpf are
shown for control (A) and KA4+KB4 morphants (B-D). B-D illustrates
variability in the G3MC morphant phenotype at 60hpf.
Scale bars are 100m.
TN= terminal nerve; hyp= hypothalamus
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KA4+KB4 MO KA4+KB4 MO Rescue
Figure 5.14   Olfactory (OMPG) phenotype for KA4 and KB4 morphants 
at 36hpf
A-I show OMPG confocal images of single olfactory pits at 36hpf for the
control (A); KA4 morphant (B); KB4 morphant (C); „KA4+KB4‟ morphant
(D-H); and „rescue‟ (I) embryos. D-H illustrates variability in the KA4+KB4
morphant phenotype. Scale bars are 25m.
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Most of the KA4 and KB4 single morphants had a similar wild-type-like phenotype, 
except several KA4 morphants which had a slightly defasciculated olfactory nerve 
bundle (n=8/52, 3 experiments, Figure 5.14B), and several KB4 morphants which 
showed a failure in defasciculation at the presumptive olfactory bulb region 
(n=17/58, 3 experiments, Figure 5.14C), but this may represent a delay in terminal 
axonogenesis, because, by 60hpf, the defasciculation pattern at the telencephalon 
appeared quite normal i.e. similar to the control embryo (data not shown). Similarly, 
the KA4 morphants had an apparently normal phenotype by 60hpf, when taking into 
account the natural variance in olfactory axonal phenotype (data not shown), 
suggesting that the defect in the pioneer olfactory axonogenesis at 36hpf was 
rectified by the later, secondary, round of olfactory axonogenesis by 60hpf. 
Whilst there was some variability in the KA4+KB4 double morphant 
phenotype (Figure 5.14D-H), it was, in general, a more severe olfactory phenotype 
than any of the KA4 or KB4 single morphants. The actual morphology of the 
olfactory pit was more disorganised compared with the coMO embryos, where the 
olfactory pit had a much rounder „rosette‟ appearance. Sometimes, in fact, it would 
appear that some of the olfactory epithelial cells were „displaced‟ away from the 
normal perimeter of the olfactory pit (n=19/92, 3 experiments, Figure 5.14F, G); a 
phenotype that was never seen in any of the control embryos. Whilst most of the 
time the olfactory axons did project in, at least a „rudimentary‟, fasciculated 
olfactory bundle towards the presumptive olfactory bulb region, despite an often 
premature defasciculation and/or failure to fasciculate properly at all (n=47/92, 3 
experiments, Figure 5.14D-F); in some embryos, this bundle of axons appeared to 
be completely missing at 36hpf (n=33/92, 3 experimentsFigure 5.14G, H). Also, in 
the majority of embryos which did have axons projecting to the olfactory bulb, there 
was an apparent failure of proper defasciculation of the olfactory axons at the 
presumptive olfactory bulb region i.e. abnormal terminal targeting of the olfactory 
axons (n=76/92, 3 experiments, Figure 5.14D-H); which is always seen in the 
control embryos (n=56/56, 3 experiments, Figure 5.14A). 
For the majority of the „rescue‟ (, KA4+KB4 & Kal1a/Kal1b RNA co-
injected) embryos (n=37/44, 2 experiments, Figure 5.14I), the olfactory pits were 
largely intact, though not completely „roundish‟ („rosette-shaped‟) in morphology. 
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Moreover, there were no displaced epithelial cells apparent; and, an apparently 
„normal‟ fasciculated bundle of axons projecting towards the olfactory bulbs was 
present (n=42/44, 2 experiments, Figure 5.14I). However, the defasciculation of 
olfactory axons in the presumptive olfactory bulb region was perhaps not 
completely „wild-type‟ in character in some embryos (n=23/44, 2 experiments, 
Figure 5.14I); and therefore not completely rescued. Overall though, it can be 
concluded that the rescue was largely successful, and that the olfactory defects 
present in the KA4+KB4 morphants were mostly specific consequences of knocking 
down Kal1a and Kal1b by KA4 and KB4 (see discussion). 
Amongst the KA4+KB4 double morphants, there was an apparent reduction 
in olfactory pit size at 36hpf. To quantify this reduction in olfactory pit size in these 
morphants, both olfactory pits from 18 embryos (i.e. 36 olfactory pits in total) from 
each morphant group were measured digitally from a confocal stack, in the anterior-
posterior (A-P) direction; the same method that was used to assess olfactory pit size 
in the Fgf8a morphants in chapter 4.  The average A-P length (in brackets) of the 
four morphant groups are as follows: coMO (76.9m +4.53); KA4 (76.7m +4.86); 
KB4 (72.9m +7.72); KA4+KB4 (58.2m +13.11); and rescue embryos (73.4m 
+6.12). 
For the KA4+KB4 morphants, some of these olfactory defects had persisted 
until 60hpf (Figure 5.16C, E); but, for the KA4 or KB4 single morphants, the 
phenotype was apparently normal (data not shown), compared to the control 
embryos, which had „rosette‟-shaped olfactory pits and normal-appearing olfactory 
axonal projections (n=35/35, 2 experiments, Figure 5.16A). For some of the 
KA4+KB4 double morphants, the olfactory pits were largely intact, but with some 
„displaced‟ cells, and, for most of these embryos, it was apparent that many 
olfactory axons had projected towards, and defasciculated at, the olfactory bulbs 
(n=17/41, 2 experiments, Figure 5.16C; see asterisks). For other KA4+KB4 
morphants, the olfactory pits were even more disrupted, and were barely 
recognisable as olfactory pits (n=7/41, 2 experiments, Figure 5.16E), whilst the 
remaining KA4+KB4 morphants embryos had apparently normal olfactory pits 
(n=17/41, 2 experiments, data not shown). The majority of the rescued embryos 
(n=13/18, 1 experiment, Figure 5.16G) did have more „spherical‟ olfactory pits, with  
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Figure 5.15   Vomeronasal phenotype for KA4 and KB4 morphants at 
36hpf
A-I show TRPC2:Venus confocal images of single olfactory pits at 36hpf for
the control (A); KA4 morphant (B); KB4 morphant (C); „KA4+KB4‟
morphant (D-H); and „rescue‟ (I) embryos. D-H illustrates variability in the
KA4+KB4 morphant phenotype. Scale bars are 25m.
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Figure 5.16   Olfactory and vomeronasal phenotype for KA4 and KB4 
morphants at 60hpf
OMPG (A, C, E, G) and TRPC2:Venus (B, D, F, H) is shown for control (A,
B); KA4+KB4 morphant (C-F) ; and Rescue (G, H) embryos at 60hpf . C-F
illustrates variability in the KA4+KB4 morphant phenotype.
Scale bars are 50mm.
* *
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an apparently „normal‟ olfactory axonal bundle extending to the olfactory bulbs; 
whilst a few embryos did show some evidence of „displaced‟ olfactory epithelial 
cells (n=5/18, 1 experiment, data not shown).   
 
 
Vomeronasal (pTRPC2:Venus) axonal phenotype 
Whilst taking into account the high levels of natural variance in the wild-
type pTRPC2:Venus phenotype, a representative control (coMO) phenotype is 
shown in Figure 5.15A. Both the KA4 (n=40/40, 2 experiments, Figure 5.15B) and 
KB4 (n=37/37, 2 experiments, Figure 5.15C) single morphants fell within the same 
range of wild-type variance, so therefore did not appear to have defective 
vomeronasal axonal phenotypes. It was also difficult to ascertain whether or not the 
KA4+KB4 double morphants had any defective vomeronasal axonal morphologies 
(Figure 5.15D-H).  In most cases, there was evidence of vomeronasal axonal 
projections to the presumptive olfactory bulb region (n=37/45, 2 experiments, 
Figure 5.15D-G); although it was difficult to assess whether these axonal 
projections were normal, due to the inherent variability in early vomeronasal 
axonogenesis in the zebrafish, even in wild-types at 36hpf. However, a proportion of 
the KA4+KB4 embryos did have vomeronasal axons that were deficient (n=14/45, 2 
experiments, Figure 5.15E, F, H), or appeared more disordered i.e. putatively mis-
projecting (n=18/45, 2 experiments, Figure 5.15D, G) compared with the controls. 
The majority of the rescue embryos had vomeronasal axons which projected 
normally, taking into consideration the variance in wild-type variation in 
vomeronasal phenotype (n=15/17, 1 experiment, Figure 5.15I). 
To find out if there were any defects at the level of actual vomeronasal 
(Venus-positive) cell number, a cell count was carried out. Control (coMO) embryos 
had an average of 13.3 vomeronasal cells, for KA4 morphants this was 12.8, for 
KB4 morphants this was 14.2, for KA4+KB4 morphants this was 6.8, and for the 
rescue embryos this was 11.6 (averages were based on cell counts from 10 embryos 
i.e. 20 olfactory pits from each morphant group). So, in summary, the KA4+KB4 
morphants had 49% fewer vomeronasal cells than the control embryos, whilst the 
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KA4 single morphants had only 3.8% fewer cells, and the KB4 single morphants 
had 6.8% more cells. 
By 60hpf, the KA4 and KB4 single morphants still had apparently normal 
vomeronasal morphologies (data not shown), whereas vomeronasal axonal defects 
in some KA4+KB4 morphants had become more clearly apparent. Specifically, in 
some KA4+KB4 morphants, the vomeronasal axons were missing entirely on one 
(n=4/19, 1 experiment, Figure 5.16D; right side) or both (n=1/19, 1 experiment) 
sides. In other KA4+KB4 morphants, there were mis-projected vomeronasal axons 
across the midline (n=5/19, 1 experiment, Figure 5.16F). Whilst in the remaining 
embryos, the vomeronasal axons were apparently normal on both sides (n=9/19, 1 
experiment) i.e. comparable to the control phenotype (n=16/19, 1 experiment, 
Figure 5.16B). For the rescue embryos, the vomeronasal axons were apparently 
projecting to the olfactory bulbs normally on both sides for most embryos (n=9/15, 
1 experiment, Figure 5.16); whilst, in the remainder, some embryos had mis-
projected vomeronasal axons (n=6/15, 1 experiment), suggesting that the „rescue‟ 
was not complete. 
 
 
Forebrain commissure phenotype 
Anti-acetylated tubulin immuno-labelling was used to visualise both 
forebrain commissures (AC and POC) in the KA4 and KB4 morphants (Figure 
5.17). At 36hpf, in the KA4 morphants, there was a subtle deficiency in the number 
of axons crossing over at the AC (n=33/54, 3 experiments, Figure 5.17B). Whilst, in 
the KB4 morphants, there was a more significant reduction in the number of axons 
crossing the midline (at the AC) at this stage (n= 37/59, 3 experiments, Figure 
5.17C). For the KA4+KB4 morphants, this anterior commissure formation defect 
became even more apparent, as the commissure either failed to form altogether (n= 
31/72, 3 experiments, Figure 5.17D), or the AC commissural axons were mis-
projected across other midline regions, including towards the POC (n= 37/72, 3 
experiments, Figure 5.17D). The POC was present and normal for the KA4 single 
morphants (n=54/54, 3 experiments, Figure 5.17B), but was slightly defasciculated 
in some KB4 morphants (n=6/59, 3 experiments, Figure 5.17C) and more severely  
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Figure 5.17   Forebrain commissural phenotype for KA4 and KB4 
morphants at 36hpf and 60hpf
Confocal images of anti-acetylated tubulin immuno-labelling is shown for
control (A, G); KA4 morphant (B); KB4 morphant (C); KA4+KB4 morphant
(C-E, H) ; and Rescue (F) embryos at 36hpf (A-F) and 60hpf (G and H). D
and E illustrates variability in the KA4+KB4 morphant phenotype. Scale bars
are 100m.
OE= olfactory epithelium; OB= olfactory bulb; AC= anterior commissure;
POC= post-optic commissure.
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defasciculated in some KA4+KB4 morphants (n=11/72, 3 experiments, Figure 
5.17E). Both commissures (AC and POC) were present and normal (tightly 
fasciculated) in most of the „rescue‟ embryos (n=29/35, 2 experiments, Figure 
5.17E), apart from a few which had slightly fewer axons crossing at the AC (n=6/35, 
2 experiments; data not shown). 
By 60hpf, a very significant number of axons have crossed the midline 
across the AC in the coMO-injected embryos (n=42/42, 2 experiments, Figure 
5.17G), but not all of these axons will be labelled by acetylated tubulin antibody, as 
this antibody will only label newly-formed axons.  Most of the KA4+KB4 double 
morphants had a few axons crossing over at the midline at the AC by 60hpf, but 
these axons were much fewer in number compared to the controls (n=33/45, 2 
experiments, Figure 5.17H). In fact, a „tangle‟ of probable „arrested‟ axons can be 
seen gathered at either side of the midline, where the AC should have formed (see 
asterisks in Figure 5.17H).  
From Figure 5.17H, it is also apparent that there are much fewer glomeruli 
(olfactory axonal condensations) within the presumptive olfactory bulbs of the 
KA4+KB4 morphants (n=29/45, 2 experiments, compared with the control embryos 
(n=42/42, 2 experiments, Figure 5.17G); further supporting the olfactory/ 
vomeronasal axon defects reported above in the KA4+KB4 morphants. 
 
 
5.2.5  Exon-6-targetted splicing-blockers: confirming the 
specificity of the phenotypes caused by loss of exon 4 
In order to confirm the morphant phenotypes described above for KA4 and 
KB4 sbMOs, a second pair of sbMOs were also used. These sbMOs were designed 
to target the loss of exon 6 from Kal1a and Kal1b mRNA, and are therefore named 
„KA6‟ and „KB6‟, respectively.    
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High knock-down efficiency confirmed by RT-PCR 
Initially, to confirm that these new morpholinos could knockdown Kal1a and 
Kal1b just as efficiently as the KA4 and KB4 sbMOs, RT-PCR analysis was carried 
out (Figure 5.18), as described above in the previous section.  
From KA6 morphant cDNA samples, a lower (620bp) „morphant‟ band was 
obtained (blue asterisk, Figure 5.18A); which, after DNA sequencing, was shown to 
completely lack exon 6 (Figure 5.18B), as predicted. This causes a frame-shift in the 
mRNA and introduces an early stop codon, resulting in a truncation of anosmin-1a 
within the first fibronection type III domain (shown schematically in Figure 5.18D).  
A new set of primers were used for Kal1b PCR, as the primers used to 
confirm KB4 knockdown did not encompass exon 7 and would therefore not 
amplify the exon 6 region (or lack thereof). The new primer pair successfully 
amplified pat of Kal1b (an 858bp PCR product) as confirmed by DNA sequencing 
(data not shown). However, there were also two other PCR products amplified by 
this new primer set (marked by green crosses in Figure 5.18A) which could not be 
identified by sequencing, so are most probably non-specific (i.e. not Kal1b), and, as 
such, have been disregarded from this analysis.  
From KB6 morphant cDNA samples, a lower (728bp) „morphant‟ band was 
obtained (red asterisk, Figure 5.18A); which, after DNA sequencing, was shown to 
completely lack exon 6 (Figure 5.18B), which, similar to KA6 above, resulted in a 
fibronectin-domain truncated anosmin-1b (shown schematically in Figure 5.18E). 
However, there were also two other lower bands for the Kal1b PCR of the KB6 
morphant cDNA. The lower of the two was sequenced and shown to lack both exon 
5 and 6 (resulting in the loss of the whole of the first fibronectin domain, data not 
shown); however, the other band could not be sequenced. Because the „top‟ 
morphant band (marked by red asterisk) is the most prominent, it can be assumed 
that most of the anosmin-1b is fibronectin-domain-truncated, as shown in Figure 
5.18E. 
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Figure 5.18   Confirming knockdown of Kal1a and Kal1b by a second set of 
splice-blocking morpholinos: targeted loss of exon 6
A: An agarose gel depicting RT-PCR analysis of Kal1a and Kal1b transcript
from KA6 and KB6 morphant cDNA (as figure 5.08). A GAPDH control PCR
reaction („G‟ lanes) and a PCR reaction encompassing exon5-7 for Kal1a („A‟
lanes) or Kal1b („B‟ lanes) is shown for control (1), KA6* morphant (2),
KB6*morphant (3), or KA6+KB6 morphant cDNA samples.
B and C show the raw sequencing data from the bands in A marked by blue
and red asterisks, respectively: demonstrating that exon 6 is missing from Kal1a
(B) and Kal1b (C) morphants. D and E illustrate the expected FnIII-1-truncated
Kal1a (D) and Kal1b (E) proteins that result from loss of exon 6.
* Splice-blocking morpholinos targeted against exon 6 of Kal1a (KA6) and
Kal1b (KB6) were used at concentrations of 2.0mM and 1.0mM, respectively.
x
* *
Chapter 5: Results (III) 
 
266 
 
Confirmation of the olfactory, GnRH, and commissure phenotypes 
Using KA6 and KB6 to knock down Kal1a and Kal1b resulted in defects in 
the formation of the anterior commissure (Figure 5.19A, B), in olfactory 
axonogenesis (Figure 5.19C, E), and in GnRH3 neuronal system development 
(Figure 5.19D, F), which were analogous to those defects caused by KA4 and KB4 
described above. Further proof, therefore, that these defects are specific to the 
knocking down of Kal1a and Kal1b gene function in vivo. 
 
Specifically, KA6+KB6 morphants had fewer  axons crossing over at the 
AC, in association  with mis-projected axons across other regions of the midline, 
including some axons projecting towards the POC (n=43/51, 2 experiments, Figure 
5.19B-B‟‟). KB6 single morphants also had a noticeable reduction in the number of 
axons crossing the AC (n=29/37, 2 experiments, data not shown), but KA6 single 
morphants had apparently normal forebrain commissural phenotypes (n=38/39, 2 
experiments, data not shown). The KA6+KB6 double morphants also had a reduced 
number of olfactory axons projecting to the olfactory bulbs, and disrupted olfactory 
pits at 36hpf (n=17/22, 1 experiment, Figure 5.19E). Finally, the KA6+KB6 
morphants also had reduced or absent GnRH3 neuronal projections across the 
anterior commissure, as well as fewer G3MC neuronal cell bodies localised to the 
hypothalamus by 42hpf (n=15/20, 1 experiment, Figure 5.19E), compared with the 
control embryos. 
 
5.2.6  Testing the hypothesis that Kal1a and Kal1b act 
through the Fgf8a signalling pathway in vivo 
Loss of either Fgf8a or Kal1a+Kal1b gene function during zebrafish 
embryogenesis is sufficient to cause defective anterior commissure formation. 
Therefore, it can be assumed that all three genes are required for proper anterior 
commissural development, but it is unclear whether or not these gene products 
interact in this process, or whether they have separate independent roles (and 
signalling pathways). So, the question arises, does Kal1a and Kal1b act through the 
Fgf8a signalling pathway during anterior commissure formation?  
Chapter 5: Results (III) 
 
267 
 
C D
E F
A A’ A’’
B B’ B’’
36hpf
36hpf
36hpf
36hpf
42hpf
42hpf
CoMO
KA6+KB6 MO
Figure 5.19   KA6 and KB6 replicate the phenotypic aspects of KA4 and 
KB4 knockdown
Anti acetylated tubulin immuno-staining with DAB at 36hpf (A, B), OMPG at
36hpf(C, E), and G3MC at 42hpf (D, F) is shown for control (A, C, E) and
„KA6+KB6‟morphant (B, D, F) embryos. A and B are lateral views; A‟, B‟C-
F are ventral views; A‟‟ and B‟‟ are ventral-lateral views. C and E are confocal
images. D and F were visualised on a standard light microscope, with
fluorescence.
Scale bars are 50m (C, E) 100m (A, B, D, F).
TN= terminal nerve; hyp= hypothalamus.
KA6+KB6  MO
CoMO
TN TN
hyp
TN
TN
hyp
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           To investigate this, KA4+KB4 and Fgf8a MOs were titrated down to 
concentrations that brought about no discernible forebrain commissural 
abnormalities. The functional concentration (i.e. the concentration that causes AC 
formation defects in >80% of embryos) for KA4+KB4 was earlier determined to be 
1mM +1mM (n=39/43, 2 experiments, Figure 5.20B) and for Fgf8a MO was also 
found to be 1mM (n=38/46, 2 experiments, Figure 5.20C).  
So, to titrate these morpholinos down to non-functional concentrations (i.e. 
the concentration that results in mild AC formation defects in less than 20% of 
embryos), KA4+KB4 or Fgf8a MO concentrations of 0.25mM, 0.5mM, and 
0.75mM were tested, and AC formation was assessed in these putative partial 
morphants at 36hpf. For KA4+KB4 at 0.75mM, embryos still had reduced AC 
projections (n=12/21, 1 experiment, data not shown); but, at 0.5mM, most embryos 
had apparently normal AC projections (n=20/24, 1 experiment, Figure 5.20D); and 
at 0.25mM all embryos were apparently normal (n=18/18, 1 experiment, data not 
shown). Similarly, using Fgf8a MO at 0.75mM, many embryos still had AC defects 
(n=19/27, 1 experiment, data not shown), but this number was significantly reduced 
when using Fgf8a MO at 0.5mM, and most embryos showed normal AC formation 
(i.e. n=21/25, 1 experiment, Figure 5.20E). And, again at 0.25mM Fgf8a MO, all 
embryos had normal forebrain commissures (n=22/22, 1 experiment, data not 
shown). 
When, KA4+KB4 and Fgf8a MOs were co-injected at 0.25mM 
concentrations, there were no obvious defects in forebrain commissure formation 
(n=31/33, 2 experiments, data not shown)). However, when KA4+KB4 and Fgf8a 
MOs were co-injected at 0.5mM concentrations, many of the embryos had defects in 
AC formation (n=41/48, 2 experiments, and sometimes both AC and POC formation 
were defective (n=13/48, Figure 5.20F). This data would suggest that Kal1a and/or 
Kal1b are acting through the same signalling pathway as Fgf8a during forebrain 
commissure formation (see discussion). 
Finally, for completion, Kal1a and Kal1b were knocked down separately 
with Fgf8a (i.e. KA4+Fgf8a MO or KB4+Fgf8a MO; all at 0.5mM morpholino 
concentrations). Preliminary results showed that knocking down Kal1a and Fgf8a  
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Figure 5.20   Testing the hypothesis that Kal1a/Kal1b act through the 
Fgf8a signalling pathway in vivo
Anti acetylated tubulin immuno-staining with DAB at 36hpf for control (A,
A‟), „1mM KA4+KB4‟ (B, B‟), „1mM Fgf8a MO‟ (C, C‟), „0.5mM
KA4+KB4‟ (D, D‟), „0.5mM Fgf8a MO‟ (E, E‟), and „0.5mM KA4+KB4‟ +
„0.5mM Fgf8a MO‟ (F, F‟). Ventral views for A-F and lateral views for A‟-F‟.
Scale bars are 100m. (See Fig5.21 for a summary of these results.)
1mM  Fgf8a MO
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together had no noticeable effect on forebrain commissure formation (data not 
shown), whereas knocking down Kal1b with Fgf8a had a subtle effect on anterior 
commissure formation in a few embryos i.e. 3/18 embryos had slightly fewer 
crossings over at the midline. So, in conclusion, knocking down Kal1a and Kal1b 
together with Fgf8a (all at 0.5mM morpholino concentrations) was required for the 
more severe, fully penetrant, failure of AC (and POC) formation. 
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5.3  Discussion 
5.3.1  Anosmin-1a and anosmin-1b are both expressed in 
the olfactory epithelium region during early embryogenesis 
There is a noticeable disparity between the spatio-temporal expression 
patterns seen for the Kal1a/Kal1b in situ hybridisation analyses, compared with the 
anosmin-1a/ anosmin-1b immuno-labelling studies. At 24hpf through to 60hpf, 
Kal1a and Kal1b transcripts were detected widely across the midbrain/hindbrain 
regions, whilst only Kal1b was detected in the olfactory placodal region. In contrast, 
the expression of their protein products, anosmin-1a and anosmin-1b, were both 
restricted to the olfactory epithelium during these stages, with no other brain-
specific expression detectable, except in the presumptive pituitary (see section 
5.3.2). However, consistently, Kal1a and Kal1b transcript were both detected in the 
PLLP and otic vesicle, two regions where their protein products were also detected 
by immuno-labelling.    
Previous in situ hybridisation analyses carried out by Ardouin et al showed 
that Kal1a transcript is detected in the olfactory pits by 37hpf (Ardouin et al., 2000), 
but in the current analysis, Kal1a transcript could not be detected in this region. In 
fact, it was Kal1b that was detected in the olfactory pit region, in this study, at 
around 24hpf; whereas, previously it had been shown to localise to the olfactory 
bulb region from around 48hpf. However, this previous study, and our current study, 
both showed significant staining throughout several midbrain and hindbrain regions 
during these stages, suggesting that Kal1a/Kal1b in situ expression is largely 
reproducible.  
The anti-anosmin-1a and anti-anosmin-1b that were used in this study were 
two rabbit polyclonal antibodies raised against the N-terminal residues 151 to 197 of 
anosmin-1a (Genbank AF163310) and the N-terminal residues 51 to 102 of 
anosmin-1b (Genbank AF163311), respectively. Moreover, their specificity for 
either anosmin-1a or anosmin-1b only was previously confirmed by Western blot 
analysis (Yanicostas et al., 2008; Yanicostas et al., 2009). It can therefore be 
assumed that these antibodies are highly specific for their respective proteins, and 
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that the immuno-labelling analysis faithfully portrays the expression of anosmin-1a 
and anosmin-1b during development.  
Whilst there are notable differences in our in situ analysis, in terms of which 
of the two KAL1 orthologues are expressed in the olfactory epithelium (compared to 
a previous report), it is clear that the midbrain/hindbrain staining reported by both 
studies cannot be recapitulated by immuno-labelling analysis. This could simply be 
because the Kal1a/Kal1b transcript is not translated into protein in the 
midbrain/hindbrain; and that they are expressed in the olfactory epithelium region, 
at low levels or for short periods of time, such that they are not always detectable by 
in situ hybridisation analysis. 
Significantly, both anosmin-1a and anosmin-1b are expressed in the pioneer 
olfactory axons as they first begin to establish the olfactory axonal pathway to the 
presumptive olfactory bulb region from around 24hpf. By 48hpf, they both continue 
to be expressed in the secondary ORN axons, which, by this stage, have replaced the 
earlier pioneer axons, suggesting that anosmin-1a and anosmin-1b may have a 
continued role in olfactory axonogenesis throughout early zebrafish development. 
Interestingly, at 60hpf, Kal1a and Kal1b transcripts are clearly detected in 
the region of the anterior commissure and terminal nerve projections, and may be 
expressed in this region much earlier than this, but their expression in this region is 
obscured by broad midbrain/diencephalon labelling. In fact, in the immuno-labelling 
analysis, anosmin-1a and anosmin-1b can both clearly be seen expressed along the 
anterior commissure between 36hpf and 60hpf (Figure 5.03C-H), and even as early 
as 30hpf (data not shown). Whilst not proof that Kal1a and Kal1b were involved in 
the formation of the anterior commissure, this data suggested that they could have 
such a role, similar to two of the other KS gene orthologues, Fgf8 and Fgfr1, which 
were discussed in the previous chapter. 
The in situ analysis also showed expression of Kal1b in the region of the 
terminal nerve GnRH cells, medial to the olfactory pits, at 24hpf. It would need to 
be confirmed by double in situ hybridisation analysis with GnRH3 probes that this 
expression was actually in the same GnRH cells in this region. However, analysis of 
a single confocal „z-layer‟ through the olfactory pit region of anosmin-1a/-1b 
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immuno-labelled embryos reveals that both anosmin-1a and anosmin-1b are both 
expressed in a „broad‟ olfactory pit region which also encompasses the terminal 
nerve GnRH3 cells (appendix, Figure A2). This suggests that anosmin-1a and 
anosmin-1b could also be involved in the development of the terminal nerve GnRH 
system; and subsequent hypothalamic GnRH neuronal migration that putatively 
depends on the correct development of the terminal nerve GnRH system and its 
associated axonal projections. 
 
5.3.2  Anosmin-1b is highly expressed in the presumptive 
pituitary during early embryogenesis 
Anosmin-1b was highly expressed in the presumptive pituitary between 
36hpf and 60hf, whereas anosmin-1a was apparently absent from this region during 
these times points. However, because the „background‟ (non-specific) labelling of 
the anti-anosmin-1a antibody was higher than anti-anosmin-1b, it may simply be the 
case that anosmin-1a was expressed in the pituitary too, but perhaps at a lower level, 
which was „masked‟ by the high „background‟ labelling. Further analysis would 
need to be carried to confirm that this structure labelled by anti-anosmin-1b was 
definitely the pituitary, perhaps by using a pituitary-specific marker, such as POMC 
(proopiomelanocortin) transgenic reporter line (Liu et al., 2003). However, its 
spatial localisation within that area of the brain, as well as its overall morphology, 
would certainly suggest that this is the pituitary. 
Anti-anosmin-1b immuno-labelling was carried out on G3MC embryos, in 
order to visualise the „early wave‟ hypothalamic GnRH3 neurons in relation to the 
pituitary, at 48hpf. After confocal imaging was carried out on a representative 
embryo, 3D rendering image analysis was then performed. This demonstrated that 
the presumptive pituitary was located caudal to the hypothalamic GnRH3 (mCherry-
positive) cells at 48hpf, and that the pituitary cells closely abutted these GnRH3 
cells. No evidence of neurite interactions between the hypothalamic GnRH3 cells 
and the putative gonadotrophs was detectable; however, this is not surprising, given 
the close proximately of the two cell types, and the technical difficulties in 
visualising such an interaction. In fact, specific synapse markers would be required 
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to identify specific synapse formation in this region, in early embryos. Moreover, if 
such synapses were identified at this stage, or some later stage, it would then need to 
be confirmed that they were actually „functional‟ (hypophysiotropic) interactions 
between GnRH-secreting cells and pituitary gonadotrophs, perhaps by upregulation 
of specific GnRH receptor genes in those target gonadotrophs, or GnRH secretion at 
the synaptic junction from the GnRH axon terminals. 
However, it remains to be established what the role of anosmin-1b is in the 
pituitary at these stages, and how this may reflect upon the role of its related 
orthologues in the pituitary of other vertebrates, such as humans. Whilst a functional 
role for anosmin-1b cannot be assumed simply from its pituitary expression, it is 
tempting to speculate on some of the possibilities. For example, anosmin-1b may be 
required as a chemoattractant cue for GnRH3 cell migration to the hypothalamus in 
zebrafish, or perhaps as a cell survival or GnRH cell differentiation factor once they 
arrive at the hypothalamus. Or, anosmin-1b activity at the pituitary may be required 
for proper synapse formation between hypothalamic GnRH cells and the pituitary 
gonadotrophs; or perhaps may be required to keep such synapses functional. 
Moreover, because pituitary expression appears to be restricted to anosmin-1b only 
(not anosmin-1a), these putative roles would seem to be a sub-function of this 
particular orthologue only. 
 
5.3.3  Translation-blocking morpholinos 
against Kal1a & Kal1b show incomplete 
knockdown, resulting in only subtle olfactory/ 
commissural defects 
Incomplete knockdown 
So far, according to the scientific literature, only translation-blocking 
morpholinos have been used to knockdown Kal1a and Kal1b in zebrafish. However, 
whilst the same Kal1b tbMOs („B-MOs‟) have been used in this project, our Kal1a 
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tbMO („A-MO‟) target sequences have differed (see Figure 5.05B). So, whilst all 
three A-MOs target the same „ATG‟ translational start site of Kal1a, the A-MO used 
by one group has 14 upstream target nucleotides (Whitlock et al., 2005b), whereas 
that used by another group has only 6 (Yanicostas et al., 2008; Yanicostas et al., 
2009), and the A-MO used in this project had 10.  
The tbMOs used in this thesis, were acquired prior to any of these other 
research papers being published, so it was not possible to use the same A-MO from 
the start. However, since the publication of the first Kal1a/Kal1b knockdown 
several years ago by Whitlock and colleagues, we have ordered, and tested, the 
same A-MO that was reported in their publication (Whitlock et al., 2005b). 
However, in our hands, we were unable to obtain levels of knockdown that were any 
higher than our existing A-MO, as assessed by Western immuno-blot analysis (data 
not shown). The A-MO used by Soussi-Yanicostas and colleagues was published 
more recently (Yanicostas et al., 2008; Yanicostas et al., 2009), and has therefore 
not been independently tested by us. 
The knockdown efficiencies for our A-MO and B-MO were assessed 
qualitatively by immunoblot analysis, and both of these morpholinos were found to 
have an approximately 50-75% knockdown at 1.5mM, with A-MO having the 
slightly higher knockdown efficiency. These approximate knockdown efficiencies 
were based upon analysis of pooled lysates from ten embryos, and were assessed 
visually, based on the relative intensity of the „knockdown band‟ compared with the 
„control band‟. Of course, using pooled lysates meant that the knockdown level 
visualised is indicative of an „average knockdown‟, so, in fact, some embryos may 
have had higher/lower levels of knockdown than this average. However, as this 
analysis was carried out on several pooled lysates (data not shown), this „average 
knockdown‟ was found to be representative of the tbMO morphants‟ knockdown 
efficiencies.  
Immunoblotting on single embryos was not permissible because the anti-
anosmin-1a/-1b signal from this analysis was too weak. Also, densitometry analysis 
of the band intensities would have given far greater accuracy in the relative 
comparisons; however, the more important outcome of this analysis was to show 
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that the tbMOs did not give close to 100% knockdown i.e. ~25% of the anosmin-
1a/-1b protein expression was unaffected in the „average‟ tbMO morphant embryo. 
Therefore, an alternative knockdown approach would need to be considered, to 
achieve higher levels of knockdown (see section 5.3.5). 
In contrast, Soussi-Yanicostas and colleagues did manage to demonstrate 
approximately 100% knockdown of Kal1a and Kal1b, using tbMOs at 
concentrations of 0.5mM (Ayari and Soussi-Yanicostas, 2007; Yanicostas et al., 
2008; Yanicostas et al., 2009). However, as mentioned, using the same B-MO, and 
their same anti-anosmin-1b antibody, we were unable to reproduce such high levels 
of knockdown. Perhaps this was due to the different strain of zebrafish they were 
using (“AB strain”), which may have a different genetic background to the strain 
that we used, which may have influenced the knockdown efficiency. 
 
GnRH3 neuronal phenotype apparently normal 
The GnRH neuronal defects reported by K. Whitlock and colleagues, in 
Kal1a morphants, could not be verified in this study because when GnRH immuno-
labelling was carried out earlier in this thesis (see chapter 3) in the same way that 
had been described (Whitlock et al., 2005b), hypothalamic GnRH cells were not 
detectable at 56hpf (see Fig.3.04). Therefore, as the pGnRH3:mCherry (G3MC) 
transgenic line labels the same terminal nerve GnRH cells as the GnRH antibody 
(LRH13), as well as am „early wave‟ hypothalamic GnRH cluster by around 36hpf, 
the G3MC line was used instead to assess the GnRH3 neuronal phenotype in this 
project.  
The A-MO+B-MO double morphant embryos had an apparently normal 
G3MC phenotype at 36hpf, and only at 60hpf were there some subtle differences 
noticeable in these double morphants (whereas the A-MO and B-MO single 
morphants remained normal throughout). Specifically, there was no difference in the 
hypothalamic cluster of cells, with just a slight reduction in GnRH3 (mCherry) 
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expression) in these cells by 60hpf. Therefore, knockdown of 50-75% Kal1/Kal1b 
was not sufficient to give any observable GnRH3 neuronal defects. 
 
Subtle defects in olfactory axonogenesis and forebrain commissure 
formation 
Despite the lack of a GnRH3 neuronal phenotype in the partial knockdown 
Kal1a/Kal1b (tbMO) double morphants, subtle olfactory defects and forebrain 
commissure defects were noticeable. Specifically, the A-MO+B-MO embryos, 
despite apparently projecting normally to the anterior forebrain, were less 
defasciculated at the olfactory bulbs, which inevitably resulted in a more disordered 
pattern of potential glomeruli in this region. Moreover, there was less decussation 
(crossing over) at the midline in the AC (but not POC) by 36hpf. Together, this 
indicates that a combined 50-75% reduction in Kal1a and Kal1b gene function was 
sufficient to bring about mild-moderate defects in olfactory and AC formation, but 
did not noticeably affect GnRH system formation. Therefore, another approach was 
required in an endeavour to obtain closer to 100% Kal1a/Kal1b knockdown in order 
to assess the affects of a „true null‟ morphant (although, it‟s probably more 
reasonable to expect a  >95% knockdown, rather than a true „knock-out‟). 
 
5.3.4  Kal1a/ Kal1b over-expression causes no observable 
defects in olfactory, GnRH, or forebrain commissure 
phenotype  
The known role of anosmin-1 in modulating Fgf signalling (at least in ex 
vivo culture), and because the Fgf signalling pathway is required extensively during 
embryogenesis, severe morphological abnormalities are expected to result from 
anosmin-1 over-expression. In fact, previous experiments in the nematode worm C. 
elegans have indeed demonstrated that anosmin-1 over-expression does cause an 
axonal branching phenotype in AIY interneurons, which receive synaptic input from 
olfactory neurons in this organism (Bulow et al., 2002; Bulow and Hobert, 2004). 
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Therefore, over-expression of anosmin-1 in other organisms such as the zebrafish 
may also be expected to induce axonal branching defects (or similar phenotypes); 
however, this was not the case. 
At higher concentrations (i.e. 2.0μM) of Kal1a and Kal1b mRNA, there was 
a very significant elevation in embryonic death by 24hpf. However, it is not possible 
to say for sure whether or not this was a non-specific effect of injecting too much 
exogenous mRNA, or whether it was a specific result of Kal1a/Kal1b interfering 
with Fgf signalling at critical events during embryogenesis (e.g. gastrulation). When 
GFP mRNA was injected at a concentration of 2.0μM the embryo lethality was low, 
but many embryos had shortened trunks, indicative of the non-specific effects 
caused by excessive mRNA. Therefore, it is highly likely that the lethality caused by 
2.0μM of Kal1a and Kal1b mRNA was also non-specific. 
0.5-1.0μM was the most appropriate concentration for Kal1a or Kal1b 
mRNA, due to the much lower embryo lethality. However, no neuronal defects were 
detectable in those systems which were assessed (olfactory, GnRH, and forebrain 
commissures). Similarly, over-expression of Kal1a and Kal1b together, at 
concentrations of 0.5μM, did not affect the formation of these forebrain systems 
either. This may suggest that zebrafish are more resistant to the effects of 
Kal1a/Kal1b over-expression than C. elegans, perhaps because zebrafish have 
mechanisms to counter-act the putative imbalance in Fgf signalling, brought about 
by the increased presence of Kal1a/Kal1b; perhaps by upregulating other Fgf 
modulators which restore Fgf signalling to normal, functioning levels. Similarly, in 
humans, KAL1 partially escapes X-inactivation in females, effectively meaning that 
they may have double the KAL1 expression levels compared to males (Dode et al., 
2003; Cadman et al., 2007). Therefore, it is likely that some mechanism may happen 
during human embryogenesis to ensure that inappropriately high Fgf signalling 
levels do not occur in regions where ansomin-1 is expressed (i.e. during 
olfactory/GnRH neuronal development).  It will be useful to investigate which 
modulators, if any, are up- or down-regulated in response to Kal1a/Kal1b over-
expression in order to maintain fully-functional levels of Fgf signalling during 
olfactory and GnRH neuronal development.  
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Moreover, whilst GnRH/olfactory neuronal development was apparently 
normal in those embryos where Kal1a/Kal1b was over-expressed, it can not be ruled 
out that development of these systems may have been initiated prematurely i.e. 
olfactory axonogenesis, for example, may have begun earlier than usual. Whilst this 
may have resulted in „apparently normal‟ olfactory projections, these axons may 
have reached the anterior forebrain too prematurely for normal olfactory bulb 
morphogenesis to proceed correctly. Therefore, functional defects in the olfactory 
and GnRH systems may exist in the Kal1a/Kal1b mRNA-injected embryos, and the 
only way to prove this may be to carry out functional/behavioural studies in adults, 
to assess reproductive and olfactory capabilities.  
 
5.3.5  Using exon-4 targeted splice-blocking morpholinos 
against Kal1a & Kal1b resulted in very efficient knockdown  
KA4 and KB4, the splice-blocking morpholinos which targeted the loss of 
exon 4 from Kal1a and Kal1b, respectively, gave significantly higher levels of 
Kal1a/Kal1b knockdown, compared with the translation-blocking morpholinos 
described above (A-MO and B-MO). Moreover, upon sequencing of the Kal1a and 
Kal1b morphant bands, it was determined that the whole of exon 4 was lost, as 
predicted, resulting in severely truncated translated protein-product, which part of 
the WAP domain and all fibronectin domains. This WAP-truncated anosmin-
1a/anosmin-1b are very unlikely to retain any of the native functions of the full-
length proteins. It is possible that the remaining Cys-box may have some residual 
signalling capability in some contexts. But, even if this is true, it is unlikely that the 
truncated anosmin-1a/anosmin-1b would have a very long half-life (i.e. in all 
likelihood, these truncated proteins will be targeted for degradation soon after 
translation). 
When the knockdown levels were assessed by RT-PCR across eight 
individual KA4 or KB4 morphant embryos, it was determined that in approximately 
three quarters of the embryos, an almost complete knockdown of Kal1a or Kal1b 
was achieved, whilst in the remaining morphants, a knockdown of around 75% was 
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achieved. This of course means that in approximately 75% of the KA4 or KB4 
morphants there is an almost complete functional loss of Kal1a or Kal1b activity. 
However, it is unlikely that there is an actual 100% loss in Kal1a/Kal1b in the 
morphant embryos, due to the mechanism of gene knockdown by morpholinos i.e. it 
is unlikely that the morpholino can bind to and block correct exon 4 splicing in 
every single Kal1a/Kal1b transcript. Moreover, the RT-PCR analysis will not reveal 
residual transcripts if the full to levels below around 95% because this will be 
beyond the detection limits of the agarose gel electrophoresis analysis. However, it 
can be concluded that Kal1a/Kal1b knockdown was as high as could be measured in 
the majority of KA4/KB4 morphants, and Kal1a/kal1b activity has effectively been 
abrogated in these embryos. Currently, the best way to achieve a targeted absolute 
knock-out of gene function in zebrafish embryos, which has longer-lasting effects, is 
to use customised zinc finger nucleases (ZFNs) which permit efficient genome 
modification in zebrafish (Foley et al., 2009). 
Disrupted terminal nerve GnRH cells, concomitant with a decrease in 
hypothalamic GnRH cell number by 36hpf 
Knocking down Kal1a or Kal1b individually did not result in noticeable 
defects in GnRH3 neuronal development, compared with the controls; whereas, 
knocking down Kal1a and Kal1b together did. However, the KA4+KB4 morphant 
phenotype was very variable: approximately 32% of embryos hypothalamic GnRH 
neurons which were within the normal range of „early wave‟ hypothalamic cell 
number at 36hpf, but were often disorganised in their spatial arrangement; whilst 
another 38% of embryos had approximately 50% or fewer of the „average‟ number 
of hypothalamic cells at this stage; 17% of the embryos had apparently completely 
absent hypothalamic GnRH cells; whilst the remaining embryos had normal-
appearing GnRH3 neuronal phenotypes. Co-injection of Kal1a/Kal1b mRNA with 
the morpholinos „rescued‟ much of the abnormalities that were caused by KA4 and 
KB4; that is, the majority of these embryos did not have disorganised hypothalamic 
GnRH clusters at 36hpf. This confirms that these defects were specifically caused 
by Kal1a/Kal1b knockdown, because the co-injected Kal1a/Kal1b mRNA was able 
to provide a substitute source of Kal1a/Kal1b protein, when the native Kal1a/Kal1b 
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transcripts were made non-functional by KA4 and KB4. Because the Kal1a/Kal1b 
mRNA was able to do this, the defects caused by KA4 and KB4 must have been 
caused predominantly by loss of Kal1a/Kal1b. However, whilst none of the rescue 
embryos had absent hypothalamic GnRH neurons, a minority of them did have 50% 
or fewer hypothalamic GnRH neurons, suggesting that the injected Kal1a/Kal1b 
mRNA levels were not sufficiently high enough to completely rescue loss of native 
Kal1a/Kal1b transcript in all embryos. 
By 60hpf, the KA4+KB4 morphant phenotype was less variable: around 
60% of the embryos had an organised cluster of hypothalamic GnRH neurons of a 
cell number comparable to the average cell number observed in the control 
embryos; whilst the remaining 40% of embryos had approximately 50-75% of the 
average hypothalamic cell number, which were organised closely together in the 
hypothalamic region, as normal. Combined, this data suggests that Kal1a and Kal1b 
are both required for the correct positioning of the „early wave‟ hypothalamic GnRH 
cells neurons by 36hpf; however, these cells may still be able to reach the 
hypothalamus by 60hpf, if they fail to get there earlier. It is however, unclear 
whether the early failure in accumulation of GnRH3 cells in the hypothalamus by 
36hpf represents a failure in GnRH neuronal migration (from the nasal 
compartment) or a failure in the specification of these neurons in the hypothalamus 
(or nasal compartment); or indeed, whether it is a combination of a failure in both 
processes. Furthermore, there may be a much more significant disruption in the 
organisation of the brain regions, or their boundaries, as both Kal1a and Kal1b are 
expressed throughout the diencephalon during early zebrafish embryogenesis and 
may have an important role in diencephalon morphogenesis. Moreover, if the loss of 
hypothalamic GnRH cells is caused by a migrational defect in these cells, this may 
be caused by a failure in forebrain commissure formation and its associated tracts, 
which are believed to form part of the axonal scaffold that GnRH neurons use to 
migrate into the forebrain. Alternatively, if Kal1a/Kal1b are required for GnRH 
neuronal specification in the nasal compartment, Kal1a/Kal1b may be acting via the 
Fgf8a signalling pathway in this region; suggesting that the loss of hypothalamic 
GnRH cells may be associated with an increase in apoptosis in this region, resulting 
from a reduction in Fgf8a signalling levels (see conclusion for further discussion). 
Chapter 5: Results (III) 
 
282 
 
The terminal nerve neurons were also noticeably disrupted in approximately 
half of the KA4+KB4 morphant embryos by 60hpf; and there was a noticeable 
failure in terminal nerve GnRH neuronal projections across the AC in around 81% 
of these morphants too. As mentioned above, the axonal scaffold formed by the 
terminal nerve GnRH cells is believed to have a putative role in the migration of the 
hypothalamic GnRH neurons, so the disruption of the AC projections may affect 
this process. Furthermore, it has been proposed that the hypothalamic GnRH 
neurons may arise from the terminal nerve GnRH neuronal population, as embryos 
which had their terminal nerve GnRH cells ablated had a missing hypothalamic 
GnRH neuronal population in adulthood (Abraham et al., 2010); indicating that the 
disruption of the terminal nerve GnRH cells may affect the „later wave‟ 
hypothalamic GnRH neuronal migration, even if it does not significantly affect the 
„early wave‟ hypothalamic GnRH cells. Moreover, the terminal nerve GnRH 
neuronal system has been shown to have an important role in the neuromodulation 
of reproductive behaviour, so a loss of the terminal nerve GnRH  system, and its 
likely interactions with the olfactory/vomeronasal systems, may significantly alter 
the reproductive activity of the KA4+KB4 morphants. Finally, a disruption of the 
terminal GnRH cells may also be secondary to a disruption in the organisation 
and/or specification of cells in the nasal compartment (see below).  
As already discussed in Chapter 3, at 56hpf, Whitlock and colleagues were 
able to immuno-label a migrating population of „endocrine‟ GnRH-expressing cells 
that were migrating from the nasal compartment region towards the presumptive 
preoptic area/hypothalamic region. Moreover, when they knocked down Kal1a gene 
function (using tbMOs; see Figure 5.05B), these „migrating‟ hypothalamic GnRH 
cells were completely lost; whereas the terminal nerve GnRH immuno-positive cells 
in these embryos were still present, although mildly disrupted (Whitlock et al., 
2005b). In contrast, the „migrating‟ hypothalamic GnRH immuno-positive cells 
were only mildly affected (data not shown) in the Kal1b morphants. Even though 
the same antibody (LRH13) and same protocol was used, it was not possible for us 
to detect the same „migrating‟ population of hypothalamic GnRH immuno-positive 
cells at 56hpf (see Figure 3.04B‟); instead, only the terminal nerve GnRH cells were 
detectable. Whilst the „early wave‟ hypothalamic GnRH cells (from the G3MC 
transgenic line) were detected during a similar stage (i.e. between 30-60hpf), they 
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do not seem to occupy the same brain location as the migrating GnRH cells detected 
by Whitlock and colleagues i.e. the „early wave‟ G3MC cells already reside in the 
hypothalamus by 36hpf. However, it is possible that the hypothalamic GnRH 
neurons switch off GnRH gene expression once they reach the hypothalamus, 
whereas the mCherry (G3MC) expression is switched on only when these cells 
reach the hypothalamus. This may explain these conflicting observations; although 
it does not explain why we weren‟t able to detect the „migrating‟ hypothalamic 
GnRH immuno-positive cells- although this may be an experimental/technical issue 
(as discussed in chapter 3). 
In our analysis it was necessary to knock down both Kal1a and Kal1b gene 
function to obtain the GnRH3 neuronal defects described above; conversely, it was 
necessary to only knockdown one of these genes, Kal1a, for Whitlock and 
colleagues to observe a comparative loss in hypothalamic „endocrine‟ GnRH 
neurons (Whitlock et al., 2005b). Firstly, it should be noted that the G3MC 
hypothalamic GnRH cells are yet to be fully confirmed as bona fide 
„endocrine‟/hypophysiotropic GnRH cells, so some caution is needed when 
referring to these cells. Similarly, the migrating hypothalamic GnRH cells reported 
by Whitlock and colleagues, whilst GnRH immuno-positive, are yet to be identified 
independently by us, and, in our opinion, are yet to be fully characterised and 
confirmed as hypophysiotropic GnRH cells. Significantly, these „migrating‟ 
hypothalamic GnRH immuno-positive cells are not detected by GnRH3 or GnRH2 
in situ analysis (Palevitch et al., 2007), and are not observed in the same brain 
region in the G3MC transgenic line, or the characterisation of the similar 
pGnRH3:EGFP transgenic line reported by Abraham and colleagues (Abraham et 
al., 2008). In summary, assuming that we and K.Whitlock and colleagues are 
observing the bona fide „endocrine‟/hypophysiotropic hypothalamic GnRH cells at 
between 30-60hpf, it can be concluded that Kal1a and Kal1b both have a role in the 
accumulation of hypothalamic GnRH neurons by 60hpf. 
The development of the proposed second wave of GnRH neuronal migration 
to the hypothalamus (termed the „later wave‟ in chapter 3), was not assessed in the 
KA4+KB4 morphants, but remains an important future goal of this project. 
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Olfactory and vomeronasal projections are missing or mis-projected 
In their report describing the loss of „endocrine‟ GnRH cells in Kal1a 
morphants, Whitlock and colleagues also observed that the disruption terminal nerve 
GnRH cells seen in these embryos were probably due to a disrupted adjacent 
olfactory epithelium. Using similar tbMOs against Kal1a and Kal1b (see Figure 
5.05B), Yanicostas and colleagues (Yanicostas et al., 2009) recently reported that 
Kal1a, but not Kal1b, is required for the proper fasciculation of olfactory axons and 
their terminal targeting at the olfactory bulbs; using the same pOMP:tauEGFP 
transgenic line (Yoshida et al., 2002) that was used in this thesis. However, before 
the publication of this report, our analyses demonstrated that both Kal1a and Kal1b 
were required for normal olfactory axonogenesis in zebrafish embryos.  
The KA4 and KB4 single morphants both had olfactory axonal defects; 
however, the most severe olfactory defects were observed in the KA4+KB4 double 
morphants. Specifically, some KA4 morphants had some abnormal defasciculation 
of the olfactory nerve bundle projecting to the presumptive olfactory bulb region, by 
36hpf. This is a similar defect to what was reported recently by Yanicostas and 
colleagues (Yanicostas et al., 2009); however, in our experience, this phenotype was 
present in only a few of the Kal1a morphants. Moreover, they also reported a failure 
of terminal targeting of the olfactory axons to the olfactory bulbs; however, whilst 
we also observed this defect, we found that this happened in the Kal1b morphants 
instead, but only in a proportion of the embryos. The most severe, fully penetrant, 
phenotypes were observed in the KA4+KB4 double morphants. Around one third of 
these embryos had disrupted olfactory pits, often with eptopic olfactory cells outside 
of the normal „rosette‟ arrangement of the olfactory epithelium, suggesting an 
abnormal specification of the olfactory epithelial cells within the nasal 
compartment, similar to the Fgf8a morphants. Moreover, in approximately 51% of 
these KA4+KB4 morphants, there was a failure of the olfactory axons to properly 
fasciculate into an olfactory axonal bundle, whilst in around 21% of these embryos 
there was a failure to form a recognisable olfactory nerve bundle at all. Moreover, in 
around 83% of these morphants, there was a failure of terminal axonal targeting i.e. 
the olfactory axons failed to defasciculate properly at the presumptive olfactory bulb 
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region; a defect that is likely to cause a failure in subsequent olfactory bulb 
morphogenesis.  
The 36hpf rescue embryos (KA4+KB4 morphants co-injected with 
Kal1a/Kal1b mRNA) mostly had a normal-appearing, apparently tightly-
fasciculated, olfactory bundle. However, whilst there was much improvement in 
terminal olfactory targeting in the rescue embryos, approximately half of the 
embryos still had some defects in defasciculation at the presumptive olfactory bulbs, 
but this was more subtle compared with the morphants. Although the rescue was not 
complete, there was nonetheless a rescue to some significant extent, suggesting that 
the olfactory defects observed are likely to be specific consequences of loss of 
Kal1a/Kal1b. 
Furthermore, there was an approximately 24% reduction in the average 
olfactory epithelium size (A-P length) at 36hpf for the KA4+KB4 morphants, 
compared with the controls. Whereas the reduction in average A-P length for the 
Kal1a and Kal1b individual morphants was only 0.3% and 5.2%, respectively. 
There was still a reduction in the average A-P length for the rescue embryos (4.8%), 
but it was a much smaller reduction compared with the KA4+KB4 morphants 
without the rescue Kal1a/Kal1b mRNA co-injection, suggesting that the reduction 
in olfactory pit size was specifically caused by loss of Kal1a/Kal1b activity. This is 
very similar to the 20.3% average olfactory epithelium size that was reported for the 
Fgf8a morphant embryos (or 26.4% for the Fgf8a+Fgf8b morphants). This, together 
with observations that KA4+KB4 morphants also had disorganised olfactory pits 
and failure in terminal targeting of olfactory axons, as well as defects in GnRH 
neuronal development (see above) and forebrain commissure formation (see below), 
suggested that Kal1a/Kal1b could be involved in the Fgf8a signalling pathway 
during these processes (see sections 5.37 and 5.4). 
The presence of defects in olfactory axonogenesis by 36hpf, suggest that 
Kal1a and Kal1b are required for the establishment of the pioneer olfactory 
pathway; however, the secondary olfactory axons which replace these pioneer axons 
by 60hpf are also affected. Both Kal1a and Kal1b are expressed in the olfactory 
epithelium between 24hpf and 60hpf during pioneer and secondary olfactory 
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axonogenesis so may have a role in establishing both pathways.  By 60hpf, despite a 
persistence of the olfactory pit disorganisation phenotype, the olfactory axons had 
projected to the presumptive olfactory bulbs in the majority of the KA4+KB4 
morphants; although in approximately 17% of these embryos, there was a severe 
disruption in the olfactory pit formation and axonal pathfinding, with many 
olfactory axons meandering away from the presumptive olfactory bulbs. In contrast, 
the majority of the rescue embryos had normal-appearing olfactory pit „rosettes‟ 
with apparently normal olfactory projections; although some embryos still had 
displaced olfactory cells. Together, this data suggests that Kal1a and Kal1b have a 
more important role in establishing the pioneer olfactory pathway, and if enough 
pioneer axons (above a certain threshold) can establish the pioneer olfactory 
pathway by 36hpf, the proceeding secondary ORNs may establish a normal-
appearing secondary olfactory axonal pathway (although this may be too late for 
normal olfactory bulb morphogenesis; see conclusions) by 60hpf. Conversely, if 
insufficient pioneer olfactory axons have established the pioneer pathway, the 
proceeding secondary (ORN) olfactory axons are denied their precisely-guided 
navigational pathway to the presumptive olfactory bulb region, so instead meander 
in abnormal directions, as occurs in around 17% of the KA4+KB4 morphants by 
60hpf. Similarly, it was demonstrated in the Cxcr4b („odysseus‟) mutant, which, that 
if pathfinding by pioneer axons is significantly impaired by 36hpf, the following 
ORNs fail to exit the olfactory placode, and were found to accumulate instead 
around the olfactory epithelium by 72hpf (Miyasaka et al., 2007). 
Despite the high levels in natural variance with the vomeronasal neuronal 
phenotype at 36hpf and 60hpf, it was possible to detect some defects in a minority 
of the KA4+KB4 morphants. Specifically there were absent or mis-projected 
vomeronasal axonal projections, which were not seen in the controls or the majority 
of rescue embryos, as well as a 49% reduction in the vomeronasal cell number for 
the KA4+KB4 morphants at 36hpf, compared to only a 13% reduction in the rescue 
embryos. In fact, it is likely that the absence in vomeronasal projections in some 
KA4+KB4 morphant embryos is due to the reduction in vomeronasal cell number in 
the olfactory pits of these embryos. Whilst the vomeronasal phenotypes were not 
investigated in the fgf8a morphants, this phenotype was assessed in the SU5402-
treated embryos, and similar axonal projection defects and vomeronasal neuronal 
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loss was observed in those embryos that had their Fgf signalling blocked between 
14hhpf and 22hpf. This suggests that Kal1a and Kal1b may be exerting their action 
on the Fgf signalling pathway during zebrafish vomeronasal development. 
By 60hpf, vomeronasal axons were missing or mis-projected in around half 
of the KA4+KB4 morphants; a phenotype that was present, but to a lesser extent in 
fewer rescue embryos. The incomplete rescue suggests that these vomeronasal 
defects may not be entirely specific to Kal1a/Kal1b knockdown, but may instead 
reflect the difficulty in accurately assessing „normal‟ vomeronasal axonogenesis at 
60hpf. Nonetheless, the vomeronasal axonal defects were noticeably much more 
severe in the KA4+KB4 morphants, compared with controls and rescue embryos.  
In mice, GnRH neurons are observed closely migrating with vomeronasal 
axons towards the forebrain. However, unlike mice which have a separate 
vomeronasal organ and accessory bulb for their vomeronasal projections, zebrafish 
vomeronasal neurons arise from the olfactory epithelium, along with the olfactory 
neurons, and navigate to a similar olfactory bulb target region in the forebrain. It 
remains to be demonstrated whether vomeronasal axons are important for putative 
GnRH neuronal migration from the nasal compartment in zebrafish, but such a 
mechanism is possible; so, disruption of these vomeronasal (and olfactory) axons 
may affect GnRH neuronal migration in the zebrafish too. 
So, in summary, although knockdown of Kal1a or Kal1b alone resulted in 
mild to moderate olfactory axonal defects in some embryos; knocking down both 
Kal1a and Kal1b together resulted in much more severe defects in olfactory 
epithelium organisation and axon pathfinding, in a greater proportion of morphant 
embryos. Similarly, vomeronasal axonogenesis was apparently only affected in the 
KA4+KB4 morphants. This would suggest that there is some redundancy in the 
action of Kal1a and Kal1b during olfactory/vomeronasal (and GnRH) neuronal 
development.  
However, the conflicting findings from two other research groups suggesting 
that Kal1a alone has a crucial role during olfactory axonogenesis and hypothalamic 
GnRH neuronal migration may be unified with our findings by better understanding 
the different morpholinos strategies used. Firstly, morpholino knockdown is very 
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unlikely to give a 100% knockdown of gene function, despite immunoblotting or 
RT-PCR analyses indicating that all protein or full-length transcript has been lost. 
This is because when protein or transcript levels are reduced to below 5-10% of 
their normal (wild-type) levels, such levels may no longer be distinguishable by the 
antibody (for immunoblotting) or the UV spectrophotometer (for RT-PCR/ agarose 
gel electrophoresis); thus falsely indicating a complete loss of protein or normal 
transcript, when this may not be the case. Therefore, it is possible that up to ~5-10% 
of Kal1a full length transcript may be retained in the KA4 morphants embryos that 
appear to show 100% knockdown; which, despite being very low, may, along with 
normal Kal1b, have some residual activity (i.e. above the combined signalling 
threshold of Kal1a+Kal1b). Conversely, using translation-blocking morpholinos, it 
may have actually been possible for other groups to obtain a more complete Kal1a 
knockdown, which made the combined levels of Kal1a+Kal1b for below what is 
required for active Kal1a/Kal1b signalling. Furthermore, in the complete absence of 
Kal1a, Kal1b signalling may be insufficient for normal olfactory/GnRH neuronal 
development; despite having a role at low levels of Kal1a (i.e. when the combined 
Kal1a+Kal1b threshold is high enough). 
However, it was found that Kal1b does have an important role in forebrain 
commissure formation; a role that could not be fulfilled by normal background 
Kal1a gene expression levels in these embryos, although knocking down Kal1a and 
Kal1b together gave more severe defects in AC/POC formation (see below). 
 
Anterior commissure does not form correctly- phenocopying the Fgf8a morphants  
As discussed already in chapter 4, the forebrain commissure defects that are 
observed in Fgf8a morphants may help to explain the role of Fgf signalling in the 
molecular pathogenesis of bimanual synkinesis (upper body mirror movements) 
found in some KS patients with mutations in genes involved in the FGF signalling 
pathway (FGF8 and FGFR1). As Bimanual synkinesis is found in more than 75% of 
patients with KAL1 mutations (Kim et al., 2008), and because anosmin-1 (the KAL1 
gene product) has been implicated as an extracellular modulator of FGFR1 
signalling (in vitro) (Gonzalez-Martinez et al., 2004b), KA4/KB4 morphants were 
assessed for defects in forebrain commissure formation too. Moreover, such 
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analyses also bear direct relevance to the function of the olfactory and terminal 
nerve GnRH neurons which project across the AC (and POC) (Whitlock, 2004). 
Kal1a knockdown resulted in a subtle reduction in the number of axons 
crossing the AC at 36hpf; whereas the Kal1b morphants had a similar phenotype, 
but more of their decussating AC axons were affected. However, knocking down 
both Kal1a and Kal1b together gave the strongest, most penetrant, phenotype at 
36hpf. In most of the KA4+KB4 morphants the AC axons failed to project across 
the midline or mis-projected towards regions of the midline that they would 
normally be excluded from, including towards the POC. Consistent with the 
forebrain defects described for the Fgf8a morphant in chapter 4, the POC was only 
affected in around 15% of the KA4+KB4 morphants. Whilst most of the rescue 
embryos had normal AC and POC formation, a small percentage of embryos had 
fewer AC axons crossing the midline, demonstrating that the forebrain commissures 
defects caused by KA4+KB4 were mainly due to the specific loss of Kal1a and 
Kal1b. By 60hpf, most embryos had at least a few AC axons crossing the midline, 
but many more AC axons were observed in an axonal „tangle‟ at either side of the 
defective commissure, presumably caused by their failure to respond to a guidance 
cue (or absence of said guidance cue) instructing them cross the midline. 
As anosmin-1 has previously been implicated in the FGFR1 signalling 
pathway in vitro, and both KAL1 and FGFR1 mutations result in corpus callosum 
defects in humans (and mice: Fgfr1 only), it may be speculated that the mechanisms 
proposed for the similar AC/POC defects caused by Fgf8a loss (in chapter 4) may 
be the same mechanism occurring in the zebrafish Kal1a/Kal1b morphants. That is 
Fgfr1/Fgf8 signalling at the midline is required for the specification and localisation 
of midline glial structure (a „glial bridge‟) which, by secreting guidance cues, 
permits the correct pathfinding of the AC and POC axons across the midline. The 
exact role of Kal1a and Kal1b in these processes may be as modulators of 
Fgf8/Fgfr1 signalling, a role that has been demonstrated previously in vitro 
(Gonzalez-Martinez et al., 2004b). The putative interaction of Kal1a/Kal1b with the 
Fgf8a signalling pathway is discussed below.  
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However, whilst in situ hybridisation analyses demonstrated that Kal1a and 
Kal1b transcripts are present in cells of the anterior midline during early zebrafish 
embryogenesis, immuno-labelling analyses showed that Kal1a and Kal1b proteins 
are detected only in the elongating AC axons between 24hpf and 60hpf, suggesting 
that Kal1a and Kal1b are more likely to be acting directly on these commissural 
axons, rather than specifying the midline „glial bridge‟ cells. Interestingly, it has 
been demonstrated in the mouse Fgf signalling is involved in more than use 
determining the midline glial structures during commissure formation, as Fgfr1 
hypomorphs have normal midline glial structures, but still have missing/aberrant 
commissures. Therefore, it was proposed that Fgf signalling was also required for 
the elongation/pathfinding of the commissural growth cones. Assuming this is true, 
it can be speculated that Kal1a/Kal1b may be modulating Fgf8a signalling in the AC 
(and to a lesser extent, the POC) and thus altering the pathfinding capabilities of 
these axons. 
The AC defects reported for the KA4+KB4 morphants are consistent with 
the absence of GnRH3-positive AC projections that were reported above. Given the 
importance of the AC in both the olfactory and GnRH systems in zebrafish, which 
both project axons across this commissure, it is likely that loss of the AC may have 
repercussion for the correct functioning and coordination of both system, and 
possibly with their interactions which each other. 
 
5.3.6  Olfactory, GnRH, and commissure phenotypes were 
confirmed by a second pair of morpholinos against Kal1a 
and Kal1b 
A second pair of splice-blocking morpholinos which targeted the loss of 
exon 6 from Kal1a and Kal1b, KA6 and KB6, respectively, was used to further 
confirm the specificity of the forebrain defects caused by Kal1a and Kal1b 
knockdown. Firstly, RT-PCR analysis was carried to confirm the knockdown 
efficiencies of these new morpholinos. KA6 and KB6 were both shown to give 
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Kal1a/Kal1b knockdown levels of close 100%, like KA4 and KB4. The 
predominant PCR product for both morphants was the morphant band comprising 
loss of exon 6; resulting in first-fibronectin domain-truncated mis-spliced proteins 
which are predicted to be inactive due to the functional loss of the essential first 
fibronectin domain.  
Consistent with the KA4+KB4 morphants, the KA6+KB6 morphants had 
defects in AC formation (including fewer GnRH3-positive decussating axons), 
failure in olfactory axons to project correctly to the presumptive olfactory bulb 
region, and hypothalamic GnRH neuronal deficiency. Therefore, all of the major 
forebrain defects caused by KA4+KB4 knockdown were shown to be specific (using 
Kal1a/Kal1b mRNA rescue) and reproducible using a second independent pair of 
morpholinos against Kal1a/Kal1b. Moreover, the use of KA6 and KB6 also 
confirmed that knocking down Kal1a and Kal1b individually does not, in our 
experience, result in the severe, fully penetrant defects in forebrain development that 
were demonstrated by knocking down both genes together.  
 
5.3.7  Kal1a/Kal1b may be acting via the Fgf8a signalling 
pathway in vivo during embryogenesis 
Given the extensive similarities of the forebrain defects caused by Fgf8a or 
Kal1a/Kal1b knockdown, including during formation of the AC; the final 
experiment of this thesis aimed to investigate whether Kal1a/Kal1b may be acting 
via the Fgf8a signalling pathway in these developmental processes. 
Fgf8a or Kal1a/Kal1b were sufficiently knocked down at a morpholino 
concentration of 1mM to cause failure of AC formation; and, if this morpholino 
concentration was reduced to 0.5mM, this effect was then reduced significantly or 
abolished (i.e. AC formation was again normal, excepting subtle defects). However, 
when Fgf8a and Kal1a/Kal1b morpholinos were all co-injected at the same 
concentration of 0.5mM, the phenotype of defective AC formation re-occurred; 
suggesting that Fgf8a and Kal1a/Kal1b were acting via the same signalling pathway 
during AC formation (see Figure 5.21 for a summary of these findings). 
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Figure 5.21   The additive effect of Fgf8a & Kal1a/Kal1b during anterior 
commissure (AC) formation
This schematic diagram summarises the findings from Fig5.20. The level of
Fgf8a and Kal1a/Kal1b expression are indicated by blue and orange bars,
respectively (not drawn to scale). For the purposes of this illustration it is
assumed that Fgf8a signalling levels are insufficient for normal AC formation
without a certain level of Kal1a/Kal1b, which modulates the Fgf8a signalling
levels. The wild-type and morphant groups (1) & (2) have sufficient functional
Fgf8a signalling for normal AC formation (as indicated by arrows); whereas
morphant groups (4), (5), & (6) have Fgf8a signalling levels which are below
the required‟ threshold (green dotted line), and so fail to initiate normal AC
formation.
Active signalling 
threshold
Fgf signalling
Fgf8a
Kal1a/Kal1b
Expression level:
(1) Wild-type:
(2) 0.5mM Fgf8a MO:
(3) 0.5mM KA4/KB4:
(4) 0.5mM Fgf8a MO + 0.5mM KA4/KB4: 
(5) 1.0mM Fgf8a MO:
(6) 1.0mM KA4/KB4:
Normal ACAC defects
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           This data is consistent with the observation in vitro analyses that showed that 
anosmin-1 induces neurite outgrowth and cytoskeletal rearrangements through an 
FGF2/FGFR1-dependent mechanism (Gonzalez-Martinez et al., 2004b). It may be 
speculated that the mechanism is used by Kal1a/Kal1b to initiate/maintain 
commissural axon elongation across the midline during AC formation. Similarly, 
Kal1a/Kal1b may modulate Fgf8a signalling during its proposed role in olfactory 
neurogenesis and GnRH neuronal specification at the nasal compartment (see 
chapter 4); although such a mechanism will need to be investigated further.  
It may also be possible that Kal1a/Kal1b act though another signalling 
pathway which converges downstream with the Fgf8a signalling pathway. Or, Kal1a 
and Kal1b may be acting entirely independently of Fgf8a, perhaps as a directional 
cue for the commissural axons as they cross the midline, at a similar point along 
their navigational route when Fgf8a signalling is also required. Therefore, the 
combined reduction of both the directional cue and signalling activity is sufficient to 
cause aberrant commissure formation. However, given the extensive in vitro and ex 
vivo data supporting the direct action of anosmin-1 on the FGF signalling pathway, 
a more direct role during AC formation seems highly plausible.  
Future work will involve identifying the downstream signalling cascades 
which propagate the Fgf8a and Kal1a/Kal1b signal intracellularly during AC/POC 
forebrain commissure formation, and olfactory/GnRH system development; thus 
allowing novel avenues of investigation into other novel KS disease loci. 
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5.4 Conclusions  
Previous studies have suggested that Kal1a, but not Kal1b, are required for 
hypothalamic GnRH neuronal migration and olfactory axonogenesis in the 
zebrafish; however, experiments carried out in this chapter have cast doubt on this 
assertion. It has been demonstrated in the course of this chapter that Kal1a and 
Kal1b are both required during at least three forebrain developmental processes in 
zebrafish: 1) the GnRH system, 2) the olfactory system, and 3) the forebrain 
commissures (AC and POC); although Kal1b notably had an important individual 
role in AC/POC formation as well. 
During zebrafish GnRH system development, Kal1a and Kal1b are required 
together to ensure that the correct number of GnRH3 cells are accumulated and 
properly distributed at the hypothalamus by 36hpf i.e. a tight cluster positioned at 
the midline, rostral to the POC, and caudal to the pituitary in the G3MC transgenic 
line (termed the „early wave‟ in chapter 3). Moreover, Kal1a and Kal1b are also 
required to ensure that the terminal nerve GnRH cells remains localised between the 
olfactory epithelium and anterior forebrain, and project axons across the AC and 
POC.  
During zebrafish olfactory system development, Kal1a and Kal1b are 
required together for the proper organisation of the olfactory epithelium, by 
maintaining the right number of cells and ensuring they form a typical „rosette‟-
shaped formation. Moreover, Kal1a and Kal1b are also required to ensure that the 
olfactory and vomeronasal axons project to the anterior forebrain in a tightly-
fasciculated bundle, and then defasciculate appropriately in the presumptive 
olfactory bulb region, a necessary pre-requisite for olfactory bulb morphogenesis. 
During zebrafish olfactory system development, Kal1a and Kal1b are 
required together for correct formation of the AC, and to a lesser extent, the POC. 
Loss of Kal1b alone was sufficient to cause these AC defects; however, the loss of 
both Kal1a and Kal1b together resulted in a more severe phenotype, demonstrating 
that both Kal1a and Kal1b are required during forebrain commissure formation. 
When Fgf8a and Kal1a/Kal1b were knocked down together at sub-functional 
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morpholino concentrations, the AC defects were again observed, demonstrating that 
Kal1a, Kal1b and Fgf8a are acting together during the formation of the AC. 
Given that anosmin-1 induces neurite outgrowth in vitro, in an FGFR1-
dependent manner, and that Kal1a and Kal1b are expressed in the forming AC 
projections; it is likely that Kal1a/Kal1b have a direct role in the pathfinding of the 
AC/POC axons across the midline, via their modulation of the Fg8a signalling 
pathway. It is likely that a similar mechanism is used by the terminal nerve GnRH 
axons which also project across the AC and POC. If confirmed, such a mechanism 
may explain the malformation of the commissures (including the corpus callosum) 
in human KS patients with KAL1 mutations, which is a proposed cause of the upper 
body mirror movements seen in more than 75% of X-linked KS patients (Kim et al., 
2008). 
The proposed role of Kal1a/Kal1b in the Fgf8a signalling during forebrain 
commissure axonogenesis may also be similar to the role played by Kal1a/kal1b 
during olfactory and GnRH system development, given that the defects in these 
systems caused by Kal1a/Kal1b or Fgf8a gene knockdown are so comparable. 
However, in the nasal compartment, Fgf8a was primarily implicated in 
olfactory/GnRH neuronal specification (i.e. olfactory/GnRH progenitor 
maintenance), and not olfactory axonogenesis. Therefore, it can be speculated that 
Kal1a/Kal1b, which are expressed in the olfactory placode soon after it first appears 
during zebrafish embryogenesis, modulate Fgf8a signalling during olfactory 
neurogenesis. Assuming the „early wave‟ GnRH3 neurons are also specified in the 
nasal compartment, their failure to reach the hypothalamus by 36hpf may indicate 
that their progenitor cells have been lost due to increased levels of apoptosis, due to 
the reduced Fgf8a signalling that may result from the loss of positive-regulation by 
Kal1a/Kal1b. It remains to be demonstrated whether the „later wave‟ of GnRH 
neuronal migration are similarly affected. 
Loss of Kal1a/Kal1b apparently primarily affected the pioneer neurons 
which establish the olfactory pathway by 36hpf, subsequently denying the 
secondary (ORN) a navigational pathway towards the presumptive olfactory bulb 
region. Yanicostas and colleagues recently reported that there is a severe decrease in 
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the number of GABAergic and dopaminergic olfactory bulb neurons in the Kal1a 
morphant embryos by 5dpf, together with their data showing Kal1a protein 
accumulation in the presumptive olfactory bulbs from around 72hpf (Yanicostas et 
al., 2009), suggest that the absence of differentiated olfactory bulb glomeruli in the 
Kal1a/Kal1b morphants may be the cause of incorrect olfactory bulb 
morphogenesis. In our studies, olfactory projection defects were greater in the 
embryos at 36hpf, compared with later stage (60hpf) Kal1a/Kal1b morphants; 
suggesting that Kal1a/Kal1b had an important role during establishing the pioneer 
olfactory pathway (perhaps by maintaining olfactory neurogenesis at the olfactory 
pit); whereas the secondary olfactory axons may be able to navigate to the 
presumptive olfactory bulbs following an incomplete pioneer pathway. However, if 
this proposal is true, it is unknown whether the glomeruli that are formed by 60hpf 
are precisely formed (and therefore functional); and whether the failure/misrouting 
of the pioneer olfactory pathway affects olfactory bulb morphogenesis, regardless of 
whether the secondary ORNs reach the presumptive olfactory bulb region. 
In summary, it is hypothesised that Kal1a/Kal1b modulate the Fgf8a 
signalling pathway in decussating axons of the anterior commissure in the zebrafish, 
during forebrain commissure formation; and a similar mechanism may be 
responsible for the corpus callosum malformation that is believed to be a cause of 
upper body mirror movements in X-linked KS patients. Kal1a/Kal1b are also 
hypothesised to modulate Fgf8a signalling during olfactory and GnRH neurogenesis 
and/or olfactory/vomeronasal axonal pathfinding and GnRH „early wave‟ neuronal 
migration/specification at the hypothalamus. 
 
.  
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5.5 Future prospects 
To further investigate the underlying cause of the various defects in 
olfactory/GnRH neuronal development and AC/POC formation, several further 
experiments are required.  
Firstly, it will be necessary to use forebrain (and midbrain/hindbrain) 
regional and boundary markers to assess the morphogenesis of the brain region in 
the KA4/KB4 morphants, and ensure that the aforementioned defects are not due to 
a more major failure in brain region formation/specification. However, when the 
morphant embryos were examined there was not any noticeable reduction in head 
size, and brain formation appeared morphologically normal, so defects in brain 
regionalisation/morphogenesis are not expected. For example a loss of specific 
hypothalamic neuronal lineages or regions may cause the loss of GnRH3 neurons 
which may putatively arise from within the developing hypothalamus at 36hpf. 
Secondly, a glial cell marker, such as GFAP, will be required to immuno-
label the „glial bridge‟ in the KA4+KB4 morphants at around 16-20hpf (prior to 
AC/POC formation) to determine whether a loss or disorganisation of the midline 
glial structure is the cause of forebrain commissure formation in the KA4/KB4 
morphants. 
Thirdly, apoptosis (and proliferation) analysis will be required to investigate 
whether there is an increase in cell death at the olfactory epithelium, which may 
suggest that Kal1a/Kal1b may be involved in the Fgf8a signalling pathway that has 
been proposed to maintain the cell survival of olfactory progenitor cells (and 
specification of GnRH neurons) within the olfactory epithelium. 
Finally, the availability of a Kal1a and Kal1b knockout mutant, which has 
permanent loss of functioning Kal1a or Kal1b genes, will greatly assist in 
deciphering whether Kal1a/Kal1b are required for olfactory/vomeronasal 
axonogenesis (and not just olfactory/vomeronasal specification). For example, cells 
from the olfactory placode of a Kal1a/Kal1b knockout mutant (pOMP:tauEGFP 
transgenic) embryo may be transplanted to the olfactory placode of a wild-type 
embryo to see if GFP-positive Kal1a/Kal1b–negative olfactory neurons are able to 
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project axons to the presumptive olfactory bulbs in a wild-type background. If they 
were able to project axons, it would suggest that Kal1a/Kal1b are not required for 
olfactory axonogenesis (at least not within the neuron that they are expressed, 
anyway). Conversely, if the axons fail to project, it would suggest that Kal1a/Kal1b 
are required for olfactory axonal extension/pathfinding. If mutant Kal1a/Kal1b 
knockouts do not become available, these experiments can be done transplanting 
olfactory placodal cells from KA4/KB4 morphant embryos. The same experiment 
can also be carried out using cells transplanted from the olfactory placode of an ace 
embryo, to investigate whether Fgf8a is required for olfactory axonogenesis, as well 
as maintenance of olfactory neurogenesis. 
In the present study, wild-type Kal1a and Kal1b mRNA was used to rescue 
the morpholino-induced phenotypes. However, the plasmid constructs containing 
the wild-type Kal1a or Kal1b coding sequence was specifically mutated, by site-
directed mutagenesis, to generate mutant Kal1a and Kal1b constructs with a KS-
specific single nucleotide change (i.e. one of the following human KAL1 mutations: 
C172R, N267K, or E514K (Kim et al., 2008)). The specific site of these intended 
nucleotide changes was identified by sequence alignment of Kal1a and Kal1b with 
human KAL1 coding sequence. Time-restraints have meant that these constructs 
have not yet been used; however, in future experiments the mutant Kal1a/Kal1b 
mRNA that they encode will be used in Kal1a/Kal1b morphant rescue experiments. 
It is predicted that the mutant Kal1a/Kal1b mRNAs will not rescue Kal1a/Kal1b 
morphant phenotypes, or that the rescue will be incomplete, because they are 
predicted to be loss-of-function mutations. These experiments would thereby 
confirm that the KS mutations are disease-causing because the KAL1 gene product 
is non-functional, and that the mutated amino acid is therefore essential for the 
correct activity of anosmin-1.  
Now that it has been determined that Kal1a/Kal1b are likely to be acting via 
the Fgf8a signalling pathway in vivo, it may now be investigated whether Fgf8a 
mRNA can rescue the AC defects that were observed in the KA4+KB4 morphants; 
thus demonstrating that Kal1a/Kal1b are positive regulators of fgf8a signalling 
during AC formation. However, this experiment will only work if levels of Fgf8a 
ligand  is a limiting factor during AC formation because if functional levels of Fgf8a 
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are maximal, excess Fgf8a ligand will make no difference to the level of fgf8a 
signalling (although Kal1a/Kal1a may potentiate the Fgf8a signalling, even at 
maximum Fgf8a usage). Given the expected role of Kal1a/Kal1b as a modulators of 
Fgf8a signalling, not an Fgf ligand by themselves (Gonzalez-Martinez et al., 2004b), 
it is unlikely that Kal1a/Kal1b mRNA could rescue Fgf8a morphant phenotypes; 
assuming that most of the Fgf8a ligand is lost in these morphants. 
It has been shown previously that Fgf3, like Fgf8a, is another Fgf ligand that 
is required for the formation of the AC and POC. Therefore, it will be interesting to 
ascertain whether or not Kal1a/Kal1b can also act through the Fgf3 signalling 
pathway in the formation of the AC. If so, it would then be logical to find out the 
putative involvement of Fgf3 in olfactory and GnRH system development too; and, 
if so, whether FGF3 mutations are found in KS patients. If Fgf3 morpholinos, when 
titrated down with KA4/KB4 to non-functioning levels, do not give the same result 
as the Fgf8a MO (i.e. AC defects), it will indicate that Kal1a/Kal1b do not signal via 
the Fgf3 pathway, thus permitting Fgf3 to be used as a negative control for similar 
future experiments testing the role of other putative Fgf ligands. 
Up to 30% of KS patients with mutations in the KAL1 gene also present with 
a missing kidney (unilateral renal agenesis) (Kim et al., 2008), indicating that 
anosmin-1 may have a role in human kidney development. In zebrafish, Kal1a and 
Kal1b are expressed in the region of the developing pronephric duct, the zebrafish 
equivalent of a kidney, from around 24hpf onwards (see appendix, Figure A1); 
suggesting that the putative role of anosmin-1 in kidney development is also 
conserved in the zebrafish. A future aim of this project is to investigate the putative 
role of Kal1a and Kal1b during zebrafish pronephros morphogenesis, using various 
early-expressing pronephric markers. 
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Chapter 6: Final Conclusions  
 Kallmann syndrome is a congenital disorder of olfactory and pubertal 
failure, resulting from olfactory bulb dysgenesis and hypothalamic GnRH neuronal 
loss, respectively. These defects are proposed to result from a failure of olfactory 
axons to target the anterior telencephalon, combined with a failure of GnRH neurons 
to migrate into the hypothalamus, during early embryogenesis. 
Broadly speaking, the rostral-caudal distribution of GnRH neurons along the 
ventral telencephalon and diencephalon is evolutionarily conserved across 
vertebrates, including humans, mice, chickens, and zebrafish. However, there are 
some distinct differences in the early ontogeny of the GnRH system in these species. 
Human, chick and mouse embryos exhibit the classical „migratory stream‟ of 
GnRH-immunoreactive neurons detected at their origin in the nasal compartment, 
migrating across the nasal-forebrain junction, and then on into the hypothalamus. 
Whereas, in zebrafish embryos, GnRH-immunoreactive cells are first detected in the 
terminal nerve region (adjacent to the olfactory epithelium), and then much later (in 
comparative developmental staging) in the hypothalamus from around 1-2 weeks 
later.  
However, using a transgenic reporter line which labelled all GnRH3-
expressing cells with a red fluorescent protein, it was possible to detect a much 
earlier hypothalamic GnRH neuronal population, soon after the appearance of the 
terminal nerve GnRH cells at the nasal compartment region. Although the GnRH 
neuronal identity is yet to be verified (i.e. confirmed that they are bona fide 
„endocrine‟ GnRH cells), we have speculated that there may be two „waves‟ of 
hypothalamic GnRH neuronal migration and/or accumulation: one occurring around 
the time of (or before) the olfactory axons reach the anterior forebrain („the early 
wave‟); and a much later „wave‟ occurring after olfactory bulb morphogenesis („the 
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later wave‟). This hypothesis is consistent with observations of two waves of GnRH 
neuronal migration during human embryogenesis. The early wave of GnRH cells 
was detected just rostral to the optic chiasm, and just caudal to (and closely abutting 
with) the presumptive pituitary. 
Whilst the origin of the „later wave‟ of hypothalamic GnRH neuronal 
migration is likely to be within the nasal compartment (from where they then 
migrate into the forebrain); the origin of the proposed „early wave‟ of GnRH 
neurons is less certain. For example, these „early wave‟ GnRH cells may also arise 
within the nasal compartment region and pioneer a pathway into the hypothalamus, 
thus, perhaps establishing the migratory route for the much later wave of GnRH 
neuronal migration. The absence of early GnRH neuronal detection along this 
pathway may simply indicate the absence of GnRH expression of these cells until 
they reach the hypothalamus. Unfortunately, the absence of early GnRH neuronal 
progenitor markers has so far hampered further investigation of this proposal. 
Alternatively, some or all of the hypothalamic GnRH neurons may arise from a stem 
cell population within the diencephalon itself, thus negating the requirement for 
migration of this „early wave‟. However, using pGnRH3:mCherry, the presence of 
mCherry-positive cells within the olfactory epithelium around 30-36hpf may 
suggest that cells within the olfactory epithelium do contribute to the GnRH 
neuronal system in zebrafish.  
The kisspeptin-GPR54 signalling pathway has an important role in the onset 
of puberty in vertebrates. However, when the two GPR54 and KiSS1 orthologues 
were upregulated during zebrafish embryogenesis, there were no observable 
abnormalities in terminal nerve GnRH expression; or premature GnRH immuno-
expression within the hypothalamus. Although, gene knockdown strategies will 
need to be carried out to confirm whether or not kisspeptin-Gpr54 signalling has a 
role in the formation of the GnRH system during zebrafish embryogenesis. 
Two of the autosomal genes which have been implicated in around 10-15% 
of KS cases are FGFR1 and FGF8. Both genes have previously been shown to have 
an important role in olfactory bulb morphogenesis and hypothalamic GnRH 
neuronal development; the two main systems affected in KS patients with mutations 
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in these genes. Moreover, these genes also have a very important role at the midline 
where Fgf8/Fgfr1 signalling has been shown to have a very important role in brain 
commissure formation. 
Zebrafish have two orthologues of FGFR1 (Fgfr1a and Fgfr1b), as well as 
two orthologues of FGF8 (Fgf8a and Fgf8b). Using the zebrafish model system 
which was established in chapter 3, the role of Fgf8a/Fgf8b, as well as Fgfr 
signalling in general, during GnRH/olfactory neurogenesis and forebrain 
commissure formation were further investigated in chapter 4.  
It has been proposed that olfactory bulb morphogenesis is induced by the 
arrival of olfactory axon terminals, which bring about a local Fgf-dependent 
reduction in proliferation (and increase in differentiation), which allows the 
olfactory bulb to evaginate from the anterior telencephalon. Therefore, the accurate 
pathfinding of olfactory axons to the anterior telencephalon is an essential pre-
requisite for olfactory bulb morphogenesis; and it has been proposed that a failure in 
the terminal axonogenesis of the olfactory axons is the cause of olfactory bulb 
dysgenesis in human KS patients. 
Knocking down Fgf8a gene function in the zebrafish resulted in smaller 
olfactory epithelia, combined with fewer and/or mis-projected olfactory axons. 
Similarly, blocking Fgfr signalling between 14-22hpf gave similar defects in 
olfactory axonogenesis; demonstrating that this may be the critical period for Fgf8a 
signalling. It was previously demonstrated in Fgf8 conditional mouse mutants, that 
Fgf8 is required for olfactory neurogenesis in the olfactory epithelium, and that loss 
of Fgf8 in this region results in increased olfactory neuronal cell death. We 
speculate that Fgf8a, which is expressed in the olfactory placodes in zebrafish, may 
also have a role in olfactory neurogenesis, by maintaining the survival of an 
olfactory stem cell population in the olfactory epithelium; however, this mechanism 
is yet to be proven in zebrafish. We propose that the failure and/or abnormalities in 
olfactory axonogenesis in zebrafish may be secondary to the reduction in normal 
olfactory neurogenesis in the olfactory epithelium i.e. the increased cell death, and 
improperly-specified olfactory neurons which may lack their normal olfactory path-
finding apparatus. However, further experiments will be required to assess the 
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specific role of Fgf signalling in the correct navigation of the olfactory axons to the 
anterior telencephalon e.g. by using constructs which cause the loss of Fgf 
signalling in a small subset of olfactory neurons (or single neurons) at the expected 
time of olfactory axonogenesis (around 24hpf). Similarly, transplantation of Fgf-
deficient olfactory epithelial cells to the olfactory pits of wild-type embryos will 
also help us to understand the pathfinding capabilities of Fgf-deficient olfactory 
axons.  
As well as their important role in olfactory bulb morphogenesis, previous 
studies in mice have also shown that Fgf8 and Fgfr1 are required for development of 
the GnRH system; hence, mice which are homozygous for hypomorphic Fgf8 or 
Fgfr1 (but not Fgfr3) have absent or fewer hypothalamic GnRH neurons. Similarly, 
zebrafish Fgf8a morphants also had reduced/absent „early wave‟ hypothalamic 
GnRH cells (the effects on „the later wave‟ are yet to be assessed). The failure of 
normal olfactory axonogenesis in these mouse and zebrafish mutants suggests that 
the loss/reduction of hypothalamic GnRH cells may be caused by the 
abnormalities/loss of the olfactory/vomeronasal axonal „scaffold‟ which they require 
for their migration. However, in the mouse Fgf8 mutant, the GnRH cells never 
emerge from the olfactory pit (i.e. they are not specified); such an absence makes it 
impossible to comment on whether or not they are capable of migrating into the 
hypothalamus. Similarly, absence of the „early wave‟ in the zebrafish Fgf8a 
morphants may signify a failure in the specification at the nasal compartment or in 
the diencephalon. Identification of markers for early GnRH progenitors in zebrafish 
will assist in the investigation of whether or not the hypothalamic GnRH cells are 
improperly specified in the Fgf8a morphants. 
Mice deficient in Fgf8 or Fgfr1 have severe midline defects, which include 
failure of commissure formation. Similarly, zebrafish Fgf8a mutants lack proper 
forebrain commissure formation; as do embryos which have their Fgfr signalling 
blocked between 14hpf and 22hpf. It has been demonstrated in mice that loss of Fgf 
signalling blocks formation of the midline glial structures which have a crucial role 
in guiding commissural axons across the midline; however, Fgf signalling is also 
likely to have a second role in commissural axonogenesis as well, as heterozygote 
Fgfr1 mutants have normal midline glial structures, but still have failed commissure 
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formation. Similarly, it is proposed that the anterior commissure (AC) and post-
optic commissure (POC) in the zebrafish forebrain also require „glial bridges‟ to 
guide their commissural axons across the midline and by „channelling‟ through the 
correct decussation point.  
Although an important role for the second FGF8 orthologue, Fgf8b, during 
GnRH/olfactory neurogenesis and forebrain commissure formation could not be 
established, the failure to completely knockdown Fgf8b gene function means that 
such a putative role cannot be ruled out yet. As such, further Fgf8b morpholinos will 
need to be tested, in order to try and attain an approximately 100% knockdown of 
Fgf8b. 
Kal1a and Kal1b are the two zebrafish orthologues of KAL1, the gene 
implicated in patients with X-linked KS. At the outset of this project, no reports had 
been published using zebrafish (or any other vertebrate) as an in vivo model to study 
the role of Kal1/Kal1b during development. However, during this time period, there 
have been two reports regarding the essential role of Kal1a, but not Kal1b, during 
development of the „endocrine‟ (hypothalamic) GnRH cells and the targeting of the 
olfactory axons to the presumptive olfactory bulb region. However, using different 
morpholino approaches, combined with alternative GnRH and olfactory analyses, as 
well as assessment of the forebrain commissure phenotype, we were able to further 
advance the understanding of the role played by Kal1a and Kal1b during zebrafish 
forebrain development. 
Specifically, we found that, similar to the Fgf8a morphants, Kal1a+Kal1b 
morphants had smaller olfactory epithelia, with absent, fewer and/or aberrant 
projections to the presumptive olfactory bulb region, combined with loss/reduction 
of „early wave‟ hypothalamic GnRH neurons. Moreover, a specific role for Kal1b in 
AC formation was also determined; although, much more severe, fully penetrant, 
defects in AC/POC formation were obtained in the Kal1a+Kal1b morphants. So, in 
summary, we observed that Kal1a and Kal1b are required together for proper 
olfactory/GnRH neuronal development and forebrain commissure formation, using 
splice-blocking morpholino approaches. 
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The defects in forebrain commissure formation seen in the Fgf8a and 
Kal1a/Kal1b morphants are similar to the corpus callosum commissure defects that 
have been reported in some X-linked and autosomal KS patients, suggesting that 
defects in commissure formation may be the source of the upper body mirror 
movements which may be seen in these patients. 
It was previously demonstrated, using in vitro cell cultures, that anosmin-1 
interacts with, and modulates the signalling of FGFR1, which is understood to be 
the main Fgf receptor for Fgf8 during mouse telencephalic development. Together 
with the findings here that Fgf8a and Kal1a/Kal1b expression in the nasal 
compartment overlap during early development, and that the forebrain defects 
caused by their knockdown are similar, suggest that Kal1a/Kal1b may be acting via 
the Fgf8a signalling pathway during olfactory/GnRH neuronal development and 
forebrain commissure formation. If so, this may suggest that Kal1a/Kal1b may be 
modulating Fgf8 signalling in the nasal compartment, and thus, by extension, means 
that Kal1a/Kal1b also have a role in maintenance of olfactory (and GnRH) 
neurogenesis in this region. Similarly, Kal1a and Kal1b may also have a role in 
modulating Fgf signalling during olfactory bulb morphogenesis; as well as during 
midline glial bridge formation and/or commissural axonogenesis. These proposed 
roles, will, of course, need to be investigated further and confirmed.  
In order to try and establish whether Kal1a/Kal1b may be acting via the 
Fgf8a signalling pathway in vivo, Kal1a/Kal1b and Fgf8b morpholinos were titrated 
down to levels where there were no (or subtle) AC defects; and then injected 
together at these concentrations. The data is preliminary, and will need to be 
repeated and confirmed with negative controls, but it does suggest that Kal1a/Kal1b 
are acting together with Fgf8a during AC formation. However, the mechanism of 
action will need to be investigated further.  
Some of the other future aims include utilising behavioural assays to assess 
the actual olfactory and reproductive capabilities of the Kal1a/Kal1b and Fgf8a 
morphants. Also, the molecular/developmental basis of the other occasional defects, 
such as kidney dysgenesis, should also be investigated. 
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Currently, the genes underlying only around 30-40% of KS cases have thus 
far been identified. Future work will involve using the zebrafish model established 
in this project, along with the human KS patient DNA database, to identify the 
remaining 60-70% of causative genes. It is likely that other upstream and 
downstream modulators and effectors of Fgf signalling will be involved; and 
possibly other FGF ligands and/or receptors. Understanding the other genes 
involved in KS, and other hypogonadotrophic hypogonadic disorders may help in 
the identification of novel targets for modulating puberty and/or reproductive 
competency in adults. Furthermore, a better understanding of the Fgf signalling 
pathway, as well as the other molecular pathways required for the development of 
the reproductive and olfactory systems, may prove beneficial for identifying novel 
routes to treatments and diagnosis of other conditions, such as spinal repair and 
some cancers, which also involve the FGF signalling pathway in their pathologies.  
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Appendix 
 
 
Table A1  Optimising the morpholino concentrations  
 
 
 Proportion of embryos dead or with non-specific MO-induced toxicity*  
 
MO   
conc. 
 
MO 
Name 
 
0.5mM 
 
1.0mM 
 
1.5mM 
 
2.0mM 
stage: 
 
36hpf 60hpf 36hpf 60hpf 36hpf 60hpf 36hpf 60hpf 
Fgf8A 
MO 
3/64 
 
4/64 9/72# 12/72# 11/76 15/76 35/53 38/53 
Fgf8B 
MO 
3/51 
 
5/51 7/63 9/63 7/66# 10/66# 16/58 21/58 
A-MO** 2/71 
 
5/71 9/76# 13/76# 17/79 19/79 N/A N/A 
B-MO** 9/85 
 
13/85 19/93# 22/93# 28/74 29/74 N/A N/A 
KA4 8/118 
 
9/118 11/109# 15/109# 16/91 23/91 45/61 46/61 
KB4 11/126 
 
14/126 18/133# 25/133# 36/58 39/58 All 
died 
All 
died 
KA6 4/51 
 
5/51 2/48 2/48 5/47 7/47 4/58# 6/58# 
KB6 5/67 
 
8/67 14/71# 17/71# 41/49 All 
died 
All 
died 
All 
died 
coMO 4/74 
 
6/74 3/69 4/69 2/64# 4/64# 6/56 6/56 
 
* Including significant levels of head/brain/eye/trunk necrosis and heart oedema 
(remaining embryos were morphologically normal or with very minor defects).  
** Translational-blocking morpholinos against Kal1a and Kal1b (refer to text). 
# indicates the morpholino (MO) concentration used for experiments in this thesis.  
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Table A2  Optimising the mRNA concentrations 
 
  
Proportion of embryos dead or with 
non-specific mRNA-induced toxicity* by 36hpf 
 
 
         RNA 
          conc. 
 
RNA 
Name 
 
0.5M
 
1.0M 
 
1.5M 
Kal1a 13/78 
 
 
19/89 68/82 
Kal1b 11/75 
 
 
17/87 31/81 
Kal1a 
+Kal1b 
 
16/96** 
 
 
59/86*** 
ALL DIED 
 
* Including significant levels of head/brain/eye/trunk necrosis and heart oedema 
(remaining embryos were morphologically normal or with very minor defects).   
** 0.5M+0.5M (1.0M total).  
*** 1.0M+1.0M (2.0M total).  
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Figure A1   Anosmin-1a & anosmin-1b immuno-reactivity in the 
pronephric duct
Anosmin-1a (A) and anosmin-1b (B) are both expressed in the pronephric duct
region by around 30hpf. The dotted box in A demarcates the region along the
trunk which is shown in more detail in A‟, with arrows pointing out the
pronephric duct region.
A A’
B
Anosmin-1a
Anosmin-1b
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Figure A2 Anosmin-1a/anosmin-1b immuno-expression in the nasal
compartment
A and B illustrate a single Z-layer of the olfactory epithelium region from a
confocal stack of anosmin-1a and anosmin-1b immuno-labelled G3MC
embryos at 30hpf. This demonstrates that anosmin-1a and anosmin-1b are both
expressed in a broad olfactory epithelial/ nasal compartment region that
includes the terminal nerve GnRH3 -expressing cells.
Anosmin-la/ GnRH3
A B
30hpf 30hpf
Anosmin-lb/ GnRH3
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